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ABSTRACT
Background: Effective case management is a key element of malaria control. Health 
workers’ performance of assessment, diagnosis, treatment and counseling tasks in 
accordance with evidence-based standards is critical to ensure adequate quality of malaria 
case management.
Methods: In children below 5 years, the quality of outpatient case management in 
accordance with national guidelines and factors influencing treatment practices were 
measured. In older children and adults, the quality of clinical assessment, the accuracy of 
diagnosis and the ability of clinical signs and symptoms to predict malaria were 
evaluated. The effects of routine microscopy on malaria case management were described 
across all-age groups. Data were collected from government facilities in 4 Kenyan 
districts, in a series of age-specific surveys using a full range of quality of care 
assessment tools.
Results: The majority (89%) of children with malaria were diagnosed in line with 
national recommendations; however, only 55% of children with uncomplicated malaria 
had recommended treatment prescribed. The assessment and counselling components 
were the weakest parts of the case management. Associations between several 
programmatic interventions (i.e. training, guidelines, wall charts...) and higher quality of 
treatment were demonstrated. In older children and adults, the performance of clinical 
assessment tasks was sub-optimal and massive overdiagnosis (80%) of malaria was 
apparent. Clinical signs and symptoms showed little promise of being able to improve 
health worker’s ability to predict malaria. While routine microscopy might overcome the
II
problem it was characterised by inaccuracy (SEN = 67%; SPE = 61%; PPV = 23%; NPV 
= 92%) and an extremely common practice of ignoring negative results across all age 
groups (67-78%).
Conclusions: As we embark upon a new era of more expensive and more complex to use 
antimalarial treatments, improvement in clinical practice and careful consideration of 
malaria diagnostic strategies are urgently needed. This thesis highlighted the problems, 
suggests some solutions and provides some support for the view that programmatic 
approaches might improve health workers performance if  implemented effectively at 
scale.
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CHAPTER 1:
Introduction and literature review
1.1 Malaria -  the biology of transmission
1.1.1 Malaria parasites
The discovery in 1880 by Charles Louis Alphonse Laveran of the causative organism of 
malaria in a patient with intermittent fever in Algeria was one of the milestones in the 
history of medicine (Wemsdorfer & McGregor, 1988). Malaria is a parasitic disease 
caused by a unicellular protozoan of the genus Plasmodium, family Plasmodiidae, 
suborder Haemosporidiidae, order Coccidia. There are about 120 species of Plasmodium 
found in the blood of mammals, reptiles and birds. Four commonly infect humans: 
Plasmodium falciparum, P. vivax, P. ovale and P. malariae. P. falciparum is the 
commonest species throughout the tropics and subtropics, most prevalent in sub-Saharan 
Africa and is responsible for the greatest part of malaria’s global morbidity and mortality. 
P. vivax has the widest geographical range; it is prevalent in many temperate zones, as 
well as in the subtropics and tropics. P. malariae is focally distributed over the same 
range as P. falciparum but much less common. P. ovale occurs mainly in sub-Saharan 
Africa, but also in the West Pacific (Lysenko & Beljaev, 1969).
1.1.2 Malaria vectors
Mosquitoes of the genus Anopheles were first identified as the vector of malaria in 1897 
in India when Sir Ronald Ross discovered pigmented parasite’s oocysts on the stomach 
wall of an Anopheles mosquito (Wemsdorfer & McGregor, 1988). The subfamily 
Anophelinae belongs to the family Culicidae of the order Diptera and comprises 3 
genera: Chagisa, Bironella and Anopheles. Anopheles is the only genus known which is 
able to transmit human malaria. Of around 430 known species of Anopheles mosquitoes,
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70 are malaria vectors and only 40 are of medical importance (Service & Townson, 
2002). Though most common in tropical and subtropical regions, Anopheles mosquitoes 
have an almost worldwide distribution with different mix of species transmitting malaria 
in various parts of the world.
A group of species with common morphological criteria and line of descent comprise a 
species complex, whose constituent members may differ in their host preference, 
breeding sites, favoured sites for resting or feeding and even their capacity to transmit 
malaria. The An. gambiae complex is the dominant malaria vector in Africa. It is 
comprised of seven species: Anopheles gambiae sensu stricto (s.s.), An. arabiensis, An. 
melas, An. merus, An. quadriannulatus, An. quadriannulatus Species B and An. 
Bwambae (Coluzzi, 1984). The most medically important in the complex are two: 1) An. 
gambiae s.s, a fresh water breeder, predominant in humid areas, preferring feeding on 
humans and resting indoors, and a highly efficient malaria vector, and 2) An. arabiensis, 
a fresh water breeder which bites humans and may rest indoor, but it often feeds on cattle 
and rests outdoors, and is more tolerant of the drier savannah regions. An. gambiae s.s. 
and An. arabiensis are found in 70% of the African continent and An. funestus is the next 
most abundant vector in tropical Africa (Gillies & Coetzee, 1987; Lindsay et al., 1998).
1.1.3 Life cycle of the malaria parasite
A fundamental discovery in the history of malaria occurred in 1898 when Sir Ronald 
Ross and Giovanni Batista Grassi described the complete transmission cycle of 
Plasmodium in birds and humans respectively (Wemsdorfer & McGregor, 1988). All
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malaria parasites develop in two phases and require the presence of two hosts to complete 
their life cycle: the exogenous sexual cycle (.sporogony) develops in their definitive host, 
Anopheles mosquito, and the endogenous asexual cycle (.schizogony) in the human, their 
intermediate host (Figure 1.1). The asexual cycle consists of two phases that take place in 
the blood (<erythrocytic schizogony) and in the liver (exo-erythrocytic schizogony).
Figure 1.1: Life cycle of Plasmodium in man and in the mosquito
('http://www.cdc.gov/malaria/biology/life cycle.htnf)
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1.1.3.1 Sexual cycle of the parasite in the mosquito host
The female Anophelene needs a human blood meal to support production of eggs. After 
ingesting blood, the asexual stages of the parasite are digested together with the red blood 
cells in the stomach of the mosquito while the mature sexual cells (gametocytes) continue
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further development. After completion of the maturation process of the female 
gametocytes and exflagellation process of the male gametocytes, the fertilisation between 
male and female gamete occurs, resulting with the creation of a zygote.
Within 18-24 hours the zygote develops into an ookinete which forces its way through 
the mosquito’s stomach wall, settles down on its outer surface and is now called an 
oocyst. Within each oocyst an average of 1000 sporozoites are produced which burst the 
wall of the cyst and enter the mosquito’s body cavity. Sporozoites find their way to the 
salivary glands of the female Anopheles which now becomes infective and awaits the 
mosquito’s feeding on a vertebrate host. The duration of the sporogony is affected by the 
ambient temperature and can take between 7 days if  the environmental temperature is 
about 31°C, to 20 days if  the temperatures are about 20°C (Wemsdorfer & McGregor, 
1988).
1.1.3.2 Asexual cycle of the parasite in the human host
After the mosquito bites a human host, the sporozoites pass with saliva into the peripheral 
circulation in which they circulate for a short time, usually less than 60 minutes. Many of 
them are destroyed by phagocytes but some invade parenchymal liver cells (hepatocytes) 
where they develop and multiply in a process known as exo-erythrocytic schizogony or 
the tissue phase. Here, sporozoites develop into schizonts that produce large numbers of 
merozoites per hepatocyte (10,000-30,000 depending on the parasite species) and release 
them into the circulation. The liver Kupffer cells ingest much of the released merozoites, 
but some escape and reach the peripheral circulation to invade erythrocytes. They reach
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erythocytes within a few minutes and the invasion takes only about 30 seconds. The 
duration of the tissue phase can be as short as 5.5 days for P. falciparum and as long as 
16 days for P. malariae. P. vivax and P. ovale are able to form a dormant liver stage, the 
hypnozoite, that release merozoites into the peripheral circulation at a later point in time 
and cause relapsing malaria.
The youngest stages of the parasite within the erythrocytes have an annular appearance 
and are known as ring forms. As they grow they become more irregular in shape. All 
early stages of the parasite within the erythrocytes are called trophozoites. They digest 
haemoglobin and leave a pigment called haemozoin that can be seen by microscopy in 
the body of the parasite. Trophozoites multiply asexually to form schizonts within which 
up to thirty merozoites develop and these are released into the blood circulation. 
Merozoites invade young erythocytes, multiply within them and cause their rupture. 
Peaks of fever are coincidental with the ruptures of erythrocytes as a response to the 
release of toxins into the blood circulation. The erythrocytes rupture in synchronised 48- 
hour cycles in P. falciparum, P. vivax and P. ovale infections and in 72 hours cycles for 
P. malariae. A small fraction of merozoites will develop at later rounds of erythrocyte 
invasion into the sexual forms of parasites, the gametocytes, which are taken up by 
mosquitoes during the blood meal to continue the cycle.
1.1.4 Measures of transmission
The underlying principles of malaria transmission dynamics are common to many 
infectious diseases and can be summarised as the probability that a susceptible host
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becomes infected on contact with a pathogen. A variety of mathematical models of the 
probability of transmission have been developed, most have used as their basis those 
developed by Ross and Macdonald (MacDonald, 1957). The most common descriptions 
of the probability of malaria transmission are the basic reproduction rate and the vectorial 
capacity. The basic reproduction rate is defined as the average number of new cases of 
disease that will arise from the introduction of an infective host into a wholly susceptible 
population. Specifically for malaria, the basic reproduction rate is defined as the average 
number of successful offspring that a parasite can potentially produce (MacDonald, 
1957). The vectorial capacity is defined as the mean number of probable inoculations 
transmitted from one case of malaria in a unit of time (Anderson & May, 1992). Intensity y  
of malaria transmission may vary within short geographical distances and over time 
within and between years, the size of variations mainly determined by the time and space 
variations of malaria seasons, local climate and susceptive ecologies for malaria 
transmission.
1.1.5 Describing malaria endemicitv
The term endemicity refers to the intensity of malaria transmission and has been used 
since the 1950s to indicate the amount or severity of malaria in an area. Malaria is 
generally described as endemic when it is normally found in a population, as opposed to 
non-endemic when transmission is non-existent or very sporadic, either in areas that 
never had malaria or in areas where endemic malaria has been eradicated by successful 
anti-malarial interventions. Conventionally, if  malaria disease ceased to be transmitted 
over at least 3 years in area malaria is no longer endemic.
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Endemic malaria transmission may be broadly classified as stable or unstable depending 
on the amount of variation present in malaria transmission over time. Under stable 
endemic conditions, there is a temporal continuation of year-to-year transmission, 
however variation in the amount of malaria may exist within and between years. On the 
other hand, unstable malaria is characterised by great and irregular variability in 
transmission over space and time. Malaria epidemics maybe considered a form of highly 
unstable malaria.
1.1.5.1 Measures of the endemicitv
The entomological inoculation rate (EIR) is the most direct measure used to describe the 
intensity of malaria transmission across endemic areas. EIR is defined as the number of 
infective mosquito bites received per person per unit of time, usually, expressed per year. 
The annualised EIR is the preferred measure of malaria endemicity as it reflects the 
incidence of new infections received by the human population exposed to the local 
vectors. The values of EIR from the various malaria endemic areas of Africa may range 
from one infective bite every 3 years up to several infective bites every night (Hay et al.,
2000). However, given the complexity of data collection, non-standardized methods of 
measurement (Githeko et al., 1996), frequent difficulties in the interpretation of the 
results (Mbogo et a l , 2003) and most importantly the overall paucity of reliable data 
(Hay et al. 2000), the EIR is rarely used as a marker for mapping malaria endemicity in 
sub-Saharan Africa (Rogers et al., 2002).
Other methods, more commonly used to measure malaria endemicity, are the prevalence 
of peripheral blood-stage infections {parasite rate) and the proportion of enlarged spleens 
{spleen rate) in the childhood population. The classification of malaria endemicity based 
on parasite and spleen rates was introduced at WHO conference in Kampala in 1950 and 
later revised in relation to the parasite rate only (Metselar & Van Thiel, 1959). The 
descriptive classification of malaria endemicities and their definitions based on the 
parasite and spleen rates have not changed over the years and are presented in Table 1.1.
Table 1.1: Descriptive classification of malaria endemicity based on parasite and spleen rates
Type Spleen rates Parasite rates
Hypoendemicity Not exceeding 10% in children 2-9 
years
Not exceeding 10% in children 2-9 years 
but may be higher for part of the year
Mesoendemicity Between 11% and 50% in children 
2-9 years
Between 11% and 50% in children 2-9 
years
Hyperendemicity Constantly >50% in children 2-9 
years. Also high in adults (>25%).
Constantly over 50% among children 2-9 
years.
Holoendemicity Constantly >75% in children 2-9 
years. But low in adults.
Constantly over 75% among infants 0-11 
months.
1.1.5.2 Global distribution of malaria endemicity and population
Recently, Hay et al. (2004) and Snow et al. (2005) have reviewed the past, present and 
future of the global distribution of malaria in relation to the population and endemicity 
classes. They have shown that malaria has been markedly reduced in its spatial
|L
distribution during the 20 century and that the global surface of malarious areas was 
decreased by nearly half; from 77.6 million km2 in 140 countries occupying 53.2% of 
global land surface during the pre-control period in 1900, to 39.8 million km2 in 88 
countries occupying 27.2% of land surface in 2002. However, global population growth
tVifrom 1 to 6 billion during the 20 century has resulted in a 2 billion increase in the total 
population exposed to malaria risk. During the 20th century, human efforts to control
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malaria have been most successful at lower endemicity ranges with reductions of the 
epidemic, hypoendemic, and mesoendemic areas of 100%, 66% and 45%, respectively. 
Conversely, there were negligible effects in areas of hyperendemic and holoendemic 
malaria with reductions of only 16% and 0%, respectively.
Today, the global distribution of malaria endemicity indicates that 19.6% of malarious 
areas are hypoendemic, 32.2% are mesoendemic, 31.2% are hyperendemic and 12.6% are 
holoendemic. The majority of the global population at risk live in hypoendemic areas 
(51.2%) followed by mesoendemic (30.0%) and combined hyper-holoendemic areas 
(18.8%). The population living in Africa accounts for only 23.6% of the global 
population at malaria risk, however, within hyper-holoendemic class nearly all (99.7%) 
population at risk is situated on this continent. The distribution of population across 
malaria endemicity is markedly different in Africa compared to other regions. While in 
Africa only 7.5% of the population lives in hypoendemic areas, the same endemicity 
class accounts for 50.1% of population at risk in other parts of the world. Snow et al. 
(2005) estimates of the populations at malaria risk in 2002 across WHO world regions 
and malaria endemicity are presented Table 1.2.
Table 1.2: Populations (millions) at risk in 2002 by WHO region and malaria endemicity 
(Snow et a l 2005)
Population according P. falciparum endemicity classes
Unclass­
ified
Hypo­
endemic
Meso­
endemic
Hyper-holo
endemic
Total population at 
risk
Africa 13.6 39.3 67.4 414.3 521.0
Americas 3.5 43.9 10.5 0 54.5
South East Asia 47.8 827.6 486.0 0.3 1,313.9
Western Pacific 22.4 77.6 63.4 1.0 142.0
Eastern Mediterranean 32.3 143.0 33.4 0 176.4
Europe 1.1 0.3 3.2 0 3.5
World 120.7 1,131.7 663.9 415.6 2,211.3
10
1.2 Burden of malaria
In an effort to define disease-specific mortality rates and aid cross-country comparisons, 
the Disability Adjusted Life Year (DALY) is a widely accepted measure. DALYs are the 
sum of life years lost due to premature mortality and years lived with disability adjusted 
for severity. In 2001, it was estimated that malaria was the eighth largest contributor to 
the overall burden of disease globally, the eighth highest contributor to the global DALY 
and the second in Africa (WHO, 2002a).
1.2.1 Malaria morbidity burden
The global burden of malaria is thought to be between 300 and 500 million clinical cases 
each year, with about 90% of these occurring in sub-Saharan Africa, mostly caused by P. 
falciparum (WHO, 2000a). However, more recent estimates by Snow et al. (2005) 
revealed that there were 515 (range: 300-660) million episodes of clinical P. falciparum 
malaria in 2002, of which 365 million (71%) were in Africa. These estimates are 
significantly higher than those reported previously, reflecting the WHO’s reliance upon 
passive national reporting in countries outside Africa. With regard to the endemicity 
class, the majority (68.5%) of malaria cases worldwide occur in combined hyper- 
holoendemic areas, of which nearly all (99.7%) are in Africa. Snow et al. (2005) 
estimates of the burden of P. falciparum clinical attacks in 2002 across WHO world 
regions and malaria endemicity are presented Table 1.3.
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Table 1.3: P. falciparum malaria cases in 2002 (millions) by WHO region and endemicity 
(Snow et a l 2005)___________________________________________________________
P. falciparum endemicity classes
TotalHypo­
endemic
Meso­
endemic
Hyper + Holo­
endemic
Africa 1.69 11.52 351.77 364.98
Americas 1.89 1.80 0 3.69
South East Asia 35.59 83.11 0.24 118.94
Western Pacific 3.34 10.84 0.85 15.03
Eastern Mediterranean 6.15 5.71 0 11.86
Europe 0.01 0.54 0 0.55
World 48.67 113.52 352.86 515.05
1.2.2 Malaria mortality burden
Worldwide, between 1.1 and 2.7 million people die of malaria each year, of whom about 
1 million are children under the age of 5 years in sub-Saharan Africa (WHO, 2000a). The 
estimates of mortality burden in sub-Saharan Africa have varied between 0.5 and 2 
million malaria deaths each year (Bruce-Chwatt, 1952; Sturchler, 1989; Greenwood, 
1990; Schwartlander, 1997); however, a lot of skepticism has been raised about the 
methodological validity of these approximations. The estimates provided by Snow et al 
(2003a) employed empirical epidemiological measures of mortality risks, structured 
according to age and malaria transmission. It is similar to the approach used previously 
by Snow et a l (1999), which estimated 1 million malaria deaths in sub-Saharan Africa, 
but is cognisant of new data, refined endemicity classifications, broader health 
consequences and temporal effects associated with changing anti-malarial drug 
sensitivity.
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Therefore, the most recent estimates suggested that 1.14 million malaria deaths occurred 
in 2000 in sub-Saharan Africa, of which 64.8% were in children below 5 years of age, 
18.8% in older children 5-14 years and 16.3% in adults above 14 years of age (Snow et 
al., 2003 a).
1.2.3 Indirect burden of malaria infection
There are a number of features of the malaria related burden that are not a result of direct 
and immediate clinical effects of malaria infection but are consequential to malaria 
disease. Patients who survive severe malaria may be left with debilitating sequelae, such 
as neurological or cognitive impairments (Mung'Ala-Odera et al., 2004). In sub-Saharan 
Africa, Snow et al. (2003a) estimated that the number of children impaired each year 
following cerebral malaria is between 2,700 and 3,000 for epilepsy; 7,000 to 7,800 for 
learning difficulties; and 770 to 860 remain with severe deficits including quadriparesis. 
Furthermore, the management of severe malaria anaemia with blood transfusion might 
contribute a further 5,300 to 8,500 HIV related deaths in endemic Africa each year. 
Likewise, the adverse drug reactions, such as hepatotoxicity, agranulocytosis and aplastic 
anaemia, consequent upon managing febrile illness could further contribute a minimum 
of 2,500 deaths.
1.2.4 Burden of malaria in pregnancy
The relation between adverse effects of malaria infection in pregnancy and premature 
births, low birth weight and maternal anaemia is well recognised (Murphy & Breman,
2001). In a review provided by Guyatt & Snow (2001), the median prevalence of severe
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anaemia among pregnant women across sub-Saharan Africa was reported to be 8.2%, of 
which 26% are assumed to be due to malaria. The authors estimated that 400,000 
pregnant , women may have developed severe anaemia as a result of malaria infection in 
1995. Brabin et al. (2001) suggested that malaria-associated anaemia contributes to 3.7% 
of maternal mortality in sub-Saharan Africa or approximately 5,300 maternal deaths 
annually. Furthermore, it has been estimated that between 71,000 and 190,000 children 
will die during the first year of life because they were bom of low-birth weight as an 
indirect result of their mother’s being infected by P. falciparum in 2000 (Snow et al., 
2003a).
1.2.5 Burden of fevers
Patient’s history of fever is the entry point for presumptive diagnosis and treatment 
practices for malaria across Africa, and underpins the basis of case management 
guidelines (Gove, 1997; WHO, 2000a; 2003 a). It should be recognised that not all reports 
of fever are febrile and not all febrile episodes are malaria. However, when examining 
demand for services and commodities such as antimalarial dmgs the incidence of 
perceived fever is more important than the precise incidence of clinical malaria. With this 
caveat in mind it is obvious that the estimates of the burden of fevers would be several­
fold higher than estimates of malaria burden. In 2000, in sub-Saharan Africa, Snow et al. 
(2003b) estimated that the age-structured annual burden of fevers was 850 million in 
children below 5 years of age, 640 million among children aged 5-14 years and 1,350 
million among adults. Currently, when expensive, artemisinin-based combination 
therapies (ACT) are promoted as treatments for malaria, the burden of malaria fevers is
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of critical importance to estimate appropriate volume of drugs and funds required to 
support an effective policy transition.
1.2.6 Economic burden of malaria
To show the effect of malaria on the economic welfare of affected countries, Gallup and 
Sachs (2001) performed a cross-country regression analysis, taking into account initial 
poverty, economic policy, life expectancy, climatic, geographic, and colonial history 
specificities, among other factors. The authors showed that a 10% decrease in malaria 
was associated with a 0.3% increase in the Gross Domestic Product (GDP) per capita 
annually, while countries with intensive malaria had 1.3% lower growth in GDP per 
capita. They also reported that countries that had eliminated malaria experienced 
increased economic growth, while the countries with intensive malaria had income levels 
in 1995 of only 33% that of countries without malaria. Malaria and poverty are thus 
closely connected, however the high levels of malaria in poor countries are not mainly a 
consequence of poverty, but are more determined by climate and ecology.
1.3 Malaria -  description and epidemiology of disease
Malaria is an acute febrile disease with extremely diverse clinical manifestations. The 
severity and course of disease will depend on the species and strain of infecting parasite; 
as well as the age, genetic constitution, state of immunity, general health and nutritional 
status of the patient, and the effects of any chemoprophylaxis or chemotherapy that has 
been used. Although the clinical presentations of malaria differ between species and
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patients, the best-known presentation of malaria, commonly used as the hallmark of the 
disease, is the febrile paroxysm, or “ague attack” as it was described historically.
1.3.1 Classical febrile paroxysm
The classical pattern of the febrile paroxysm has been summarised by Wemsdorfer and 
McGregor (1988) as having three stages. First, there is a cold stage when the patient feels 
extremely cold, clutches at blanket, may shiver and his teeth frequently chatter. The skin 
is usually cold and dry, commonly with goose pimples and cyanotic blueness. The cold 
stage lasts for some 15 minutes to an hour, the temperature gradually rises and the 
shivering eventually ceases. The second stage is the hot stage when the patient feels 
intense heat. The skin is hot and dry, the face is flushed, and the respiratory rate is 
increased. The pulse is full and bounding, and the blood pressure tends to fall. Patients 
may complain of headache, parched throat, thirst, vomiting, restlessness and excitability. 
The progression towards delirium is possible. The temperature may reach 40°C or higher 
and usually remains at about the level reached by the end of the “cold” phase, however, 
sometimes it may rise further and even reach hyperpyrexial levels. Young children may 
develop convulsions. The hot stage usually lasts for two hours or more, finishes with 
peripheral vasodilatation and continues into the third, or sweating, stage. This stage is 
characterised with profuse perspiration and the feeling of relief since the symptoms of the 
previous stage disappear. The temperature then falls and may become within normal 
limits. The patient feels exhausted and usually falls asleep. When he or she wakes up the 
patient may feel well and prepared to continue his/her daily routine. The entire three-
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stage paroxysm lasts some 6-10 hours, and may occur at any time of the day, but usually 
in the late afternoon and in the evening.
The paroxysm coincides with the rupture of mature erythocytic schizonts. The period 
between paroxysms is termed the interval. The interval is determined by the length of the 
asexual cycle. P. falciparum, P. vivax and P. ovale have 48 hours cycle and the 
paroxysms occur on alternate days (or following tertian pattern on days 1 and 3 
according to the ancient Roman way of counting). P. malariae has a 72 hours cycle 
causing quartan paroxysms on days 1 and 4. However, the periodicity of febrile 
paroxysms will develop only if the patient is left untreated and the infection is highly 
synchronized, so that the erythrocytes containing mature schizonts rupture at the same 
time. Furthermore, even at synchronized infections, intermittent fever is usually absent at 
the beginning of the disease when other non-specific symptoms are predominant.
1.3.2 Clinical presentation of P. falciparum malaria in non-immune patients 
The most detailed accounts of the clinical presentation of malaria in non-immune patients 
have been described in the 1920’s when neurosyphilis was treated with induced malaria 
parasites (James, 1931; Shute, 1951; Chemin, 1984). Initially, any species of malaria was 
used for malaria therapy but it soon became apparent that P. falciparum did not adhere to 
the history of the disease followed by other Plasmodium species, and caused much more 
severe disease requiring more patient care (Shute, 1951).
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Several days or hours before the first febrile attack, one or a combination of non-specific 
prodromal symptoms may occur. They can include headache, dizziness, malaise, pains in 
the neck, back, limbs or joints, mild gastrointestinal symptoms (nausea, anorexia, 
diarrhoea and vomiting) and transient fever not exceeding 37.7°C. The classical febrile 
paroxysm followed by an afebrile asymptomatic interval, based on the tertian periodicity 
of the asexual cycle, is unusual. P. falciparum paroxysms tended to be longer, with 
irregular fevers, better described as continuous or remittent. Rarely, the intermittent 
fevers would still have occurred, and if they did, the febrile paroxysms could follow daily 
(quotidian), every third day {tertian) or twice every three days (subtertian) pattern.
A variety of symptoms ranging from mild headache to severe prostration accompanied 
fever in the patients with induced malaria. It was observed that the greater severity was 
not necessarily associated with a higher parasite load, asynchronous infections lead to a 
more severe symptomatology than synchronized ones and the intermittent fevers with 
long intervals were associated with more pernicious signs than fevers with short intervals.
1.3.3 Clinical presentation of P. falciparum malaria in patients living in endemic areas 
Functional immunity acquired by prior infections may modify the classical clinical 
presentation of malaria described previously in non-immune patients. Several 
observational studies have described clinical features associated with P. falciparum 
malaria across a range of malaria endemicities in Africa. Schmitz & Gelfand (1976) 
provided a clinical account from Zimbabwe. They reported age-specific frequencies of 
clinical features among malaria parasitaemic patients, the majority of them (95%) due to
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P. falciparum. Most patients above 7 years of age had fever (93%), headache (73%) and 
splenomegaly (52%). Less common clinical features included vomiting (39%), 
abdominal pains (38%), cough (26%), chest pain (21%), hepatomegaly (19%), diarrhoea 
(17%), general pains (16%), back pain (15%), constipation (14%), leg pain (14%), joint 
pain (13%) and dysuria (12%), among others. In children below 7 years, fever was the 
most common feature (70%), followed by splenomegaly (64%) and hepatomegaly (51%). 
Less commonly, cough (29%), diarrhoea (22%), abdominal pains (15%) and vomiting 
(13%) among the others, were present.
Among adult patients in Tanzania, Mkawagile & Kihamia (1986) reported that headache 
(95%), fever (90%), myo-arthralgia (90%), and nausea and vomiting (15%) were the 
most common symptoms. Basset et al. (1991) described an all age group sample of 
clinically diagnosed malaria patients without parasitological confirmation in Zimbabwe. 
They reported that the most common clinical features were headache (85%), feeling hot 
(73%), body weakness (73%), chills (65%), joint pains (56%) and abdominal pains 
(51%). In Kenya, Freeman (1986) provided a detailed account of the clinical presentation 
among malaria parasitaemic patients across four age groups and two areas of different 
malaria endemicity (Table 1.4).
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Table 1.4: Frequency of malaria signs and symptoms across age groups and two areas of 
endemicities, Nyanza Province, Kenya (Freeman, 1986)______________________________
Mesoendemic Holoendemic
Age (yrs) V4 - 1 Vi 
(%)
l V i - 4 
(%)
5-14
(%)
15-90
(%)
y2 - i  y2 
(%)
i y2 - 4 
(%)
5-14
(%)
15-90
(%)
Fever 100 100 100 81.8 100 93.3 66.7 100
Headache - - - 95.7 - - - 100
Chills 55.9 64.0 88.0 86.9 0 13.3 20 0
Splenomegaly 48.6 57.7 41.7 8.7 70.0 80.0 70.0 0
Anorexia 62.9 57.7 56.0 47.8 30.0 53.3 53.3 50.0
Vomiting 37.1 42.3 40.0 13.0 40.0 6.7 33.3 25.0
Diarrhoea 38.2 46.2 8.0 30.4 40.0 33.3 46.7 25.0
Drowsiness 35.3 34.6 47.8 56.5 0 7.0 6.5 12.5
General malaise 64.5 55.9 78.3 82.6 0 13.3 7.0 50.0
Abdominal pain - - - 55.2 - - - 50.0
Joint pain - - - 78.3 - - - 37.5
Convulsions 8.8 26.9 8.3 0 0 6.7 0. 0
The majority of malaria patients living in endemic areas develop an uncomplicated 
malarial attack and recover either spontaneously without medical intervention or by 
taking antimalarial drugs. However, a small proportion, particularly of non-immune 
children, will progress towards severe disease and may eventually die. The clinical 
presentations of severe forms of P. falciparum malaria are described in the following 
section.
1.3.4 Severe forms and complications of P. falcivarum malaria
Severe P. falciparum malaria is defined by the presence of potentially fatal 
manifestations or complications of malaria in patients with asexual forms of P. 
falciparum for whom other diagnoses have been excluded (WHO, 1986). The other 
functional definition of severe malaria is malaria requiring inpatient care. WHO has 
specified clinical and laboratory criteria for severe and complicated malaria and they 
include the following: coma, severe malarial anaemia, hypoglycaemia, circulatory
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collapse, renal failure, pulmonary oedema, spontaneous bleeding, repeated convulsions, 
acidosis, haemoglobinuria, impaired consciousness, jaundice, prostration, hyperpyrexia 
and hyperparasitaemia (described in Warrell et al., 1990). Most of the recommended 
WHO criteria, however, were not based on observations made in African children, the 
population accounting for 90% of P. falciparum associated mortality.
Marsh et al. (1995) provided the first comprehensive clinical description of severe 
malaria in African children. The authors studied 1,844 children admitted to a paediatric 
ward in a Kenyan hospital with a primary diagnosis of malaria and calculated the 
frequency and mortality rate for each of the clinical and laboratory criteria comprising 
WHO defined severe malaria. The results indicated that the prevalence of WHO criteria 
among children with severe malaria were the following: coma (10.0%), severe malarial 
anaemia (17.6%), hypoglycaemia (13.2%), respiratory distress as substitute for WHO 
criterion of pulmonary oedema (13.7%), circulatory collapse (0.4%), renal failure (0.1%), 
spontaneous bleeding (0.1%), repeated convulsions (18.3%), haemoglobinuria (0.1%), 
impaired consciousness (8.2%), jaundice (4.7%), prostration (12.2%), hyperpyrexia 
(10.6%) and hyperparasitaemia (8.9%).
Furthermore, Marsh et al. (1995) demonstrated that children presenting with clinical and 
laboratory features not including impaired consciousness, severe respiratory distress or 
severe anaemia were associated with very low mortality (0.6%). A striking conclusion 
from this study was that life-threatening malarial disease in African children, as defined 
by poor outcome in the presence of good management, was mostly present within two
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overlapping syndromes: malaria with impaired consciousness and malaria with severe 
respiratory distress. The mortality rate in children with severe malarial anaemia was 
4.7%, but in the majority, who had neither impaired consciousness nor severe respiratory 
distress, it was only 1.3% (Figure 1.2).
Figure 1.2: Prevalence, overlap and mortality for major clinical sub-groups of severe 
malaria in children -  total numbers are in parenthesis and mortality is given as percentage 
(Marsh et a l 1995)
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1.3.5 Epidemiology of malaria disease
One of the most important factors affecting the epidemiology of malaria disease is the 
acquisition of functional immunity caused by the repeated infections during a lifetime. At 
present there are no valid immunological markers to directly relate immune responses to 
the various risks of clinical malaria, however, certain epidemiological features of 
immunity have been examined through the relation between age and various exposure 
patterns of malaria disease.
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1.3.5.1 Pattern of mild malaria by age and transmission intensity
The relation between the age, intensity of transmission and mild malaria morbidity during 
childhood has been summarised by Snow & Marsh (1998). The authors analysed age- 
specific (1-7 years of age) incidence of mild malaria from six areas of different 
transmission intensities in Tanzania, Ghana, Senegal, Sierra Leone and The Gambia. The 
results illustrated two major features: 1) among the populations exposed to high intensity 
of transmission, rates of mild morbidity declined throughout a childhood, whilst the 
incidence of mild malaria in lower transmission settings showed minor age-specific 
variations in the same period; and 2) under all transmission settings, with the exception of 
the holoendemic area, the incidence of malaria was lower in the first year of life 
compared to the second year of life.
Few studies have examined the incidence of mild malaria across all age groups. In 
Senegal, Trape & Rogier (1996) compared the age-specific incidence of mild malaria 
between two markedly different transmission settings. In a high transmission setting (EIR 
= 200) the incidence of clinical attacks peaked in early childhood (age of 2 years) and 
rapidly declined afterwards. However, in an area of moderate transmission (EIR = 20), 
the peak incidence came later (age of 5 years), remained constant during late childhood 
and declined in teenage years and adulthood (Figure 1.3). It might be expected that 
populations living in high transmission settings would have a higher overall incidence of 
malaria than populations living in low transmission areas. Interestingly, despite these 
marked differences, Trape & Rogier (1996) reported from Senegal that the overall 
number of clinical episodes was approximately equal in both areas, and if anything higher
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in low transmission setting. However, these analyses did not examine the clinical severity 
of such episodes and this is the subject of discussion in the following section.
Figure 1.3: Clinical malaria attacks in two areas of differing transmission intensity in Senegal 
(Trape & Rogier, 1996)
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1.3.5.2 Pattern of severe malaria by age and transmission intensity
Snow et al. (1997) presented the age-specific pattern of severe malaria admissions from 
five sites of different malaria transmission intensities in Kenya and The Gambia. The 
childhood prevalence of P. falciparum  infection at these sites ranged from the lowest, 2% 
in Bakau, The Gambia to the highest, 83% in Siaya, Kenya. The prevalence at the 
remaining sites was 37% at Sukuta, The Gambia, 49%, Kilifi North, Kenya and 74% at 
Kilifi South, Kenya. The mean age of paediatric malaria admissions below 10 years of 
age increased from 17 months at two sites of the most intense transmission to 63 months 
at the lowest intensity transmission site.
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At two sites with most intense transmission, the risks of developing severe disease were 
the highest during the first two years of life; thereafter the risks declined rapidly and from 
the age of 3 years remained at a low level of less than 10 episodes/1,000 children/year. 
In areas of moderate transmission, the risks of severe disease peak at the age of one year 
and then declines gradually to a level of about 10-25 episodes/1,000 children/year in the 
5 year olds. In the area of lowest malaria transmission, the disease risk was evenly spread 
throughout childhood at low rates of less than 10 episodes/1,000 children/year.
Consistent with observations of mild disease in Senegal (Trape & Rogier, 1996), an 
overall rate of severe malaria admissions in children 0-9 years old was lower in areas of 
high transmission intensity than in areas of moderate transmission (Figure 1.4). This 
pattern was markedly pronounced for cerebral malaria, notable for low incidence in areas 
of high malaria transmission (Snow et al., 1994). The findings of these studies were in 
accordance with the study in Brazzaville, Congo where the incidence of severe malaria 
was approximately the same across different settings, indeed the lowest in children 
exposed to the most intense transmission (Trape et al., 1987). Here, the critical issue to 
arise is whether the patterns described for mild and severe disease would remain true for 
deaths from malaria in the community. This issue is discussed in the next section.
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Figure 1.4: Incidence of severe malaria admissions per 1000 children aged 1-59 months per 
year from five communities with different malaria transmission intensities (Snow et al., 1997)
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1.3.5.3 Malaria mortality and transmission intensity
Intuitively, it might be expected that the majority o f malaria deaths would occur in areas 
with the highest malaria transmission. However, in a review of 11 studies on malaria 
specific mortality at different levels of transmission, Snow & Marsh (1995) showed that, 
in spite of various limitations of the data, a number of interpretations of malaria mortality 
were possible with regard to the increase of malaria transmission: malaria mortality could 
rise, reach a plateau or fall with increasing transmission.
These observations created considerable debate and a series of analyses of the same and 
additional data followed (Trape & Rogier, 1996; Lengeler et al., 1997; D ’Alessandro & 
Coosemans, 1997; Shiff, 1997; Trape, 1997; Greenwood, 1997). Interpretations of these 
comparative studies can be broadly divided into those which concluded that malaria 
mortality amongst children aged less than 5 years rises linearly with increasing
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transmission intensities and those which showed that initial linear rises in mortality 
saturate under conditions of moderate-to-high transmission.
A more recent addition to this debate was provided by Smith et al., (2001) who reviewed 
published and unpublished data from 1980-1999 and looked at all-cause mortality in 
infants 0-11 months and children 1-5 years of age against an estimate of the intensity of 
transmission as measured by the EIR. The data showed that all-cause mortality in infants 
increased with transmission intensity, however, there was no difference in the mortality 
rate in the children 1-5 years of age with increasing transmission (Figure 1.5).
Figure 1.5: Distribution of all-cause mortality 0-11 months (closed circles) and 12-59 
months (squares) from 20 sites in Africa by the annual P. falciparum  entomological 
inoculation rate (Smith et a l 2001)
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A further recent and comprehensive contribution to this debate was a review provided by 
Snow & Marsh (2002) on 26 studies conducted since 1980 where all-cause mortality 
from 0-5 years was measured, but instead of EIR, the mortality data points were 
categorised according to whether the parasite prevalence rates was less than 25% (low
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transmission intensity), 25-50% (low-to-moderate transmission intensity), 51-74% 
(moderate-to-high transmission intensity) and greater than 74% (high transmission 
intensity). The authors concluded that children living under low intensity of transmission 
have all-cause mortality rates about half of those o f children living under moderate-to- 
high transmission. The second striking observation, consistent with the analysis provided 
by Smith et al. (2001), was that deaths in the first year of life rise linearly with increasing 
exposure to malaria over a wide range of transmission intensities. By contrast all cause 
mortality under 5 years appears to vary very little within a broad range of malaria 
transmission intensities and saturates at relatively low levels of transmission (Figure 1.6).
Figure 1.6: Box plot showing median (central lines), 25%, 75% quartile ranges around the 
median (box width) and upper and lower limits (T) all-cause childhood mortality per 1000 
children aged 0-4 years per annum recorded during the surveillance of communities located 
in (1) areas of low, (2) low-to-moderate, (3) moderate-to-high or (4) high intensity 
transmission (Snow & M arsh, 2002)
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The public health importance of these findings with regard to the interventions that 
reduce exposure to malaria parasites, such as insecticide treated nets (ITNs), has been
28
summarised by Snow & Marsh (2002). The authors concluded that ITNs would have the 
greatest impact when used in areas where burden of malaria is high but the frequency of 
parasite exposure is low-to-moderate. In areas of high transmission, initial reductions in 
mortality may prove difficult to sustain as the reduced level of transmission may still lie 
on the part of the curve where mortality has saturated.
1.3.5.4 Summary of the age impact on malaria infection, morbidity and mortality
In most areas of malaria transmission the age-specific curves of parasite prevalence, mild 
and severe disease, and malaria deaths shift right with increasing intensity of 
transmission if all other factors were held constant. Parasite prevalence peaks in an older 
age group in areas of moderate transmission and much earlier for those in areas of high 
transmission. The rate of mild malaria begins to fall in older ages compared to declines in 
risk of severe malaria. The rates of severe malaria drop very rapidly and there are few 
cases of severe malaria and malaria deaths in older children and adults.
1.4 Malaria diagnosis
Traditionally in clinical practice, a case of malaria is confirmed upon microscopic 
demonstration of Plasmodium parasites in a patient presenting with the clinical features 
of the disease, the most important hallmark being fever. However, in most African 
settings, especially at the periphery of the health care system, microscopic support to 
diagnose malaria is not available and malaria is routinely diagnosed on a clinical basis 
only. In this section the accuracy of current practices in diagnosis of malaria are
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summarised, clinical and laboratory approaches to diagnosis of malaria are reviewed and 
the public health importance of malaria diagnosis is discussed.
1.4.1 Accuracy of clinical malaria diagnosis in Africa -  current practices 
A striking feature of the clinical presentation of malaria in the semi-immune patient is the 
large variety of signs and symptoms that can mimic many other acute febrile illnesses, 
such as pneumonia (Redd et al., 1992; O’Dempsey et al., 1993; Kallander et al., 2004), 
bacteraemia (Akpede et al., 1992; Berkley et al., 1999), typhoid (Richens et al., 1992) 
and bronchitis (Williams, 1940). Given the non-specific presentation of malarial signs 
and symptoms and frequent recommendations suggesting treatment of all fevers as 
malaria (Gove, 1997; WHO, 2000a; 2003a), current health worker practices result in 
significant overdiagnosis of malaria cases. The high rate of overdiagnosis has been 
reported from numerous studies across different age groups across various intensities of 
malaria transmission.
In several studies focusing on childhood populations across Africa (Nigeria, Tanzania, 
Kenya and Senegal), 37-80% of the patients diagnosed clinically as malaria did not have 
a positive malaria smear (Hendrickse et al., 1971; Okeahialam et al., 1972; Freeman, 
1986; Gaye et al., 1989; Nsimba et al., 2002). Similarly, the studies looking at adult 
patients in Tanzania and Malawi reported 52-76% of malaria overdiagnosis (Mkawagile 
& Kihamia, 1986; Jonkman et al., 1995, Font et al., 2001). In several studies including 
patients across all age groups, the overdiagnosis rates were reported to range between 56- 
77% (Stein & Gelfand, 1985; Basset et al., 1991; Font et al., 2001; Bamish, 2002).
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Two studies reported the differences in health workers diagnostic accuracy between 
different malaria transmission seasons. In Niger, the rate of overdiagnosis during the high 
and low transmission season was 46% and 96% respectively (Olivar et al., 1991). Similar 
results were reported from Namibia: 51% of patients were overdiagnosed during wet 
season and 93% during dry season (Bamish, 2002). In Kenya, Freeman (1986) compared 
diagnostic accuracy between two areas of different malaria endemicities and reported 
higher rates of overdiagnosing among all age group patients in holoendemic (67%) 
compared to mesoendemic areas (48%). On the other hand, in children below 15 years of 
age, the frequency of overdiagnosis was equal (37%) between both areas of malaria 
endemicity.
1.4.2 Clinical algorithms for the diagnosis of malaria
As described in the previous section, the problem and magnitude of malaria 
overdiagnosis has been recognised for some time. In response to this problem, several 
research groups have attempted to improve malaria diagnostic accuracy based on signs 
and symptoms alone. Extensive exploration of clinical algorithms has been done 
primarily in children; however, a few studies have investigated clinical predictors of 
malaria among older children and adults. Chandramohan et al. (2002) have provided a 
comprehensive review of the studies investigating clinical algorithms in children. The 
performance of various algorithms suggested by the reviewed studies is presented in 
Table 1.5.
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In most of the clinical predictors studies in children, a malaria case was defined as a child 
with a fever or a history of fever in the presence of malaria parasitaemia. Several studies 
used fever and a cut-off parasitaemia of 5,000 parasites/pl as a gold standard malaria 
diagnosis (Weber et al., 1997; Olaleye et al., 1998; Bojang et al., 2000). The significant 
association between individual clinical predictors and gold standard malaria diagnosis 
(measured as relative risk or odds ratios) was demonstrated for a variety of signs and 
symptoms. However, all signs and symptoms associated with malaria in the univariate 
logistic regression analysis, demonstrated poor sensitivities and specificities on their own. 
The sensitivity and specificity of the clustered groups of the clinical predictors or the 
clinical scores generated, usually improved the accuracy (Table 1.5.); however, no 
malaria case definition or clinical score with the improved specificity had an acceptable 
level of sensitivity to justify withdrawal of an antimalarial treatment in a febrile child 
(Marsh et al., 1996; Chandramohan et al., 2002).
A further complication of the proposed clinical algorithms in children is that their 
performance is usually site and time specific, depending on the intensity of malaria 
transmission and prevalence of other diseases in the community. The most illustrative 
example comes from The Gambia where two studies undertaken in areas of similar 
malaria endemicity and following the same methodology failed to suggest the same 
clinical predictors (Olaleye et al., 1998; Bojang et al., 2000). The predictive values of the 
clinical algorithm improved during the malaria season in Niger (Rougemont et al., 1991); 
but also with the increase of the acute lower respiratory infections in the Philippines 
(Gomes et al., 1994). However, in one study in Ethiopia, it was suggested that the
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algorithms performed better during the low malaria season (Muhe et al., 1999). The poor 
predictive values revealed in the study undertaken in low endemic area in India, 
prompted authors to conclude that the algorithms perform even more poorly in malaria 
low endemic than in high endemic areas (Chandramohan et al., 2001).
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Table 1.5: Clinical algorithms derived for the diagnosis of non-severe malaria in children 
(Chandramohan et a l 2002)_________________________________________________
Country SPR
(%)
Species
(%)
Criteria with the best 
predictive values
Sen
(%)
Spe
(%)
PPV
(%)
NPV
(%)
Tanzania1 59 Pf 97 Pm 3 Intermittent fever 2-3 days 73 98 99 71
Philippines2
67a
37b
Pf 67 
Pv 22 
Mixed 11
History of fever + (chills and/or 
sweating)
55a
50b
79a
89b
84a
77b
46a
70b
Papua New 
Guinea3 73
Pf 55 
Pv 22 
Pm 6
Enlarged spleen + no cough 
Temperature >38°CC
NR
NR
NR
NR
90
46°
NR
NR
Rural
Malawi4 60 Mostly Pf
Rectal temperature >37.7°C or 
nailbed pallor or splenomegaly 85 41 68 64
Gambia5 7 Mostly Pf Chills, sweating or shaking 9394d
19
19d
8
5d
97
99d
Thailand6 24
Pf43 
Pv 50 
Mixed 7
History of fever +headache + no 
cough 51 72 64 59
Ethiopia7
30e
6f
Pf 58 
Pv 42 
Mixed 1
History .of fever+ headache + no 
cough
83e
75f
51e
60f
42e
l l f
87e
97f
Gambia8 39 Mostly Pf Weighted Malaria Score >8‘ Weighted Malaria Score >9‘
88s
61e
64g
82s
65g
728
87g
73g
Gambia9 35 Mostly Pf Weighted Malaria Score >T Weighted Malaria Score >8l
89h
70h
63h
78h
56h
63h
90b
82h
India10
Pf 16 Unweighted Malaria Score >3J 80 37 10 95
7 Pv 83 
Mixed 1
Unweighted Malaria Score >4J 60 61 11 94
Among children enrolled at home;b Among children enrolled at the study clinic;
c Predictive values refer to diagnosing malaria with parasite density >10,000/pl; 
d Predictive values refer to diagnosing malaria with parasite density >5000/pl; 
e Parasite prevalence and predictive values refer to high transmission season; 
f Parasite prevalence and predictive values refer to low transmission season; 
g Predictive values refer to malaria with temperature >38°C plus parasite density >5000/jil; 
h Predictive values refer to malaria with temperature >37.5°C and parasitaemia >5000/pl;
1 Weighted Malaria Score was calculated from the following nine predictors: Sleepy, reduced feeding, 
absence of cough, shivering, feels hot, cough not heard, pallor of palm, absence of rash, increased 
respiratory rate. Each predictor was given a score of 1 if present and 0 if absent except feeling hot which 
was given 3 if present and 0 if absent.
J Unweighted Malaria Score was calculated from the following 10 predictors: chills, feeling cold, vomiting 
absence of cough, absence of runny nose, absence of diarrhoea, feels hot, palpable spleen, palpable liver, 
axillary temperature >3.7°C. Each predictor was given a score of 1 if present and 0 if absent.
1 Rooth & Bjorkman (1992);2 Gomes etal. (1994);3Genton etal. (1994);4Redd etal. (1996);5 Weber et 
al. (1997); 6 Luxemburger et al. (1998);7 Muhe et al. (1999);8 Olaleye et al. (1998);9 Bojang et al. (2000);
10 Chandramohan et al. (2001).
SPR = slide positivity rate (>1 parasite of any species); Sen = sensitivity; Spe = specificity; PPV = positive 
predictive value; NPV = negative predictive value; Pf = P. falciparum', Pv = P. vivax; Pm = P. malariae; NR 
= not reported
Only four studies have investigated clinical predictors in adult patients while only one 
focused on older children. In patients above 15 years of age in a low endemic area of
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India, Chandramohan et al. (2001) proposed a model including the following predictors: 
chills, feeling cold after an episode of fever, feeling hot to touch, temperature > 37 °C, 
vomiting, palpable spleen, palpable liver, absence of cough, absence of diarrhoea and 
absence of runny nose. The best performing clinical score of 5 demonstrated poor 
sensitivity (55%) and specificity (58%).
In the same age group in a holoendemic area of Papua New Guinea, Genton et a l (1994) 
reported that the absence of cough and normal stools were the only predictors associated 
with a positive blood slide, while only vomiting was associated with parasitaemia 
>10,000 parasites/pl. In a holoendemic area in Tanzania, Oster et al. (2000) observed 
among adult patients that some of the clinical criteria such as difficulties in breathing, 
sore throat, chest pain and cough, abnormal chest sounds and enlarged lymph nodes were 
associated with a diagnosis other than malaria, however the sensitivities of predictors 
presented were generally unsatisfactory (range: 17-55%).
In an area of moderate malaria transmission in Kenya, Mwangi et al. (2005) suggested 9 
clinical predictors in older children (5-14 years) and only 3 predictors in adults (>14 
years). The predictors associated with malaria diagnosis in older children were: 
temperature >37.5°C, shivering, vomiting, normal chest sound, absence of rhinitis, cough 
not heard, absence of wounds, absence of rashes and palpable spleen. Three predictors 
associated with malaria in adults were: patient hot on palpation, joint pains and absence 
of chest pain. Individually, all predictors in both age groups had either poor sensitivities 
or poor specificities when cross-tabulated with malaria diagnosis. In older children the
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best performing score of 5 had a sensitivity of 86% and a specificity of 72%, performing 
better than the best performing score of 2 in adults (sensitivity of 29% and specificity of 
84%).
The conclusion of most studies that have explored clinical algorithms across all age 
groups and different areas of malaria endemicity is that the validity of malaria diagnosis 
based on signs and symptoms is largely unsatisfactory and that laboratory confirmation is 
required to improve diagnostic accuracy.
1.4.3 Laboratory methods for diagnosis of malaria
The major laboratory methods for diagnostic confirmation of malaria include light 
microscopy, fluorescence microscopy, detection of specific nucleic-acid sequences and 
rapid diagnostic tests (RDT). The light microscopy and RDTs are the methods that have 
potential for widespread routine use in Africa and are described in the following sections.
1.4.3.1 Light microscopy
Conventional light microscopy, using blood obtained from a finger prick and examining 
both, the thick and thin blood smear is an established method for the laboratory 
confirmation of malaria. Giemsa staining is recommended as the standard method, 
Field’s stain is an option (Lema et al., 1999), and both methods are superior to Wright’s 
stain (Haditsch, 2004). The thick blood smear concentrates the layers of red blood cells 
and improves the detection of low parasitaemias compared to the thin blood smear; 
however, the thin blood smear is preferred method for the routine differentiation of
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parasite species (Moody, 2002). By examining the thick blood smear, the experienced 
microscopist can detect as low as 5-10 parasites per pi, however, under routine field 
conditions the detection of 100 parasites per pi is a more realistic target (WHO, 2000b).
To estimate the parasite density, a parasite count per 1 pi of blood using the standard 
value of 8000 white blood cells (WBC) is a recognised method (Moody, 2002). Counting 
the number of parasites present until 200 WBC have been seen and then multiplying the 
number of parasites by 40 will give the parasite count per pi. Another method includes 
counting the number of parasites in 100 fields and multiplying by four to give parasites 
per one pi, assuming a blood volume of 0.25 pi per 100 microscopic fields (Kilian et al.,
2000). A simpler plus system method for enumerating parasites and indicating the 
relative parasite count should be used only when it is not possible to undertake a parasite 
count per pi of blood (WHO, 1991). The plus system results should be reported as 1-4 
codes according to the following definitions:
+ = 1-10 parasites per 100 thick-film fields 
++ = 11-100 parasites per 100 thick-film fields 
+++ =1-10 parasites per thick-film field 
++++ = more than 10 parasites per thick-film field
The parasitaemia may also be estimated in the thin blood smear by calculating the 
number of parasitised red blood cells (RBC) seen in 10,000 RBCs and expressing the 
number of parasitised cells seen as a percentage (Moody, 2002). While microscopic
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examination is accepted as the current gold standard method for the diagnosis of malaria, 
there is no accepted single standard method for the quantification of parasites. If the 
comparisons between parasitaemias are to be made it is of paramount importance that 
exactly the same methods are applied for their quantification.
Although microscopy is a sensitive, informative and inexpensive method, and recognised 
as a gold standard method for malaria diagnosis, it is also labour-intensive and time- 
consuming, depending absolutely on good techniques, reagents, microscopes and, most 
importantly, well trained and supervised technicians (WHO, 2000b).
1.4.3.2 Rapid diagnostic tests
Malaria rapid diagnostic tests (RDT) are lateral flow immunochromatographic tests, 
which are based on the capture of parasite antigen from peripheral blood using 
monoclonal antibodies prepared against a malaria antigen target. Malaria antigens 
currently targeted by RDTs are: 1) histidine-rich protein II (HRP-II) produced by 
trophozoites and young gametocytes of P. falciparum (Shiff et al., 1993); 2) parasite 
lactate dehydrogenease (pLDH), an enzyme produced by all blood stage parasites (Piper 
et al., 1999); and 3) Plasmodium aldolase, an enzyme produced by all four species 
(Moody, 2002).
The first malaria RDT marketed was ParaSight F test, an HRP-II-based assay capable of 
detecting P. falciparum (Shiff et al., 1993). Today, at least 25 branded products are 
commercially available, the majority targeting P. falciparum alone (WHO, 2003b). Some
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1RDTs are capable of distinguishing between P. falciparum and non-P. falciparum 
species, however, they do not differentiate non-P. falciparum species from each other, 
and mixed infections of P. falciparum and non-P falciparum species from P  falciparum 
monoinfections. The persistence of HRP-II antigenaemia after malaria therapy has 
limited the use of this antigen for the clinical monitoring of the therapeutic response 
(Humar et al., 1997; Wongsrichanalai, 2001); however, pLDH-based assays representing 
only viable parasites have overcome this problem and its detection was closely related to 
the microscopic demonstration of the parasites (Moody, 2002). Semi-quantitative 
correlation between the RDT band intensity and level of parasitaemia has been observed 
for both HRP-II and pLDH tests; however, the variability was considerable (Forney et al., 
2001; Craig et al., 2002; Mason et al., 2002).
The early studies evaluating the accuracy of RDTs showed promising results (Beadle et 
al., 1994; Garcia et al., 1996; Palmer et al., 1998; Quintana et al., 1998). The systematic 
reviews of the earlier studies generally agreed that RDTs are capable of detecting P. 
falciparum with sensitivities >90% and with specificitity close to 100% at parasitaemias 
higher than 100 parasites/pl of blood (Hanscheid, 1999; Wongsrichanalai, 2001; Moody, 
2002).
In more recent studies, however, the variability of the RDT performance characteristics 
significantly increased, both within and between RDTs. Murray et al. (2003) reviewed 
the studies undertaken after 2000 and reported that the sensitivity for detection of P. 
falciparum ranged from 35-97% with specificities of 77-100%; for P. vivax or non-P.
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falciparum species the variability in the sensitivities was even greater (range: 2-97%) 
while specificity ranged from 97-100%. It has been thought that the recent poor results 
may reflect increased exposure of RDTs to the environment during the transport and 
storage, poor quality of RDTs perhaps as result of scaling up to larger manufacturing lots, 
but also the fact that researchers may now be more willing to publish poor results (WHO, 
2003b).
Although, the accuracy of RDTs is the most important parameter and further refinements 
in this aspect are required by the industry, there are several advantages of RDTs over 
traditional microscopy. RDTs do not require electricity, special equipment or complex 
health worker training. Several studies have shown that volunteer health workers can be 
successfully trained to perform tests correctly (Bell et a l , 2001; Cho-Min-Naing & 
Gatton, 2002). RDTs are relatively robust, simple to perform and interpret, and the 
interpretation of the results varies relatively little among the individual users. WHO 
(2000b) summarised comparative advantages and disadvantages between the light 
microscopy RDTs and they are presented in Table 1.6.
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Table 1.6: Comparison of the requirements, performance, direct costs and technical 
specifications of microscopy and RDTs (WHO, 2000b)________________________
Microscopy RDTs
Requirements
Equipment Microscope None
Electricity Preferred None
Supplies Blood collection, staining reagents and supplies, water
Blood collection, staining 
(supplied in some kits)
Training Trained microscopist Minimal training
Performance
Test duration Minimum 60 minutes 15-20 minutes
Labour intensiveness High Low
Subjectivity High Low
Robustness Average High
Direct costs
Cost per test 0.12-0.40 USD 0.60-2.60 USD
Technical specifications
Detection threshold 5-10 parasites/pl of blood 40-100 parasites/pl of blood
Quantification Possible Not possible
Differentiation between 
non-P. falciparum species 
Differentiation between 
sexual and asexual stages
Possible
Possible
Not possible 
Not possible
Detection of P. falciparum 
sequestered parasites No Yes
Antigen persistance Not applicable Some RDTs
RDT = rapid diagnostic test
1.4.4 Public health importance of malaria diagnosis
Misdiagnosis remains a major contributor to malaria morbidity and mortality 
(Ghebreyesus et al., 1999); therefore, an early and accurate diagnosis is a key element of 
effective malaria case management (WHO, 2000a). However, the two diagnostic 
approaches traditionally used, clinical and microscopic malaria diagnosis, are not 
anymore entirely satisfactory. As described previously, clinical diagnosis inevitably 
results in overdiagnosis and overtreatment of malaria. This has been an acceptable and 
cost-effective practice during the era when cheap and safe first-line drugs, such as 
chloroquine and sulfadoxine-pyrimethamine were highly effective. However, the
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introduction of new, more expensive and more complex to use drugs such as Artemisinin- 
based combination therapies (ACT), challenge the appropriateness of clinical diagnosis 
and increase the importance of minimising unnecessary drug use (WHO, 2001a). 
Furthermore, it has been argued that unnecessary use of antimalarial drugs may lead to 
the increased selection of drug-resistant parasites, however, this remains to be proven, 
since no data exist to date to quantitatively correlate patterns of drug use with the 
emergence of resistance.
Microscopic diagnosis of malaria has been seen as a potential tool to reduce the number 
of treated individuals but, in high malaria endemic areas, does not necessarily overcome 
the problem of asymptomatic, coincidental malaria parasitaemia in a febrile patient sick 
for another reason (Greenwood et al., 1987; Armstrong-Schellenberg et al., 1994). In 
Malawi, the introduction of microscopes into a hospital decreased significantly the 
number of unnecessary antimalarial prescriptions in adults and produced annual savings 
of 3% in the drugs budget for the hospital (Jonkman et al., 1995). However, during the 
study in Malawi all clinicians strictly adhered to the recently introduced guidelines, 
prescribing antimalarial drugs only to the parasitaemic patients. In the studies performed 
under routine practice conditions in Kenya, Zambia, Benin and Tanzania, the introduction 
of microscopy did not change significantly the clinical diagnosis of malaria as 30-87% of 
patients with a negative blood slide still received antimalarial treatment (Barat & Kramer, 
1999; Barat et al., 1999; Holtz & Kachur, 2000; Makani et al., 2003). Furthermore, it has 
been shown from several countries that the quality of malaria microscopy including the
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accuracy of blood slide readings has been difficult to maintain in remote and poorly 
resourced areas (Durrheim et al., 1997; Kachur et al., 1998; Barat et al., 1999).
The role of RDTs in Africa has been recently summarised by Bell (2004). The usefulness 
of RDTs in malaria case management will depend on whether the level of misdiagnosis 
can be reduced and the cost savings accrued by health services and patients. The cost- 
benefit ratios will depend on the cost of the RDT, the cost of the treatment, parasite 
prevalence, and the effect of the RDT on treatment practice. It is likely that the impact of 
RDTs would be higher in areas of lower malaria endemicity; if  a high proportion of 
febrile patients have parasitaemia, the additional cost of diagnosis may not be recouped 
through the treatment saved. Similarly, the usefulness of RDTs is likely to be higher in 
malaria less-vulnerable adult patients where the incidence of disease is generally lower 
than in children (Snow & Marsh, 1998). Furthermore, the RDTs should overcome the 
problems experienced with microscopy where clinicians commonly ignore negative 
malaria slides. It is believed that the clinicians’ confidence in malaria diagnosis using 
RDTs might be better maintained if the tests with high sensitivities are used and the 
quality assurance process is ensured from the procurement to the point of use (WHO, 
2003b).
In conclusion, during an era of malaria case management where confirmatory diagnosis is 
urgently needed, malaria RDTs should be considered as a means of extending parasite- 
based diagnosis to areas where good quality microscopy cannot be maintained. However,
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the cost-benefit impact of RDTs should be carefully evaluated in prospective, operational 
trials, randomised on the basis of the diagnostic strategy applied.
1.5. Malaria case management recommendations
Various international and national guidelines, clinical algorithms, wall charts and 
technical reports provide recommendations addressing specific components of malaria 
case management. Although the content and terminology used in different documents 
varies, the major components of the clinical process important for malaria case 
management can be classified into four areas: 1) clinical assessment, which includes 
history taking and clinical examination; 2) diagnosis, including the classification of 
malaria and the use of laboratory support; 3) effective treatment; and 4) adequate 
counselling and drug dispensing. Furthermore, some or all of the case management 
recommendations are commonly provided with regard to the particular patient groups 
(children, adults, pregnant women, travelers), intensity of malaria transmission (high 
endemic, low endemic, epidemic), severity of disease (uncomplicated, severe), type of 
management required (outpatient, inpatient, pre-referral) and level of care available 
(referral hospital, district hospital, peripheral health facility, facilities with available 
laboratory support, community level). Many of these classifications overlap and the terms 
are used interchangeably. In this section, the malaria case management recommendations 
presented focus broadly on the management of malaria at the outpatient, health facility 
level with the distinction of specific age groups where possible or appropriate.
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1.5.1 Recommendations on the clinical assessment
The recommendations on the clinical assessment tasks are reflected in several 
international and national guidelines (Gove, 1997; MoH, 1998; 2000a; WHO, 1996a; 
2003a). The primary goal of the evaluation of a patient with suspected malaria was 
distinguishing between uncomplicated and severe disease (WHO, 1996a). According to 
WHO, the assessment should include: 1) basic clinical examination (assessment of 
“central nervous system function, including presence or history o f  convulsions and 
mental s t a t u s assessment of “respiratory distress checking for respiratory rate, nasal 
flaring, chest indrawing, grunting, deep breathing and the use o f accessory muscles o f  
re sp ir a tio n assessment of hydration status; assessment of hyperpyrexia by measuring 
temperature; and assessment of “anaemia, either by laboratory testing or by clinical 
signs such as palmar, nailbed or conjunctival pallor"); 2) assessment o f uwhether the 
patient can take oral medications"; and 3) determination “whether the patient has 
received previous antimalarial treatment”.
Similarly, the Kenyan National Malaria Control Programme’s (NMCP) guideline (MoH, 
1998) emphasises early recognition of severe malaria in children recommending 
assessment of the following signs at the outpatient level: “prostration (child cannot sit up 
i f  old enough or cannot feed in a younger child), impaired consciousness (using Blantyre 
coma scale) and respiratory distress (rapid deep breathing or chest indrawing)”. Very 
little is recommended by this guideline for the assessment tasks for uncomplicated 
malaria. The guideline states that “history o f clinical symptoms, previous drugs and travel
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should be taken to guide diagnosis and treatment o f  uncomplicated malaria at outpatient 
level ”.
The recent WHO guideline for the African Region (WHO, 2003 a) is more specific with 
regard to uncomplicated malaria and recommends that the assessment should include a 
complete history of common malaria symptoms such as: “fever, history o f  fever, chills, 
headache, joint pains and anorexia. In addition, the age, place o f residence, recent 
history o f  travel, previous treatment and other illnesses should be noted. In children 
refusal to eat or feed, decreased activity and other symptoms may be present”. 
Furthermore, the patients with severe malaria should be assessed for “extreme weakness, 
change in behaviour, convulsions, drowsiness, fast breathing, colour o f urine, pregnancy, 
time o f last drink or food”. The physical examination of the same patients should include 
the following assessment: “palmar and conjunctival pallor (anaemia), behaviour change, 
coma and convulsions (cerebral malaria); sweating, weakness and cold skin 
(hypoglycaemia); pulmonary oedema and acidotic breathing (breathing difficulties); 
spontaneous bleeding from gums, skin and venepuncture sites; dark urine and yellowness 
o f conjunctiva and palms (severe jaundice)”.
Malaria specific guidelines traditionally use a classified disease (uncomplicated or severe 
malaria) as an entry point to describe clinical features of malaria and provide the 
assessment recommendations. However, a major weakness of such approach, limiting its 
practical use as a job aide, is that patients do not present with classified disease but with
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signs and symptoms either spontaneously reported by a patient, or requiring active 
identification by the health worker. This has been recognised by the IMCI guidelines.
Both the IMCI guidelines (generic and Kenyan specific) provide the most comprehensive 
and explicit recommendations with regard to the performance of the assessment tasks in 
children (Gove, 1997; MoH, 2000a). The IMCI uses an integrated approach to the sick 
child and specifies assessment tasks that should be performed for each sick and febrile 
child aged 2-59 months during their initial visit to a health facility. Among the other 
assessment tasks, each sick child should be assessed for palmar pallor, and the presence 
of the following general danger signs should be determined: “i f  child is able to drink or 
breast feed, does the child vomit everything, has the child had convulsions and i f  the 
child is lethargic or unconscious”. The assessment of all febrile children (defined as 
history of fever, hotness of body or temperature >37.5°C) in the absence of any general 
danger signs should include: “decision on malaria risk (high or low, based on an 
arbitrary threshold o f 5% childhood fevers due to malaria); determination o f  duration o f  
fever; every day presence offever iffever present more than 7 days; presence o f measles 
in the last three months; presence o f stiff neck, runny nose and signs o f measles”. Such an 
integrated approach to the sick child is not malaria specific, however, it assures 
systematic clinical assessment of most of the signs and symptoms related to severe 
malaria in children and provides a clear basis for further clinical decision making in the 
management of uncomplicated malaria.
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In conclusion, various international and national malaria case management guidelines use 
different formats and terminology to provide recommendations with regard to the 
performance of assessment tasks. The content of recommendations are rarely harmonised 
between guidelines, the instructions are commonly ambiguous and incomplete, and clear 
and explicit assessment recommendations for adult patients are almost non-existent. The 
most explicit instructions are provided by IMCI guidelines; however, these guidelines 
only refer to the children below 5 years of age.
1.5.2 Recommendations on malaria diagnosis
Malaria diagnosis is a key element of malaria case management and all guidelines 
provide instructions on how malaria should be diagnosed in variety of clinical settings 
(Gove, 1997; MoH, 1998; 2000a; WHO, 1996a; 2000a; 2003a). Broadly, most of the 
guidelines differentiate recommendations for clinical malaria diagnosis from parasite- 
based diagnosis.
1.5.2.1 Recommendations for clinical malaria diagnosis
The IMCI guideline is the only one that does not advocate the use of microscopy and 
ignores its use in algorithms for the diagnosis of malaria in children at the outpatient level 
(Gove, 1997; MoH, 2000a). In areas of high malaria endemicity, IMCI recommends for 
all children aged 2-59 months during the initial visit, “diagnosis o f  malaria based solely 
on the presence o f  fever (which includes history o f  fever, feels hot, or a temperature >  
37.5 °C)”. In low endemic areas, ‘ fever in the absence o f measles, running nose or any 
other identifiable cause o ffever” presents a clinical indication to diagnose malaria. In
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both areas of endemicity, if  a child, previously diagnosed as having malaria, comes back 
to the facility for “follow up visit with fever (persistent fever after 2 days or return within 
14 days), malaria treatment failure is diagnosed in the absence o f any cause o f fever 
other than malaria". A child presenting during initial or follow up visit with “any general 
danger sign or stiff neck", regardless of the level of malaria endemicity, should be 
classified as having “very severe febrile disease", should receive pre-referral 
management including antimalarial treatment and be sent to hospital urgently.
The WHO guideline for the African Region (WHO, 2003 a) does not make any age 
distinction for diagnosis of uncomplicated malaria at peripheral facilities, uses an IMCI 
approach based on malaria risk and recommends that “malaria should be clinically 
diagnosed in any patient who has fever or history o f fever in the previous 48 hours in 
high malaria risk areas”', while in low risk areas “other causes o f  fever should be 
considered before treatment is started”. Furthermore, a clinical diagnosis of severe 
malaria should be made “based on history, general danger signs and features o f  any o f 
the signs o f severe disease in the absence o f signs o f alternative diagnosis ”.
Specifically for older children and adults, the latest WHO Expert Committee on Malaria 
(WHO, 2000a) suggests that in high endemic areas “the sole criterion to diagnose 
malaria clinically in older children and adults is a history o f  fever, however absence o f 
alternative explanation for the fever may be useful, especially in drawing attention to 
other conditions that may need to be treated”. The same committee states that in low 
endemic areas “the absence o f an alternative explanation o f fever has been
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recommended, but there is need for more local clinical epidemiological research on 
specific criteria for the diagnosis o f m a l a r ia The Kenyan malaria specific NMCP 
guideline provides only a small section for children aged above 5 years and adults. In 
this age group clinical diagnosis of malaria is recommended in patients with “fever or 
history o f  fever, chills, rigors, headaches, joint aches and pains in the absence o f other 
causes offever” (MoH, 1998).
In summary, most of the recommendations for children below 5 years of age equate 
presence of fever with malaria diagnosis in areas of high malaria endemicity. In areas of 
low endemicity and in older children and adults regardless of the level of endemicity, it 
appears that all guidelines recognise the importance of identifying other causes of fever, 
yet none of them, with the exception of IMCI guidelines, clearly state how this criterion 
should be used and what signs and symptoms present an alternative explanation of fever.
1.5.2.2 Recommendations for parasite-based diagnosis
The majority of international and national malaria specific guidelines promote the use of 
microscopy wherever it is possible (WHO, 1996a; 2000a; 2003a; MoH, 1998). When 
microscopy is available, the diagnosis of uncomplicated malaria is commonly 
recommended for the patient presenting with “history o f fever and positive blood smear ” 
(WHO, 2003a), or in patients with “parasitaemia and any o f the clinical features o f  
malaria and no sign o f  severe or complicated malaria ” (MoH, 1998).
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However, the guidelines rarely specify clinical indications for the use of microscopy; 
some provide non-specific recommendations suggesting its use in case of clinical 
suspicion (WHO, 2003a), yet no guideline has provided explicit signs and symptoms 
indicating malaria microscopy in different patients groups or areas of endemicity. 
Furthermore, most guidelines are ambiguous with regard to the interpretation of blood 
smear results. For example, the Kenyan NMCP guideline states that “in certain cases a 
slide may be negative even when the patient has malaria and conversely, malaria 
parasitaemia may not be the cause o f the presenting illness” (MoH, 1998). Similar 
recommendations can be found in international guidelines. The WHO guideline states 
that “the presence o f  signs and symptoms o f disease with negative blood smear does not 
preclude the diagnosis o f  malaria, particularly in endemic areas with high transmission ” 
(WHO, 2003a). Furthermore, not much clearer is the recommendation of the latest WHO 
Expert Committee on Malaria: “Malaria disease may exist despite a negative microscopy 
result, but, unless the patient has already started treatment and there is a high suspicion 
o f malaria, treatment for uncomplicated malaria should not be given, as long as 
microscopy is negative ” (WHO, 2000a).
Similar ambiguities are present in the WHO decision charts for diagnosis of malaria 
based on the results of malaria RDT (WHO, 2004). It has been specified that negative test 
result does not always exclude malaria and “in case o f  high clinical suspicion patient 
should be treated fo r  malaria while other illnesses should be excluded”.
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In summary, current international and national recommendations promote the use of 
parasite-based diagnosis, however, the messages conveyed to the clinicians on the role of 
microscopy and RDTs in malaria diagnosis are incomplete and ambiguous. Since the 
critical aspect for the success of any guideline is its clarity, its lack in most malaria case 
management guidelines represents their major limitation.
1.5.3 Recommendations on effective malaria treatment
The effective treatment of malaria is a cornerstone of malaria case management (WHO, 
2000a). For nearly 50 years, chloroquine has been the bedrock of malaria case 
management in Africa. In Africa since the 1980s, the clinical efficacy of chloroquine 
declined rapidly (Talisuna et al., 2004) and several countries, including Kenya, have 
replaced chloroquine with sulfadoxine-pyrimethamine (SP) as their first-line treatment 
for uncomplicated malaria. However, in recent years, in many areas of eastern and 
southern Africa SP resistance has been emerging rapidly (EANMAT, 2003; Talisuna et 
al., 2004; Myint et al., 2004).
As a response to increasing levels of antimalarial resistance, WHO currently recommends 
that all countries experiencing resistance to conventional monotherapies, such as 
chloroquine, SP or amodiaquine, should use combination therapies, preferably those 
containing artemisinin derivatives (ACTs) (Bosman & Olumese, 2004). WHO currently 
recommends the following therapeutic options:
1. artemether-lumefantrine,
2. artesunate plus amodiaquine,
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3. artesunate plus sulfadoxine-pyrimethamine (for areas where SP efficacy remains high),
4. artesunate plus mefloquine (for areas with low transmission),
5. amodiaquine plus sulfadoxine-pyrimethamine (for areas where efficacy of both drugs 
remains high, mainly limited to countries in West Africa and only as short-term, 
interim treatment policy, while preparing to adopt an ACT).
Since 2001, twenty African countries, including Kenya, have adopted ACTs as first-line 
treatment for uncomplicated malaria, five countries adopted ACTs as second-line 
treatment while three countries have selected amodiaquine plus sulfadoxine- 
pyrimethamine as their first-line treatment (Olumese, 2004).
At present, quinine remains the recommended treatment for severe and complicated 
malaria. Of relevance for outpatient management, patients with severe malaria should 
receive intramuscular quinine and should be urgently referred for hospitalisation (MoH, 
1998; 2000a; WHO, 2003a). Rectal artesunate is not yet officially recommended but 
presents a great potential for pre-referal management of severe malaria, particularly in \ /  
areas where parenteral treatment would not be feasible (Barnes et a l , 2004).
Furthermore, an adequate antimalarial treatment does not include only an effective 
antimalarial drug but also provision of supportive treatment at health facility level. 
Several guidelines have addressed this issue and provided recommendations (Gove, 
1997; MoH, 1998; 2000a; WHO, 2003a). Supportive treatment for malaria at outpatient 
level may include measures to reduce temperature such as tepid sponging, fanning and 
oral antipyretics, iron and folate for anaemia, intravenous or rectal anticonvulsants if
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convulsions occur, or in case of low blood sugar concentrated glucose administered by 
nasogastric tube or by slow intravenous injection.
1.5.4 Recommendations on adequate drug dispensing and counselling 
The most comprehensive recommendations on drug dispensing standards for treatment 
provided to sick children at the outpatient level are provided by IMCI guidelines (Gove, 
1997; MoH, 2000a). Health workers should perform the following tasks for every oral 
drug to be given at home: “determine the appropriate drugs and dosage fo r  the child’s 
weight or age; tell the mother the reason for giving the drug to the child; demonstrate 
how to measure a dose; watch the mother practice measuring a dose by herself; ask the 
mother to give the first dose to her child; explain carefully how to give the drug, then 
label and package the drug; i f  more than one drug will be given, collect, count and 
package each drug separately; explain that all oral drugs must be used to finish the 
course o f  treatment, even i f  child gets better; and check the mother’s understanding 
before she leaves the clinic”.
Furthermore, IMCI guidelines recommend explicit counselling tasks to be provided to the 
caretakers of sick children. For example, children treated for malaria as outpatients 
should return to the health facility for “follow up visit in 2 days i f  fever persists”. Any 
sick child, including children with malaria, “should be breastfed more frequently and for  
longer at each feed , or, should be given increased quantity o f fluids” if child is not 
breastfeeding. All sick children should immediately return to the health facility “i f  child 
becomes sicker or unable to drink or breastfeed”.
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1.6 Quality of malaria case management
In this section the general concepts of the quality of care are introduced, the descriptive 
and interventional studies focusing on the quality of outpatient malaria case management 
are presented and methodological limitations of the studies on health workers 
performance are discussed.
1.6.1 Introduction to the general concept of the quality of care
The evaluation of the quality of case management focuses on performance according to 
standards because adherence to evidence-based standards is associated with improved 
health outcomes (Grimshaw & Russel, 1993). In a health systems view of care delivery, 
the standards can be applied to any of three components: structure (the conduit through 
which care is delivered, such as trained staff, equipment, supply), process (activities and 
tasks of actual care given, such as diagnosis and patient care management) and outcomes 
(the clinical consequence of care, influenced by the structure and the process) (Campbell 
et al., 2000).
Donabedian (1980) suggests that the most direct approach to assessment of health care 
quality is to focus on the process of care and evaluate this against established standards. 
Furthermore, Gilson et al. (1995) argued that the priority in assessment of the quality of 
primary health care in developing countries is not an outcome component since primary 
health care is largely based on interventions for which effectiveness has already been 
demonstrated, therefore, it is more important to know why interventions are not properly
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executed than to know their potential impact on the health status. The focus of discussion 
in this section will be the clinical process of care.
The standards of the clinical process of care can be presented in various formats such as 
clinical guidelines, algorithms, pathways, procedures, protocols or standing orders; 
however, a critical component of each standard is to contain explicit and measurable 
statements (Marquez, 2001). The performance according to standards can be measured 
using various direct and indirect methods, each of them having its advantages and 
disadvantages (Table 1.7).
Table 1.7: Methods for measuring performance according to standards, (Marquez, 2001)
Methods_______________Advantages____________ Disadvantages________________
• Time-consuming
• Requires careful standardization of 
observers to obtain reliable results
Greater validity • Some care activities are difficult to observe
• Presence of observer may influence
Observation of service delivery 
(by expert observers, peers, 
supervisors)
• Greater validity than indirect • Time-consuming
methods • Requires careful training and
Simulated client • Eliminates observation effect standardization of simulated clients
because health providers are not 
aware of being observed
• Some care activities are difficult to observe
Audit of individual patient • Inexpensive
records
• Records are often incomplete; tasks may 
have been performed but not recorded
Review of data from automated • Inexpensive 
information system_________________________
• Data available through automated system 
may be very limited____________________
Testing (written tests, 
simulation with standardized 
patients, computer-based 
testing)__________________
• Affords greater consistency in 
presentation of cases
Cannot evaluate interpersonal interactions
Health worker interview (self- 
report)
• Relatively quick and easy to 
implement
• Subject to bias due to inaccurate recall, not 
understanding the question, and the desire to 
appear Competent_______________________
Patient exit interview (patient 
report, including by health 
workers themselves)
• Relatively quick and easy to 
implement
• Subject to inaccurate recall, lack of 
awareness of all the clinical tasks performed, 
failure to understand the question and the 
desire to provide the responses to please the 
interviewer
Measurement of patient 
outcomes linked to correct 
health provider performance
Avoids observation effect
• Association between patient outcome and 
provider performance is only implied, not 
directly measured______________________
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1.6.2 Quality of outpatient malaria case management
There is overwhelming evidence that inadequate performance is strikingly widespread, as 
documented in studies of child health, sexually transmitted diseases, family planning, 
obstetrics, mental disorders, injuries, and diabetes (Rowe et al., 2005). Maybe the most 
illustrative example was presented in 1993, when WHO reviewed data from surveys 
conducted in 28 countries with national training programs for the control of diarrhoeal 
diseases and they found that only 16% of children with diarrhoea were correctly assessed, 
and only 20% were correctly re-hydrated (WHO, 1993).
Despite the volume of the studies on health workers performance, comparatively few 
examined the quality of malaria case management. For example, in a methodologically 
rigorous review of the interventional studies to improve the use of antimicrobials in 
developing countries, only 6 of 52 studies included malaria as a target health condition, 
and of these 6, only 3 were published in peer-reviewed journals (WHO, 2001b). 
However, some information on the quality of various aspects of malaria case 
management is available from the descriptive studies undertaken using various study 
designs and analytical approaches. More structured data became available with the 
implementation of IMCI programme, which among other illnesses, addresses malaria 
under the broader management of the febrile child. In the following sections, clinical 
performance indicators from descriptive, baseline studies evaluating either outpatient 
malaria case management or malaria components embedded into IMCI guidelines are 
presented.
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1.6.2.1 Performance indicators from descriptive malaria case management surveys
A variety of performance indicators were measured in several cross-sectional studies 
focusing on outpatient malaria case management. In Tanzania, Font et al. (2001) 
analysed all age patients routinely diagnosed with malaria and reported that 6% were 
weighed, 38% had temperature recorded, 24% had respiratory rate checked, 27% had 
conjunctival pallor checked, 3% had dehydration checked, 6% were given health 
education advice and 94% had an antimalarial drug prescribed, of which 10% were 
underdosed and 11% were overdosed. In Malawi, Lin & Franco (2000) reported that 
among children with fever the diagnostic process was adequate in only 18-42% of cases 
observed, a drug selected was correct in 71% of children but only 53% received the 
correct choice of drug, dosage, frequency and duration.
Studies of fever management across several countries showed that health workers failed 
to measure the patient’s temperature in 10-54% of encounters, failed to ask about fever 
duration in 0-69% of encounters and ask about fever pattern in 36-90% of encounters 
(Nicholas et al., 1991). On the Kenyan Coast, Abuya (2001) reported the performance of 
the following tasks among febrile children below 10 years of age: weight measured (4%), 
anaemia checked (65%), seizures assessed (27%), breaths counted (32%), malaria 
correctly diagnosed (72%), antimalarial treatment correctly prescribed (54%) and advice 
provided on treatment use (65%) and follow up (42%). In Western Kenya, Nyamongo & 
Oloo (2001) reported that 60% of patients were physically examined and that advice on 
the following was provided: vomiting (49%), follow up (27%) and immediate return to 
the facility (46%).
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1.6.2.2 Performance indicators from the baseline IMCI surveys
More performance indicators related to outpatient malaria case management in children 
were revealed through a series of methodologically similar health facility surveys 
preceding the implementation of the IMCI programme (Lee, 1994; Herman, 1999; Kipera 
& Tsuma, 2000; Rowe et al., 2000; 2001; 2003; Osterholt, 2002; Armstrong- 
Schellenberg et al., 2004). The results of these surveys revealed that health workers 
rarely (<10%) assessed general danger signs or performed counselling tasks related to the 
child’s follow up and immediate return to the facility (see Section 1.5 for definitions). 
Although the majority of these clinical skills were taught during the pre-service training 
and some during the various disease-specific in-service trainings, it was, however, not 
surprising that health workers without IMCI training rarely performed tasks presented for 
the first time in such a standardised and integrated format.
Despite the fact that health workers performance improved with regard to malaria 
diagnosis and treatment, frequent non-adherence to IMCI guidelines was more surprising 
since IMCI definitions reflected extensively promoted malaria case management 
standards such as presumptive diagnosis of all childhood fevers and prescription of 
recommended antimalarial treatment. Among patients with fever meriting diagnosis of 
uncomplicated malaria 67-92% of children were diagnosed as such by health workers 
(Lee, 1994; Herman, 1999; Kipera & Tsuma, 2000; Rowe et al., 2001), and 45-84% of 
children with uncomplicated malaria had a recommended antimalarial drug prescribed 
(Lee, 1994; Kipera & Tsuma, 2000; Osterholt, 2002; Rowe et al., 2000; 2003). However, 
in Uganda and Tanzania, where correct dosage of antimalarial drug was included in the
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definition of correct treatment, only 24% and 25% of children with uncomplicated 
malaria were correctly treated respectively (Gouws et al., 2004; Armstrong-Schellenberg 
et al., 2004). Interestingly, within the same district in Kenya, prescription of the 
recommended antimalarial drug was only 14% in non-government health facilities 
(Herman, 1999) compared to 84% in government facilities (Lee, 1994). The summary of 
the results on correct malaria diagnosis and treatment is presented in Table 1.8.
Table 1.8: Correctness of malaria diagnosis and treatment from the health facility surveys 
assessing performance of health workers before IMCI training_______________________
Reference Country Year of survey
HF
ownership
Age
(months)
Correct
diagnosis
Correct
treatment
Lee, 1997 Kenya 1994 Gov 2-59 79% 84%
Herman, 1999 Kenya 1999 Non-gov 2-59 92% 14%
Kipera & Tsuma, 2000 Kenya 2 0 0 0 Mixed3 0-59 91% 6 8 %
Rowe et al., 2000 CAR 1995/96 Mixed3 2-59 NA 50%
Rowe et al., 2001; 2003 Benin 1999 Mixed3 2-59 67% 63%
Osterholt, 2002 Malawi 1999 Mixed3 2-59 NA 45%
Gouws et al., 2004 Uganda 2 0 0 0 Gov 2-59 NA 24%b
Armstrong-Schellenberg et al, 2004 Tanzania 2 0 0 0 Gov 2-59 NA 25%b
3 Mixed category includes government and non-government facilities
b Not pre-interventional, baseline survey, but data from comparison districts without IMCI training
HF = health facility; NA = information not available; CAR = Central African Republic; Gov = government;
Non-gov = non-government
1.6.3 Improvements in the quality of malaria case management through IMCI programme 
In this section the improvements in the quality of malaria case management as a result of 
the interventions related to the implementation of IMCI programme are presented. In 
Bungoma and Vihiga districts in Kenya, between 1994 and 2002, a series of health 
facility surveys around multiple, IMCI related interventions have been performed. 
Herman (2003) comparatively summarised the performance indicators from three 
surveys, undertaken in the following years: 1994 (before IMCI training), 1997 (following
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IMCI training and implementation of the strengthened supervision), and 2002 (following 
package of interventions including site visits by senior staff, non-monetary incentives and 
provision of IMCI clinical registers). Herman (2003) demonstrated consistent 
improvements over time across all performance indicators assessed, especially those 
related to assessment and counselling, but also observed that, in spite of study limitations, 
no single intervention was associated with improved performance. Table 1.9 presents a 
comparative evolution of the performance indicators in Bungoma and Vihiga districts of 
relevance for malaria case management.
Table 1.9: Comparison of malaria related performance indicators between 1994 baseline, 1997
Performance indicators 1994a(%) 1997a (%) 2002b (%)
Assessment of three general danger signs0 0 42 73
Assessment of fever 83 93 97
Assessment of palmar pallor 5 73 8 8
Correct diagnosis of very severe febrile disease 0 1 1 59
Correct diagnosis of severe anaemia 0 1 1 2 0
Correct diagnosis of non-severe malaria 79 91 93
Correct diagnosis of moderate anaemia 3 2 1 37
Correct treatment of very severe febrile disease 13 48 63
Correct treatment of non-severe malaria 84 95 90
Correct treatment of moderate anaemia 1 16 41
Advise to return immediately if the child becomes sicker 8 56 69
Advise to return immediately if child unable to drink/breastfeed NA 37 38
Advise caretaker to continue feeding or breastfeeding NA 48 58
Advise caretaker to give extra fluids NA 33 54
1994 and 1997 surveys performed in government health facilities in both districts 
b 2002 survey performed in government and non-government facilities in Bungoma district only 
c It includes asking if child unable to drink or breast feed, vomiting everything and convulsions 
NA = information not available
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In Tanzania, Armstrong-Schellenberg et al. (2004), as part of the multi-country 
evaluation of IMCI, compared the quality of case management between districts that 
implemented IMCI through the standard 11 days course for health workers and 
comparison districts without IMCI activities. The authors concluded that children in 
IMCI districts received better care than children in comparison districts: they were more 
thoroughly assessed, they were more likely to be diagnosed correctly and strikingly better 
performance was demonstrated with regard to treatment, drug administration and 
counselling.
However, compared to Tanzania, the effects of the IMCI training on health workers 
performance was significantly lower in a similar type of evaluation in Uganda (Gouws et 
al., 2004). Possible explanations provided by Gouws et al. (2004) was that IMCI 
programme in Uganda was less controlled, the quality of training, supervision and follow 
up may have been of lower quality and the effect may have been diminished by the 
abolition of user fees and existing low morale of health workers. Table 1.10 presents 
several performance indicators related to the appropriateness of antimalarial treatment 
and advice given to caretakers by health workers with and without training in IMCI in 
Tanzania and Uganda.
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Table 1.10: Comparison of malaria related performance indicators between health workers 
with and without training in IMCI in Tanzania (Armstrong-Schellenberg et a l 2004) and 
Uganda (Gouws et a l 2004)____________________________ _____ ________________
Tanzania Uganda
IMCI Not 
Performance indicators2 trained trained
(%)a (%)a
IMCI Not 
trained trained 
(%)a (%)a
Child needs antimalarials and receives ^  ^  
correct prescription
Child receives the first dose of treatment „ . 1 
at the facility
Caretaker of child who is prescribed ^  j 3  
antimalarials ia advised how to use them
Caretaker of sick child is advised to give 4  
extra fluids and continue feeding
Sick child whose caretaker is advised on ^   ^
when to return immediately
49 24 
21 3 
46 22 
NA NA 
NA NA
a All country-specific differences statistically significant at 5% level of significance 
NA = information not available
1.6.4 Determinants of the quality of malaria case management
In several cross-sectional health facility surveys, rigorous multi-level methods of analysis 
were applied and a variety of health facility, health worker, patient and consultation 
factors influencing health worker performance, and in particular the quality of treatment 
provided to children with uncomplicated malaria, were examined (Rowe et al., 2000; 
2001; 2003).
In Benin, Rowe et al. (2001; 2003) examined a range of health worker performance 
outcomes and reported that various in-service trainings, including the malaria specific 
one, were not associated with any of the measured performance outcomes including the 
quality of treatment for uncomplicated malaria. Indeed, the only association found was 
the higher likelihood of trained health workers in diarrhoea management to pinch the skin 
of a child to assess for dehydration (Rowe et al., 2001). Similarly, results from Central 
African Republic did not show an association between malaria in-service training and
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prescription of the correct treatment for children with fever (Rowe et al., 2000). It 
appears that these findings are consistent with a less rigorous interventional trial in 
Ghana, where it was suggested that malaria in-service training improved health workers 
knowledge of the clinical management of the disease, however, the effect of knowledge 
improvement was not translated into better clinical practice over the longer term (Ofori- 
Adjei & Arhinful, 1996).
Similarly, studies in Benin and Central African Republic did not show an association 
between health workers’ supervision, possession of guidelines, and the various 
performance outcomes including the correct treatment for uncomplicated malaria (Rowe 
et al., 2000; 2001; 2003). It appears that results on the effects of guidelines in these 
studies are consistent with findings from developed countries where educational materials 
alone have little or no effect at all on performance according to standards (Marquez,
2001). With regard to the effect of wall charts on correct treatment for uncomplicated 
malaria conflicting results were reported; in Benin the presence of wall charts was 
associated with better performance (Rowe et al., 2003) and in Central African Republic 
the wall charts were associated with more treatment errors (Rowe et al., 2000).
The findings of these studies should not imply that malaria in-service training or 
supervision are ineffective as a strategy, however given the common lack of qualitative 
details on training and supervision, it may have been that such interventions were simply 
insufficient or inadequate in the study settings (Rowe et al., 2003). This may explain why 
evaluations within the more robustly implemented IMCI programme, which frequently
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includes standardised follow up and supervisory visits, have demonstrated the positive 
effect of in-service training on health workers performance (Naimoli, 2001; Herman, 
2003; Gouws et a l , 2004; Armstrong-Schellenberg et al., 2004).
The findings of previous studies can be complemented by a review summarising 
interventional trials testing the effects of in-service training and supervision on broader 
drug prescribing practices for a variety of health conditions (Ross-Degnan et al., 1997). 
With regard to training, of 14 studies meeting strict methodological criteria, 3 achieved 
large improvements, 7 showed moderate effects and 4 had little impact; however, 2 of 3 
high impact interventions did not measure actual change in practice. However, it has 
been shown that supervision can improve pharmaceutical use of drugs in primary care in 
developing countries in the short term (Ross-Degnan et al., 1997). In the long term, if 
correctly done, it could be a mechanism for providing professional development and 
increasing motivation and job satisfaction (Rowe et al., 2005).
1.6.5 Methodological limitations of the studies on health workers performance 
Studies of health worker performance suffer from multiple limitations and the major ones 
are presented in this section. First, in developing countries, randomised control trials as 
“gold standard” investigations to test the effect of a determinant or an intervention on 
health worker performance, are rarely performed. However, if rigorous methods are used 
and careful interpretation of results is applied, trials with time-series or pretest-posttest 
study designs, or cross-sectional surveys, can provide useful data on what happens under 
real life conditions (Rowe et al., 2005). Qualitative research methods may complement 
quantitative results and help to better describe contextual factors, sophisticated aspects of
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interventions and latent variables such as motivation (Victora et al., 2004). Second, the 
studies on health worker performance, and especially those not appearing in peer- 
reviewed journals, are frequently poorly documented with unavailable and inadequate 
explanation of the research methods. Third, description of the tested interventions or 
determinants is frequently incomplete or confusing, making it difficult to determine to 
what the observed effects should be attributed. Fourth, the sample sizes are frequently 
small, non-probability samples and this is rarely accounted for in the analysis. For 
example, non-probability samples occur when health facilities are sampled from the 
sampling frame with unequal probability of selection or when within the facility only 
limited number of observations is performed during the clinical service delivery day. 
Fifth, data collection techniques related to patient-provider clinical interaction are mostly 
based on observation-based methods and rarely complemented with exit examination to 
present “gold standard” diagnosis and determine with greater confidence the 
appropriateness of health workers practices. Sixth, the observation of patient-provider 
clinical interactions has the limitation that the presence of the study observer may cause 
the health workers to perform better or worse than usual (the Hawthorn effect); however, 
there is no perfect method since the other commonly used techniques such as review of 
patient records or simulated clients suffer from other disadvantages (Table 1.7). Seventh, 
in many studies only a narrow range of potential determinants has been investigated and 
when multiple factors were examined an attempt to adjust for confounding by using 
multivariate techniques has rarely been made. Eighth, the data collected in health facility 
surveys are cluster-correlated and multi-level in nature (numerous clinicians seeing 
multiple patients within different facilities); statistical analysis failing to account for the
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similarities within the cluster may result in an underestimation of variance and increased 
type I error rate. Ninth, health workers performance results may be difficult to interpret 
when standards are not in the form of explicit or measurable statements, or the outcome 
measured does not indicate if  the performance is appropriate (i.e. percentage of all 
patients with antimalarial prescribed).
1.7 Kenyan context
This section describes the basic Kenyan health system context, the setting of the thesis 
and focuses on the importance of adequate malaria case management within the current 
malaria control activities specified in the National Malaria Strategy. The section further 
discusses the role of malaria case management within the context of new antimalarial 
drug policy change.
1.7.1 Location and basic health indicators
Kenya is located in East Africa and shares borders with Uganda to the west, Tanzania to 
the south, Ethiopia to the north, Sudan to the northwest, Somalia to the east, and the 
Indian Ocean to the south-east. The country lies between latitudes 5°00’N and 4°40’S; 
and between longitudes 33°83’E and 41°76’E, covering the surface of approximately 
580,367 km2 (Ojany & Ogendo, 1988). The country is divided into five administrative 
levels; there are eight provinces sub-divided into 70 districts that are further divided into 
divisions, locations, and sub-locations. In 1999, Kenya had a population of approximately 
29 million persons, of whom 44% were aged below 15 years, 52% were between 15 and 
64 years and 4% were 65 years and above (CBS, 2001).
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The health status of Kenyans improved significantly from independence in 1963 until the 
early 1980s, however, since the early 1990s a decline has been observed. Between 
independence and the early 1980s the annual infant mortality rate was reduced from 119 
to 58 deaths per 1000 live births (MoH, 2004a; NCPD, 1989); likewise, mortality among 
children under five years of age had dropped from 106 in the 1970s to 89 in 1989 
(NCPD, 1994). Both indicators showed evidence of an increase by the early 1990s 
(NCPD, 1989; 1994; 1999), and in 2003, infant and childhood mortality reached levels of 
78 and 114 deaths per 1000 live births respectively (CBS, 2003).
1.7.2 Basic description of the formal health system in Kenya
Formal health services in Kenya are provided through government (GoK), non­
government (NGO), local authority, mission, and private health facilities. Noor et al. 
(2004) estimated that there were 6,674 health facilities in Kenya in 2004; the GoK run 
approximately a third of these facilities, a further 18.2% were run by the mission and 
NGO sector, 1.4% by local authorities and 44.2% of facilities belonged to the private 
sector. GoK health facilities are organised through a pyramidal network of providers, 
starting with dispensaries at the lowest level of service, followed by sub-health centres, 
health centres, rural training health centres, sub-district hospitals, district hospitals, 
provincial general hospitals, and finishing with a facility of the highest level, the 
Kenyatta National Hospital (Owino, 1997).
Facilities become increasingly complex in diagnostic, therapeutic and rehabilitative 
services at the upper levels, which serve also as the referral levels (Owino, 1997; Noor et
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al., 2004). At the district level, although the GoK facilities are nominally categorised as 
described above, in reality with regard to the services provided, there are difficulties 
distinguishing between various levels of service, such as dispensaries versus sub-health 
centres or rural health training centres versus sub-district hospitals. However, as a general 
rule, outpatient services are provided at facilities at all levels while the limited provision 
of inpatient services starts at the level of health centres (Noor et al., 2004). At dispensary 
and health centres, most of the outpatient services are provided by enrolled and registered 
nurses whose 3 and 4 year of nursing training respectively includes the management of 
the most common conditions. In hospitals, clinical officers with a three-year diploma in 
clinical medicine are the major providers of outpatient services.
1.7.3 Burden of malaria in Kenya
Kenya has a diverse ecology that supports the entire range of stable and unstable P. 
falciparum transmission conditions (Snow et al., 1998b). To describe malaria 
transmission intensities in Kenya, Snow et al. (1998b) used 124 cross-sectional, 
childhood (0-10 years), community-based malaria prevalence surveys measuring parasite 
ratios (PR) and broadly classified malaria endemicities into high (PR >70%), moderate 
(PR 20-69%) and low (PR<20%) areas of transmission. Furthermore, to model the risk of 
malaria morbidity and mortality across various intensities of malaria transmission the 
authors attributed Kenya climate data, 1989 population census figures, and demographic 
surveillance data from across Africa using verbal autopsy method with known accuracy 
errors (Snow & Marsh, 1992; Todd et al., 1994; Anker, 1997; WHO, 1999).
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Results indicated that in 1997, approximately eight million people were exposed to 
unstable malaria and five million were exposed to a low risk of stable transmission in 
Kenya. Over 11 million people were estimated to be exposed to moderate levels of P. 
falciparum transmission and about four million people including 677,000 children lived 
under areas of high transmission intensity. The authors concluded that in 1997 in Kenya, 
approximately 26,000 malaria deaths may have occurred among children aged less than 
five years and that approximately 145,000 children aged 0-4 years would have been 
hospitalised for severe malaria. The figures increase with epidemics in epidemic-prone 
and low risk arid areas of Kenya (Table 1.11).
Table 1.11: Populations exposed to risk of different malaria endemicities in Kenya and risk 
estimates for malaria mortality and morbidity (Snow et al. 1998b)
Feature Unstable 
Rainfall Limiting
Unstable
Non-rainfall
Low Stable 
(PR <20% )
Moderate Stable 
(PR 20-69%)
High Stable 
(PR >70%)
1997 total population 680,247 7,834,477 4,945,381 11,113,368 3,737,639
1997 0-4 years population 115,961 1,375,255 848,946 1,960,626 677,006
Malaria mortality per 1000 
children 0-4 years p.a.
0
(29-125)3 0.55 0.55 9.33 9.77
Numbers of deaths 0-4 
years p.a.
0
(3,363-14,495)a 756 467 18,293 6,614
Malaria admission rates per 
1000 children 0-4 years p.a. -
21.38 21.38 38.58 32.30
Expected malaria 
admissions 0-4 years p.a. - 29,403 18,150 75,641 21,867
a In epidemic year; PR = parasite ratio; p.a. = per annum
1.7.4 Kenyan National Malaria Strategy
The Ministry of Health’s Division of Malaria Control (DOMC) is the operational arm of 
the National Malaria Control Programme and is responsible for overseeing the 
implementation of the Kenya National Malaria Strategy (KNMS). The KNMS was 
launched in April 2001 with the main objective to reduce the level of malaria mortality in
70
Kenya by 30% by the year 2006, and to sustain that improved level of control to 2010 
(DOMC, 2001).
The KNMS has four main pillars of disease control that are congruent with those of the 
RBM initiative (www.rbm.who.int accessed 15/01/2005; DOMC, 2001). The four pillars 
comprise the following:
1. Clinical management: providing effective and prompt treatment
2. Management o f malaria and anaemia in pregnancy
3. Vector control using insecticide treated bed nets (ITN) and other methods
4. Epidemic preparedness and response
These four pillars are supported by two crosscutting strategies: “Information, Education, 
and Communication” and "Monitoring, Evaluation and Research
1.7.4.1 Clinical management as the first pillar of the KNMS
With regard to the first pillar - clinical management - the KNMS presents the set of 
policies made to ensure that:
1. All fevers are treated as early and as close to a patient’s home as possible, with 
acceptable quality and correct dosages o f  the first-line antimalarial and supportive 
treatment.
2. First-line therapeutic failures will be appropriately referred and managed with 
recommended second-line treatment.
3. All complications o f malaria will be referred and managed according to national 
guidelines.
The KNMS specifies a series of mid-term clinical management targets to be achieved by 
the year 2006, and they are the following:
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1. 80% o f households at risk will receive targeted IEC materials
2. 80% o f Government o f  Kenya facilities will have continuous and adequate supplies o f  
drugs essential fo r the management o f malaria
3. 80% o f all antimalarial drugs provided through formal and informal sectors will be 
o f internationally acceptable standard o f quality
4. 60% o f all fevers which are treated at home by family members or caretakers will be 
managed appropriately
5. 80% o f all cases offever treated by community health workers or outpatient facilities 
will be managed according to national recommendations
6. 80% o f first-line therapeutic failures and severe, complicated malaria cases will be 
correctly managed by health personnel in appropriate health facilities.
To achieve the above targets, the implementation of the policies within the clinical 
management pillar emphasises the improvement of malaria case management and 
monitoring of drug efficacy among other activities (DOMC, 2001). The proposed 
activities aiming at the improvement of case management include development and 
dissemination of malaria case management guidelines and provision of pre-service and 
in-service training activities. Between 1998 and 2000, two national malaria specific case 
management guidelines were developed: “National Guidelines for Diagnosis, Treatment 
& Prevention o f  Malaria for Health Workers” (MoH, 1998) and “A Simplified National 
Guideline on Malaria Control for Community Resource Persons (MoH, 2000b), and 
malaria component of the IMCI guideline has been finalised and incorporated into the 
broader IMCI algorithms (MoH, 2000a). Between 1999 and 2001, 12,000 and 80,000 
copies of the malaria specific guidelines for health workers and community resource 
persons were disseminated to a wider spectrum of health service providers respectively 
(Snow et al., 2001a).
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Furthermore, the DOMC partnered with a number of organisations to undertake a series 
of in-service training programs around malaria case management in support of the 
produced malaria specific guidelines. Between 1999 and 2001, the Mission for Essential 
Drugs, the African Medical Research Foundation, Medecins Sans Frontieres, MERLIN, 
PLAN International, and the DOMC undertook various in-service training programs. It 
has been estimated that approximately 2,800 health workers had been trained by the end 
of 2001 nationwide (Snow et al, 2001a). However, by 2001 the implementation of the 
IMCI programme was still in the nascent stages and only 3 districts had been covered 
with IMCI training.
In 1998, following the change of the national antimalarial drug policy and abandoning of 
chloroquine, the East African Network for Monitoring Anti-malarial Therapy 
(EANMAT) was established and eight sentinel sites were determined to monitor first-line 
and second-line antimalarial drug efficacy in Kenya. Between 1998 and 2004, the first- 
line antimalarial drug recommended for use in Kenya was sulfadoxine-pyrimethamine 
(SP) with amodiaquine and oral quinine reserved as second-line treatment (MoH, 1998). 
However, resistance to SP emerged rapidly (EANMAT, 2001; 2003) and Kenya was 
faced with no option but to change first-line therapy once again. This time, following 
advice from WHO and the international research community, artemisinin-based 
combination therapy (ACT) was adopted (WHO, 2001a). After careful consideration of 
the limited ACT options artemether-lumefantrine (ART-LUM) was selected as the only 
adequate choice for Kenya and in April 2004 the new first-line policy for uncomplicated 
malaria recommending ART-LUM was adopted (MoH, 2004b).
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1.7.5 Importance of adequate malaria case management within the ACT drug policy
There is a substantial difference between the new era of ACTs and the era when cheap 
and simple to administer first-line drugs such as chloroquine and SP were effective 
against malaria. Effectiveness of ART-LUM treatment will differ from the efficacy in a 
number of ways and one of the most important determinants may be the effect of 
adherence. ART-LUM has a complicated 6-dose treatment schedule and an unfavorable 
pharmacokinetic profile; a poor level of oral bioavailability characterises lumefantrine, 
absorption varies considerably between individual doses and between patients, and 
absorption is significantly reduced in the acute phase of malaria (White et al., 1999; 
Ezzet et al., 2000). Therefore, from the health worker perspective, adequate performance 
in drug prescribing, patient’s counselling and drug dispensing will be of critical 
importance to ensure optimum effectiveness of ART-LUM treatment.
Furthermore, a subsidised cost of 2.4 USD for an adult treatment course with ART-LUM 
(WHO, 2003c) is still thirty-fold higher than the cost of the previous treatment with SP 
fhttp://erc.msh.org. accessed 15/01/2005). In a country with limited financial resources 
such as Kenya, despite the promising commitments from external donors, it is reasonable 
to believe that a previously tolerated strategy of presumptive treatment of all fevers as 
malaria should be reconsidered. The change of malaria diagnosing practices intending to 
reduce number of treatments, either by introducing parasite-based diagnosis or by 
applying clinical criteria, will require strengthening of malaria case management with a 
particular focus on the adequate performance of clinical assessment tasks, use and 
interpretation of diagnostics, and adequate differential diagnoses.
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Therefore, the quality of malaria case management is a critical component of any malaria 
control strategy, however, given the importance of treatment as a cornerstone of malaria 
case management, the significance of health workers performance will become even 
more pronounced in the era of ACTs. Many lessons can be learned by examining the 
current health workers practices and understanding factors influencing them. This thesis 
is aimed at contributing to this body of evidence and will hopefully lead to the 
development and implementation of improved malaria case management strategies.
1.8 The scope of the thesis
Chapter 1 describes the basic biology of malaria transmission, the measures and 
distribution of malaria endemicity and population with the focus on sub-Saharan Africa. 
The chapter then describes the clinical presentation of malaria and the epidemiology of 
malaria disease in relation to the acquisition of the functional immunity. It continues 
with a detailed section on malaria diagnosis, elaborating on difficulties of clinical 
diagnosis of malaria, parasite-based diagnostic methods and the public health importance 
of malaria diagnosis. The subsequent sections present international outpatient malaria 
case management recommendations, introduce the concept of the quality of care and 
presents the studies and limitations of health worker performance research with a focus 
on malaria case management. The chapter ends with the basic description of Kenyan 
context and the national malaria strategy, highlighting the importance of malaria case 
management.
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Chapter 2 describes the materials and methods used to capture empirical data for each of 
two separately undertaken, age-specific health facility surveys. The chapter provides 
detailed information about study areas, national malaria case management standards and 
definitions used in the analysis, sampling procedures, data collection tools, training of the 
field workers, health facility survey procedures, statistical analysis performed and 
methodological limitations encountered.
Chapter 3 presents descriptive results on the quality of the outpatient malaria case 
management in children below 5 years of age. The chapter starts with a short introduction 
to the topic of the chapter, presents performance data for each component of the clinical 
process (assessment, diagnosis, treatment and counselling), describes health worker and 
health facility characteristics considered important for adequate performance of malaria 
case management and ends with discussion on the significance of the findings in the 
Kenyan context1.
Chapter 4 presents the predictors analysis of multi-level variables (health facility, health 
worker, and patient or consultation) in relation to national treatment recommendations for 
uncomplicated malaria in children. The analysis uses recent statistical approaches 
applying multiple binomial logistic regression modeling for three categories of treatment 
quality (recommended, minor errors, and inappropriate). The chapter ends with a
1 Some results from Chapter 3 have been published in Annals o f Tropical Medicine and Parasitology; see 
details in bibliography under Zurovac et al. (2005).
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comparative discussion of the determinants of health workers’ performance between 
studies with a similar design .
Chapter 5 focuses on older children and adults, providing a short introduction to the topic 
and then proceeds to present the thesis data on the accuracy of the routine clinical 
diagnosis of malaria, the health workers practices in clinical assessment of febrile 
patients, and the ability of clinical signs and symptoms to predict malaria infection in 
febrile patients. The chapter ends with discussion and the implications of study findings 
on present and future national antimalarial drug policies.
Chapter 6 focuses on the effects of microcopy on malaria case management in Kenya. 
The chapter provides a short introduction to the topic, presents observational data 
collected on current clinical and laboratory practices from the facilities with functional 
microscopy, and discusses the current effectiveness of malaria case management using 
microscopy and the implications of the results on malaria diagnostic strategies in Kenya.
Finally Chapter 7 provides a summary of the thesis emphasising the major findings, 
overall importance of the findings in Kenyan context and identifies some of the areas that 
demand further investigation.
2 Chapter 4 has been published in International Journal o f Epidemiology; see details in bibliography under 
Zurovac et al. (2004).
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CHAPTER 2:
Background, materials and methods of health 
facility surveys
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2.1 Background
This chapter describes the materials and methods adopted for two separate health facility 
surveys, undertaken for children below 5 years and patients above 5 years. The chapter 
provides detailed information about the study areas, national malaria case management 
standards and definitions used in the analysis, sampling procedures, data collection tools, 
training of the field workers, health facility survey procedures, statistical analysis 
performed and methodological limitations encountered.
2.2 Background on the selection of the study districts
The Kenyan Ministry of Health’s (MoH) Division of Malaria Control (DOMC) has 
identified four districts across the country as sentinel sites for prospective monitoring and 
evaluation of national malaria control activities at community and health facility level, 
including monitoring of antimalarial drug sensitivity at already existent sites identified by ^  
the East African Network for Monitoring of Antimalarial Treatments (EANMAT). 
Furthermore, these four districts were purposively selected because they represent the 
four principal malaria ecologies in Kenya and they were: Kwale (coastal environment 
with moderate to high transmission), Bondo (lakeside environment with perennial high 
transmission), Kisii comprising Kisii Central and Gucha (highland environment with 
highly seasonal transmission) and Makueni (semi-arid environment with acutely 
seasonal, low intensity transmission) (Figure 2.1.). From the national DOMC perspective 
these four districts were programmatically equally treated as any other district in Kenya, 
however, the health systems differences such as number of health facilities have existed 
between the selected districts. The studies of this thesis were developed in collaboration
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with the DOMC and therefore took place in four districts previously identified for 
monitoring and evaluation activities.
Figure 2.1: Map of Kenya with four study districts
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2.3 Characteristics of the study districts
2.3.1 Bondo district
Bondo district is one of the twelve districts in Nyanza Province. The district lies between 
latitude 0.400° south to 0.05° north and from longitude 33.967° to 34.433° east, and 
covers a surface of 987 km2. Along its western border lies Lake Victoria. In 1999, the 
district had a population of 238,780 people and a density of 242 persons per km2 (CBS, 
2001). The population are predominantly JaLuo (95%). In Kenya, mortality rates are not
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available at district level; however, infant and childhood mortality rates of 176 and 257 
per 1000 live births respectively were reported from Asembo Bay Division of Bondo 
district (McElroy et al., 2001). A nutritional survey undertaken in Bondo and Siaya 
districts in 1994 among 138 children aged 6-59 months showed that 33.8% of children 
were stunted, 3.8% wasted and 15.8% were undernourished (CBS, 1994).
2.3.1.1 Climate characteristics
Rainfall and temperature data are not available for Bondo district, however, to describe 
climatic characteristics of the district, data from neighbouring Kisumu district, 
harbouring a similar malaria ecology and located on Lake Victoria were used. Daily data 
on rainfalls and temperature were collected from Kisumu Meteorological Station for the 
time period between 1998 and 2003. The mean monthly rainfall and the mean monthly 
temperature were calculated for the period 1998-2003 and are presented in Figure 3.2. 
The mean monthly rainfall between 1998 and 2003 was calculated for each of 12 
calendar months by adding quantity of rainfalls for particular month and dividing the ^  
total by 6 years examined. The total annual rainfall in the same time period ranged from 
1216 to 1618 mm/year with a range of 4 to 317 mm of rain a month. The rains occur 
throughout the year, however, the long rains usually fall between March and May, and 
short rains have their peaks in September and January. The mean monthly temperature 
for each month between 1998 and 2003 was calculated from the mean monthly maximum
J
and minimum temperatures for the respective months. The mean monthly temperature 
between 1998 and 2003 was calculated for each of 12 calendar months by adding mean 
monthly temperatures for particular month and dividing the total by 6 years examined.
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Between 1998 and 2003, the average monthly maximum temperature was 29.9°C with a 
monthly range of 28.6-31.6°C, and the average monthly minimum temperature was 
17.2°C with a monthly range 16.6-18.1°C. The month of February, just before the long 
rains, is the hottest month of the year while the coolest month is June at the end of the 
long rains (Figure 2.2.).
Figure 2.2: Mean monthly rainfall (bars) and mean monthly temperature (line) with 
intervals presenting one standard deviation around the monthly means: data from Kisumu 
Meteorological Station, Kisumu district, 1998-2003
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2.3.1.2 Seasonality of malaria transmission
In Bondo district malaria transmission is present throughout the year and is considered as 
stable and intense with estimated average of 0.75 infective bites per person per day (Beier 
et al., 1994). However, a seasonal increase of malaria cases usually occurs between May 
and July, and between December and February. The increase in malaria cases usually
82
lasts three months and starts one month after the beginning of the rainy season. The 
paediatric survey in Bondo district was conducted in the month of October. The example 
of a consecutive series of monthly, outpatient, all age malaria diagnoses reported from 
Bondo District Hospital between January 1998 and December 2000 demonstrates the 
pattern of malaria seasons in the district (Figure 2.3.).
Figure 2.3: Consecutive series of monthly, outpatient, all age malaria diagnoses, Bondo 
District Hospital, January 1998 - December 2000
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2.3.1.3 Age structured profile of outpatient malaria diagnoses
The age structured, monthly, outpatient malaria diagnoses were collected from 6 health 
facilities in Bondo district between 1998 and 2000 (Table 2.1). The age-specific 
distribution of malaria diagnoses shows that 19.3% (range 10.0-23.4%) of malaria 
diagnoses were reported in children less than one year, 25.3% (range 14.1-30.2%) in age 
group 1-4 years and 12.0% (range 8.8-18.2%) in age group 5-14 years. Patients older than 
14 years accounted for 42.8% (range 36.5-60.2%) of malaria diagnoses.
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Table 2.1: Distribution of malaria diagnoses across age groups: results from 6 health 
facilities in Bondo district between 1996 and 2001
No of 
months3
< 1  year 
(% total)
1-4 yrs 
(% total)
5-14 yrs 
(% total)
< 5 yrs NS 
(% total)
> 15 yrs 
(% total)
Total
Bondo District 60 6541 8446 2456 289 10209 27941
Hospital (23.4) (30.2) (8 .8 ) (1 .0 ) (36.5)
Abidha 36 979 1198 730 13 2270 5190
Health Centre (18.9) (23.1) (14.1) (0.3) (43.7)
Madiany 36 1808 1948 1171 53 4199 9179
Health Centre (19.7) (2 1 .2 ) (1 2 .8 ) (0 .6 ) (45.7)
Nyagoko 36 539 1 1 1 1 978 2 2 2717 5367
Dispensary (1 0 .0 ) (20.7) (18.2) (0.4) (50.6)
Gobei 36 1383 2063 1116 48 \  3126 7736
Dispensary (17.9) (26.7) (14.4) (0 .6 ) (40.4)
Ujawi 30 741 957 989 15 4082 6784
Dispensary (10.9) (14.1) (14.6) (0 .2 ) (60.2)
Overall 6  HFs 11991 15723 7440 440 26603 62197(19.3) (25.3) (1 2 .0 ) (0.7) (42.8)
“Total number of months between 1996 and 2001 for which data were collected 
NS = children below 5 yrs without specified age; HF = health facility
2.3.1.4 P. falciparum prevalence rates
As previously mentioned, Bondo district is characterised by intense, perennial malaria 
transmission. The combined P. falciparum prevalence rate, among children aged 0-10 
years, derived from 7 community-based surveys between 1959 and 1996 (Table 2.2), was 
71.3% (range 47.9-88.5%). The combined prevalence rate in children less than one year 
was 60.8% (range 30.4-80.0%). Based on these data the district can be best described as 
hyper-holoendemic (Metselaar & Van Thiel, 1959).
Table 2.2: P. falciparum prevalence rates during the community surveys among children 
population in Bondo district, 1959 -  1996_________________________________________
Reference M
< 1 year 1-4 years 5-10 years All age (0-10 yrs)
Examined
(positive)
PR
(%)
Examined
(positive)
PR
(%)
Examined
(positive)
PR
(%)
Examined
(positive)
PR
(%)
Heisch, 1959 5 23 (7) 30.4 69 (54) 78.3 77 (36) 46.8 169(97) 57.4
Anonymous, 1979 5 14(8) 57.1 49 (37) 75.5 100 (70) 70.0 163(115) 70.6
Anonymous, 1979 5 12(5) 41.7 47 (40) 85.1 106 (34) 32.1 165 (79) 47.9
Kaseje, 1989 3 145 (77) 53.1 758 (517) 68.2 1256 (911) 72.5 2159(1505) 69.7
Kaseje, 1989 5 59 (47) 79.7 527 (469) 89.0 1200(1064) 88.7 1786(1580) 88.5
Ouma, 1994 2 10(8) 80.0 35(21) 60.0 428 (218) 50.9 473 (247) 52.2
Ouma, 1996 2 48 (37) 77.1 69 (48) 69.6 473 (218) 46.1 590 (303) 51.4
M = month in a year: 1 = January,... 12 = December; PR = prevalence rate
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2.3.1.5 Antimalarial drug resistance studies
In 2000 and 2003, EANMAT carried out two antimalarial drug sensitivity studies among 
children 6-59 months following the WHO protocols (WHO, 1996b; 2003d). The results 
showed that in studies over 14 days follow up the efficacy of SP was 66.7% in 2000 and 
62.5% in 2003. During the study in 2003 the follow up was extended by day 28 and SP 
was efficacious in only 30.9% of children. During the same studies amodiaquine 
remained highly efficacious, however, in the most recent study with extended follow up 
over 28 days the efficacy was reduced to 83.0%. The results of antimalarial drug 
resistance studies in Bondo district are presented in Table 2.3.
Table 2.3; SP and amodiaquine drug resistance studies performed in Bondo district
Author Drug Year Follow up 
completed
%
ETF + LTF
%
ACR-dl4
%
LPF
%
ACPR-dl4
%
ACPR-d28a
EANMAT SP 2000 60 26.7 73.3 6.7 66.7 ND
EANMAT SP 2003 112 21.4 78.6 16.1 62.5 30.9
EANMAT AQ 2000 59 0.0 100.0 0.0 100.0 ND
EANMAT AQ 2003 114 0.9 99.1 0.9 98.2 83.0
a Results not PCR corrected for the possibility of reinfection
ETF (Early treatment failure) = development of danger signs or severe malaria within the first three days (with 
parasitaemia) or a history of fever (axillary temperature >37.5°C) on Day 2 or 3 in the presence of parasitaemia. 
Parasitaemia on Day 3 >25% of the count on Day 0 on its own also qualifies as ETF (WHO, 1996b); LTF (Late 
treatment failure) = recorded if danger signs or severe malaria occur on Days 4 to 14 (with parasitaemia), or there is fever 
with parasitaemia on Days 4 to 14 without previously meeting criteria for ETF (WHO, 1996b); ACR (Adequate clinical 
response) = achieved if there is no parasitaemia or no fever on Day 14 without previously meeting the criteria for ETF or 
LTF (WHO, 1996b); LPF (Late Parasitological Failure) = presence of parasitaemia on Day 14 or 28 and axillary 
temperature < 37.5°C, without previously meeting criteria for ETF or LTF (WHO, 2003d); ACPR (Adequate Clinical and 
Parasitological Response) = absence of parasitaemia on Day 14 (or Day 28), irrespective of axillary temperature, without 
previously meeting any of the criteria for ETF, LTF or LPF (WHO, 2003d); ND = not done
2.3.2 Kisii Central & Gucha Districts
Former Kisii district was split in 1997 to form Kisii Central and Gucha districts. For the 
purpose of this study they will be regarded as Kisii district. The district is located in the 
southern highlands of Nyanza province and lies between latitude 0.5° and 0.967° south
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and longitude 34.7° and 35.083° east. It occupies an area of about 1,310 km2. According 
to the 1999 national census, the districts had a combined population of 952,725 people 
resulting in a population density of 727 persons per km2 (CBS, 2001). The population are 
predominantly Kigusii. Nyanza Province infant and childhood mortality was 135 and 199 
per 1000 live births respectively in 1998 (NCPD, 1999). The nutritional survey 
undertaken in Kisii district in 1994 among 261 children aged 6-59 months showed that 
40.6% of children were stunted, 6.2% wasted and 23.4% were undernourished (CBS, 
1994).
2.3.2.1 Climate characteristics
Kisii district is a hilly area located between 1200 and 2200 metres above sea level 
receiving an average of over 2000 mm of rainfall per year. Daily data on rainfalls and 
temperature were collected from Kisii Meteorological Station for the time period between 
1998 and 2003. The monthly variations in the level of rainfall and temperature were 
expressed as the monthly means for the period 1998-2003 and presented in Figure 2.4. 
The total annual rainfall ranged from 2107 to 2305 mm/year with a monthly range of 31 
to 424 mm of rain. The rainfall pattern is bimodal: long rains occur from March to June 
while the short rains occur from October to November. In the period 1998-2003, the 
average monthly maximum temperature was 25.8°C with a mean monthly range of 24.5- 
28.1°C, and the average monthly minimum temperature was 15.4°C with a mean monthly 
range of 14.6-16.5°C. The hottest month of the year is February just before the long rains 
while the coolest months are June and July at the end of the long rains (Figure 2.4.).
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Figure 2.4: Mean monthly rainfall (bars) and mean monthly tem perature (line) with 
intervals presenting one standard deviation around the monthly means: data from Kisii 
Meteorological Station, Kisii district, 1998-2003
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2.3.2.2 Seasonality of malaria transmission
Malaria transmission is present throughout the year but is highly seasonal and varies in 
magnitude between years depending largely on rainfall and constitutes the typology of 
“highland” malaria (Cox et al., 1999). The increase in malaria cases usually starts one 
month after the beginning of the rainy season and most frequently occurs between May 
and July and between January and March. In Kisii district, the paediatric, and older 
children and adult surveys were conducted in the months of July and March-April, 
respectively. The example of a consecutive series of monthly, outpatient, all age malaria 
diagnoses reported from Kisii District Hospital between January 1998 and December 
2000 demonstrates the pattern of malaria seasons in the district (Figure 2.5.).
87
Figure 2.5: Consecutive series of monthly, outpatient, all age malaria diagnoses, Kisii 
District Hospital, January 1998 - December 2000
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2.3.2.3 Age structured profile of outpatient malaria diagnoses
The age structured, monthly, outpatient malaria diagnoses were collected from 7 health 
facilities in Kisii district between 1998-2000 (Table 2.4). The age-specific distribution of 
malaria diagnoses shows that 9.6% (range 4.4-12.4%) of malaria diagnoses were reported 
in children less than one year, 20.0% (range 18.0-23.8%) in age group 1-4 years, and 
20.9% (range 14.6-24.8%) in age group 5-14 years. Patients older than 14 years 
accounted for 48.8% (range 43.2-60.2%) of malaria diagnoses.
Table 2.4: Distribution of malaria diagnoses across age groups: results from 7 health 
facilities in Kisii district between 1998 and 2000
No of 
months3
< 1 year 
(% total)
1-4 yrs 
(% total)
5-14 yrs 
(% total)
<5 yrs NS 
(% total)
> 15 yrs 
(% total)
Total
Keumbu Sub- 36 3308 4992 6856 519 11942 27617
D. Hospital (12.0) (18.1) (24.8) (1.9) (43.2)
Magena 36 1389 4170 4640 0 9477 19676
Dispensary (7.1) (21.2) (23.6) (48.2)
Kenyenya 23 747 2217 2193 29 5814 11000
Health Centre (6.8) (20.2) (19.9) (0.3) (52.9)
Nyakwana 20 596 1218 1131 39 2544 5528
Dispensary (10.8) (22.0) (20.5) (0.7) (46.0)
Kisii District 7 1395 2927 2395 0 8697 15414
Hospital (9.1) (19.0) (15.5) (56.4)
Gucha Sub- 8 1120 2147 1320 0 4450 9037
D. Hospital (12.4) (23.8) (14.6) (49.2)
Magenche 8 73 296 286 0 991 1646
Dispensary (4.4) (18.0) (17.4) (60.2)
Overall 7 HFs 8628 17967 18821 587 43915 89918(9.6) (20.0) (20.9) (0.7) (48.8)
a Total number of months between 1998 and 2000 for which data were collected 
NS = children below 5 yrs without specified age; HF = health facility
2.3.2.4 P. falcivarum prevalence rates
The combined P. falciparum prevalence rate, among children aged 0-10 years, derived 
from 8 community-based surveys between 1994 and 2000 (Table 2.5), was 26.0% (range 
10.9-70.7%). The combined prevalence rate in children less than one year was 15.7% 
(range 0-53.6%). Based on the prevalence rate the district can be best described as 
mesoendemic (Metselaar & Van Thiel, 1959).
Table 2.5: P. falciparum prevalence rates during the community surveys among children 
population in Kisii district in 1994 and 2000_______________________________________
Reference M
< 1 year 1-4 years 5-10 years All age (0-10 yrs)
Examined
(positive)
PR
(%)
Examined
(positive)
PR
(%)
Examined
(positive)
PR
(%)
Examined
(positive)
PR
(%)
UNICEF, 1994 4 28(15) 53.6 232(166) 71.6 54 (41) 75.9 314(222) 70.7
UNICEF, 1994 4 33 (17) 51.5 203 (139) 68.5 51 (29) 56.9 287(185) 64.5
Zurovac, 2000 3 10(0) 0 60(4) 6.7 160 (21) 13.1 230 (25) 10.9
Zurovac, 2000 3 20(1) 5.0 42 (9) 21.4 126 (26) 20.6 188 (36) 19.1
Zurovac. 2000 4 15(0) 0 67(8) 11.9 183 (30) 16.4 265 (38) 14.3
Zurovac, 2000 4 20 (0) 0 81 (13) 16.1 190 (42) 22.1 291 (55) 18.9
Zurovac, 2000 5 41(0) 0 217 (29) 13.4 547 (89) 16.3 805 (118) 14.7
Zurovac, 2000 5 56(2) 3.6 187 (27) 14.4 387 (76) 19.6 630(105) 16.7
M = month in a year: 1 = January,... 12 = December; PR = prevalence rate
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2.3.2.5 Antimalarial drug resistance studies -
The recent results of antimalarial drug sensitivity studies according to the WHO protocol 
(WHO, 1996b; 2003d) show that efficacy of SP and amodiaquine over 14 day follow up 
was 70.4% and 94.7% respectively. However, extended follow up over 28 days 
demonstrated low success rates for both drugs: amodiaquine efficacy declined to 77.0% 
and the efficacy of SP was only 39.6%. The results of antimalarial drug resistance studies 
are presented in Table 2.6.
Table 2.6: SP and amodiaquine drug resistance studies performed in Kisii district8
Author Drug Year Follow up % % % % %
completed ETF + LTF ACR-dl4 LPF ACPR-dl4 ACPR-d28b
EANMAT SP 2003 108 29.6 70.4 0.0 70.4 39.6
EANMAT AQ 2003 131 5.3 94.7 0.0 94.7 77.0
a Definitions of treatment outcomes are provided under Table 2.3 
b Results not PCR corrected for the possibility of reinfection
2.3.3. Kwale district
Kwale district is one of the seven districts in Coast province, located in the south-eastern 
comer of Kenya on the border with Tanzania. The district lies between latitudes 3.55° 
south and 4.667° south and longitudes 38.45° and 39.667° east. Kwale district is located 
along the Indian Ocean on the east and the United Republic of Tanzania to the south. 
According to the 1999 national population census the district had a population of 496,133 
(CBS, 2001). The district has a land surface of 8,335 km2 and low population density of 
60 persons per km2. The majority of the population are of the Mijikenda ethnic group 
(80%). The Coast province has infant and childhood mortality of 70 and 96 per 1000 live 
births respectively (NCPD, 1999). The nutritional survey undertaken in Kwale district in
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1994 among children aged 6-59 months showed that 53.0% of the children were stunted, 
5.2% were wasted and 29.1% were undernourished (CBS, 1994).
2.3.3.1 Climate characteristics
Daily data on rainfall were collected from Kinango Agricultural Institute for the time 
period between 1998 and 2003. Data on temperatures were not available. The total annual 
rainfall ranged from 711 to 1353 mm/year with a range of 0 to 310 mm of rain a month. 
The long rains usually occur between March and June. The short rains occur most 
commonly between October and January, however with significant variations between 
the years. The monthly variations in the level of rainfalls were expressed as the monthly 
mean for the period 1998-2003 and presented in Figure 2.6.
Figure 2.6: Mean monthly rainfall with intervals presenting one standard deviation around 
the monthly means: data from Kinango Agricultural Institute, Kwale district, 1998-2003
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2.3.3.2 Seasonality of malaria transmission
Malaria transmission in Kwale is stable, present throughout the year, with seasonal 
distribution associated with rainfall patterns. The increase in malaria cases usually occurs 
between May and September, and between January and February. The paediatric, and 
older children and adult surveys were conducted in the months of August, and August- 
September, respectively. The example of a consecutive series of monthly, outpatient, all 
age malaria diagnoses reported from Mackinon Dispensary between January 1998 and 
December 2000 demonstrates the pattern of malaria seasons in the district (Figure 2.7.).
Figure 2.7: Consecutive series of monthly, outpatient, all age malaria diagnoses, Mackinon 
Dispensary, January 1998 - December 2000
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2.3.3.3 Age structured profile of outpatient malaria diagnoses
The age structured, monthly, outpatient malaria diagnoses were collected from 5 health 
facilities in Kwale district between 1998 and 2000 (Table 2.7). The age-specific
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distribution of malaria diagnoses shows that 12.8% (range 4.4-14.8%) of malaria 
diagnoses were reported in children less than one year, 24.0% (range 20.0-30.7%) in the 
age group 1-4 years, and 15.6% (range 12.3-18.4%) in the age group 5-14 years. Patients 
older than 14 years accounted for 46.9% (range 43.1-58.1%) of malaria diagnoses.
Table 2.7: Distribution of malaria diagnoses across age groups, results from 5 health 
facilities in Kwale district between 1998 and 2000
No of 
months8
< 1  year 
(% total)
1-4 yrs 
(% total)
5-14 yrs 
(% total)
<5 yrs NS 
(% total)
> 15 yrs 
(% total)
Total
Mackinon 36 387 1787 1471 16 5075 8736
Dispensary (4.4) (20.5) (16.8) (0 .2 ) (58.1)
Lunga Lunga 36 2429 3363 2955 90 8005 16842
Dispensary (14.4) (2 0 .0 ) (17.5) (0.5) (47.5)
Vigurangani 36 1295 2004 1608 2 3829 8738
Dispensary (14.8) (22.9) (18.4) (0 .0 2 ) (43.8)
Kikoneni Health 35 1806 4241 1700 116 5947 13810
Centre (13.1) (30.7) (12.3) (0 .8 ) (43.1)
Msambweni 24 1280 2029 1033 134 3431 7907
District Hospital (16.2) (25.7) (13.1) (1.7) (43.4)
Overall 5 HFs 7197 13424 8767 358 26287 56033(1 2 .8 ) (24.0) (15.6) (0 .6 ) (46.9)
a Total number of months between 1998 and 2000 for which data were collected 
NS = children below 5 yrs without specified age; HF = health facility
2.3.3.4 P. falciparum prevalence rates
The combined P. falciparum prevalence rate, among children aged 0-10 years, derived 
from 8 community-based surveys between 1968 and 2003, has shown to be 61.3% (range 
31.0-87.0%). The combined parasite rate in children less than one year has shown to be 
49.5% (range 26.7-68.6%). Based on the prevalence rate the district can be best described 
as hyperendemic (Metselaar & Van Thiel, 1959).
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Table 2.8: P. falciparum prevalence rates during the community surveys among children 
population in Kwale district, 1968 -  2003_________________________________________
< 1 year 1-4 yrs 5-10 yrs All age (0-10 yrs)
Reference M Examined
(positive)
PR
(%)
Examined
(positive)
PR
(%)
Examined
(positive)
PR
(%)
Examined
(positive)
PR
(%)
Obwond, 1968 4 15(4) 26.7 130(45) 34.6 65(16) 24.6 210(65) 31.0
Anonymous, 1979 11 18(6) 33.3 30(14) 46.7 95 (27) 28.4 143 (47) 32.9
Anonymous, 1979 11 15(7) 46.7 24(12) 50.0 190(152) 80.0 229(171) 74.7
Lugogo, 1994 3 0 NA 50(23) 46.0 84 (28) 33.3 134 (51) 38.1
Marsh, 2003 8 31 (20) 64.5 216(195) 90.3 ND NA 247 (215) 87.0
Marsh, 2003 8 44 (21) 47.7 210(119) 56.7 ND NA 254 (140) 55.1
Marsh, 2003 8 42 (17) 40.5 200(147) 73.5 ND NA 242(164) 67.8
Marsh, 2003 8 35 (24) 68.6 185(152) 82.2 ND NA 220 (176) 80.0
M = month in a year: l=January,... 12=December; PR = prevalence rate; ND = not done; NA = not applicable
2.3.3.5 Antimalarial drug resistance studies
In 2000 and 2001, EANMAT carried out two antimalarial drug sensitivity studies among 
children 6-59 months following the WHO protocol with follow up over 14 days (WHO 
1996b). The results showed that efficacy of SP declined from 96.8% in 2000 to 86.8% in 
2001. In the same studies, amodiaquine remained highly efficacious, with low rates of 
treatment failures ranging from 0 to 2.5%. Until now, the studies with follow up over 28 
days were not performed in Kwale district. The results of antimalarial drug resistance 
studies undertaken in Kwale district are presented in Table 2.9.
Table 2.9: SP and amodiaquine drug resistance studies performed in Kwale district3
Author Drug Year Follow up 
completed
%
ETF + LTF
%
ACR-dl4
%
LPF
%
ACPR-dl4
%
ACPR-d28
EANMAT SP 2000 63 0.0 100.0 3.2 96.8 ND
EANMAT SP 2001 53 7.6 92.4 5.7 86.8 ND
EANMAT AQ 2000 64 0.0 100.0 1.6 98.4 ND
EANMAT AQ 2001 57 0.0 100.0 0.0 100.0 ND
a Definitions of treatment outcomes are provided under Table 2.3; ND = not done
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2.3.4 Makueni district
Makueni district is one of the twelve districts of Eastern Province and lies between 
longitudes 37.144° and 38.517° east and latitudes 1.523° and 2.987° south and covers a 
land surface area of 8,266 km2. According to the 1999 population census, the district had 
a population 771,545 people with an average density of 97 persons per km2 (CBS, 2001). 
The majority of the population are WaKamba (97%). The Eastern province has infant and 
childhood mortality of 53 and 77 per 1000 live births respectively (NCPD, 1999). The 
nutritional survey undertaken in Makueni district in 1994 among children aged 6-59 
months showed that 50.0% of the children were stunted, 2.7% were wasted and 22.3% 
were undernourished (CBS, 1994).
2.3.4.1 Climate characteristics
Daily data on rainfall and temperature were collected from Makindu Meteorological 
Station for the time period between 1998 and 2003. The monthly variations in the level of 
rainfall and temperature were expressed as the monthly means for the period 1998-2003 
and presented in Figure 2.8. The total annual rainfall ranged from 521 to 1003 mm/year 
with a monthly range of 0 to 537 mm of rain. The long rains occur mainly between 
March and April with short rains between November and January. The time period 
between June and October is usually dry with very little rainfall. In the period 1998-2003, 
the average monthly maximum temperature was 28.9°C with a mean monthly range of 
26.8-31.2°C, and the average monthly minimum temperature was 17.3°C with a mean 
monthly range 14.7-19.3 °C. The hottest month of the year is March at the beginning of 
the long rains while the coolest months are June to August after the long rain season 
(Figure 2.8.).
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Figure 2.8: Mean monthly rainfall (bars) and mean monthly tem perature (line) with 
intervals presenting one standard deviation around the monthly means: data from Makindu 
Meteorological Station, Makueni district, 1998-2003
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2.3.4.2 Seasonality of malaria transmission
Malaria transmission is acutely seasonal and largely dependent on the level of rainfall. 
The increase in malaria cases starts after the beginning of the rainy season and usually 
occurs between January and March and between June and July. The paediatric survey in 
Makueni district was conducted in the month of February. The example of a consecutive 
series of monthly, outpatient, all age malaria diagnoses reported from Kato Dispensary 
between January 1998 and December 2000 demonstrates the pattern of malaria seasons in 
the district (Figure 2.9.).
96
Figure 2.9: Consecutive series of monthly, outpatient all age malaria diagnoses, Kato 
Dispensary, January 1998 - December 2000
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2.3.4.3 Age structured profile of outpatient malaria diagnoses
The age structured, monthly, outpatient malaria diagnoses were collected from 5 health 
facilities in Makueni district between 1998 and 2000 (Table 2.10). The age-specific 
distribution of malaria diagnoses shows that 7.3% (range 5.3-11.4%) of malaria 
diagnoses were reported in children less than one year, 16.0% (range 12.8-21.1%) in the 
age group 1-4 years, and 28.4% (range 19.5-32.8%) in the age group 5-14 years. Patients 
older than 14 years accounted for 45.1% (range 39.8-48.9%) of malaria diagnoses.
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Table 2.10: Distribution of malaria diagnoses across age groups, results from 5 health 
facilities in Makueni district between 1998 and 2000
No of 
months3
< 1  year 
(% total)
1-4 yrs 
(% total)
5-14 yrs 
(% total)
<5 yrs NS 
(% total)
> 15 yrs 
(% total)
Total
Kato 35 633 1677 3525 274 4617 10761
Dispensary (5.9) (15.6) (32.8) (2.5) (42.9)
Kathonzweni 35 718 1784 3986 410 6656 13554
Dispensary (5.3) (13.2) (29.4) (3.0) (40.2)
Nzui 36 1327 2136 3182 372 4641 11658
Dispensary (11.4) (18.3) (27.3) (3.2) (39.8)
Kikumini 24 2 2 0 454 1025 155 1696 3550
Health Centre (6 .2 ) (1 2 .8 ) (28.9) (4.4) (47.8)
Sultan Hamud 24 369 1168 1080 2 1 0 2709 5536
Health Centre (6.7) (2 1 .1 ) (19.5) (3.8) (48.9)
Overall 5 HFs 3267 7219 12798 1421 20319 45024(7.3) (16.0) (28.4) (3.2) (45.1)
“Total number of months between 1998 and 2000 for which data were collected 
NS = children below 5 yrs without specified age; HF = health facility
2.3.4.4 P. falciparum prevalence rates
Characteristic of the district is acute seasonal low intensity malaria transmission with 
marked spatial heterogeneity. The combined P. falciparum prevalence rate, among 
children aged 0-10 years, derived from 7 community-based surveys between 1951 and 
2003 (Table 2.11), has shown to be 11.5% (range 0.4-33.3%). The combined parasite rate 
in children less than one year was 6.2% (range 0-28.9%). Based on the prevalence rate 
the district can be best described as hypo-mesoendemic (Metselaar & Van Thiel, 1959).
Table 2.11: P. falciparum prevalence rates during the community surveys among children 
population in Makueni district__________________________________________________
Reference Ma •
< 1 year 1-4 yrs 5-10 yrs All age (0-10 yrs)
Examined
(positive)
PR
(%)
Examined
(positive)
PR
(%)
Examined
(positive)
PR
(%)
Examined
(positive)
PR
(%)
CPK, 1951 NR 38(5) 13.2 61 (16) 26.2 118 (21) 17.8 217(42) 19.4
CPK, 1951 NR 38(11) 28.9 61 (19) 31.1 118(21) 17.8 217(51) 23.5
Mugo, 1993 8 0 NA 57(18) 31.6 102 (35) 34.3 159 (53) 33.3
Marsh, 2003 8 52(0) 0 214 (7) 3.3 ND NA 266 (7) 2.6
Marsh, 2003 8 49 (0) 0 189(1) 0.5 ND NA 238 (1) 0.4
Marsh, 2003 8 52(0) 0 173 (8) 4.6 ND NA 225 (8) 3.6
Marsh, 2003 8 44(1) 2.3 204(17) 8.3 ND NA 248 (18) 7.3
M = month in a year: 1 = January,... 12 = December; PR = prevalence rate; ND = not done; NA = not applicable
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2.3.4.5 Antimalarial drug resistance studies
The results of antimalarial drug sensitivity studies with follow up over 14 days (WHO, 
1996b) showed that efficacy of SP declined from 81.8% in 2000 to 45.2% in 2002. The 
most recent study carried out by EANMAT reported that efficacy of SP over 14 days 
follow up was 83.1%; however, the same study revealed that SP was efficacious in only 
46.4% of children with extended follow up over 28 days (WHO, 2003d). Between 2000 
and 2003, four studies with follow up over 14 days, reported efficacy of amodiaquine to 
be in range 84.0-100%; however, the most recent study in 2003 with extended follow up 
over 28 days revealed that the efficacy of amodiaquine declined to 68.5%. The results of 
antimalarial drug resistance studies are presented in Table 2.12.
Table 2.12: SP and amodiaquine drug resistance studies performed in Makueni district3
Author Drug Year Follow up 
completed
%
ETF + LTF
%
ACR-dl4
%
LPF
%
ACPR-dl4
%
ACPR-d28b
EANMAT SP 2 0 0 0 1 1 18.2 81.8 0 . 0 81.8 ND
EANMAT SP 2 0 0 1 19 15.8 84.2 10.5 73.7 ND
EANMAT SP 2 0 0 2 31 51.6 48.4 3.2 45.2 ND
EANMAT SP 2003 71 8.5 91.6 8.5 83.1 46.4
EANMAT AQ 2 0 0 0 14 7.1 92.9 0 . 0 92.9 ND
EANMAT AQ 2 0 0 1 25 16.0 84.0 0 . 0 84.0 ND
EANMAT AQ 2 0 0 2 34 0 . 0 1 0 0 . 0 0 . 0 1 0 0 . 0 ND
EANMAT AQ 2003 95 8.4 91.6 3.2 88.4 68.5
a Definitions of treatment outcomes are provided under Table 2.3; 
b Results not PCR corrected for the possibility of reinfection; ND = not done
2.3.5 Summary characteristics of four study districts
The major characteristics of four study districts related to their population, climate, 
malariology, antimalarial drug efficacy studies and timing of the surveys are summarised 
in Table 2.13
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Table 2.13: Summary characteristics of four study districts
Characteristics BONDO KISII KWALE MAKUENI
Population 238,780 952,725 496,133 771,545
Density of population per km2 242 727 60 97
Climate
Long rain season3 Mar-May Mar-June Mar-June Mar-April
Short rain season3 Sep-Jan Oct-Nov Oct-Jan Nov-Jan
Hottest month February February NA March
Coolest month June July NA July
Malariology
P.falciparum PRs (range) 
Endemicity classification
71.3%
(47.9-88.5%)
Hyper-
holoendemic
26.0%
(10.9-70.7%)
Mesoendemic
61.3%
(31.0-87.0%)
Hyperendemic
11.5%
(0.4-33.3%)
Hypo-
mesoendemic
Malaria seasons3 May-JulyDec-Feb
Jan-Mar
May-July
Jan-Feb
May-Sep
Jan-Mar
June-July
Age-profile of malaria diagnoses
<5 years (%) 45.3 30.3 37.4 26.5
5-14 years (%) 1 2 . 0 20.9 15.6 28.4
>14 years (%) 42.8 48.8 46.9 45.1
Antimalarial drug efficacy (latest studies)
SP (ACPR-dl4) 62.5 70.4 8 6 . 8 83.1
SP (ACPR-d28) 30.9 39.6 ND 46.4
Amodiaquine (ACPR-dl4) 98.2 77.0 1 0 0 88.4
Amodiaquine (ACPR-d28) 83.0 94.7 ND 68.5
Time o f studies
Children survey Oct 2001 July 2001 Aug 2001 Feb 2002
Older children and adult survey ND Mar-Apr 2003 Aug-Sep 2003 ND
3 Seasons usually occur between these months but may vary between years
PR = prevalence rate; ND = not done; NA = not available; ACPR = Adequate Clinical and Parasitological 
Response
2.4 Development of district Geographic Information System maps
To develop health facility sampling frames and facilitate effective planning of the survey, 
a spatially linked database of health facilities was developed for each of four districts. 
These health facility databases were based on the provisional district specific lists, reports 
and maps found in Nairobi at the Ministry of Health, Christian Health Association of 
Kenya, Family Planning Logistic Management Organisation, Central Bureau of Statistics 
and the Government’s Gazette. Furthermore, the existence of each facility was
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counterchecked with District Health Management Teams (DHMT) and the lists were 
updated where necessary. Finally each facility was visited and a precise longitude and 
latitude was taken using a hand-held Global Positioning System (GPS). During the 
facility visit, basic information was also collected on the type and ownership of facility, 
staffing characteristics and type of services provided. The positions of all health facilities 
were then overlaid into the previously digitised district maps encompassing 
administrative boundaries, transport networks, rivers and other water bodies among other 
features (Noor et al., 2003). This thesis focuses on Government of Kenya (GoK) health 
facilities. The study district maps displaying the GPS positioned GoK health facilities 
according to the facility type are presented in Figure 2.10.
101
Fi
gu
re
 
2.
10
: 
St
ud
y 
di
str
ic
t 
m
ap
s 
wi
th 
GP
S 
po
sit
io
ne
d 
go
ve
rn
m
en
t 
he
alt
h 
fa
ci
lit
ie
s
+•
+ +
•  +
102
2.5 Government health service structure with respect to malaria case management
In Kenya, at the level of district, the provision of government health services is primarily 
organised through a three-tiered health system comprising dispensaries, health centres 
and a district hospital. With respect to malaria case management, dispensaries provide 
only outpatient care, without laboratory support and are supposed to stock nationally 
recommended, first (oral SP), second-line (oral amodiaquine or quinine) and pre-referral 
(injectable quinine) antimalarial drugs. Health centres provide outpatient and limited 24- 
hour inpatient care, have laboratory support and are supposed to stock first and second- 
line outpatient drugs and drugs for the management of severe malaria; there are no blood 
transfusion services available. A district hospital provides outpatient and inpatient care 
including blood transfusion services, has laboratory support, and should stock all drugs 
and equipment necessary for the management of uncomplicated and severe malaria. A 
small number of sub-health centres and sub-district hospitals, as the inter-level health 
facilities, also exist. Since the service capacities of these levels of care, related to malaria 
case management, do not differ significantly from any of the above belonging to the 
three-tiered structure, for the purpose of this study, sub-health centres can be classified 
with dispensaries and sub-district hospitals with health centres. Nurses and clinical 
officers provide outpatient services in dispensaries and district hospitals respectively. In 
health centres, outpatient consultations are performed by both nurses and clinical officers. 
The distribution of GoK health facilities across four districts and type of health facility is 
shown in Table 2.14.
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Table 2.14: Distribution of government health faci ities across districts and types of facility
Type o f health facility BONDO KISII KWALE MAKUENI TOTAL
Dispensary 
Sub-health centre 
Health centre 
Sub-district hospital 
District hospital 
All facilities
15
0
5
0
1
21
27
3
10
3
1
44
39
0
6
2
1
48
34
10
11
3
1
59
115
13
32
8
4
172
2.6 Development of the final sampling frame
2.6.1 Development of the final sampling frame for the paediatric survey 
The sampling frame for the paediatric survey was stratified by the type of health facility. 
Health facilities considered not relevant for our survey by either not providing general 
outpatient services, not operating regularly or not functional during the survey days were 
excluded from the sampling frame. Two strata of health facilities providing outpatient 
care were defined: 1) dispensaries, and 2) combined health centres and district hospitals 
(each district had only one district hospital).
The primary units of analysis for this survey were sick child consultations; therefore, to 
maximise recruitment of patients and optimise the use of limited resources, facilities 
attending too few sick children in a day (defined as less than five on average) were 
excluded from the sampling frame. The exclusion of facilities using patients’ caseload 
was based on the monthly attendance figures from the same month of the previous year. 
These figures were obtained through routine health facility morbidity reports and 
retrospective surveys collecting data on age-specific malaria burden for DOMC’s 
monitoring and evaluation activities. For each facility an average number of children seen 
per day was calculated by dividing the monthly number of children by an average of 22
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working days in a month. The health facilities were ordered according to the average 
daily paediatric (0-4 years) caseload. The monthly cumulative number and percentage of 
sick child consultations was attributed to each facility within each stratum.
By applying exclusion criterion of less than 5 sick children a day, cumulative percentage 
of excluded facilities was calculated with attributed cumulative percent of excluded sick 
child consultations for each stratum (dispensaries versus health centres and hospitals), 
district and for four districts together. None of the health centres and district hospitals 
were excluded from the sampling frame. Among dispensaries, the highest percentage of 
excluded facilities across four districts was in Kisii district (24.1%). The highest 
cumulative percentage of excluded sick child consultations among all dispensary strata 
was also in Kisii district (8.5%). Overall, among all types of facility in four districts, only 
1.8% of potential sick child consultations were excluded from the sampling frame.
It was important that this procedure did not exclude too many facilities and sick child 
consultations from the universe of the sampling frame. The WHO recommends that if 
more than 25-30% of sick children are seen in excluded facilities, then the sample should 
include these facilities (WHO, 2002b). In this study, the WHO cut-off of 25% was not 
exceeded in any of the strata sampled. Table 2.15 shows development of the sampling 
frame for the paediatric survey and the percentage of excluded facilities and sick child 
consultations.
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Table 2.15: Develoipment of the sampling frame for paediatric survey
Sampling Sampling Sampling Excluded Excluded
District frame frame frame facilities children
(GIS)a (NR)b (Final) 0 (%)d (%)e
KWALE
Dispensaries 39 38 36 5.3 0.9
HC/DH 9 9 9 0 0
All facilities 48 47 45 4.3 0.5
KISII
Dispensaries 30 29 2 2 24.1 8.5 ■
HC/DH 14 14 14 0 0
All facilities 44 43 35 18.6 5.4
BONDO
Dispensaries 15 13 1 2 7.7 1.3
HC/DH 6 5 5 0 0
All facilities 2 1 18 17 5.6 0.9
MAKUENI
Dispensaries 44 40 37 7.5 1.7
HC/DH 15 15 15 0 0
All facilities 59 54 51 5.6 1 . 1
TOTAL
Dispensaries 128 1 2 1 107 1 1 . 6 2 . 8
HC/DH 44 42 42 0 0
All facilities 172 163 149 8 . 6 1 . 8
“Initial GIS sampling frame (Table 2.14) 
b Sampling frame after exclusion of non-relevant facilities
c Final sampling frame after excluding facilities seeing in average less than 5 sick children in a day 
d Percentage of facilities excluded from the sampling frame adjusted for non-relevant facilities 
e Cumulative percent of sick child consultations excluded from the sampling frame (NR)
HC = health centre; DH = district hospital; NR = non-relevant;
2.6.2 Development of the final sampling frame for the older children and adult survey 
The older children and adult survey was undertaken in two districts (Kisii and Kwale) 
and the sampling frame was stratified in each district according to the availability of 
functional malaria microscopy at health facilities. Two strata were defined: 1) facilities 
without microscopy, and 2) facilities with microscopy.
To obtain the final sampling frame of health facilities for each district, the same patient 
caseload exclusion criteria as described previously for the paediatric survey was used and
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the percentage of excluded facilities with attributed cumulative percent of excluded 
patients was calculated. The calculation was done for each stratum (facilities with and 
without microscopy), each district and for the two districts together. None of the facilities 
with microscopy were excluded from the sampling frame. Among facilities without 
microscopy the highest percent of excluded facilities (10.3%) and patients (8.5%) was in 
Kisii district. Among all facilities in both districts, 8.1% were excluded from the 
sampling frame. These facilities attended only 7.4% of all patients older than 5 years. 
More facilities and patients were excluded in Kwale (8.5% and 3.3% respectively) than in 
Kisii district (7.7% and 4.8% respectively). Table 2.16 shows development of the 
sampling frame for the older children and adult survey and percentage of excluded 
facilities and patients’ consultations across two districts and two strata.
Table 2.16: Development of sampling frame for older children and adult survey
District
Sampling
frame
(GIS)a
Sampling
frame
(NR)b
Sampling
frame
(Final)c
Excluded
facilities6
(%)"
Excluded
patients
(%)e
KWALE
HFs without microscopy 34 33 29 1 2 . 1 4.8
HFs with microscopy 14 14 14 0 0
All facilities 48 47 43 8.5 3.3
KISII
HFs without microscopy 34 29 26 10.3 8.5
HFs with microscopy 1 0 1 0 1 0 0 0
All facilities 44 39 36 7.7 4.8
TOTAL
HFs without microscopy 6 8 62 55 11.3 5.2
HFs with microscopy 24 24 24 0 0
All facilities 92 8 6 79 8 . 1 7.4
a Initial GIS sampling frame (Table 2.14) 
b Sampling frame after exclusion of non-relevant (NR) facilities
0 Final sampling frame after excluding facilities seeing in average less than 5 sick patients in a day 
d Percentage of facilities excluded from the sampling frame adjusted for non-relevant facilities 
e Cumulative percent of patients consultations excluded from the sampling frame (NR)
HF = health facility; NR = non-relevant
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2.7 Sampling procedures
2.7.1 Sampling procedures for paediatric survey
The paediatric survey was a cross-sectional, stratified, cluster sample health facility 
survey. A cluster was defined as all health worker-sick child consultations occurring at a 
facility during two survey days. As explained in the section 2.6.1, in each district two 
strata were defined according to the type of health facility. Using the average daily sick 
child attendance figures it was estimated that a minimum 8-10 dispensaries and 7-8 
health centres (depending on the district) should be surveyed over two days each to 
provide an estimated sample size of 200 health worker-sick child consultations in each 
stratum within a district. Between 10 and 12 working days (Monday-Friday) were 
allocated for the survey in each of the districts. For a survey of 10 working days with four 
survey teams visiting each facility over two days, a maximum number of 20 health 
facilities could be surveyed.
For each health facility type stratum the number of facilities to be surveyed was 
determined by the number of facilities required to obtain the estimated sample size of 
children and the number of available days allocated for the survey. Health facilities in 
each stratum were sampled by systematic random sampling (apart from purposive 
selection of a district hospital) if the number of facilities in the sampling frame exceeded 
the minimum number of facilities required. In the strata where the number of facilities in 
the sampling frame was equal or below the required number of facilities all health 
facilities were surveyed. To increase precision of estimates and account for uncertainty in 
the size of design effect, in the strata where the number of facilities in the sampling frame
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and number of days allocated for the survey allowed greater number of facilities to be 
surveyed than required, the greater sample of health facilities was selected.
Systematic random sampling was applied by ordering the sampling frame of health 
facilities in each stratum according to the children caseload and defining the sampling 
interval by dividing the number of facilities in the sampling frame with the maximum 
number of facilities that could be sampled within the survey time period. The first 
selected facility was decided using the random number table and presented the starting 
point of the sample. The next facility from the list was selected by counting down for the 
sampling interval. The procedure was repeated until the maximum sample size of health 
facilities in each stratum was obtained. After all health facilities had been selected, they 
were randomly assigned to the consecutive pair of two working days (Monday to Friday) 
within the time period allocated for the survey in each district. Surveys were undertaken 
during malaria seasons according to the following schedule: Kisii - July 2001, Kwale -  
August 2001, Bondo -  October 2001 and Makueni -  February 2002. The sampling 
process for paediatric survey is presented in Table 2.17.
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Table 2.17: Sampling process for paediatric survey across the districts and strata
District
Sampling
frame
Average No of 
children per 
HF per 2 days
No of 
required 
facilities1*
Max. No of 
HFs to be 
surveyed3
No of 
surveyed 
facilities
No of 
enrolled 
children
KWALE (12 days3)
Dispensaries 36 23 9 15 15 228
HC/DH 9 25 8 9 9 204
KISII (10 days3)
Dispensaries 22 25 8 10 10 208
HC/DH 14 32 7 10 9 267
BONDO (10 days3)
Dispensaries 12 22 9 12 12 218
HC/DH 5 30 7 5 5 175
MAKUENI (11 days3) 
Dispensaries 
HC/DH
37
15
20
26
10
8
11
11
11
10
173
221
Number of working days (Monday-Friday) allocated for the survey 
b Number of required facilities obtained by dividing estimated sample size (200) with average number of sick 
children per facility over two days
c Maximum number of facilities which could be surveyed given the number of available days for the survey and 
number of facilities in the sampling frame;
HF = health facility; HC = health centre; DH = district hospital
2.7.2 Sampling procedures for older children and adult survey
The older children and adult survey was a cross-sectional, stratified, cluster sample health 
facility survey conducted in two districts, Kwale and Kisii. As explained in Section 2.6.2, 
in each district two strata were defined according to the availability of functional malaria 
microscopy at the health facility. A cluster was defined as all consultations for patients 
above 5 years of age occurring at a facility during two survey days. Using the average 
daily attendance figures for outpatients above 5 years it was estimated that a minimum of 
10 and 7 facilities in Kwale and Kisii respectively should be surveyed over two days each 
to provide an estimated sample size of 200 health worker-patient observations at facilities 
with microscopy. At facilities without microscopy, it was estimated that a minimum 15 
and 14 facilities in Kwale and Kisii respectively should be surveyed over two days each 
to provide an estimated sample size of 400 health worker-patient observations. The
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survey was carried out with one field team and 50 and 42 working days (Monday-Friday) 
were allocated for the surveys in Kwale and Kisii districts respectively.
Health facilities in each district and each stratum were sampled by systematic random 
sampling using the same sampling procedure as in the paediatric survey (Table 2.18). 
After all health facilities had been selected, they were randomly assigned to the 
consecutive pair of two working days (Monday to Friday) within the time period 
allocated for the survey in each district. Surveys were undertaken during the expected 
malaria seasons according to the following schedule: Kwale - August and September 
2002 and Kisii -  March and April 2003.
Table 2.18: Sampling process for ole er children anc adult survey across cistricts and strata
Sampling
frame
Average No of No of Max. No of No of No of
District patients per HF 
per 2 days
required
facilities5
HFs to be 
surveyed0
surveyed
facilities
enrolled
patients
KWALE (50 days3)
HFs without microscopy 29 29 15 15 15 412
HFs with microscopy 14 33 7 10 10 218
KISII (42 days3)
HFs without microscopy 26 20 14 14 14 418
HFs with microscopy 10 29 7 7 7 210
a Number of working days (Monday-Friday) allocated for the survey
b Number of required facilities obtained by dividing estimated sample size (400 at HFs without microscopy and 200 at HFs 
with microscopy) with an average number of sick patients >5 years of age per facility over two days 
0 Maximum number of facilities which could be surveyed given the number of available days for the survey and the number 
of facilities in the sampling frame; HF = health facility
2.8 National guidelines
National recommendations for malaria case management are derived from a series of 
malaria guidelines developed by the National Malaria Control Program (MoH, 1998; 
2000b), broader clinical guidelines developed by the Ministry of Health (MoH, 1994), 
and IMCI guidelines developed by WHO and UNICEF (Gove, 1997) and modified by the 
Kenyan IMCI programme (MoH, 2000a). In this study two guidelines were used as the
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benchmarks for comparison because: 1) they specifically addressed case management 
standards for health workers at health facility level; and 2) they presented the most recent 
reference material, nationally recommended at the time of the survey. These two 
guidelines were: 1) National Guidelines for Diagnosis, Treatment and Prevention o f 
Malaria fo r  Health Workers (NMCP) (MOH, 1998); and 2) Integrated Management o f 
Childhood Illnesses Guideline (IMCI) (MoH, 2000a).
The emphasis of the NMCP guideline is diagnosis and treatment standards for malaria 
case management across all age groups. The IMCI guideline covers assessment, 
diagnosis, treatment and counselling components of the clinical process within the 
broader aspects of the management of the sick child. It is important to acknowledge that 
by the time of the survey these broader quality of care standards for the management of a 
sick child were developed, approved at national level and reflected in IMCI guidelines, 
however, the dissemination of IMCI guidelines had not occurred in the surveyed districts.
2.8.1 Guidelines recommendations and study case definitions for paediatric survey 
The performance standards for a health workers malaria assessment, diagnosis, treatment 
and counselling practices reflected NMCP and IMCI recommendations for children aged 
2-59 months brought to a health facility for an initial visit. Each component of the 
clinical process was evaluated either on all sick children or on a subset of children and 
the correctness of performance was compared with these guidelines. The components of 
the clinical process evaluated, subsets of children analysed and definitions of the 
correctness of the performance are summarised in Table 2.19. The definitions were 
modified because some components of the NMCP guideline lacked precision and two
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guidelines were not always harmonised. The following sections (2.8.1.1-2.8.1.5) describe 
the guideline recommendations for each component of the clinical process and present 
case definitions applied to measure health workers performance in the paediatric survey.
Table 2.19: Components of the clinical process evaluated, subsets of sick children analysed 
and definitions of the correctness of the performance______________________________
Component of the Subsets of sick children Performance tasks measured and definition of the
clinical process correctness
1) Assessment 1 All children
Determination of age; weight; 4 general danger signs 
(inability to drink or breastfeed, history of convulsions, 
persistent vomiting, presence of lethargy or 
unconsciousness); fever; cough; diarrhoea; ear problem
2) Assessment 2 Children with fever
Assessment of temperature; duration of fever; anaemia; 
respiratory distress; dehydration; respiratory rate; 
previous use of drugs
3) Diagnosis Children with fever and absent negative blood slide
Malaria diagnosis written in the patient-held record or 
prescription of any antimalarial drug
4) Treatment of Children with fever and absent
uncomplicated
malaria
negative blood slide and not 
referred or admitted
A) Drug
1. Recommended
2. Adequate
Prescription of oral SP monotherapy or either SP, 
amodiaquine, or quinine (all as oral medications and as 
a monotherapy) when SP previously reported 
Prescription of all non-recommended antimalarials 
(apart from CQ or no antimalarial drug at all)
3. Inappropriate Prescription of CQ or no antimalarial drug at all
B) Drug and dosage
1. Recommended Prescription of recommended antimalarial drug according to the recommended dose
2. Adequate
3. Inappropriate
Prescription of recommended drug above or adequate 
drug according to or above recommended dose 
Prescription of recommended or adequate drug below 
recommended dose, CQ or no antimalarial drug at all
5) Treatment of severe 
malaria
Children with fever and absent 
negative blood slide and referred 
or admitted
1. Recommended Prescription of parenteral QN alone or parenteral QN with SP or QN tablets
2. Adequate
Prescription of all non-recommended antimalarial 
treatments (apart from chloroquine or no antimalarial 
treatment at all)
3. Inappropriate Prescription of CQ or no antimalarial treatment at all
Advice on how to give medications, extra fluids, tepid
6) Counselling Children with fever and not referred or admitted
sponging, continued feeding, when to return 
immediately, when to come for follow up and what to 
do in case of vomiting
7) Communication Children with fever and not referred or admitted
Greeting, information on diagnosis and name of 
medications and checking if any questions
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2.8.1.1 Definitions of fever, child’s initial visit malaria and severity of illness
According to NMCP and IMCI guidelines malaria in children is defined as fever during 
the present illness. In the present study a child was considered to have fever if the 
caretaker told the interviewer that the child had fever as part of the presenting illness. 
After direct questioning of the caretaker, an initial visit was defined as the first visit of 
the sick child for this illness to this facility. An independent clinical re-examination of 
sick children to establish a “gold standard” diagnosis was not performed, thus the health 
worker’s decision to manage the child as an outpatient was used as a proxy measure of 
uncomplicated malaria. Likewise, a health worker’s decision to refer for hospitalisation 
was used as a proxy measure for severe malaria. Some children treated as outpatients 
may have had severe malaria, and thus were misclassified in the analysis; however, given 
that severe disease is relatively uncommon among febrile children in outpatient setting 
(Simoes et al., 1997; Perkins et al., 1997; Kolstad et al., 1997), the potential bias this 
misclassification introduced was considered minor. Furthermore, if  a child who truly had 
severe malaria was treated as an outpatient, or if a child who truly had uncomplicated 
malaria was referred for hospitalisation because the health worker thought the child had 
uncomplicated or severe malaria respectively, an evaluation of the child’s management 
still provides useful information because the clinical tasks performed reflect the health 
worker’s performance in managing uncomplicated and severe malaria.
Therefore, in the analysis malaria was defined as a history of fever during the present 
illness (according to the study interviewers) in the absence of a negative blood slide 
(according to the record in patient-held cards). In addition, treatment of the child as an
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outpatient, or referral of child for hospitalisation (according to the observed health 
worker) was used as the criterion to distinguish uncomplicated from severe malaria.
2.8.1.2 Definitions of assessment tasks
The performance of assessment tasks was evaluated for children with fever and for all 
children regardless of the presence of fever, according to assessment tasks stated in 
NMCP and IMCI guidelines. The list of assessment tasks promoted by both guidelines is 
presented in Table 2.19. All children, regardless of the presence of fever, were included 
in the analysis to evaluate health workers performance in assessing IMCI recommended 
“general danger signs” (inability of child to drink or breastfeed, history of convulsions, 
persistent vomiting and presence of lethargy or unconsciousness) and signs of other most 
common diseases (cough, difficult breathing, diarrhoea and ear problem). Assessment 
tasks were judged as correct if the health worker “determined” that the child had a 
particular symptom. “Determined” refers to whether the health worker asked about the 
presence of the symptom or the caretaker spontaneously reported the symptom. This 
definition prevented health worker’s performance being judged as incorrect when the 
presence of the symptom was already available to the health worker.
2.8.1.3 Definitions of correct malaria diagnosis
In “high malaria risk areas” (defined according to IMCI as >5%  of childhood fevers 
caused by malaria), all children with fever or history of fever should be classified as 
having malaria. The IMCI guideline does not consider blood smear results. The NMCP 
guideline is in accordance with IMCI recommendations where microscopy is not 
available. However, at facilities with a functional laboratory, NMCP guidelines promote
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the use of microscopy but remain ambiguous about what to do when a child with a fever 
has a negative blood smear. To prevent health workers practices being judged as incorrect 
due to guideline ambiguities on the interpretation of microscopy, when the correctness of 
diagnostic and treatment practices was analysed, patients with negative blood smear 
results were excluded. A detailed analysis on how the availability of microscopy affected 
malaria case management is presented in Chapter 6. Since all of our surveyed districts 
and facilities belong to “high malaria risk areas”, “correct” malaria diagnostic practice 
was defined as malaria diagnosis written in the patient-held record or prescription of any 
antimalarial drug for the febrile child. This adjustment was done since a substantial 
number of patients (6%) did not have any diagnosis written in their cards but all of them 
had medications prescribed. This definition prevented health workers diagnostic 
performance being judged as incorrect when it was obvious that a malaria diagnosis was 
considered when antimalarial treatment was prescribed.
2.8.1.4 Definitions of correct treatment practices
For uncomplicated malaria, both IMCI and NMCP guidelines recommend oral SP as the 
first-line treatment and oral amodiaquine or quinine as the second-line treatment. 
However, the guidelines do not specify if  health workers should prescribe second-line 
drugs if the child had received treatment at home with SP. For SP and amodiaquine, the 
NMCP and IMCI guideline specify ranges of appropriate dosages according to the 
patient’s age and weight. Both guidelines give concordant recommendations with regard 
to amodiaquine dosages; however, the recommendations for SP dosages in children 1-3 
years old are not harmonised between two guidelines. Furthermore, the IMCI guideline 
recommends use of oral quinine as second-line treatment but does not specify appropriate
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dosages. The dosage recommendations for nationally recommended antimalarials are 
presented in Tables 2.20, 2.21 and 2.22.
Table 2.20: NMCP and IMCI guideline recommendations for the use of SP tablets
NMCP guideline IMCI guideline
Age group
Weight Total SP as single dose
Age group
Weight Total SP
range
(kg)
Tablets Drops range tablets as 
(kg) single dose
< 3 months 
3 -11  months
<5
5 - 9
Va
V i
12a
20 2-11 months 4 -1 0  V2
1 -3  years 10-14 Va 30 1-3 years 10-14 1
4 - 6  years 15-18 1 45 3 - 5  years 14-19 1
7 -11  years 19-37 I V 2 NA NA NA NA
12 -1 5  years 38-49 2 V 2 NA NA NA NA
16 + years 50 + 3 NA NA NA NA
a 12 drops of SP are recommended for children below 6 months or below 7 kg; NA = not applicable
Table 2.21: NMCP and IMCI guideline recommendations for the use of AQ preparations
Weight No of tablets 200 mg base or mis of syrup 50 mg base3
Age group range Day 1 Day 2 Day 3 Total
(kg) Tabs mis Tabs mis Tabs mis Tabs mis
< 6 months <7 Va 7.5 Va 7.5 5 %■ 20
6-11  months 7 - 9 >/2 10 V l 10 Va 5 IVa 25
1 -3  years 10-14 % 15 3/4 15 V2 7.5 2 37.5
4 - 5  years 15-18 1 20 1 20 y2 10 1 x/2 50
6 -1 2  years 19-37 1 J/2 1 x/2 1 X/2 NA % NA 3 % NA
13 -  15 years 38-49 2V2 2 V2 2 V2 NA 1 Va NA 6 Va N A
16 + years 50 + 3 3 3 NA 1 !/2 NA 7 V2 N A
a Syrup preparations are only recommended by NMCP guideline; mis = millilitres; NA = not applicable
Table 2.22: NMCP guideline recommendations for the use of quinine tablets
Weight range 
(kg)
No of tablets per dose given 8 hourly
Age group Quinine Sulphate 
200 mg
Quinine Bisulphate 
300 mg
< 3 months <5
3-11  months 5 - 9 V2 x/2
1 -3  years 10-14 Va %
4 - 5  years 15-18 1 1
6 - 7  years 19-25 1 Va 1 Va
8 -1 2  years 26 -  37 1 Va 1 Va
13 -1 5  years 38-49 2 V2 2V2
>16 years 50 + 3 3
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Three outcome categories were used to evaluate “correctness” of treatment practice for 
uncomplicated malaria: 1) “recommended”, defined according to national guidelines; 2) 
“adequate” or “minor errors”, treatment not in accordance with national guidelines, but 
judged to have about the same efficacy as the recommended treatment; and 3) 
“inappropriate”, treatment not belonging to any of the above two categories. This 
analytical approach separates non-recommended practices into two different categories, 
because each of them may have different clinical consequences. Therefore, as opposed to 
non-effective treatment (“inappropriate”), antimalarial treatment that is effective but not 
recommended by national guidelines (“adequate”) should not increase a child’s risk of 
developing severe malaria and death.
To define three outcome categories of the “correctness” of treatment practice two types 
of drug-related parameters were used to perform two separate analyses: 1) analysis based 
on the choice of antimalarial drug only; and 2) analysis based on the choice of drug and 
appropriateness of its dosage. Although not the only one, the choice of drug is the critical 
component of treatment quality and from a programmatic point of view the antimalarial 
prescription pattern is of particular importance for the policy makers. However, in the 
second analysis, the criterion of dosage was added because even if a drug is selected 
according to national guidelines its prescription below the recommended dose may 
present inappropriate treatment, compromise treatment quality and may have dangerous 
clinical consequences.
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To perform the analysis of the “correctness” of treatment practice based on the choice of 
antimalarial drug, three treatment categories were defined: 1) “recommended”, 
prescription of oral SP monotherapy; in addition, to prevent health workers’ practices 
from being judged as incorrect due to imprecision of the guidelines, if  the caretaker 
reported during the consultation that the child’s illness had already been treated with SP, 
the prescription of either SP, amodiaquine, or quinine (all prescribed as an oral 
medication and as a monotherapy) was considered “recommended” treatment; 2) 
“adequate” or “minor error”, prescription of all non-recommended but still effective 
antimalarial drugs; and 3) “inappropriate”, prescription of either chloroquine or no 
antimalarial drug at all.
To perform the analysis of the “correctness” of treatment practice based on the choice of 
antimalarial drug and appropriateness of its dosage, the 3 treatment categories were 
defined: 1) “recommended”, prescription of recommended antimalarial drug according to 
the recommended dose; 2) “adequate” or “minor error”, prescription of recommended 
drug above, or adequate drug given according to or above the recommended dose; if  two 
antimalarial drugs were prescribed “adequate” treatment was considered present if one or 
both drugs were prescribed according to or above the recommended dose; and 3) 
“inappropriate”, prescription of recommended or adequate drug below recommended 
dose (condition necessary for both drugs if two antimalarials are prescribed), prescription 
of chloroquine regardless of the dose or no antimalarial drug at all. With regard to the SP 
dosages, to prevent health worker’s treatment practices being judged as “inappropriate” 
due to the discordant recommendations between NMCP and IMCI guidelines, the
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recommendations from NMCP guideline were used as the gold standard and the dosage 
of % tablet was considered as the recommended treatment for the child aged 1-3 years.
For severe malaria, parenteral quinine is recommended by both guidelines, intramuscular 
as a part of pre-referral management before hospitalisation and parenteral (intravenous 
drip or intramuscular) in the inpatient setting. Therefore, “recommended” treatment was 
defined as prescription of any parenteral quinine for the patient referred for 
hospitalisation. An adequate treatment was defined as the prescription of all non- 
recommended but still effective antimalarial treatments. Inappropriate treatment was 
defined as either chloroquine or no antimalarial treatment.
2.8.1.5 Definitions of counselling tasks
The NMCP guideline does not provide recommendations on the counselling component 
of the clinical process. To evaluate health workers counselling and communication 
performance, the IMCI recommended tasks for febrile children treated on an outpatient 
basis were used as the gold standard. The list of counselling and communication tasks 
recommended by the IMCI guideline is presented in Table 2.19.
2.8.2 Guideline recommendations and case definitions for older children and adult survey 
Unlike for children below 5 years of age, the national guidelines provide limited case 
management instructions for children aged above 5 years and adults. The IMCI guideline, 
by definition, does not address patients above 5 years of age whilst the NMCP guideline 
provides only a small and inconsistent section for the management of patients in the same
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age group. In older children and adults, the NMCP guideline recommends clinical 
diagnosis of malaria in patients with fever or history of fever, chills, rigors, headaches, 
joint aches and pains in the absence of other causes of fever. However, the guideline does 
not specify what clinical assessment tasks health workers should perform and what signs 
and symptoms present sufficient clinical criteria for other causes of fever. The guideline 
does not make any age distinction when it comes to the use and interpretation of malaria 
microscopy, implying that the same ambiguous recommendations are valid as for 
children below 5 years of age (Section 2.8.1.3). There are no recommendations provided 
on the counselling component of the clinical process while the treatment 
recommendations are the same as for children below 5 years of age (Section 2.8.1.4).
Given the lack of specified clinical standards and lower malaria risks in this age group 
compared to young children (Section 1.3.5.4), the focus of the older children and adults 
survey was not primarily an evaluation of the health workers practices in accordance with 
guidelines but a broader description of the current practices in clinical assessment of 
febrile patients, the accuracy of the routine health workers diagnosis of malaria, a 
description of the use and interpretation of microscopy, and the ability of clinical signs 
and symptoms to predict P. falciparum infection in febrile older children and adults.
2.8.2.1 Definitions of fever and malaria
A patient above 5 years of age was considered to have fever if a history of fever was 
reported in the last 48 hours or axillary temperature was >37.5 °C. History of fever was 
recorded as “main complaint” if it was spontaneously mentioned in response to a general
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question as to the reason for presentation to the clinic or “prompted” if it was reported on 
subsequent systematic questioning by the study physician during the exit examination.
To evaluate the accuracy of the routine health workers’ diagnosis of malaria, a “true” 
case of malaria was defined as a patient presenting with fever and detectable parasitaemia 
of any level and species determined by two expert microscopists during the post-survey 
reading of malaria slides. This definition is a conservative one, as fever and parasitaemia 
are common among sick outpatients but are not necessarily causal. However, this is a 
valid case definition at health facilities with microscopy, as most case management 
guidelines would use fever and parasitaemia as an indication for antimalarial treatment.
To assess the ability of clinical signs and symptoms to predict P. falciparum infection in 
febrile older children and adults a “true” case of malaria was defined as a patient 
presenting with fever and P. falciparum parasitaemia of any level.
2.8.2.2 Definitions of clinical assessment tasks
To evaluate the quality of health workers clinical assessment for patients with fever, the 
list of various clinical assessment tasks was developed and separated into three groups: 1) 
the tasks related to general information such as determination of age, weight, previous 
use of drugs and whether the visit was initial or follow up; 2) the tasks related to the signs 
and symptoms traditionally associated with malaria (headache, chills, shivering, joint 
pains, backache, anaemia and splenomegaly); and 3) the tasks related to the signs and 
symptoms commonly associated with other causes of fever than malaria (cough, running
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nose, difficulties in breathing, chest pain, abnormal chest sound, throat problem, ear 
problem, urinary problem, lymphadenopathy, diarrhoea and vomiting). The performance 
of clinical evaluation tasks was judged as “determined” in relation to the health workers 
intention to detect various signs and symptoms. To prevent health worker’s performance 
of assessment tasks being judged as inadequate when the presence of the symptom or 
sign was already available to the health worker, a symptom was judged as “determined” 
if health worker asked about its presence or the patient spontaneously reported the 
symptom. Likewise, a sign was judged as determined if  health worker performed the task 
or the surveyor could obviously tell the patient had the information of interest during the 
observation of consultation.
2.9 Data collection forms
2.9.1 Data collection forms for paediatric survey
Data collection forms were developed to capture information on the management of 
malaria and fevers as articulated in NMCP and IMCI guidelines, as well as health facility 
and health worker characteristics, considered important to support adequate malaria case 
management. Five survey forms were developed: 1) direct observation (Appendix I); 2) 
exit interview (Appendix II); 3) caretaker interview (Appendix III); 4) health worker 
interview (Appendix IV); and 5) health facility assessment (Appendix V).
The direct observation form (Appendix I) was developed to capture data on health 
workers performance of assessment and counselling tasks during consultations for 
paediatric patients. The data were collected by a silent observer who recorded the
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performance of clinical tasks using a checklist. Exit and caretaker interview forms 
(Appendices II and III) were developed to collect data about the child’s age, history of 
fever, previous use of antimalarial drugs, counselling and drug dispensing practices 
outside the consultation room, and if  the visit was an initial or follow up consultation. In 
addition, information was collected from patient-held records about diagnostic 
procedures requested and results reported (i.e. malaria blood smears), medications 
prescribed, and if the child was treated as an outpatient or referred for hospitalisation. 
Interviews with caretakers were performed when they were ready to leave the facility.
The health worker interview form (Appendix IV) was developed to collect data on health 
workers demographics, pre-service training, working experience, possession of the 
guidelines, and exposure to in-service training and supervision. The health worker 
interview was performed with the observed clinician at the end of the health facility visit. 
The health facility assessment form (Appendix V) was developed to collect data on the 
availability of medical supplies and equipment related to malaria case management. All 
paediatric forms were pre-tested by the survey trainers and myself on 100 sick child 
consultations and 5 health workers at Upendo Dispensary in Nairobi.
2.9.2 Data collection forms for older children and adult survey
Four survey forms were developed to capture the performance of clinical assessment 
tasks for febrile older children and adults but also to assess practices related to the use 
and interpretation of microscopy, the accuracy of the routine health workers diagnosis of 
malaria and to assess in greater depth the ability of signs and symptoms to detect P.
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falciparum infection among a febrile outpatient population. The survey forms were: 1) 
direct observation (Appendix VI); 2) temporary patient card (Appendix VII); 3) exit 
examination (Appendix VIII), and 4) health worker interview (Appendix IX).
The direct observation form (Appendix VI) was developed to capture data on health 
workers performance of assessment tasks during consultations for patients older than 5 
years of age. The form was developed to reflect clinical standards considered either 
common or clinically important for malaria case management in this age group. The data 
were collected by the silent observer who recorded the performance of clinical tasks 
using a checklist.
The temporary patient card (Appendix VII) is the form where the observed clinicians 
recorded the clinical notes during the consultations of enrolled patients. Information 
about health workers routine practices such as medications prescribed, diagnostic 
procedures requested and results reported were collected from this form. The structured 
exit examination form (Appendix VIII) was developed to establish in greater depth the 
presence of signs and symptoms during the re-examination of patients by the study 
physician. The health worker interview form (Appendix IX) was developed to collect 
data on health workers demographics, pre-service training, working experience, 
possession of guidelines, and exposure to in-service training and supervision.
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2.10 Survey teams and training of surveyors
2.10.1 Survey teams and training of surveyors for paediatric survey
The paediatric survey work in each of the four districts was conducted with four teams
composed of three surveyors supervised by a clinician from the DOMC and myself who
also acted as trainers. Each team consisted of a clinical officer who performed
observations of consultations, health worker interviews and health facility assessments,
and two nurses who performed interviews with caretakers. Clinical officers and nurses
were recruited in the surveyed districts to ensure that all are familiar with the local
vernacular languages. The clinicians who trained the surveyors supervised the survey
teams during the facility visits to ensure that the survey protocol was correctly followed.
The training of surveyors was conducted over three days the week prior to the survey 
with patients and caretakers presenting at the outpatient departments of district hospitals. 
The training consisted of: 1) general introduction to the purpose and design of the survey;
2) instruction and practice interviewing caretakers; 3) instruction and practice observing 
and recording a health worker examining different children; and 4) problem solving and 
role-playing to assure accuracy of data collection.
To assess the surveyors’ ability to accurately observe consultations (for observers) or 
record caretaker responses (for interviewers), the role-plays of consultations and 
interviews were conducted in which a “gold standard” set of correct observations (or 
interview responses) was determined by the trainers. For each role-play, a percent 
agreement score was calculated for each surveyor, where percent agreement = (number of
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survey items the surveyor recorded that matched the gold standard / total number of 
survey items for a particular role-play) x 100%. Training continued until the agreement 
scores were greater than 90%. On the fourth day of the training, a full field trial of the 
survey tools and procedures was conducted in four facilities not selected as part of the 
survey.
2.10.2 Training of surveyors for older children and adult survey
The older children and adult survey work in each of the two districts was conducted with 
one survey team composed of three surveyors supervised by myself. Each team consisted 
of a clinical officer who performed observations of consultations and health worker 
interviews, a study physician who performed exit examination, and a laboratory 
technician who prepared malaria slide for febrile patients. I stayed permanently at the 
health facility during the survey visits and supervised the team ensuring that the survey 
protocol was correctly followed.
The selected personnel for older children and adult surveys were the same surveyors who 
previously participated in the paediatric survey and showed the best performance. Before 
the actual survey the training and accuracy testing was performed following the same 
content and procedures as in the paediatric survey. Training and accuracy testing was 
undertaken over three days in each district hospital until agreement of practice was 
greater than 90%, for both observer and exit examiner.
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2.11 Survey procedures
2.11.1 Survey procedures for paediatric survey
Prior to the surveys, I visited each of the DHMTs, presented the survey and requested 
their cooperation. The week prior to the survey, the initial GIS sampling frame was 
adjusted with DHMT members, the average number of sick children seen per day was 
counterchecked with estimates extrapolated from monthly reports and sampling of 
facilities was performed (Sections 2.6 and 2.7). In the same week, a representative of the 
DHMT and myself visited the in-charges of each selected health facility and requested 
their assistance during the survey. The in-charge of the facility was told that the DOMC 
and DHMT were observing how malaria related care is currently provided as part of 
monitoring and evaluation activities of DOMC. He/she was advised that the results were 
confidential and would not be used in any punitive way. The exact day of the survey visit 
was not announced in advance to the facility staff.
On the day of the survey, survey teams arrived at each facility without prior notice, 
before the official opening time (8:00 a.m.) and stayed until the official closing time 
(5:00 p.m.) or until the time when the night shift would take over duties in facilities 
opened 24 hours. Each survey team carried with them a letter from the Ministry of Health 
specifying the purpose and nature of the survey. After obtaining consent from the facility 
in-charge and introducing themselves to facility staff, the team asked for a brief tour of 
the facility and worked with the staff to establish posts for observation and interviews 
with caretakers and health workers. After the observed health worker and caretaker 
(usually the child’s mother) consented verbally, an observer recruited all sick children
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presenting to the outpatient departments during working hours. If more than one health 
worker was seeing sick children at a facility, all were observed and interviewed.
The data were collected using four methods in the following order. First, the surveyor 
silently observed consultations using the direct observation form. Second, caretakers 
were interviewed using exit and caretaker interview form when they were ready to leave 
the facility. Third, interviews were conducted with observed health workers at the end of 
the two-day survey visit. Fourth, a health facility assessment was performed with the 
facility in-charge either at the end of the working day or during the time when there were 
no patients at the facility.
Before leaving the facility, the team members reviewed all data forms for blanks, 
inconsistencies and illegible writing. After the second day of the survey, the supervisor 
provided confidential and constructive feedback to the facility’s in-charge and health 
workers. The team then thanked the facility staff and departed.
2.11.2 Survey procedures for older children and adults survey
The survey procedures prior to the facility visits were the same as in the paediatric survey 
(Section 2.11.1). Verbal consent from the observed clinician was sought prior to the 
commencement of the survey procedures. In particular it was explained that an evaluation 
of the overall picture of care was the aim, that an individuals performance was not being 
judged and that the aim was not to highlight or punish an individuals “poor 
performance”. The observer and myself carried out initial screening of all sick patients
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above 5 years of age presenting at the waiting area of an outpatient clinic between 8 a.m. 
and 5 p.m. Patients presenting with trauma, bums, chronic follow up conditions or 
routine antenatal visits were excluded. Prior to the observations the patients or caretakers 
were provided with a consent information sheet and the study was explained in the 
language they felt most comfortable with (Appendix X). The informed written consent 
was obtained for all recruited patients (Appendix XI).
The data were collected using four methods in the following order. First, the surveyor 
silently observed consultations using the direct observation form. The observed health 
worker performed consultations as per usual procedure and recorded the patient’s clinical 
notes in the temporary patient card that remained in the consultation room.
Second, the study physician located in a separate examination room re-examined all the 
patients using the exit examination form without seeing the temporary patient card 
completed during the first consultation. In addition, the study physician recorded clinical 
notes, diagnosis and medications into patient-held records as per routine facility 
procedures.
Third, a finger-prick blood sample for malaria microscopy was taken at the exit 
examination by the study laboratory technician if  the patient had an axillary temperature 
>37.5°C or reported a history of fever in the last 48 hours. Thick and thin blood films 
were prepared at the facility and stained with Giemsa 10%. If a blood film was requested 
during the initial health worker consultation the study malaria slide was prepared
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simultaneously in the facility’s clinical laboratory. During the post-survey work two 
independent expert microscopists examined all collected slides at the KEMRIAVellcome 
Trust laboratories in Nairobi and the number of parasites per 200 white blood cells 
(WBC) was counted. Parasite density/pl of blood was calculated assuming an average 
leukocyte count of 8,000 WBC/pl of blood.
Fourth, interviews were conducted with observed health workers at the end of the two- 
day facility visit. Before leaving the facility, team members reviewed all data forms to 
ensure they were complete and correct and provided confidential and constructive 
feedback to the facility’s in-charge and health workers regarding specific assessment, 
diagnosis and treatment steps. The team then thanked the facility staff and departed.
2.12 Data entry, management and storage
Data entry and validation were undertaken using Microsoft Access 2000 (Microsoft Inc, 
Redmond, Washington) through customised data entry screens with in-built range and 
consistency checks. All forms were entered twice by independent data entry clerks and 
completed data sets were compared for data-entry errors. All data entry and management 
was undertaken at the KEMRIAVellcome Trust Programme in Nairobi and data stored on 
PCs and on CDROMs at this centre.
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2.13 Statistical analysis
2.13.1 Statistical analysis of the children’s survey
All analyses were performed using STATA, version 6.0 (StataCorp, College Station, 
Texas). The major analyses of the children survey were descriptive and included an 
analysis of predictors of treatment practice in accordance with guidelines.
2.13.1:1 Descriptive analysis
Descriptive analysis of the health worker performance indicators was performed for each 
district and combined for four districts across the two facility type strata. The results are 
presented aggregated for four districts and all types of facility if  significant differences 
between districts or between types of facility within four districts were not observed 
(Chapter 3). Descriptive analysis of the health workers practices from facilities with 
functional microscopy was performed for four districts together and across two age 
groups (< 1 year and 1-4 years) (Chapter 6). In each analysis the precision of proportions 
(95% confidence interval) was estimated accounting for the cluster sampling design by 
defining all sick child consultations occurring at a surveyed health facility as the primary 
sampling unit. To account for unequal probabilities of selection of health facilities, 
sampling weights were applied when results from different strata were combined. The 
weights were calculated as the inverse probability of selection of the health facility 
(Table 2.23).
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Table 2.23; Distribution of sampling weights across districts and strata
District No of HFs in sampling frame
No of surveyed 
facilities
Probability of 
HFs selection3 Weightb
KWALE
Dispensaries 36 15 0.42 2.40
HC 8 8 1 1
District Hospital 1 1 1 1
KISH
Dispensaries 22 10 0.46 2.20
HC 13 8 0.62 1.63
District Hospital 1 1 1 1
BONDO
Dispensaries 12 12 1 1
HC 4 4 1 1
District Hospital 1 1 1 1
MAKUENI
Dispensaries 37 11 0.30 3.36
HC 14 9 0.64 1.56
District Hospital 1 1 1 1
a Probability of selection = number of surveyed facilities/number of facilities in sampling frame 
b Weight = 1/probability of selection 
HF = health facility; HC = health centre
2.13.1.2 Predictors analysis
The predictors analysis of the health workers treatment practices was performed on 
aggregated data from the four districts (Chapter 4). To identify predictors of three 
categories of treatment quality (recommended, minor errors, and inappropriate), multiple 
binomial logistic regression modeling was used (Rowe et al., 2003). With this technique, 
a series of binomial logistic regression models were created (one model for each category 
of treatment quality), and the results were interpreted together. The logistic regression 
models were fitted with the STATA xtgee procedure using an exchangeable working 
correlation matrix. This procedure uses generalised estimating equations to account for 
the potential correlation of treatment quality among children seen by the same health 
worker (Horton & Lipsitz, 1999). The exchangeable correlation structure assumes the
correlation of the treatment quality between any pair of children is approximately 
constant.
In the univariate analysis, the odds ratio (OR), p-value, and 95% confidence interval for 
the association of each category of treatment quality was computed with the series of 
potential predictors. All logical statistical interactions were examined. To adjust for 
confounding, factors with a p-value <0.15 from the univariate analysis and interaction 
terms with p-value <0.05 were entered into three multivariate logistic regression models 
(as in the univariate analysis, one model for each category of treatment quality). Factors 
that did not initially meet the entrance criteria for the multivariate analysis (i.e. “non­
significant” [p >0.15]) were then entered into the three multivariate models, one factor at 
a time. If the addition of a “non-significant” variable changed the OR of any already- 
included variable by >10%, the additional variable was retained in the final multivariate 
model. The three multivariate models were forced to contain the same variables: any 
variable meeting the entrance criteria for one model was automatically entered into the 
other two models. This approach ensured that the three ORs (one from each model) for a 
given factor would be adjusted for the same covariates. The list of all factors examined 
and statistical procedures for each variable are presented in Chapter 4.
2.13.2 Statistical analysis of older children and adult survey
The major analyses of the older children and adult survey were descriptive and predictors 
analysis and were performed using STATA software, version 8.0 (StataCorp, College 
Station, Texas).
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2.13.2.1 Descriptive analysis
The major descriptive analyses in older children and adults survey were the following:
1) Analysis of the health workers clinical assessment practices (Chapter 5),
2) Analysis of the accuracy of the routine health workers diagnosis of malaria (Chapter 5),
3) Analysis of the health workers practices related to the use and interpretation of 
microscopy (Chapter 6), and
4) Analysis of the accuracy of the routine reading of malaria slides (Chapter 6).
The analysis of the health workers clinical assessment practices (analysis 1) was 
performed on the non-stratified sample for each of the two study districts (Kwale and 
Kisii) and overall for two districts together. Furthermore, comparative age-specific 
analysis on the combined data sets from the two districts was performed between two age 
groups (5-14 years and above 14 years). The analysis of the accuracy of the routine health 
workers diagnosis of malaria (analysis 2) was performed across two age-groups (5-14 
years and above 14 years) at the health facilities without functional microscopy, in each 
district and overall for two districts together. The analysis of the health workers practices 
related to the use and interpretation of microscopy (analysis 3), and the accuracy of 
routine reading of malaria slides (analysis 4) was performed on the patients from 
facilities with functional microscopy, on district combined data sets and across two age 
groups (5-14 years and above 14 years of age).
In all descriptive analyses, the precision of proportions (95% confidence interval) was 
estimated accounting for the cluster sampling design by defining all consultations
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occurring at a surveyed health facility as the primary sampling unit. The district- 
combined results stratified on the basis of the availability of microscopy did not require 
weighting since the probability of the selection of health facilities was equal in each 
district (sampling weight was 1.9 at facilities without microscopy and 1.4 at facilities 
with microscopy). The relative sampling weights between strata within a district were of 
small magnitude (1.9/1.4 = 1.36). The differences between non-stratified weighted and 
unweighted results were examined and were trivial (not exceeding 0.3%), not affecting 
interpretation of the results for any of the estimates measured. Therefore, only the 
unweighted results are presented.
To analyse the accuracy of the routine health workers diagnosis of malaria and the quality 
of the routine reading of malaria slides, parasitaemia of any level and species in the 
febrile patient determined by two expert microscopists was used as a gold standard. The 
sensitivity, specificity, and positive and negative predictive values were calculated 
according to the following formula:
Accuracy o f the routine malaria diagnosis:
Sensitivity = Routine diagnosis of malaria / Malaria parasitaemia present 
Specificity = Routine diagnosis of non-malaria / Malaria parasitaemia absent 
Positive predictive value = Malaria parasitaemia present / Routine diagnosis of malaria 
Negative predictive value = Malaria parasitaemia absent / Routine diagnosis of non-malaria
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Quality o f  the routine reading o f  malaria slides:
Sensitivity = Routine malaria slide positive / Malaria parasitaemia present 
Specificity = Routine malaria slide negative / Malaria parasitaemia absent 
Positive predictive value = Malaria parasitaemia present / Routine malaria slide positive 
Negative predictive value = Malaria parasitaemia absent / Routine malaria slide negative
2.13.2.2 Predictors analysis
The analysis of the ability of various signs and symptoms to detect P. falciparum malaria 
in febrile patients was performed after stratification based on the patients’ age (older 
children vs adults); however, due to the small number of true malaria cases district 
specific analysis could not be performed and the data were combined from the two study 
districts.
The univariate analysis of the strength of association between clinical predictors and 
malaria was estimated using logistic regression modeling, and the odds ratios (OR) with 
associated p-values were calculated for each investigated sign and symptom. To adjust 
for confounding, clinical predictors with a p-value <0.20 from the univariate analysis 
were entered into two age-specific multivariate logistic regression models. Using 
backward elimination strategy clinical predictors independently associated with malaria 
(OR with p-value <0.05) were identified. To analyse the ability of an individual and a 
group of clinical predictors to detect P. falciparum malaria in a febrile patient the 
sensitivity, specificity, and positive and negative predictive values were calculated 
according to the following formula:
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Sensitivity = Clinical predictor absent / P. falciparum infection present 
Specificity = Clinical predictor absent / P. falciparum infection absent 
Positive predictive value = P. falciparum infection present / Clinical predictor present 
Negative predictive value = P. falciparum infection absent / Clinical predictor absent
2.14 Study limitations
The health facility surveys experienced several important methodological limitations. 
First, the presence of the study observer may have caused health workers to perform 
better than usual (the Hawthorn effect, as suggested by results from Benin [Rowe et al., 
2002]) or worse than usual, if  observers made health workers nervous. Second, as 
explained in detail in Section 2.8.2.1, there was no clinical re-examination during the 
paediatric survey to provide a “gold standard” diagnosis in accordance with guidelines; 
therefore, we relied upon the proxy measures to classify severity of malaria diagnosis. 
Third, during the paediatric survey, the child’s temperature was not measured during the 
exit interview; therefore, the case definition of a febrile child, based solely on the 
caretaker’s history, may have underestimated the presence of malaria according to 
guidelines. Fourth, during the older children and adult survey, the microscopic “gold 
standard” diagnosis of malaria did not necessarily overcome the problem of coincidental 
malaria parasitaemia in a febrile patient unwell for another reason. Fifth, since multiple 
comparisons in all analyses were performed some differences may have been significant 
by chance. Conversely, the true differences for certain indicators between different strata 
may not have been demonstrated due to the size of design effect and inadequate sample 
size. Sixth, due to the small number of malaria cases, district specific analysis of clinical
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predictors of malaria in older children and adults could not be performed and data from 
two districts had to be combined. Seventh, during the predictors analysis on the quality of 
the treatment in children, not all potential factors were studied such as health workers 
perceptions or complexity of guidelines and only limited details were available on key 
programmatic interventions such as supervision and training.
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CHAPTER 3:
Evaluation of outpatient malaria case management 
in children
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3.1 Introduction
Malaria case management, emphasising prompt diagnosis and effective treatment, 
especially in children below 5 years, forms the bedrock of malaria control in Africa 
(WHO, 1996a; 2000a). In East and Southern Africa, since the early 1990’s, under-five 
malaria mortality rates have risen significantly, coincidental with the emergence of 
resistance to widely used first-line therapeutic chloroquine (Snow et al, 2001b; 
Korenromp et al., 2003). Countries of these regions have struggled in recent years to 
define affordable alternatives to the rapidly declining effectiveness of chloroquine. Drug 
policy revisions have been slow but now implemented in a number of East African 
countries (EANMAT, 2003) and South Africa (Craig et a l , 2004).
However, deciding to change first-line drugs is only part of a complex process aimed at 
improving the overall process of malaria case management. The adequate provision of 
good clinical practice up to the standards of care defined in evidence-based guidelines 
remains indispensable. Furthermore, good clinical practice requires programmatic health 
systems supports, which include effective training and supervision of health workers, 
development and dissemination of guidelines and adequate provision of antimalarial 
drugs.
To tackle the risks posed by malaria to broad development targets the Ministry of Health 
launched the Kenya National Malaria Strategy (KNMS) in April 2000. This strategic 
framework gives considerable importance to clinical management, with emphasis on 
prompt and effective treatment (DOMC, 2001). The KNMS reflects approaches
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established in a series of guidelines developed during the change of treatment policy from 
chloroquine to SP between 1998 and 2000 (MoH, 1998; 2000b) and the more recent 
adoption of approaches to IMCI (Gove, 1997; MoH, 2000a).
This chapter presents the results of a series of performance indicators among government 
health service providers according to their ability to assess, diagnose, treat and counsel 
febrile paediatric patients. In addition, health systems support indicators related to 
malaria case management are also presented. Furthermore, these indicators, measured 
three years following the introduction of new malaria case management guidelines, will 
also serve to evaluate the progress towards the malaria case management targets at health 
facility level, set up optimistically by the KNMS to be above 80% and achieved by 2006.
3.2 Methods
Detailed presentation of the materials and methods used to evaluate outpatient, childhood 
malaria case management is provided in the following sections of Chapter 2:
1) Characteristics of the study districts (Section 2.3)
2) Development of the sampling frame (Section 2.6.1)
3) Sampling procedures (Section 2.7.1)
4) National guidelines and study case definitions (Section 2.8.1)
5) Data collection forms (Section 2.9.1)
6) Survey teams and training of surveyors (Section 2.10.1)
7) Survey procedures (Section 2.11.1)
8) Statistical analysis (Section 2.13.1)
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The components of the clinical process evaluated, subsets of children analysed and 
definitions of the correctness of the performance are summarised in the previous chapter 
(Table 2.19).
3.3 Results
3.3.1 Description of the sample
The survey was undertaken at the outpatient departments of 81 government health 
facilities where 142 health workers were observed as they performed 1864 sick child 
consultations. No health worker or caretaker refused to participate in the study. However, 
of 1864 children, 170 caretakers (9.1%) left the health facility before the study team 
could interview them. These 170 consultations were excluded from the analysis. Of 142 
observed health workers, interviews were conducted with 135 health workers. Seven 
(4.9%) health workers, who performed a total of 40 consultations, urgently left the health 
facility before an interview could be performed and could not be found within three days. 
The health facility assessment was performed for all 81 facilities. Dispensaries and 
combined health centres and district hospitals (HC/DH) accounted for 49% and 51% of 
observations, respectively. The distribution of the assessed health facilities and analysed 
health worker-sick child consultations across four districts and two types of facility is 
presented in Table 3.1.
143
Table 3.1: Distribution of the assessed health facilities and analysed health worker-sick
child consultations across four districts and two types of facility
District Dispensary HC/DH Total
KWALE
Health facilities 15 9 24
Health workers 23 19 42
Consultations 228 204 432
KISH
Health facilities 10 9 19
Health workers 19 19 38
Consultations 208 267 475
BONDO
Health facilities 12 5 17
Health workers 17 11 28
Consultations 218 175 393
MAKUENI
Health facilities 11 10 21
Health workers 13 21 34
Consultations 173 221 394
TOTAL
Health facilities 48 33 81
Health workers 72 70 142
Consultations 827 867 1694
HC = health centre; DH = district hospital
3.3.2 Characteristics of sick children, health workers and health facilities
3.3.2.1 Characteristics of sick children
Among the 1694 consultations analysed, 81 (4.4%) children were younger than 2 months, 
515 (29.4%) were 2-11 months and 1098 (66.2%) were 12-59 months. Infants accounted 
for 33.8% of consultations. The average number of participating children per health 
facility and health worker was 20.9 and 11.9 respectively. The age distribution of 
participating children is presented in Table 3.2.
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Table 3.2: Age distribution of participating children
Age group (months) N=1694 (%)
0-1
2-11
12-23
24-35
36-47
48-59
81 (4.4) 
515 (29.4) 
406 (24.5) 
280(16.8) 
215(13.0) 
197 (11.9)
Of 1613 sick children aged 2-59 months, 1516 (94.0%) were brought to the facility for an 
initial consultation. The performance of the assessment tasks was evaluated on all 1516 
initial visits and on the subset of 1237 initial visits of children with fever. Of 1516 initial 
consultations, 1103 met our definition of malaria: uncomplicated malaria accounted for 
1040 (95.3%) and severe malaria for 63 (4.7%) initial consultations. Of 63 children with 
severe malaria, 21 (37.7%) patients were referred for hospitalisation from facilities 
without an inpatient department and 42 (62.3%) were admitted at facilities with inpatient 
services. The subsets of sick children used for the evaluation of different components of 
clinical process across four districts are presented in Table 3.3.
Table 3.3: Subsets of sick children across four districts51
Subset o f children KWALE KISH BONDO MAKUENI Total
Assessment 1 363 450 358 345 1516
Assessment 2 303 393 277 264 1237
Diagnosis 264 355 262 222 1103
Treatment of uncomplicated malaria 257 318 246 219 1040
Treatment of severe malaria 7 37 16 3 63
Counselling and communication 294 349 260 260 1163
a See Table 2.19 for definitions of the subsets
Fever and cough accounted for the majority (71.4% and 54.9% respectively) of the sick 
children’s main complaints (complaints stated by caretaker without prompting), and
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commonly children had both of these symptoms (41.0%). Diarrhoea, vomiting and non­
specific symptoms, such as not eating well and stomach ache, were the main complaints 
among 13-19% of sick children. The average number of main complaints per child was 
2.9. The sick child main complaints are presented in Table 3.4.
Table 3.4: Summary of the sick child’s main complaints
Main complaint N=1694 (%) 95% Cl
Fever 1199 (71.4) 68.1,74.8
Cough 898 (54.9) 49.9, 59.8
Vomiting 358 (19.1) 16.2, 22.0
Diarrhoea 261 (14.6) 12.1, 17.0
Not eating well 249 (13.9) 11.2,16.6
Stomach ache 226 (13.4) 11.0,15.8
Difficult breathing 198 (12.0) 9.4, 14.7
Skin problem 195(10.2) 8.2, 12.2
Runny nose 142 (8.7) 5.9, 11.5
Malaria 69 (5.6) 2.5, 8.8
Headache 63 (3.9) 2.9, 5.0
Mouth or throat problem 58 (3.6) 2.4, 4.8
Eye problem 51 (3.0) 2.1, 3.9
Ear problem 48 (2.9) 2.0, 3.9
Convulsions 35 (2.2) 1.4, 3.0
Swellings 32(1.8) 1.0, 2.7
Crying a lot 31 (1.6) 0.9, 2.3
Traumas 19(1.2) 0.6,1.7
Worms 13 (0.9) 0.4, 1.4
Constipation 17 (0.8) 0.2, 1.3
Bums 5 (0.3) 0, 0.5
No complaint 15 (0.9) 0.2, 1.6
Others 55 (2.7) 1.7, 3.8
Fever and cough 663 (41.0) 36.9, 45.2
3.3.2.2 Characteristics of health workers
Of 142 observed health workers, 135 participated in health worker interview and 
provided information on their demographics, exposure to in-service training, guidelines 
and supervision. The mean age was 38 years (range: 20-65) and the majority of the health 
workers were nurses (76.8%), while clinical officers (15.0%) constituted the largest
second group. Clinical officers, registered nurses (apart from one) and one doctor worked 
only in health centres and hospitals, while enrolled nurses and nursing aides worked 
mostly in dispensaries. The median health workers professional experience and the time 
spent in the surveyed facility were 12 years (IQR: 6-22 years), and 5 years (IQR: 3-7 
years) respectively. Sixty (45.8%) health workers were in charge of the health facilities, 
more commonly in dispensaries than in HC/DHs. The demographics of health workers 
according to the type of facility are presented in Table 3.5.
Table 3.5: Demographics of health workers according to the type of facility
Health workers characteristics Dispensary HC/DH Total
N=71 (%) N=64 (%) N=135 (%)
Male sex 32 (45.8) 34 (52.0) 66 (48.0)
In-charge of health facility 44 (61.1) 16(26.3) 60 (45.8)
Pre-service training
Doctor 0 1(1.9) 1 (0.7)
Clinical officer 0 29 (43.2) 29(15.0)
Registered nurse 1 (1.5) 8(13.1) 9(5.6)
Enrolled nurse 62 (89.2) 23 (37.5) 85 (71.2)
Nursing aide 8 (9.3) 3 (4.3) 11 (7.6)
HC = health centre; DH = district hospital
No health worker received IMCI training or vertical training programmes preceding 
IMCI, such as trainings on the management of acute respiratory infections (ARI) or 
control of diarrhoeal diseases (CDD). Fifty-nine (44.9%) health workers attended in- 
service training on malaria. Six health workers were trained twice. About one-third of 
health workers who received malaria training were trained between 1998 and 1999, and 
about two-thirds were trained between 2000 and 2001. The duration of malaria training 
was 1 day for 32 (50.1%) health workers, 2-3 days for 18 (33.3%), and 5-7 days for 9 
(16.6%). The malaria training course of 25 (43.8%) health workers included clinical
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practice. In three out of four districts, the Ministry of Health trained the majority of 
health workers (93.4%) and only in Kisii district, a non-governmental organisation 
Medecins Sans Frontieres trained most of health workers (83.9%). The majority (76.3%) 
of health workers had at least one supervision visit in the past 6 months. Of these health 
workers, 67.6% had 1-3 supervisory visits, 28.1% had 4-6 visits, and 4.4% had 7-10 
visits. The majority (78.8%) of supervisory visit did not include observation of 
consultations or provision of feedback. Characteristics of health workers exposure to in- 
service training, guidelines and supervision according to the type of facility are presented 
in Table 3.6.
Table 3.6: Characteristics of health workers exposure to training, guidelines and supervisionM MI7AV v* MVVVA M. tJ VI v U VF M. UVMA«>U TV X/A A&VA kj Vi&MVUMA V  ^V
Health workers characteristics Dispensary HC/DH Total
HWs exposure to training, guidelines and supervision N=71 (%) N=64 (%) N=135 (%)
HW received in-service malaria training 37 (50.3) 22 (34.8) 59 (44.9)
HW has malaria guidelines 43 (60.2) 34 (53.5) 77 (57.8)
HW had at least one supervision visit in past 6 months 62 (89.3) 32 (51.8) 94 (76.3)
Characteristics o f  training N=37 (%) N=22 (%) N=59 (%)
Duration of in-service malaria training
1 day 17(42.8) 15 (69.9) 32 (50.1)
2-3 days 13 (37.7) 5 (27.2) 18(33.3)
5-7 days 7(19.5) 2 (8.9) 9(16.6)
Type of training
Training without clinical practice 22 (58.0) 12(51.4) 34 (56.2)
Training including clinical practice 15 (42.0) 10(48.6) 25 (43.8)
Characteristics o f  supervision N=62 (%) N=32 (%) N=94 (%)
Number of visits in past 6 months
1-3 visits 42 (71.8) 18(53.9) 60 (67.6%)
4-6 visits 18 (24.8) 12 (38.7) 30(28.1%)
7-10 visits 2(3.4) 2 (7.4) 4 (4.4%)
Supervision performed by
Resident HW 10(16.7) 17 (54.4) 27 (25.6)
External HW 52 (83.3) 15 (45.6) 67 (74.4)
Type of supervision
Supervision without observation and feedback 50 (82.1) 23 (68.2) 73 (78.8)
Supervision with observation and feedback 12(17.9) 9(31.8) 21 (21.2)
HC = health centre; DH = district hospital; HW = health worker
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3.3.2.3 Characteristics of health facilities
SP was in stock on the day of survey in 80 of 81 facilities while either amodiaquine or 
quinine was available in 53.1% of facilities, more commonly in HC/DHs than in 
dispensaries. Injectable quinine was available in only 32.7% of facilities. Chloroquine 
was still available in the majority (64.3%) of health facilities. Malaria treatment wall 
charts were exposed in consultation rooms of 27.0% of facilities. The characteristics of 
health facilities according to the type of facility are presented in Table 3.7.
Table 3.7: Characteristics of health facilities
Health facility characteristics Dispensary HC/DH TotalN=48 (%) N=33 (%) N=81 (%)
Malaria treatment wall chart in the consultation room 10 (22.2) 12 (38.9) 22 (27.0)
SP (any formulation) in stock 47 (96.8) 33 (100) 80 (97.7)
Amodiaquine (any formulation) in stock 11 (26.6) 15 (45.8) 26 (32.1)
Quinine tablets in stock 4 (8.4) 14(42.1) 18(18.1)
Injectable quinine in stock 15 (33.3) 11 (31.0) 26 (32.7)
Chloroquine (any formulation) in stock 29 (68.3) 18 (54.2) 47 (64.3)
Any formulation of amodiaquine or quinine in stock 20 (46.0) 23 (68.5) 43 (53.1)
HC = health centre; DH = district hospital; SP = sulfadoxine-pyrimethamine
3.3.3 Duration and timing of consultations and distribution of patients time at the facility 
The duration of consultation ranged from less than one minute to 35 minutes. Twenty- 
two percent of consultations were shorter than 3 minutes, while only 3.2% were longer 
than 10 minutes. Nearly half (48.3%) of consultations lasted 3-5 minutes. Consultations 
were not evenly distributed throughout the day: 82.9% occurred between 9:00 a.m. and 
1:00 p.m., 16.7% after 1:00 p.m. and only 0.1% before 9:00 a.m. The median 
consultation time was 4.0 minutes (IQR: 3-6 minutes). No significant difference in the 
duration of consultation and their timing was observed between districts or between types
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of facility. The distribution of duration and timing of consultations is presented in Table 
3.8.
Table 3.8; Duration and timing of consultations
Duration and Timing N=1694 (%)
Duration o f consultation
< 3 min 376 (22.2)
3-5 min 819 (48.3)
6-10 min 445 (26.3)
> 10 min 54 (3.2)
Timing o f consultation
< 9:00 a.m. 1 (o.i)
9:00 a.m. -10:00 a.m. 177 (10.1)
10.00 a.m. -  1:00 p.m. 1233 (72.8)
> 1:00 p.m. 283 (16.7)
The majority of patients (79.6%) arrived at the facility between 9:00 a.m. and 1:00 p.m., 
10.5% arrived before 9:00 a.m. and only 9.8% came to the facilities after 1:00 p.m. 
Within 30 minutes of their arrival, 27.2% of patients were attended, while 20.1% waited 
for more than 2 hours before being seen. Sixty-seven percent of patients spent less than 2 
hours at the facility, however, a significant proportion of patients (15.6%) spent more 
than 3 hours. The median time patients waited to be attended and total time spent at the 
facility was 60 minutes (IQR: 87-115 minutes) and 81 minutes (IQR: 39-142 minutes) 
respectively. No significant difference in the distribution of patient’s time at the facility 
was observed between districts or between types of facility. The distribution of patient’s 
time at the health facility is presented in Table 3.9.
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Table 3.9; Distribution of patient’s time at health facility
Patient’s time at facility N=1694 (%)
Arrival time
< 8:00 a.m. 21 (1.2)
8:00-9:00 a.m. 158 (9.3)
9:00 -10:00 a.m. 322 (19.0)
10:00 a.m. -  1:00 p.m. 1027 (60.6)
>1:00 p.m. 166 (9.8)
Waiting time before consultation
< 30 min 461 (27.2)
30 min - lh 373 (22.0)
lh - lh30min 306 (18.1)
lh30min - 2h 214(12.6)
>2h 340 (20.1)
Total time spent at health facility
< 1 h 630 (37.2)
1 -2 h 505 (29.8)
2 - 3 h 294 (17.4)
3 - 4 h 138(8.1)
>4h 127 (7.5)
3.3.4 Characteristics of clinical process
3.3.4.1 Assessment
Among 1516 initial consultations for sick children aged 2-59 months, health workers 
determined the age and weight for 90.7% and 52.7% of children, respectively. Apart from 
determining whether a child was awake or alert, IMCI proposed “general danger signs” 
were rarely assessed (5.1-9.5%). Presence of fever was determined for the majority of 
patients (88.1%), more frequently than cough or difficult breathing (67.5%), diarrhoea 
(29.6%) or ear problems (4.9%). Apart from asking for fever (47.8%), explorative history 
tasks such as asking for cough or difficult breathing, diarrhoea and ear problem were 
rarely done for the patients not voluntarily presenting these symptoms as main complaints 
(1.9-23.1%).
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Among 1237 children with fever the temperature was either measured or the hotness of 
body was felt for 62.1% of children. Duration of fever and assessment of anaemia were 
performed for 69.3% and 53.3% of children respectively. Assessment of patients with 
fever for the signs of suspected severe malaria by assessing for respiratory distress 
(looking at chest indrawing or deep breathing, counting breaths) and dehydration 
(pinching the skin) was rarely performed (0-9%). Previous use of drugs was inquired in 
42.2% of children and whether a visit was an initial or follow up visit was determined in 
18.2% of febrile children. No significant difference in the performance of assessment 
tasks was observed between districts or between types of facility. The results of 
assessment practices are presented in Table 3.10.
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Table 3.10: Assessment tasks performed for children aged 2-59 months who were brought 
to an outpatient facility for an initial consultation________________________________
Assessment task No (%) 95% Cl
For all children (N=1516)
Health worker determined3 if the child
Had convulsions 60 (5.1) 3.1, 7.2
Was lethargic or unconscious 1438 (94.7) 92.3, 96.4
Was unable to drink or breastfeed 143 (9.5) 6.4,12.6
Vomited everything 104 (7.9) 4.7,11.2
Health worker determined3 if the child had
Fever (by history, feeling or measuring) 1323 (88.1) 85.2, 90.9
Fever (by feeling hotness of the body) 678 (40.3) 32.0, 48.6
Fever (by measuring temperature) 403 (28.4) 18.9, 37.9
Cough or difficult breathing 998 (67.5) 63.4,71.6
Diarrhoea 455 (29.6) 24.6, 34,7
An ear problem 70 (4.9) 3.6, 6.2
For children with fever (N—1237) 
Health worker checked
Temperature (by measuring or feeling) 793 (62.1) 52.9,71.3
Temperature by measuring 368 (31.7) 21.3,42.2
Hotness of the body by feeling 581 (42.9) 34.2,51.5
Duration of the fever by asking 875 (69.3) 60.3, 78.3
Conjunctival pallor 727 (52.9) 44.1,61.8
Palmar pallor 54 (4.7) 1.3, 8.1
Anaemia (conjunctival or palmar pallor) 731 (53.3) 44.6, 62.0
Chest indrawing by observing the chest 87(9.4) 4.0, 14.8
Respiratory rate by counting breaths 2 (0.2) 0, 0.5
Dehydration by pinching the skin 37 (2.3) 1.0, 3.6
Previous use of drugs by asking 556 (42.2) 33.6, 50.7
a Determined refers to whether the health worker was exposed to information (i.e. either asked for the 
information or caretaker spontaneously reported the information or the surveyor could obviously tell the 
child had the information of interest); Cl = confidence interval
3.3.4.2 Diagnosis
Malaria accounted for the majority of all diagnoses made by health workers (67.8%), 
followed by upper respiratory tract infections (35.1%), diarrhoeal diseases (6.6%), worms 
(6.2%) and skin infections (4.6%). Non-specified respiratory tract infections and lower 
respiratory tract infections were both present in 4.7% of patients. All other diagnoses 
were made in less than 3% of patients. Pattern of diagnosis did not show any significant
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differences between types of facility or between the districts. A summary of diagnoses is 
presented in Table 3.11.
Table 3.11: Summary of diagnoses made by health workers
Diagnosis N=1694 (%) 95% Cl
Malaria 1170(67.8) 60.8, 74.8
Upper respiratory tract infection 565 (35.1) 29.0,41.1
Diarrhoea 120 (6.6) 4.5, 8.6
Worms 107 (6.2) 4.1, 8.2
Respiratory tract infection (not specified) 85 (4.7) 2.3, 7.2
Lower respiratory tract infection 81 (4.7) 3.2, 6.2
Skin infections 88 (4.6) 3.5, 5.8
Eye infection 40 (2.4) 1.6, 3.2
Otitis 37(2.4) 1.4, 3.3
Bronchitis 30 (2.3) 0.9, 3.6
Anaemia 40 (2.0) 1.1, 2.9
Oral thrush 34(1.7) 0.9, 2.6
Trauma 24(1.4) 0.8, 2.0
Abscess and cellulitis 20 (1.1) 0.5,1.6
Malnutrition 14 (0.8) 0.3,1.3
Tonsillitis 12 (0.7) 0.2,1.2
Asthma 12 (0.6) 0.2,1.0
Urinary tract infection 12 (0.6) 0.2,1.0
Bloody diarrhoea 11 (0.5) 0,1.0
Chickenpox 8 (0.4) 0.1, 0.6
Others 83 (4.5) 3.2, 5.7
Not written 96 (6.6) 2.0,11.3
Cl = confidence interval
Adherence of malaria diagnosing practices with NMCP and IMCI guidelines was high. 
Among 1103 initial consultations of febrile children aged 2-59 months, diagnosis of 
malaria was correct in 89.3% (95% Cl: 84.2-94.4) of observations (definition of 
correctness is in Section 2.8.1.3). No significant difference in health workers diagnosing 
practices was observed between districts or between types of facility.
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3.3.4.3 Treatment for uncomplicated malaria
The “correctness” of treatment was defined in three categories (recommended, adequate 
and inappropriate) based either on the choice of antimalarial drug only, or on the choice 
of antimalarial drug and appropriateness of the dosage (see definitions in Section 2.8.1.4). 
With regard to the choice of antimalarial drug, among 1040 children with uncomplicated 
malaria recommended treatment was prescribed for only 55.3% children. However,
I,
adequate treatment was prescribed for a further 30.2% of children. No significant 
difference was observed between districts, while differences in treatment practices were 
observed between types of facility. Health workers prescribed recommended treatment 
more commonly in dispensaries (65.1%) than in HC/DHs (34.7%). The results on the 
correctness of treatment based on the choice of drug for uncomplicated malaria according 
to the type of facility are presented in Table 3.12.
Table 3.12: Correctness of treatment based on the choice of drug for children aged 2-59 
months who were brought to an outpatient facility for an initial consultation with 
uncomplicated malaria: results according to the type of facility
Correctness o f 
treatmenta
Dispensary (N=596) HC/DH (N=444) Total (N==1040)
No (%) 95% Cl No (%) 95% Cl No (%) 95% Cl
Recommended b 420 (65.1) 53.6, 76.6 163 (34.7) 25.2, 44.2 583 (55.3) 45.9, 64.8
Adequate 118 (23.5) 14.0,33.0 209 (44.2) 28.9, 59.5 327 (30.2) 21.9,38.5
Inappropriate 58 (11.4) 5.7, 17.0 72 (21.1) 6.2, 35.9 130 (14.5) 8 .2 , 2 0 . 8
a See Section 2.8 .1.4 for definitions
b This category contains only SP monotherapy prescriptions, apart from 4 children where previous use of 
SP was reported and amodiaquine monotherapy was prescribed 
HC = health centre; DH = district hospital; Cl = confidence interval
Although SP monotherapy was the most common treatment prescribed for patients with 
uncomplicated malaria (55.1%), six other antimalarial drugs were prescribed either as 
monotherapies or in combination with other antimalarials. SP monotherapy was more
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commonly prescribed in dispensaries (65.1%) than in HC/DHs (33.9%). Conversely, 
amodiaquine, quinine and other antimalarial drugs, apart from chloroquine, were more 
frequently used in HC/DHs than in dispensaries, prescribed either alone or in 
combinations with SP. In summary, 77.1% of antimalarial treatments were prescribed as 
monotherapies while 22.9% were prescribed as two antimalarial drug combinations. The 
pattern of antimalarial drug prescriptions for uncomplicated malaria according to the type 
of facility is presented in Table 3.13.
Table 3.13: Antimalarial drugs prescribed for children aged 2-59 months who were brought 
to an outpatient facility for an initial consultation with uncomplicated malaria: results 
according to the type of facility_________________________________________________
Antim alarial prescription
Dispensary (N=596) HC/DH (N=444) Total (N=1040)
No % No % No %
SP 420 65.1 159 33.9 579 55.1
SP + chloroquine 60 11.6 30 5.5 90 9.7
Amodiaquine 8 1.3 57 13.0 65 5.1
SP + quinine 25 4.9 38 8.6 63 6.1
Quinine 13 2.8 25 6.1 38 3.7
SP + amodiaquine 2 0.3 29 5.1 31 1.9
Chloroquine 18 4.4 4 0.6 22 3.2
Artemisinins 0 0 16 2.9 16 0.9
Amodiaquine + chloroquine 8 2.1 5 1.1 13 1.8
Amodiaquine + quinine 2 0.3 6 1.6 ' 8 0.7
SP + artemisinins 0 0 3 0.5 3 0.2
Halofantrine 0 0 2 0.3 2 0.1
Mefloquine 0 0 2 0.3 2 0.1
No antimalarial drug prescribed 40 7.0 68 20.4 108 11.3
HC = health centre; DH = district hospital; SP = sulfadoxine-pyrimethamine
However, when correctness of treatment was additionally conditioned by the appropriate 
dose of the antimalarial drug (Section 2.8.1.4), the recommended treatment for 
uncomplicated malaria decreased from 55.1% to only 18.8%. Health workers prescribed 
recommended treatment less commonly in HC/DHs (9.7%, 95% Cl: 5.9-13.4) than in
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dispensaries (23.1%, 95% Cl: 17.1-29.0). Adequate treatment was prescribed for a further 
46.9% of patients and of particular concern the inappropriate treatment was prescribed 
for 34.3% of patients. The results on correctness of treatment based on the choice of drug 
and appropriateness of dosage for uncomplicated malaria according to the type of facility 
are presented in Table 3.14.
Table 3.14: Correctness of treatment based on the choice of drug and appropriateness of 
dosage for children aged 2-59 months who were brought to an outpatient facility for an
initial consultation with uncomplicated malaria: results according to t tie type of facility
Correctness o f 
treatmenf
Dispensary (N=596) HC/DH (N=444) Total (N=1040)
No (%) 95% Cl No (%) 95% Cl No (%) 95% Cl
Recommended
Adequate
Inappropriate
155(23.1) 17.1,29.0 
267 (46.7) 38.9, 54.5 
174(30.2) 21.1,39.4
46 (9.7) 5.9, 13.4 
228 (47.4) 36.9, 57.8 
170 (43.0) 30.7, 55.3
201 (18.8) 14.2,23.3 
495 (46.9) 40.8, 53.0 
344 (34.3) 26.7,42.0
a See Section 2.8.1.4 for definitions
HC = health centre; DH = district hospital; Cl = confidence interval
The main reasons for deviation from the guidelines are the overdose and underdose 
prescriptions of SP monotherapy (Table 3.15). Among all children who had SP 
monotherapy prescribed, 20.8% and 47.1% had SP prescribed below and above 
recommended dose, respectively. Considerably more children (28.9%) were under-dosed 
in the 12 to 47 months age group compared to infants 3 to 11 months (12.5%) and 
children aged 47 to 59 months (8.1%). Amodiaquine alone or in combination with other 
antimalarials was prescribed for 117 children with uncomplicated malaria. Only 9 
children (7.8%, 95% Cl: 0.5-15.1) had amodiaquine prescribed according to the NMCP 
recommended dose while 76 (62.8%, 95% Cl: 52.1-73.5) were underdosed and 32 
(29.4%, 95% Cl: 18.6-40.1) were overdosed.
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Table 3.15: Distribution of recommended, underdosed and overdosed prescriptions of SP
monotherapies across different child age groups
Age group
Recommended3 Underdosed Overdosed
No % 95% Cl No % 95% Cl No % 95% Cl
< 3 months (N=25) 1 2 40.4 16.6, 64.3 1 7.6 0 , 2 2 . 0 1 2 52.0 32.9,71.1
3-11 months (N=170) 107 6 8 . 0 57.2, 78.9 23 12.5 5.1, 19.8 40 19.5 10.4,28.6
12-47 months (N=313) 28 7.6 2.5, 12.7 89 28.9 18.3,39.5 196 63.5 51.9, 75.2
47-59 months (N=71) 39 58.5 44.6, 72.4 7 8 . 1 1.4, 14.8 25 33.4 20.2,46.6
Total (N=579) 186 32.2 26.6, 37.7 1 2 0 2 0 . 8 13.8,27.7 273 47.1 39.1, 55.0
a See Table 2.19 for NMCP recommendations
Cl = confidence interval
3.3.4.4 Treatment of severe malaria
Although the survey was not designed to recruit large numbers of children with severe 
malaria, there was evidence of poor adherence to the recommended treatment guidelines 
for severe malaria, particularly for children managed before referral for hospitalisation. 
Table 3.16 presents the correctness of treatment practices based on the choice of 
antimalarial drug for referred and admitted children with severe malaria.
Table 3.16: Correctness of treatment for children aged 2-59 months who were brought to an 
outpatient facility for an initial consultation with severe malaria: results according to the 
type of referral for hospitalisation___________   _____
Correctness o f Referred (N=21) Admitted (N=42) Total (N=63)
treatmenf No % No % No %
Recommended 1 4.5 20 45.2 21 29.9
Adequate 11 56.7 19 46.6 30 50.4
Inappropriate 9 38.8 3 8.2 12 19.7
a See Section 2.8 .1.4 for definitions
Children with severe malaria received 14 different antimalarial treatments. Quinine 
monotherapy in different formulations was prescribed to 25 (34.8%) children. However, 
intramuscular quinine, the recommended treatment of severe malaria before referral for
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hospitalisation, was prescribed to only one referred child. It is of particular concern that 
38.8% of children referred for hospitalisation did not receive any antimalarial drug. The 
pattern of antimalarial drug prescriptions for referred and admitted children with severe 
malaria is presented in Table 3.17.
Table 3.17: Antimalarial prescriptions for children aged 2-59 months who were brought to 
an outpatient facility for an initial consultation with severe malaria______ _____________
Antimalarial prescription
Referred (N=21) Admitted (N=42) Total (N=63)
No % No % No %
SP 8 42.7 1 1.7 9 17.2
Amodiaquine 1 6.7 7 20.1 8 15.0
Artemisinins 0 0 6 14.3 6 8.9
Quinine IV + quinine tablets 0 0 6 11.2 6 7.0
Quinine IM 1 4.5 4 10.9 5 8.5
Quinine IV 0 0 5 11.6 5 7.2
Quinine IM + quinine tablets 0 0 4 9.9 4 6.1
Quinine IV + quinine syrup 0 0 3 5.1 3 3.2
Quinine IM + quinine syrup 1 2.8 0 0 1 1.1
SP + chloroquine IM 1 4.5 0 0 1 1.7
Quinine tablets 0 0 1 2.7 1 1.7
SP + quinine IM + quinine tablets 0 0 1 1.7 1 1.1
AQ + quinine IV + quinine tablets 0 0 1 2.7 1 1.7
No antimalarial drug prescribed 9 38.8 3 8.2 12 19.7
IM = intramuscular; IV = intravenous; SP = sulfadoxine-pyrimethamine; AQ = amodiaquine
3.3.4.5 Counselling
The performance of counselling and communication tasks were analysed for 1163 initial 
consultations of patients with fever aged 2-59 months who were not referred for 
hospitalisation. Forty-two percent of mothers were greeted when bringing the child into 
the consultation room. The caretaker was told the diagnosis and asked if she or he had 
any questions in only 15.3% and 2.1% of the encounters, respectively. The following 
counselling tasks were assessed: what treatment to give and how; provision of advise on 
tepid sponging, extra fluids, continued breastfeeding or feeding; when to return
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immediately to the health facility, when to return if fever persists and what to do in case 
of vomiting. These tasks were rarely done during the consultations (ranging from 1-15%). 
Health workers performance in completing these tasks is shown in Table 3.18.
Counselling and communication tasks N=1163 (%) 95% Cl
Greeted 464 (42.0) 32.0, 52.0
Told diagnosis 182(15.3) 10.5, 20.0
Told what treatment to give 122 (12.4) 5.1, 19.8
How to give medication 128 (14.5) 5.9, 23.1
Advised to give extra fluids 48 (5.4) 1.6, 9.1
Advised about tepid sponging 78 (8.8) 3.8, 13.8
Return immediately if child unable to drink 8 (0.8) 0, 1.6
Return immediately if child becomes sicker 85 (6.7) 2.9,10.4
Advised to return for follow up 156 (14.8) 8.5,21.1
Advised to return if fever persists 33 (3.0) 0.3, 5.8
Advised on any kind of follow up 230 (20.5) 13.1,27.8
Told to continue feeding or breastfeeding 37 (3.2) 2.2, 4.3
Advised what to do in case of vomiting 22 (1.9) 0.9, 3.0
Asked if he/she has any questions 20 (2.1) 0, 4.2
Cl = confidence interval
Fortunately, one of the tasks, advice on how to give drugs, was provided for the majority 
of children (88%) by drug dispensers. However, only 10.7% of children received their SP 
while at the facility, 10.2% were observed when swallowing a drug and nearly all left the 
facility without advice on what to do in case of vomiting (97.5%). There were no 
significant differences in health workers counselling practices between districts or types 
of facility.
3.4 Discussion
Provision of effective malaria case management encompasses not only the use of an 
effective drug but also the correct performance of broader clinical tasks in accordance
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with evidence-based standards. To achieve adequate quality of care, the availability of 
antimalarial drugs, guidelines, in-service training and supervision of health workers are 
assumed pre-requisites. The observations from this study highlighted a number of 
important issues that influence delivery of appropriate malaria case management in the 
Kenyan context.
3.4.1 Assessment diagnosis and counselling
In terms of assessment and diagnosis, the focus of international (Gove, 1997; WHO, 
2003a) and national recommendations (MoH, 1998; 2000a) is primarily the assessment of 
a child’s fever, either by asking for a history of fever, measuring the temperature or 
feeling the hotness of body; and on the consequent presumptive diagnosis of all fevers as 
malaria. In this study 88.1% of patients had fever assessed by performing at least one of 
the clinical tasks and 89.3% of febrile patients were presumptively diagnosed as malaria. 
Such health worker practices present an important step that guarantees prompt access of 
febrile children to an antimalarial treatment at the health facility level in Kenya.
However, fever is the most common symptom, voluntarily reported as the presenting 
complaint by 71.4% caretakers of all sick children. In other words, even without 
performing any of assessment tasks, health workers are spontaneously exposed to the 
information on the presence of fever for the majority of febrile patients. Caretakers report 
less frequently symptoms such as cough, diarrhoea and ear problem (54.9%, 14.6% and 
2.9%, respectively), therefore the assessment tasks to find out the presence of these 
symptoms are equally important. However, such explorative history tasks were rarely
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done (1.9-23.1%). Currently, health workers limit their assessment to the presenting 
complaint reported by the caretaker. Such practice is understandable since almost half of 
the health workers participated in vertical malaria case management training but none had 
attended the course on IMCI. The IMCI training is supposed to improve these 
deficiencies; however, it is clear that this would require a radical change from the current 
practice.
Health workers performance of more complex assessment tasks, important for early 
detection of severe malaria and other severe diseases, was generally very low. Health 
workers assessed anaemia in 53% of febrile children commonly by checking the 
conjunctiva and rarely by checking palmar pallor (5%), as recommended by the NMCP 
guideline, in line with recent clinical evidence (Zucker et al, 1997) and proposed by 
IMCI guidelines. More importantly, the presence of other signs and symptoms of 
suspected severe malaria (respiratory distress, seizures or dehydration) were assessed in 
less than 10% of all febrile children. These signs and symptoms of severe disease are 
rarely volunteered by caretakers of sick children in Kenya (Mwenesi et al., 1995) and 
active clinical assessment is required to establish their presence. Such omissions from 
clinical assessment procedures are likely to miss an important group of sick children with 
a poor prognosis. Equally rare, the performance of clinical tasks such as counting of 
breaths, observation of chest indrawing and pinching of skin, raise a concern if these 
signs are used to decide upon the management of a child presenting with cough/difficult 
breathing or diarrhoea, as recommended by IMCI and vertical ARI and CDD guidelines. 
Despite the lack of health workers exposure to IMCI, ARI and CDD in-service trainings
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in this study, it should be noted that most of these signs and clinical assessment tasks are 
taught during the pre-service training but clearly not practiced during the post-training 
service. This is something IMCI would need to address.
The counselling of patients with fever represents the weakest part of the current clinical 
process. Health workers rarely provide advice, for example, when the child needs to 
return to facility if  he or she fails to improve (7%) or if fever persists (3%). These results, 
in combination with inadequate assessment of previous use of drugs and determination 
whether a visit is initial or a follow up, raise concerns on the appropriate use of first and 
second-line treatments and the appropriate follow up of patients.
Poor assessment and counselling practices related to malaria case management are in 
accordance with the results of malaria case management surveys reported in Tanzania 
(Font et al, 2001; Nsimba et al., 2002) and Malawi (Lin & Franco, 2000). However, our 
study was undertaken at the time when IMCI had not been introduced within the study 
districts. As such deficiencies in assessment and counselling practices that compromise 
the provision of effective malaria case management may improve with the extension of 
this programme nationwide. This assumption is based upon the focus of IMCI on both 
assessment and counselling and the previous studies that demonstrated significant 
improvements following the introduction of IMCI (Simoes et a l , 1997; CDC, 1998; 
Armstrong-Schellenberg et a l , 2004; Gouws et a l, 2004).
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3.4.2 Treatment practices
Three major observations in relation to the health workers treatment practices for 
uncomplicated malaria are worthy of comment. First, the adherence to the national 
treatment recommendations was very low; second, despite a low adherence to SP 
monotherapy an adequate treatment sufficient to cure malaria was however prescribed to 
the majority of patients; and third, inappropriate treatment practices insufficient to cure 
malaria were still unacceptably high.
Fifty five percent of children with uncomplicated malaria were prescribed drug according 
to national guidelines and this finding was consistent with 45-63% of the correct 
treatments reported from similar studies in the Central African Republic (Rowe et al., 
2000), Malawi (Osterholt, 2002) and Benin (Rowe et al., 2003). Yet in this study, only 
19% of children with uncomplicated malaria had the correct drug prescribed according to 
the recommended dose, the finding consistent with 25% and 24% of the dose-correct 
treatments for children with uncomplicated malaria reported among non-IMCI trained 
health workers in Tanzania (Armstrong-Schellenberg et al., 2004) and Uganda (Gouws et 
al., 2004) respectively.
The main reasons for the decrease in recommended treatment practice (from 55% to 
19%) are common prescriptions of SP below (21%) and above the recommended dose 
(47%). SP prescriptions below recommended dose are of particular concern since they 
present inappropriate treatment, inadequate to cure malaria. Contrary to the common 
view that a single dose regimen of SP, guarantees optimal effectiveness, the results of our
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study demonstrated that the high frequency of underdosed prescriptions (21%) may 
compromise treatment effectiveness. Furthermore, the NMCP guideline is deficient by 
itself. Using the weight of a child as gold standard, it has been previously demonstrated 
in Western Kenya, that the NMCP recommended, age-specific SP dosage tables, result in 
12% of children being underdosed (< 25/1.25 mg/kg of SP) and practically non-existent 
overdosing (Terlouw et al., 2003). The lack of information on children’s weights in our 
study and the evaluation of SP prescriptions based on the NMCP age-specific tables may 
have misclassified some of the children, however, it seems reasonable to conclude that 
the underdosing prescriptions combined with deficient guideline recommendations 
increase the risk of clinical failures and more rapid progression of SP resistance.
Nevertheless, even if only 19% of children had recommended drug prescribed according 
to recommended dose, an adequate treatment with non-recommended but effective drug 
in dosages sufficient to cure malaria was prescribed for a further 47% of patients. Of the 
non-recommended antimalarial treatments a wide variety of medications were prescribed. 
Of interest, over 22% were combinations of available antimalarial drugs, and particularly 
notable at the level of health centres and district hospitals. This represents a shift in 
practice, albeit in line with an international position of combination therapy (WHO, 
2001a), but at variance to current national policy at the time of the study. The major 
concern here is that such non-recommended drugs are of uncertain safety margin when 
co-administered, particularly when prescribed above recommended doses, and without 
any empirical evidence of additional benefits they present supplementary unnecessary 
cost for Kenyan Ministry of Health and patients.
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Perhaps the greatest concern is that 34% of children received an inappropriate treatment 
that is unlikely to cure uncomplicated malaria. Apart from SP prescriptions below 
recommended dose, the other reasons include use of chloroquine, underdosed 
prescriptions of amodiaquine and artemisinins, or no antimalarial prescription at all. 
Currently, health workers practices at government facilities in Kenya do not guarantee an 
access to effective antimalarial treatment. However, while these findings demonstrate 
deficiencies in treatment practices in relation to guidelines and indicate sub-optimal 
health workers’ performance it should be acknowledged that not all fevers are malaria
i  •'and recommendations equating all fevers as malaria result with significant overdiagnosis v 
as demonstrated in Section 1.4.1. Therefore, prescribing inappropriate treatments is not 
necessarily related to true malaria cases, however, the focus of this study and quality of 
care studies in general are not true malaria cases but health workers’ treatment practices 
in accordance with standards regardless of their deficiencies.
Finally, regardless of the case definition applied to measure the recommended treatment, 
the indicators of the current treatment practices for uncomplicated malaria fall far below 
the optimistic KNMS target defined as “80%) o f fevers treated at outpatient facilities 
according to national recommendations ” (DOMC, 2001). A significant improvement of 
health workers treatment practices is required if this optimistic target is to be achieved by 
the year 2006.
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3.4.3 Health systems support
The analysis of health systems support focused on health facility and health worker 
characteristics necessary for adequate performance of malaria case management. SP, the 
recommended first-line drug for uncomplicated malaria, was available in almost all 
facilities. At least one of two recommended second-line drugs (amodiaquine or quinine) 
were available in about a half of the facilities, more commonly in health centres and 
district hospitals (69%) than in dispensaries (46%). Furthermore, only one-third of 
facilities stocked injectable quinine, the recommended treatment for severe malaria prior 
to referral (Table 3.7). The KNMS specifies target of “80% o f  government facilities with 
continuous and adequate supplies o f drugs essential for the management o f malaria” 
(DOMC, 2001). In 2001, only supply of the first-line drug met this target, however, the 
supplies of second-line drugs and drugs for management of severe malaria were still 
inadequate.
With regard to the health workers characteristics, a significant proportion attended 
malaria in-service training, possessed guidelines and had at least one supervision visit in 
the past 6 months (44.9%, 57.8% and 76.3%, respectively). Health workers at 
dispensaries were more exposed to training, guidelines and supervision than their 
colleagues in health centres and district hospitals. However, qualitative aspects of malaria 
in-service training and supervision visits were far less satisfactory. It is assumed that 
health workers exposure to these interventions would improve the quality of malaria case 
management. In the following Chapter these issues are discussed and the detailed
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analysis of factors influencing the quality of treatment practices for uncomplicated 
malaria is presented.
3.5 Conclusion
This study has identified a number of deficiencies in health workers clinical practices that 
compromise the delivery of antimalarial treatment and thus limit the effectiveness of 
malaria case management. The health facility based malaria case management indicators 
are significantly lower compared to the optimistic KNMS targets of 80%. To curb 
malaria mortality in Kenya, redressing these deficiencies represents a challenge for 
clinical services, especially as we embark upon a new era of more expensive and 
complex treatment regimens, such as combination therapies.
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CHAPTER 4:
Predictors of the quality of health worker 
treatment practices for uncomplicated malaria
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4.1 Introduction
Several authors have examined the factors that influence good clinical practice and 
adherence to national clinical guidelines (Section 1.6.4). In this chapter the facility, health 
worker and patient characteristics described in Chapter 3 are examined in relation to the 
health workers adherence to national treatment recommendations for uncomplicated 
malaria using new statistical approaches for modelling multi-level data as described in 
section 2.13.1.2.
4.2 Methods
Detailed presentation of the methods and materials used to conduct the paediatric health 
facility survey is provided in Chapter 2. In the same chapter (Section 2.13.1.2) the 
analytic strategy of multiple binomial logistic regression is presented. In the Methods 
section of this chapter the definitions used for the predictors analysis of treatment quality 
are laid out and the detailed statistical procedures used for the multilevel modeling of 
each studied factor are explained.
4.2.1 Definitions
The definitions of uncomplicated malaria and correctness of treatment are presented in 
Section 2.8.1. Briefly, uncomplicated malaria was defined as a history of fever during the 
present illness (according to the study interviewers), the absence of a negative blood slide 
(according to the record in patient-held cards) and child treated as an outpatient 
(according to the observed health worker). Three categories of treatment quality were 
defined (recommended, minor errors, and inappropriate) and the definition of the 
“correctness” of antimalarial treatment was based on the choice of antimalarial drug only,
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without considering the appropriateness of the dosage (Section 2.8.2.4). The inclusion of 
dosage would have been an additional layer of refinement that would have resulted in 
comparatively small, multiple outcomes and would have reduced the study’s ability to 
statistically test broad predictors of treatment choice. Drug doses are dealt with separately 
as part of the descriptive analysis in Section 3.3.4.3.
4.2.2 Statistical procedures for the factors examined
In the univariate analysis, the odds ratio (OR), p-value, and 95% confidence interval (Cl) 
for the association of each category of treatment quality (recommended, minor errors, 
and inappropriate) was computed with the following factors: duration of the consultation; 
starting time of the consultation (before 1:00 p.m. versus 1:00 p.m. or later); caseload 
during two days of the survey visit, both as a continuous variable and a dichotomous 
variable (>30 versus < 30 child consultations); child’s age; caretaker’s report during the 
consultation on previous use of SP; main complaint of fever; health worker’s experience 
(years working as a health worker); whether the health worker attended malaria in- 
service training and all variables listed in Table 4.3. For supervision, the previous six 
months was the focal period. The quality (in three levels: no supervision, supervision 
with observation of a consultation and feedback, and supervision without observation and 
feedback) was examined and quantity (in three levels: no supervision, 1-3 visits, and 4-10 
visits). Availability of SP could not be studied because SP was in stock in nearly all 
(97.7%) facilities. Statistical interactions were evaluated between in-service malaria 
training and health workers pre-service training, supervision and in-service training, in- 
service training and availability of malaria treatment wall charts, pre-service training and 
availability of second-line drugs, and availability of guidelines and in-service training.
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To adjust for confounding, factors with a p-value <0.15 from the univariate analysis and 
interaction terms with p-value < 0.05 were entered into three multivariate logistic 
regression models (as in the univariate analysis, one model for each category of treatment 
quality). Factors that did not initially meet the entrance criteria for the multivariate 
analysis (i.e. “non-significant” [p > 0.15]) were then entered into the three multivariate 
models, one factor at a time. If the addition of a “non-significant” variable changed the 
OR of any already-included variable by > 10%, the additional variable was retained in the 
final multivariate model.
Although meeting the entrance criteria for the multivariate analysis, variables for health 
facility type and caseload >30 were excluded because they were strongly correlated with 
health workers’ pre-service training: clinical officers were much more likely than nurses 
and nursing aides to have high caseloads and to have never worked in dispensaries. 
Similarly, the quality of supervision variable was excluded because more frequent 
supervisory visits were much more likely to include supervision with clinical 
observations and provision of feedback and variable frequency of supervision has shown 
the stronger associations with treatment quality. The malaria diagnosis variable was 
excluded because it was believed to be in the causal pathway between other independent 
variables and treatment quality. The three multivariate models were forced to contain the 
same variables: any variable meeting the entrance criteria for one model was 
automatically entered into the other two models. This approach ensured that the three 
ORs (one from each model) for a given factor would be adjusted for the same covariates.
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4.3 Results
4.3.1 Description of the sample
In 81 health facilities, 142 health workers were observed as they performed 1864 sick 
child consultations. Of 1864 children, 170 consultations (9.1%) were excluded because 
the exit interview was not performed with a caretaker (Section 3.3.1). For predictors 
analysis, a further 40 consultations (2.1%) were excluded since they were performed by 7 
health workers for whom data were not collected (Section 3.3.1). The descriptions of the 
health workers and health facilities are presented in Sections 3.3.2.2 and 3.3.2.3; a 
summary of the key factors examined in the present analysis is presented in Table 4.1.
Table 4.1: Characteristics of health workers who treated children with uncomplicated
malaria and outpatient facilities where the treatment occured
Characteristic No %
Health workers characteristics (N=135)
Male sex 66 48.0
Pre-service training
Clinical officer3 30 15.7
Nurse 94 76.8
Nursing aide 11 7.6
HW received in-service malaria training 59 44.9
HW has malaria guidelines 77 57.8
HW received at least one supervision visit in the past 6 months 94 76.3
Health facility characteristics (N=81)
Health facility type
Dispensary 48 71.3
Health centre 29 26.0
District hospital 4 2.7
Malaria treatment wall chart in the consultation room 22 27.0
SP (any formulation) in stock 80 97.7
Amodiaquine (any formulation) in stock 26 32.1
Quinine tablets in stock 18 18.1
Injectable quinine in stock 26 32.7
Chloroquine (any formulation) in stock 47 64.3
Any formulation of amodiaquine or quinine in stock 43 53.1
3 The clinical officer category contains 3 consultations done by one physician
HW = health worker; SP = sulfadoxine-pyrimethamine
173
For the predictors analysis, 1006 sick children met the definition of uncomplicated 
malaria: 567 (56.9%) received recommended treatment, 314 (30.4%) had a minor error, 
and 125 (12.7%) were given an inappropriate treatment. Only 20 caretakers reported that 
their child had been treated with SP before coming to the health facility. The distribution 
of antimalarial treatments in each category of treatment quality is presented in Table 4.2.
Table 4.2: Distribution of antimalarial treatments in each category of treatment quality
Antimalarial treatment
Recommended 
(N = 567)
Minor errors 
(N = 314)
Inappropriate 
(N = 125)
No % No % No %
SP 563 99.5 0 0 0 0
Amodiaquine 4 0.5 55 14.8 0 0
Quinine 0 0 36 12.2 0 0
Chloroquine 0 0 0 0 22 26.9
Chloroquine + SP 0 0 90 33.8 0 0
Chloroquine + amodiaquine 0 0 12 5.8 0 0
Amodiaquine + SP 0 0 31 6.5 0 0
Quinine + amodiaquine 0 0 8 2.5 0 0
Quinine + SP 0 0 63 20.7 0 0
Artemisinins 0 0 16 3.2 0 0
Artemisinins + SP 0 0 3 0.5 0 0
No antimalarial treatment 0 0 0 0 103 73.1
SP = sulfadoxine-pyrimethamine
4.3.2 Predictors of treatment quality
For each factor, ORs from the three models can be read together. For example, compared 
to children treated in consultation rooms without a malaria treatment wall chart, children 
treated in rooms with a wall chart were significantly more likely to receive recommended 
treatment (OR for recommended treatment [ORrec]= l-86, 95% Cl: 1.01-3.42) and 
significantly less likely to have a minor error (OR for a minor error [ORmin]=0.51, 95% 
Cl: 0.27-0.98); no association was found with inappropriate treatment (OR for a major 
error [ORmaj]=0.99, 95% Cl: 0.50-1.98) (Table 4.4).
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Chloroquine availability was associated with a significantly lower likelihood of 
recommended treatment (ORrec=0.56). Compared to children treated by unsupervised 
health workers, children treated by health workers supervised 4-10 times in the past 6 
months were significantly less likely to receive inappropriate treatment (ORmaj=0.28). 
Infants had significantly fewer minor errors (ORmin=0.64). Children whose caretaker 
spontaneously reported fever as the main complaint were significantly more likely to 
receive recommended treatment (ORrec=1.76) and significantly less likely to receive 
inappropriate treatment (ORmaj=0.47).
Generally, nursing aides adhered much more closely to guidelines than nurses and 
clinical officers, and the effect of health workers’ pre-service training on treatment 
quality depended on the availability of second-line drugs at the facility. When second- 
line drugs were not in stock, children were significantly more likely to receive 
inappropriate treatment if treated by a clinical officer (ORmaj=25.45) or nurse 
(ORmaj=7.11) compared to a nursing aide (Table 4.5). When second-line drugs were in 
stock, children treated by clinical officers were significantly less likely to receive 
recommended treatment and more likely to have minor errors (ORrec=0.07 and 
ORmin=13.06), and children treated by nurses were significantly less likely to receive 
recommended treatment and more likely to have major errors (ORrec=0.09 and 
ORmaj=3.27). The effect of in-service malaria training depended on whether a health 
worker possessed a copy of the NMCP guideline. When health workers did not have the 
guideline, there was no significant association between in-service training and the quality 
of treatment. However, when health workers had the guideline, children seen by trained
175
health workers were significantly more likely to receive recommended treatment 
(ORrec=2.98) and significantly less likely to receive inappropriate treatment 
(ORmaj=0.25).
Among factors excluded from the multivariate analysis, several interesting univariate 
results were found. For example, treatment quality was significantly better for children 
whose malaria was diagnosed by the health worker, for children treated in dispensaries, 
and for children treated by health workers who had a 2-day caseload <30 consultations 
(Table 4.3). However, as described in the Section 4.2.2, the influence of health facility 
type and high caseload cannot be separated from health workers’ pre-service training.
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4.4 Discussion
In this Chapter the determinants of the quality of treatment for uncomplicated malaria 
were examined. A series of associations between health facility, health worker, and 
patient or consultation level factors, and health worker performance were investigated 
using rigorous analytical techniques.
The first main finding was that several commonly used interventions for improving 
health worker practices were significantly associated with prescribing recommended 
treatment: in-service training, possession of the NMCP guideline, treatment wall charts, 
and supervision. Regarding in-service training, other studies with a similar design have 
reported a variety of results, ranging from an association with better health worker 
performance (Naimoli, 2001) to an association with more minor errors (Osterholt, 2002) 
to no association with performance (Rowe et al., 2000; Rowe et al., 2003). The results 
revealed in this study found something new: specific subgroups of health workers for 
whom training seemed beneficial (health workers possessing the guideline) or 
inconsequential (those without the guideline). The association of possessing the 
guideline, however, must be interpreted with caution because we do not know whether 
the factor was causally related to health worker practices or simply a marker for another 
characteristic not measured in the study that was causally related (i.e. motivation). 
Perhaps motivated health workers were more likely to both possess the guideline and 
benefit from training.
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Similarly, caution is needed when interpreting the association of treatment wall charts. 
Wall charts could be causally associated with better treatment, but also could be a marker 
for motivated health workers who are more likely to follow guidelines. The relationship 
may be more complex, however, given that one study found that wall charts were 
associated with treatment errors (Rowe et al., 2000).
As with in-service training and wall charts, supervision has had different reported effects 
in different studies. These findings essentially agree with the results from Philippines, 
Zimbabwe and Benin (Loevinsohn et al., 1995; Trap et al. 2001; Rowe et al., 2001), 
while results from the Central African Republic and Malawi did not show an association 
with treatment quality (Rowe et al., 2000; Osterholt, 2002). Unfortunately, most studies 
(including this one) had only limited details of the supervision, and thus it is difficult to 
make conclusions about the effectiveness of this common intervention.
The second main finding was that clinical officers and nurses were much less likely than 
nursing aides to adhere to guidelines. The results even suggested a dose-response 
relationship, with clinical officers less adherent than nurses, who were less adherent than 
nursing aides. This finding was remarkably similar to results from Benin for the treatment 
of fever (Rowe et al., 2003) and diarrhoea (Rowe et al., 2001). Furthermore, in this study, 
the effect of pre-service training depended on the availability of second-line drugs. 
Several reasons may explain these results. First, nursing aides may not know how to 
prescribe second-line drugs and therefore avoid using them. Second, nursing aides may 
be better at following clinical algorithms because they have less of a “medical 
vocabulary” of alternative diagnoses and treatments that might “interfere” with the
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simple “fever = malaria” concept upon which the guideline is based. Third, clinical 
officers and, to a lesser extent, nurses, may have been taught (or socialised) that their 
clinical judgment can overrule guidelines. Indeed, they may view guidelines as 
suggestions, rather than rules that should be followed systematically. Fourth, clinical 
officers and nurses may have lost confidence in SP. Fifth, clinical officers and nurses 
may be more susceptible to pressures to prescribe second-line drugs inappropriately, such 
as profit motives or caretaker demands. Finally, it is possible that the causal factor is not 
health worker pre-service training, but rather another closely related factor such as health 
facility type or caseload, the effects of which could not be separated from pre-service 
training.
The third main finding was that child and consultation factors were significantly 
associated with treatment quality. First, the caretakers’ report of fever as the chief 
complaint was associated with better treatment quality. A possible explanation is that 
health workers consider a fever less important if  a caretaker does not mention it 
voluntarily. The result supports interventions that teach caretakers to actively report their 
child’s fever. Similarly, it may be helpful to instruct health workers during training 
courses and supervision visits to check for fever and always pay attention to the fevers 
they identify because if  the caretaker does not mention it, malaria may be missed.
The second child-level factor was the child’s age. Infants were less likely than older 
children to have minor errors. Perhaps this reveals health workers’ concerns that second- 
line drugs such as amodiaquine or quinine are less safe for younger children. If this
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hypothesis is true and if  failure rates with SP continue to rise, then appropriate use of 
second-line drugs should be emphasised for infants. A third factor, which was a 
consultation characteristic, only had borderline significance; however, our results 
suggested that children seen after 1 p.m. received better treatment. A possible explanation 
is that health workers are less rushed in the afternoon, as most patients arrive at facilities 
in the morning. If confirmed, the results support interventions to space out consultations 
more evenly throughout the day or adding extra staff only for the mornings.
The last main finding was that two statistical interactions were identified. Although 
interactions complicate the interpretation of results (especially with three models), they 
act as a high-resolution lens for examining the influences of health worker performance. 
Intuitively, interactions, which allow the effect of a factor to be conditional on other 
factors, seem to be an appropriate element of models that explain a phenomenon as 
complex as health worker performance.
4.5 Conclusions
With all necessary caution in the interpretation of the results and methodological 
limitations encountered (Section 2.14), the study results indicated that programmatic 
interventions such as in-service malaria training, provision of guidelines and wall charts, 
and more frequent supervision were associated with better treatment quality. However, 
neither in-service training nor possession of the guideline showed an effect by itself. 
Conversely, availability of chloroquine and higher health workers’ pre-service training 
were associated with more treatment errors. Child and consultation factors such as the
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main complaint of fever, younger age and consultation in afternoon hours were also 
associated with better treatment quality. The results of this study indicated various 
determinants of health workers performance that require further validation in the 
prospective, interventional trials.
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CHAPTER 5
Accuracy of malaria diagnosis, quality of clinical 
assessment and ability of clinical signs and symptoms 
to predict malaria in older children and adults
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5.1 Introduction
People living in malaria endemic areas are infected repeatedly, and they acquire 
functional immunity to the clinical consequences of malaria infection as they get older. 
As presented in Section 1.3.5, in areas of high intensity transmission, children usually 
develop a functional immune response by school age, as demonstrated by the massive 
decline in incidence of malaria disease by this age. Furthermore, severe malaria and 
malaria death are rare events in older children and adults. This pattern of age-specific 
acquisition of functional immunity is shifted to older age groups as transmission 
intensity, measured by the frequency of parasitic exposure, decreases.
In most rural health facilities in Africa, laboratory support to diagnose malaria is not 
available and diagnosis is based on clinical signs and symptoms. However, few studies 
have investigated the clinical predictors of malaria among older children and adults in 
Africa compared to similar studies of clinical predictors in young children (Section
1.4.2).
Fever usually represents an entry point for malaria case management recommendations, 
but unlike in children below 5 years of age, where various guidelines are in agreement on 
how to manage fever, and provide explicit recommendations for fever management in 
different malaria endemic settings, case management recommendations for older children 
and adults are commonly unclear and rarely harmonised (Section 1.5.2.1). However, it 
appears that in this age group most of the guidelines recognise the importance of
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identifying other causes of fever, yet none of them clearly state how this criterion should 
be used and what signs and symptoms present an alternative explanation of fever.
Despite our understanding of the age-structured risks of clinical malaria and case 
management recommendations suggesting the search for other causes of fever, older 
children and adults appear more likely to be diagnosed as having malaria than young 
children at outpatient facilities. The examination of outpatient registers from four Kenyan 
districts of different malaria endemicities revealed that a significant proportion (district 
range: 43-49%) of all malaria diagnoses are made among populations above 14 years of 
age and there was no important difference observed between the districts of different 
malaria endemicities (Sections 2.3.1.3, 2.3.2.3, 2.3.3.3 and 2.3.4.3). The frequency with 
which “malaria” is diagnosed as a cause of outpatient attendance is hard to reconcile with 
our understanding of the clinical epidemiology of malaria (Section 1.3.5). One 
explanation for frequent malaria diagnoses in older children and adults may be that 
malaria diagnosis is simply convenient, requiring no search for other causes of fever. 
However, observational studies investigating the quality of fever assessment and clinical 
evaluation to exclude malaria in febrile older children and adults have not been 
undertaken in tropical Africa.
This chapter will focus on: 1) the accuracy of the routine clinical diagnosis of malaria; 2) 
a description of current health workers practices in the clinical assessment of febrile 
patients; and 3) the ability of clinical signs and symptoms to predict malaria infection in 
febrile older children and adults.
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5.2 Methods
Detailed presentation of the materials and methods applied in the older children and adult 
survey are presented in the following sections of the Chapter 2:
1) Characteristics of the study districts (Section 2.3)
2) Development of the sampling frame (Section 2.6.2)
3) Sampling procedures (Section 2.7.2)
4) National guidelines and study case definitions (Section 2.8.2)
5) Data collection forms (Section 2.9.2)
6) Survey teams and training of surveyors (Section 2.10.2)
7) Survey procedures (Section 2.11.2)
8) Statistical analysis (Section 2.13.2)
Briefly, the survey among older children and adults was a cross-sectional, cluster sample 
health facility survey, stratified according to the availability of functional malaria 
microscopy, and conducted in two districts: Kwale, a hyperendemic area on the Coast, 
and Kisii, mesoendemic area in the Western highlands. Data collection included direct 
observation of the routine outpatient consultations, exit examination of the observed 
patients by study physicians, health worker interview with the observed clinician and 
preparation of blood smear in febrile patients for the post-survey reading. The results on 
the use and interpretation of microscopy, and the accuracy of the routine reading of 
malaria slides are separately presented in Chapter 6 .
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5.3 Results
5.3.1 Description of the sample
The survey included 1292 direct observations of outpatient consultations for patients 
above 5 years of age that were managed by 76 health workers at 46 government health 
facilities in the two districts. Exit examination could not be performed for 34 patients 
(2.6%) and these observations were excluded from the analysis. Of 1258 analysed 
consultations, 830 were undertaken at 29 facilities without microscopy, and 428 were 
performed at 17 facilities with functional microscopy. Health worker interview was 
performed for all observed health workers (76). The distribution of the surveyed health 
facilities, health workers and patients’ consultations across two districts and two types of 
facility are presented in Table 5.1.
Table 5.1: Distribution of the surveyed health facilities, health workers and patients’ 
consultations across two districts and two types of facility___________________________
District HFs with microscopy
HFs without 
microscopy
All health 
facilities
KWALE
Health facilities 10 15 25
Health workers 17 21 38
Consultations 218 412 636
KISH
Health facilities 7 14 21
Health workers 14 24 38
Consultations 210 418 622
TOTAL
Health facilities 17 29 46
Health workers 31 45 76
Consultations 428 830 1258
HF = health facility
5.3.2 Characteristics of health workers
The mean age of the participating health workers was 37 years (range: 25-53 years). The 
average health workers professional experience and the time period spent in the surveyed
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facility were 13 years (range: 2-29 years), and 4 years and 6 months (range: 1 month-20 
years), respectively. The majority of observed health workers were nurses (77.6%), 
followed by clinical officers (19.7%) and nursing aides (2.6%). Almost half (48.7%) of 
health workers were in charge of the surveyed facilities. Fifty-three percent of health 
workers had attended in-service malaria training and possessed a NMCP malaria 
guideline, more commonly in Kisii district (84.2%) than in Kwale district (21.1%). 
Health workers characteristics across two districts are presented in Table 5.2.
Table 5.2: Health workers demographics, exposure to in-service training, guidelines and 
supervision across two districts_____________ ____________ ____________ _____ _____
Health workers characteristics KWALE KISII TOTALN=38 (%) N=38 (%) N=76 (%)
Male sex 25 (65.8) 16(42.1) 41 (53.9)
In-charge of health facility 19 (50.0) 18 (47.3) 37 (48.7)
Pre-service training
Clinical officer 10(26.3) 5 (13.2) 15(19.7)
Registered nurse 1 (2 .6) 5 (13.2) 6 (7.9)
Enrolled nurse 25 (65.8) 28 (73.7) 53 (69.7)
Nursing aide 2(5.3) 0 2 (2 .6)
HW received in-service malaria training 8 (21.1) 32 (84.2) 40 (52.6)
HW has NMCP guidelines 8 (21.1) 32 (84.2) 40 (52.6)
HW had a supervision visit in the last 6 months 29 (76.3) 38 (100) 67 (88.2)
HW = health worker
5.3.3 Characteristics of patients
5.3.3.1 Age distribution of patients
Among 1258 enrolled patients above 5 years of age, 290 (23.1%) were older children 
between 5 and 14 years of age, and 968 (76.9%) were adults above 14 years of age. It 
appeared that the proportion of older children was slightly higher in Kisii than in Kwale 
district (24.7% vs. 21.4%); however, the difference was not statistically significant (95% 
Cl in Kisii=21.0-28.5 vs. 95% Cl in Kwale=l7.5-25.3). In adults, no difference in age
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distribution was demonstrated between two districts. The age distribution of enrolled 
patients across districts is presented in Table 5.3.
Table 5.3: Age distribution of enrolled patients across districts
Age groups (years) KWALE KISII TOTALN=636 (%) N=622 (%) N=1258 (%)
5-9 73 (11.5) 85 (13.7) 158 (12.6)
10-14 63 (9.9) 69 (11.1) 132(10.5)
15-24 185 (29.1) 163 (26.2) 348 (27.7)
25-34 108 (17.0) 102 (16.4) 210(16.7)
35-44 88 (13.8) 86(13.8) 174(13.8)
>44 119(18.7) 118(18.8) 236 (18.8)
5.3.3.2 Distribution of fevers
Patients were considered to have fever if during the exit examination a history of fever 
was reported in the last 48 hours or axillary temperature was >37.5°C (Section 2.8.3.1). 
Overall, the majority of patients presented with fever (80.5%). However, fever was less 
commonly reported as the main complaint (40.8%), and only 20.8% patients had a 
temperature >37.5°C with mean and median values of 37.0°C and 36.8°C respectively. 
Generally, no significant differences were observed in overall frequencies of fevers 
between districts apart from the observation that more patients had a raised axillary 
temperature in Kisii (26.7%) compared to Kwale district (14.9%).
In both districts, significant differences were observed between age groups. Overall, 
frequencies of all types of fever were significantly higher in older children than in adults, 
and age-specific differences in frequencies of fever were more obvious in Kisii than in 
Kwale district. For example, in Kisii district, fever was spontaneously reported in 58.4% 
older children compared to 28.9% adults, and raised axillary temperature was nearly 3-
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fold more common in older children than in adults (51.3% vs. 18.6%). The distribution of 
fevers between districts and age groups is presented in Table 5.4 and Figure 5.1.
Table 5.4: Distribution of fevers across districts and age groups
District
5-14 years >15 years TOTAL
No (%) 95% Cl No (%) 95% Cl No (%) 95% Cl
KWALE N== 136 N==500 N==636
Fevera 110(80.9) 73.8, 88.0 384 (76.8) 72.0, 81.6 494 (77.7) 73.3, 82.0
History of feverb 109 (80.2) 72.8, 87.5 377 (75.4) 70.3, 80.5 486 (76.4) 71.8, 81.0
Fever MCc 80 (58.8) 50.6, 67.0 208 (41.6) 34.4,48.8 288 (45.3) 38.4, 52.1
T >  37.5°Cd 37 (27.2) 15.5,38.8 58 (11.6) 7.7, 15.5 95 (14.9) 10.6, 19.3
KISII N==154 N==468 N==622
Fevera 143 (92.9) 89.0, 96.7 376 (80.3) 75.3, 85.4 519(83.4) 79.1, 87.8
History of feverb 141 (91.6) 87.5, 95.6 366 (78.2) 73.5, 82.9 507 (81.5) 77.3, 85.8
Fever MCC 90 (58.4) 50.5, 66.4 135 (28.9) 22.7, 35.0 225 (36.2) 29.9, 42.4
T >  37.5°Cd 79 (51.3) 45.1,57.5 87(18.6) 13.7, 23.5 166(26.7) 22.2,31.2
TOTAL N=290 N==968 N= 1258
Fevera 253 (87.2) 82.7,91.8 760 (78.5) 75.1, 82.0 1013 (80.5) 77.3, 83.8
History of feverb 250 (86.2) 80.4,91.0 743 (76.8) 73.3, 80.2 993 (78.9) 75.7, 82.2
Fever MCc 170 (58.6) 53.2, 64.1 343 (35.4) 30.6, 40.2 513 (40.8) 36.3,45.2
T >  37.5°Cd 116(40.0) 32.3,47.7 145 (15.0) 11.7, 18.3 261 (20.8) 17.0, 24.5
a Reported history of fever in last 48 hours or axillary temperature >  37.5°C on survey day 
b Reported history of fever in last 48 hours (spontaneously or prompted) 
c Fever spontaneously reported as main complaint (MC) without prompting 
d Axillary temperature (T) >  37.5°C on survey day 
MC = main complaint; T = temperature; Cl = confidence interval
Figure 5.1: Distribution of increased axillary temperatures > 37.5°C across two districts and 
six age groups. Pink line represents Kisii and the blue line Kwale district.
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5.3.3.3 Parasite prevalence among patients with fever
Malaria blood smears were examined for 1013 patients presenting with fever (Section
2.11.2). Overall there were 179 (17.7%, 95% Cl: 13.6-21.7) parasitaemic patients across 
two districts: 123 (23.7%, 95% Cl: 18.7-28.7) in Kisii district and significantly less, 56 
(11.3%, 95% Cl: 7.2-15.5) in Kwale district. The majority of infections were due to P. 
falciparum  (165 or 92.2%), followed by 11 P. malariae infections (6.2%) and two P. 
ovale infections (1.1%). There was only one case of mixed P. falciparum  and P. malariae 
infection. All P. malariae infections were reported from Kwale district. Overall for two 
districts, older children aged 5-14 years had a higher P. falciparum  prevalence rate 
(30.8%, 95% Cl: 23.6-38.1) than adults above 14 years (11.4%, 95% Cl: 7.7-15.2). In 
both age groups, prevalence rates were higher in Kisii (PR5.i4=39.2%, 95% Cl: 30.4-47.9 
and PR>i4=17.6%, 95% Cl: 12.4-22.7) than in Kwale district (PR5_i4=20.0%, 95% Cl:
11.8-28.2 and PR>i4=5.5%, 95% Cl: 2.5-8.4). Figure 5.2 presents P. falciparum  
prevalence rates among febrile patients across two study districts and six age groups.
Figure 5.2: P. falciparum  prevalence rates among febrile patients across two districts and 
six age groups. Pink line represents Kisii and the blue line Kwale district.
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5.3.3/4 P. falciparum geometric mean parasite density
Among all age groups the geometric mean parasite density among P. falciparum  positive 
cases was 10,061 parasites/pl (95% Cl: 7,514-13,470) in Kisii district, significantly 
higher than 2,793 parasites/pl (95% Cl: 1,556-5,011) in Kwale district. Age-specific 
(older children 5-14 years vs adults above 14 years) parasite densities were also higher in 
Kisii than in Kwale district, however, this difference was not statistically significant in 
older children age group. Furthermore, in each study district parasite densities were 
higher in older children than in adults, however, the difference was not statistically 
significant in Kisii district. In Kwale district, geometric mean parasite density in older 
children was 6,047 parasites/pl (95% Cl: 2,610-14,011) compared to 1,245 parasites/pl 
(95% Cl: 606-2,560) in adults, while in Kisii district, parasite density in older children 
was 14,814 parasites/pl (95% Cl: 9,911-22,143) compared to 6,983 parasites/pl (95% Cl: 
4,636-10,519) in adults. Figure 5.3 presents P. falciparum  geometric mean parasite 
densities across two study districts and six age groups.
Figure 5.3: P. falciparum  geometric mean parasite densities across two districts and age 
groups. Pink line represents Kisii and the blue line Kwale district
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5.3.3.5 Frequency of the most common signs and symptoms
Table 5.5 presents the distribution of the 26 most common (frequencies >5%) signs and 
symptoms among patients with fever. In both districts, the majority of febrile patients 
presented with symptoms commonly related to malaria such as headache (78.5%), chills 
(68.5%) and joint pains (57.7%). There was no statistically significant difference in 
frequencies of the most common malaria related symptoms between the two districts. 
Other malaria related signs and symptoms were less common but varied more between 
districts. They were the following: general body weakness (47.5%), shivering (26.4%), 
backache (16.0%), general body ache (7.1%), anaemia (6.1) and splenomegaly (4.9%).
The most common signs and symptoms possibly indicative of causes of fever other than 
malaria were abdominal pain (43.2%), inflamed throat (36.8%), chest pain (28.8%), 
running nose (24.8%) and enlarged lymph nodes (11.2%). Signs and symptoms 
commonly related to respiratory diseases were significantly more frequent in Kwale than 
Kisii district: cough (49.9% vs. 36.6%), inflamed throat (64.0% vs. 11.0%), chest pain 
(43.1% vs. 15.2%), running nose (36.8% vs. 13.3%), throat pain (30.6% vs. 8.5%), 
difficult breathing (10.3% vs. 3.1%) and abnormal chest sound (7.3% vs. 2.9%). There 
was no significant differences in the frequencies of various fever characteristics across 
districts compared to all patients sample presented in Section 5.3.3.2.
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Table 5.5: Distribution of most common signs and symptoms among febrile patients across
study districts______________________________________________________________
Signs and symptomsa KWALE (N=494) KISII (N=519) TOTAL (N=1013)No % No % No %
Headache 391 79.2 404 77.8 795 78.5
Chills 340 68.8 354 68.2 694 68.5
Joint pain 291 58.9 293 56.5 584 57.7
Fever main complaint13 288 58.3 224 43.2 513 50.6
Genaral body weakness13 308 62.4 173 33.3 481 47.5
Coughb 246 49.9 190 36.6 451 44.5
Abdominal pain 219 44.3 219 42.2 438 43.2
Inflamed throatb 316 64.0 57 11.0 373 36.8
Fever more than 7 days 168 34.0 142 27.4 310 30.6
Chest painb 213 43.1 79 15.2 292 28.8
Shivering13 173 35.0 94 18.1 267 26.4
Temperature >37.5°Cb 95 19.2 166 32.0 261 25.8
Nauseab 180 36.4 76 14.8 262 25.9
Running noseb 182 36.8 69 13.3 251 24.8
Vomiting13 67 13.6 138 26.6 205 20.2
Throat painb 151 30.6 44 8.5 195 19.3
Back acheb 60 12.2 102 19.7 162 16.0
Dizziness13 32 6.5 86 16.6 118 11.7
Enlarged lymph nodesb 107 21.7 6 1.2 113 11.2
Diarrhoea 39 7.9 59 10.0 91 9.0
Skin manifestations 38 7.7 52 10.0 90 8.9
Genearal body ache 38 7.7 34 6.6 72 7.1
Difficult breathing13 51 10.3 16 3.1 67 6.6
Pallorb 55 11.2 6 1.2 61 6.1
Abnormal chest soundb 36 7.3 15 2.9 51 5.0
Enlarged spleenb 8 1.6 42 8.1 50 4.9
Constipation13 41 8.3 8 1.5 49 4.8
a Signs and symptoms with frequencies greater than 5 % in any of two districts are reported 
b Statistically significant difference between districts (at 5% level of significance)
Age-specific analysis of the same group of patients revealed that in both districts the 
following signs and symptoms were more common in febrile patients aged 5-14 years 
than in adults above 14 years of age: cough (61.7% vs. 36.9%), running nose (38.3% vs 
20.3%), vomiting (31.6% vs. 16.5%), skin manifestations (17.4% vs. 6.1%) and enlarged 
spleen (11.5% vs 2.8%). The following symptoms were more frequent in adults: joint
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pain (66 .6% vs. 30.8%), chest pain (33.2% vs. 15.8%), backache (20.4% vs. 2.8%) and 
general body ache (9.2% vs. 0.8%). For some of the most common symptoms such as 
headache, chills, general body weakness and abdominal pain, there was no significant 
difference demonstrated between age groups within the study district nor between age 
groups overall. There was no significant difference in the frequencies of various fever 
characteristics between age groups compared to all patients sample presented in Section 
5.3.3.2. Table 5.6 presents age-specific frequencies of the most common signs and 
symptoms among febrile patients across study districts.
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Table 5.6: Distribution of most common signs and symptoms among febrile patients across
Signs and symptoms'1
KWALE KISII TOTAL
5-14 yrs >15 yrs 5-14 yrs >15 yrs 5-14 yrs >15 yrs
N=110 N=384 N=143 N=376 N=253 N=760
No (%) No (%) No (%) No (%) No (%) No (%)
Headache 84 (76.4) 307 (80.0) 112(78.3) 292 (77.7) 196 (77.5) 599 (78.8)
Chills 70 (63.6) 270 (70.3) 99 (69.2) 255 (67.8) 169 (6 6 .8 ) 525 (69.1)
Joint painb 35 (31.8) 256 (66.7) 43(30.1) 250 (66.5) 78 (30.8) 506 (6 6 .6 )
Fever main complaint15 80 (72.7) 78 (30.8) 90 (62.9) 15 (35.9) 170 (67.2) 343 (45.1)
Body weakness 57 (51.8) 251 (65.4) 40 (28.0) 133 (35.4) 97 (38.3) 384 (50.5)
Coughb 73 (66.4) 173 (45.2) 83 (58.0) 107 (28.5) 156 (61.7) 280 (36.9)
Abdominal pain 45 (40.9) 174 (45.3) 63 (44.1) 156(41.5) 108 (42.7) 330 (43.4)
Inflamed throat 61 (55.5) 255 (66.4) 22 (15.4) 35 (9.3) 83 (32.8) 290 (38.2)
Fever more than 7 days b 28 (25.5) 140 (36.5) 15 (10.5) 127 (33.8) 43 (17.0) 267 (35.1)
Chest painb 31 (28.2) 182 (47.4) 9 (6.3) 70(18.6) 40(15.8) 252 (33.2)
Shivering 45 (40.9) 128 (33.3) 29 (20.3) 65 (17.3) 74 (29.3) 193 (25.4)
Temperature >37.5°Cb 37 (33.6) 60(15.6) 79 (55.2) 90 (23.9) 116(45.9) 150 (19.7)
Nausea 29 (26.4) 151 (39.3) 19(13.6) 57(15.3) 48 (19.2) 208 (27.5)
Running nose b 57 (51.8) 125 (32.6) 40 (28.0) 29 (7.7) 97 (38.3) 154 (20.3)
Vomiting b 29 (26.4) 38 (9.9) 51 (35.7) 87(23.1) 80 (31.6) 125 (16.5)
Throat pain 35 (31.8) 116(30.2) 10 (7.0) 34 (9.0) 45 (17.8) 150 (19.7)
Back acheb 2 (1 .8 ) 58 (15.1) 5 (3.5) 97 (25.8) 7 (2.8) 155 (20.4)
Dizziness 2 (1 .8 ) 30 (7.8) 17(11.9) 69(18.4) 19 (7.5) 99 (13.0)
Enlarged lymph nodes 43 (39.1) 64(16.7) 2 (1.4) 4(1.1) 45 (17.8) 6 8  (9.0)
Diarrhoea 7 (6.4) 32 (8.3) 20 (14.0) 32 (8.5) 27 (10.7) 64 (8.4)
Skin manifestations b 15 (13.6) 23 (6.0) 29 (20.3) 23 (6.1) 44 (17.4) 46 (6.1)
General body ache b 0 38 (9.9) 2(1.4) 32 (8.5) 2  (0 .8 ) 70 (9.2)
Difficult breathing 7 (6.4) 44(11.5) 4 (2.8) 12 (3.2) 11 (4.4) 56(7.4)
Pallor 1 0 (9.2) 45 (11.8) 4(2.8) 2  (0 .6 ) 14 (5.6) 47 (6.3)
Abnormal chest sound 1 2 (10.9) 24 (6.3) 5 (3.5) 10 (2.7) 17 (6.7) 34 (4.5)
Enlarged spleen b 6 (5.5) 2(0.5) 23 (16.1) 19(5.1) 29(11.5) 2 1  (2 .8 )
Constipation 8 (7.3) 33 (8 .6 ) 1 (0.7) 7(1.9) 9 (3.6) 40 (5.3)
a Signs and symptoms with frequencies greater than 5 % in any of age groups are included in the table 
b Statistically significant difference (at 5% level of significance) between age groups within a district and 
between age groups for two districts together
5.3.4 Accuracy of clinical malaria diagnosis
Among 1258 outpatients from both districts malaria diagnosis was routinely made for 
1007 (80.0%, 95% Cl: 73.5-86.6) patients. There was no significant difference in the 
frequency of malaria diagnosis between health facilities without functional microscopy
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(83.9%, 95% Cl: 76.6-91.1) and facilities with microscopy (72.7%, 95% Cl: 60.8-84.5). 
Chapter 6 presents results on the effects of microscopy on malaria case management 
practices from health facilities with functional microscopy. In this section the results on 
the accuracy of the routine clinical malaria diagnosis at facilities without functional 
microscopy are presented in relation to the presence of fever, across two study districts 
and two age groups (older children 5-14 years and adults above 14 years of age).
The majority of febrile patients (88.2%) were clinically diagnosed as malaria, this 
practice being significantly more common in Kisii (96.2%, 95% Cl: 93.6-98.7) than in 
Kwale district (80.1%, 95% Cl: 69.7-90.4). This was also true in both age groups (96.7% 
in Kisii vs 83.1% in Kwale among 5-14 years, and 95.9% in Kisii vs 79.0% in Kwale in 
adults), however the difference was not statistically significant in the older children’s age 
group (Table 5.7). Furthermore, among 161 patients without fever, malaria was 
diagnosed in 106 (65.8%, 95% Cl: 53.5-78.2) patients, more commonly in Kisii (91.9%, 
95% Cl: 85.8-98.0) than in Kwale district (43.7%, 95% Cl: 32.2-52.2). Within each 
district the frequency of malaria diagnoses were similar between two age groups and no 
significant differences were revealed. Malaria diagnosing practices for febrile patients 
across two study districts and two age groups are presented in Table 5.7.
Table 5.7: Frequency of malaria diagnosis among febrile patients across districts and age groups
District 5-14 years
>15 years TOTAL
No % 95% Cl No % 95% Cl No % 95% Cl
KWALE 
Malaria diagnosed
N=83
69 83.1 68.5,97.7
N=248 
196 79.0 69.1,88.9
N=331 
265 80.1 69.7,90.4
KISII 
Malaria diagnosed
N=92
89 96.7 91.6, 100
N=246 
236 95.9 92.4,99.4
N=338 
325 96.2 93.6,98.7
TOTAL 
Malaria diagnosed
N=175 
158 90.3 82.0,98.6
N=494 
432 87.5 81.6,93.3
N=669 
590 88.2 82.1,94.3
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The accuracy of the routine clinical malaria diagnosis among patients with fever was 
compared with results of the study malaria smear using any parasitaemia as a 
conservative gold standard (Section 2.8.3.1). In both districts and across all age groups, 
the clinical diagnosis of malaria was characterised with high sensitivities (range: 84.2- 
100%) and negative predictive values (range: 85.7-100%), and low specificities (range: 
3.7-21.4%) and positive predictive values (range: 8.2-41.6%). Apart from lower 
specificities in Kisii (range: 3.7-5.0%) compared to Kwale district (range: 19.7-21.4%), 
none of the other measures of accuracy showed statistically significant differences 
between districts or between age groups within the same district. Results on the accuracy 
of clinical malaria diagnosis across districts and age groups are presented in Table 5.8.
Table 5.8; Accuracy of clinical malaria diagnosis across districts and age groups
District 5-14 years >15 years
TOTAL
No/N % 95% Cl No/N % 95% Cl No/N % 95% Cl
KWALE
Sensitivity 2 0 / 2 2 90.9 70.7, 100 16/19 84.2 70.7, 97.8 36/41 87.8 76.7, 98.<
Specificity 12/61 19.7 5.2, 34.1 49/229 21.4 10.8,32.0 61/290 2 1 . 0 10.2, 31.1
PPV 20/69 29.0 12.4,45.6 16/196 8 . 2 2.2, 14.1 36/265 13.6 6.3, 20.9
NPV 12/14 85.7 63.4, 100 49/52 94.2 8 8 .1 , 1 0 0 61/66 92.4 87.9, 96.<
KISII
Sensitivity 37/38 97.4 93.0, 100 47/47 1 0 0 NA 84/85 98.8 96.7, 10C
Specificity 2/54 3.7 0, 12.3 10/199 5.0 0.8, 9.3 12/253 4.7 1.2, 8.3
PPV 37/89 41.6 30.1,53.1 47/236 19.9 12.2, 27.7 84/325 25.8 19.2, 32.:
NPV 2/3 66.7 NA 1 0 / 1 0 1 0 0 NA 12/13 92.3 71.7, 10C
TOTAL
Sensitivity 57/60 95.0 87.8,100 63/66 95.5 90.0, 100 120/126 95.2 91.0, 99.i
Specificity 14/115 1 2 . 2 2.6,21.7 59/428 13.8 7.5,20.1 73/543 13.4 6.9, 19.9
PPV 57/158 36.1 26.1,46.0 63/432 14.6 8.9, 20.3 120/590 20.3 14.5, 26.:
NPV 14/17 82.4 62.8,100 59/62 95.2 90.1, 100 73/79 92.4 87.9, 96.i
PPV = positive predictive value; NPV = negative predictive value; NA = not applicable
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5.3.5 Characteristics of the clinical assessment
Health workers practices in performing various assessment tasks were described to 
evaluate the quality of clinical assessment for patients with fever. A particular focus was 
on the ability of health workers to clinically assess patients to determine alternative 
causes of fever.
5.3.5.1 Characteristics of the clinical assessment across study districts 
Only 4 of 30 indicators (Table 5.9) selected to define the quality of clinical assessment 
were performed for the majority of febrile patients and they were the following: 
determination of patient’s age (94.2%), assessment of fever (74.8%), assessment of 
headache (60.5%) and inquiry on the previous use of drugs (55.2%). Performance of 
specific clinical tasks was sub-optimal in both districts. Particularly poor results were 
evident in the assessment of signs and symptoms that are commonly related to other 
causes of fever (range for 14 indicators: 0.6-39.5%). Overall, it appeared that health 
workers showed better performance in considering alternative causes of fever in Kwale 
than in Kisii district. Clinical tasks related to respiratory diseases such as the assessment 
of cough (47.2% vs. 32.2%), difficult breathing (7.5% vs. 3.3%), chest pain (29.6% vs. 
15.0%), running nose (10.3% vs. 3.5%) and chest auscultation (23.0% vs. 7.8%) were 
more frequently performed in Kwale district. However, these differences could be 
explained by the higher frequency of respiratory symptoms in Kwale district resulting 
with higher rates of patients spontaneously reporting these complaints (Table 5.5), since a 
health workers’ exposure to spontaneously reported symptom was credited as if an 
assessment task was performed. Clinical assessment practices for patients with fever 
across two study districts are presented in Table 5.9.
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Table 5.9: Clinical assessment practices for patients with fever across two study districts
Health worker determined0
KWALE (N=494) KISII (N=519) TOTAL (N=1013)
No (%) 95% Cl No (%) 95% Cl No (%) 95% Cl
General tasks
Age 425 (90.2) 84.3, 96.2 503 (97.9) 96.3, 99.4 928 (94.2) 91.0, 97.4
Weight 6(1.3) 0.2, 2.3 22 (4.3) 1.4, 7.2 28 (2.9) 1.3,4.4
Temperature 118 (24.4) 12.8,36.1 145 (28.2) 15.2,41.1 263 (26.4) 17.8,34.9
Initial or follow up visit 19 (4.0) 0.7, 7.3 240 (47.0) 31.7, 62.2 259 (26.2) 16.2,36.2
Previous use of drugs 215 (44.1) 35.3, 52.8 340 (65.8) 57.1,74.5 555 (55.2) 48.0, 62.4
Tasks related to common signs & 
symptoms o f malaria
History of fever 311 (63.0) 56.3, 69.6 404 (77.8) 69.4, 86.3 715 (70.6) 64.2, 77.0
Fever assessedb 339 (6 8 .6 ) 60.8, 76.5 419 (80.7) 72.8, 8 8 . 6 758 (74.8) 68.6,81.1
Duration of fever 83 (16.9) 10.4,23.4 360 (69.6) 60.3, 79.0 443 (44.0) 31.7,56.2
Chills 103 (20.9) 14.5, 27.2 197 (38.0) 30.7, 45.2 300 (29.6) 23.8, 35.4
Shivering 18 (3.6) 1.7, 5.5 27 (5.2) 2.8, 7.6 45 (4.4) 3.0, 5.9
Headache 255 (51.6) 44.0, 59.2 358 (69.0) 63.8, 74.1 613 (60.5) 55.7, 65.3
Joint pain 136 (27.5) 22.1,32.9 188 (36.2) 31.6,40.8 324 (32.0) 28.3,35.7
Conjunctival pallor 223 (46.3) 34.9, 57.6 267 (51.6) 37.3, 66.0 490(49.1) 40.0,58.1
Palmar pallor 5(1.0) 0 , 2 . 0 6 8  (13.2) 4.2, 22.2 73 (7.3) 2.2, 12.3
Pallor assessed0 225 (45.6) 34.8,56.3 275 (53.0) 38.9, 67.1 500 (49.4) 40.5, 58.2
Spleen palpated 47 (9.7) 4.2, 15.3 26 (5.1) 0.4, 9.7 73 (7.3) 3.8, 10.9
Tasks related to common signs & 
symptoms o f other causes offever
Cough 233 (47.2) 41.8, 52.6 167 (32.2) 25.0,39.3 400 (39.5) 34.6,44.4
Difficult breathing 37 (7.5) 5.6, 9.4 17 (3.3) 2 .0 ,4.6 54 (5.3) 4.0, 6.7
Chest pain 146 (29.6) 23.7, 35.4 78 (15.0) 13.3, 16.8 224 (22.1) 17.9,26.3
Chest auscultated 109 (23.0) 15.8,30.2 40 (7.8) 3.3, 12.3 149 (15.1) 10.5, 19.8
Running nose 51 (10.3) 6.9, 13.7 18 (3.5) 0.3, 6.7 69 (6 .8 ) 4.3, 9.3
Throat pain 34 (6.9) 4.6, 9.1 23 (4.4) 2 .2 , 6 . 6 57 (5.6) 4.0, 7.2
Throat examined 42 (8.5) 4.8, 12.2 37 (7.1) 5.0, 9.3 79 (7.8) 5.8,9.8
Ear problem 19 (3.9) 2.4, 5.3 9(1.7) 0.4, 3.1 28 (2 .8 ) 1.7, 3.8
Ear examined 19 (3.9) 2.4, 5.3 12 (2.3) 1.0, 3.6 31 (3.1) 2.1, 4.0
Breaths counted 4 (0.8) 0, 1.9 2 (0.4) 0, 0.9 6  (0 .6 ) 0 , 1 . 2
Vomiting 87 (17.6) 10.2, 25.0 129 (24.9) 16.8, 32.9 216(21.3) 15.7, 27.0
Diarrhoea 60 (1 2 .2 ) 6 .2 , 18.1 107 (20.6) 14.4, 26.9 167(16.5) 1 1 .8 , 2 1 . 2
Lymph nodes palpated 4 (0.8) 0 , 1 . 8 2 (0.4) 0, 0.9 6  (0 .6 ) 0 , 1 . 2
Urinary problem 30 (6.1) 3.4, 8.7 6  (1 .2 ) 0,2.3 36 (3.6) 2.0, 5.1
“Determined refers to performance of assessment tasks to detect signs and symptoms. Symptom was judged as 
determined if HW asked about its presence or the patient spontaneously reported the symptom. Sign was judged as 
determined if HW performed the task or the surveyor could obviously tell the patient had the information of interest 
b Assessed means that either history of fever was assessed or temperature was measured 
0 Assessed means that either conjunctival or palmar pallor was checked; Cl = confidence interval
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5.3.5.2 Characteristics of the clinical assessment across age groups
Similar to the overall results, sub-optimal performance of clinical assessment tasks was 
demonstrated in both age groups (older children 5-14 years and adults above 14 years). 
Only 4 clinical tasks were more commonly performed in older children compared to adults 
and they were the following: determination of age (98.4% vs. 92.8%), assessment of 
history of fever (84.2% vs. 66.1%), vomiting (32.0% vs. 17.7%) and diarrhoea (23.7% vs. 
4.3%). Assessment of joint pain (39.1 vs. 10.7) and chest pain (25.8% vs. 11.1%) was more 
commonly performed in adults than in children 5-14 years. For the remaining 24 
assessment indicators measured, no statistically significant difference was observed 
between two age groups. Table 5.10 presents clinical assessment practices for patients with 
fever across two age groups.
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Table 5.10: Clinical assessment practices for patients with fever across age groups
Health worker determined!1
5-14 years (N=253) >15 years (N=760)
No % 95% Cl No % 95% Cl
General tasks
Age 246 98.4 96.8,100 682 92.8 88.8,96.8
Weight 14 5.6 1.6, 9.6 14 1.9 0.7, 3.1
Temperature 87 35.1 23.0,47.2 176 23.5 15.6,31.4
Initial or follow up visit 64 25.5 14.1,36.9 195 26.4 16.4, 36.4
Previous use of drugs 145 57.3 48.1,66.5 410 54.5 47.6,61.5
Tasks related to common signs & 
symptoms o f malaria
History of fever 213 84.2 78.7, 89.6 502 6 6 . 1 58.8, 73.3
Fever assessed15 2 2 1 87.4 82.3, 92.4 537 70.7 63.6, 77.7
Duration of fever 129 51.2 36.5, 65.9 314 41.5 29.6, 53.4
Chills 57 22.5 15.6, 29.4 243 32.0 26.1,37.8
Shivering 9 3.6 0.6, 6.5 36 4.7 3.0, 6.5
Headache 159 62.9 55.0, 70.7 454 59.7 54.5, 65.0
Joint pain 27 10.7 6.4, 14.9 297 39.1 34.7,43.4
Conjunctival pallor 144 57.6 47.4, 67.8 346 46.2 36.9, 55.4
Palmar pallor 28 1 1 . 1 3.2, 19.0 45 6 . 0 1.6, 10.3
Pallor assessed0 147 58.1 47.9, 68.3 353 46.5 37.5, 55.4
Spleen palpated 2 2 8.7 3.8, 13.7 51 6.9 3.1, 10.6
Tasks related to common signs & 
symptoms o f other causes o f fever
Cough 1 2 0 47.4 39.6,55.3 280 36.8 31.9,41.8
Difficult breathing 6 2.4 0.3,4.5 48 6.3 4.7, 7.9
Chest pain 28 1 1 . 1 7.0, 15.2 196 25.8 21.0,30.6
Chest auscultated 35 14.2 7.8,20.5 114 15.4 10.6, 20.3
Running nose 23 9.1 4.4, 13.7 46 6 . 1 3.5, 8 . 6
Throat pain 8 3.2 0 .2 , 6 . 1 49 6.5 4.4, 8.5
Throat examined 13 5.1 1.8, 8.4 6 6 8.7 6.0, 11.4
Ear problem 9 3.6 1.3, 5.9 19 2.5 1.3, 3.7
Ear examined 1 1 4.4 1.9, 6 . 8 2 0 2 . 6 1.4, 3.9
Breaths counted 1 0.4 0 , 1 . 2 5 0.7 0, 1.4
Vomiting 81 32.0 23.9,40.2 135 17.7 12.4, 23.2
Diarrhoea 60 23.7 15.1,32.3 33 4.3 1 0 .1 , 18.0
Lymph nodes palpated 2 0 . 8 0, 1.9 4 0.5 0 , 1 . 1
Urinary problem 3 1 . 2 0,2.5 33 4.3 2.4, 6.3
a Determined refers to performance of assessment tasks to detect signs and symptoms. Symptom was judged as 
determined if HW asked about its presence or the patient spontaneously reported the symptom. Sign was judged as 
determined if HW performed the task or the surveyor could obviously tell the patient had the information of interest. 
b Assessed means that either history of fever was assessed or temperature was measured 
c Assessed means that either conjunctival or palmar pallor was checked; Cl = confidence interval
207
5.3.5.3 Detection of signs and symptoms with the current assessment practices
In this section the current health workers’ performance of clinical assessment tasks was 
compared with the true presence of signs and symptoms established during the exit 
examination by study physicians. Such an analysis provides an estimate of the impact of 
the current assessment practices on the detection of each sign and symptom.
As presented in Section 5.3.5, the presence of fever was the most commonly assessed 
symptom (74.8%), however, 25.2% of fevers remained unobserved. Other malaria related 
signs and symptoms were less frequently detected: headache (69.7%), anaemia (57.4%), 
joint pain (43.8%), chills (36.7%), enlarged spleen (12.0%) and shivering (5.6%). The 
detection of these signs and symptoms was generally more frequent in Kisii than in Kwale 
district (Table 5.11). Of particular importance in the older children and adults age group, 
potential symptoms and signs commonly related to other causes of fever than malaria, have 
remained substantially undetected. The respiratory symptoms such as cough and chest pain 
were assessed in 63.9% and 55.5% of patients respectively when these symptoms were 
present. However, a throat problem was either examined or asked about in only 11.0% of 
patients with throat pain complaints or inflamed throat. Assessment of signs for which 
clinical examination is required generally showed lower detection rates compared to the 
symptoms based on history taking practices. For example, while gastrointestinal symptoms 
such as diarrhoea and vomiting were detected for the majority (69.2% and 55.6% 
respectively) of patients presenting with these symptoms, chest auscultation was performed 
for 28.0% of patients with an abnormal chest sound and lymph nodes were palpated in only 
1.8% of patients with enlarged lymph nodes. There was no significant difference between 
districts in the assessment practices of symptoms and signs related to other causes of fever
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than malaria. Table 5.11 presents the detection rate of the current assessment practices for
each sign and symptom across two districts.
Table 5.11: Detection rates of various signs and symptoms with current assessment practices
Health worker determined* KWALE KISII
TOTAL
Nob % 95% Cl Nob % 95% Cl Nob % 95% Cl
Signs and symptoms commonly 
related to malaria
History of fever 307 63.2 56.5, 69.9 396 78.1 69.9, 86.3 703 70.8 64.5, 77.1
Temperature >37.5°C 36 39.6 23.2, 56.0 64 38.6 21.6, 55.5 1 0 0 38.9 27.1,50.7
Fever0 339 6 8 . 6 60.8, 76.5 419 80.7 72.8, 8 8 . 6 758 74.8 68.6,81.1
Headache 234 59.9 53.4, 66.3 320 79.2 73.2, 85.2 554 69.7 65.0, 74.3
Joint pain 105 36.1 28.1,44.1 151 51.5 44.4, 58.6 256 43.8 38.3,49.4
Chills 90 26.5 18.3,34.7 165 46.6 39.8, 53.4 255 36.7 30.1,43.4
Shivering 8 4.6 0.9, 8.4 7 7.5 2.7, 12.2 15 5.6 2.7, 8.5
Anaemiad 29 52.7 37.3, 68.1 6 1 0 0 NA 35 57.4 42.3, 72.5
Enlarged spleen 3 37.5 3.9,71.1 3 7.1 0, 17.8 6 1 2 . 0 0, 24.3
Signs and symptoms commonly 
related to other causes o f fever
Cough 175 69.2 62.4, 75.9 113 57.1 48.1,66.0 288 63.9 58.4, 69.3
Chest pain 117 54.9 49.7, 60.2 45 57.0 42.5,71.4 162 55.5 50.4, 60.6
Running nose 37 20.3 12.9, 27.8 1 1 15.9 17.3,30.2 48 19.1 12.7, 25.5
Vomiting 42 62.7 50.9, 74.4 72 52.2 41.2, 63.2 114 55.6 47.5, 63.7
Throat problem6 37 9.0 5.1, 12.8 19 2 0 . 0 12.7, 27.3 56 1 1 . 0 7.6, 14.4
Enlarged lymph nodes 2 1.9 0,4.7 0 0 NA 2 1 . 8 0,4.4
Diarrhoea 30 76.9 63.0, 90.9 33 63.5 52.1,74.8 63 69.2 60.3, 78.2
Difficult breathing 13 25.5 12.7,38.3 5 31.3 8.2, 54.3 18 26.9 16.2,37.5
Abnormal chest sound 9 25.7 13.4,38.0 5 33.3 0, 72.3 14 28.0 15.1,40.9
Ear problemf 14 63.6 44.7, 82.6 6 46.2 13.1,79.2 2 0 57.1 41.2, 73.0
Urinary problem 1 2 57.1 33.4, 80.9 1 7.1 0 , 2 2 . 6 13 37.1 20.4, 53.8
a Determined refers to the performance of assessment tasks during observation of consultations to detect signs 
and symptoms established during the exit examination. Symptom was judged as determined if HW asked about 
its presence or the patient spontaneously reported the symptom. Sign was judged as determined if HW 
performed the task or the surveyor could obviously tell the patient had the information of interest 
b Denominators for each sign and symptom are presented in Tables 5.4 and 5.5.
0 Fever refers to assessment of history of fever or measurement of temperature 
d Anaemia refers to assessment of conjunctival or palmar pallor
e Throat problem refers to assessment of throat either by asking for throat pain or performing throat inspection 
f Ear problem refers to assessment of ear either by asking for ear problem or performing ear inspection 
Cl = confidence interval; NA = not applicable
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5.3.6 Clinical predictors of malaria
To evaluate the ability of various signs and symptoms to detect malaria in febrile 
patients, data collected by study physicians during the exit examination were analysed. A 
“true” case of malaria was defined as a patient presenting with fever and detectible P. 
falciparum parasitaemia of any level (Sections 2.8.2.1. and 2.11.2). There were 43 
malaria cases in Kwale district (22 in older children and 21 in adults) and 122 in Kisii 
district (56 in older children and 66 in adults). 14 patients with evidence of non-P. 
falciparum parasites were excluded from the analysis. Analysis was performed separately 
for older children and adults, however, due to the small sample of true malaria cases the 
district-specific analysis could not be performed and data from two districts were 
combined.
5.3.6.1 Clinical predictors - univariate analysis
In the univariate analysis the strength of association between each of 27 clinical 
predictors and malaria was estimated using logistic regression modelling and odds ratios 
with associated p-values were calculated for each investigated sign and symptom. The 
results of the univariate analysis revealed that 10 and 15 clinical predictors had p-values 
<0.20 in older children and adults respectively. Interestingly, symptoms and signs 
commonly related to malaria such as shivering and joint pain did not show any significant 
association with the measured outcome in any of two age groups. Similarly, no 
significant association was demonstrated for symptoms and signs commonly related to 
alternative causes of fever such as cough, diarrhoea and skin rash. Table 5.12 presents the 
odds ratios and p-values for each of 27 clinical predictors investigated in the two age 
groups.
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Table 5.12: Clinical predictors of malaria across age groups; results of univariate analysis
5-14 years >15 years
Malaria 
N = 78
Non-malaria 
N = 165 OR p-valuea
Malaria 
N = 87
Non-malaria 
N = 669 OR p-valuea
Symptoms
Fever main complaint 57 (73.1) 103 (62.4) 1.63 0.104 42 (48.3) 298 (44.5) 1.16 0.511
Fever less than 7 days 63 (80.8) 134 (81.2) 0.97 0.934 68 (78.2) 382 (57.1) 2.69 <0.001
Chills 57 (73.1) 108 (65.5) 1.43 0.236 71 (81.6) 452 (67.6) 2.13 0.009
Shivering 27 (34.6) 45 (27.3) 1.41 0.243 23(26.4) 167(25.0) 1.08 0.766
Headache 67 (85.9) 123 (74.6) 2.08 0.049 77 (88.5) 520 (77.7) 2.21 0.023
Joint pain 28 (35.9) 48 (29.1) 1.37 0.286 443 (66.2) 59 (67.8) 1.07 0.767
Backache 1 (1.3) 6(3.6) 0.34 0.327 27 (31.0) 128(19.1) 1.90 0.011
Vomiting 33 (42.3) 44 (26.7) 2.02 0.015 28 (32.2) 97 (14.5) 2.80 <0.001
Body weakness 30 (38.5) 61 (37.0) 1.07 0.823 38 (43.7) 343 (51.3) 0.74 0.184
General bodyache 2 (2.6) 0 NA NA 11 (12.6) 58 (8.7) 1.52 0.229
Dizziness 8 (10.3) 11(6.7) 1.60 0.334 17(19.5) 80 (12.0) 1.79 0.049
Diarrhoea 17(10.3) 57 (8.5) 1.14 0.771 6 (6.9) 57 (8.5) 0.80 0.607
Constipation 4(5.1) 5(3.0) 1.73 0.424 2 (2.3) 38 (5.7) 0.39 0.201
Abdominal pain 36 (46.2) 69(41.8) 1.19 0.524 34 (39.1) 299 (44.7) 0.79 0.322
Nausea 18(23.1) 30(18.2) 1.35 0.372 21 (24.1) 189 (28.3) 0.81 0.421
Lack of appetite 7 (9.0) 7(4.2) 2.23 0.148 1 (1.2) 28 (4.2) 0.27 0.196
Absence of cough 35 (44.9) 60 (36.4) 1.42 0.205 60 (69.0) 417(62.3) 1.34 0.229
Absence of difficult breathing 77 (98.7) 155(93.9) 4.97 0.130 85 (97.7) 615(91.9) 3.73 0.071
Absence of running nose 54 (69.2) 99 (60.0) 1.50 0.165 77 (88.5) 526 (78.6) 2.09 0.034
Absence of chest pain 71 (91.0) 134 (81.2) 2.35 0.054 69 (79.3) 437 (65.3) 2.04 0.010
Signs
Temperature >37.5°C 46 (59.0) 68(41.2) 2.05 0.010 39 (44.8) 111 (16.7) 4.08 <0.001
Pallor 6 (7.7) 8 (4.9) 1.61 0.391 0 46 (7.0) NA NA
Palpable spleen 11 (14.1) 16(9.7) 1.53 0.310 9(10.3) 12(1.8) 6.32 <0.001
Absence of throat problemb 52 (66.7) 87 (52.7) 1.79 0.041 58 (66.7) 302(45.1) 2.43 <0.001
Normal chest sound 74 (94.9) 153 (92.7) 1.45 0.531 87(100) 636(95.1) NA NA
Absence of skin rash 63 (80.8) 138 (83.6) 0.82 0.581 83 (95.4) 628 (93.9) 1.35 0.572
Lymph nodes not enlarged 70 (89.7) 131 (79.4) 2.27 0.051 84 (96.6) 604 (90.3) 3.01 0.067
aIn bold are p-values < 0.20
bThe absence of throat infection on the inspection and/or history of throat pain 
OR = odds ratio; NA = not applicable
5.3.6.2 Clinical predictors - multivariate analysis
To adjust for confounding, clinical predictors with a p-value < 0.20 from the univariate 
analysis (10 predictors in older children and 15 in adults) were entered into two age- 
specific multivariate logistic regression models. Using a backward elimination strategy
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clinical predictors independently associated with malaria (odds ratios with p-value <0.05) 
were identified and sensitivities, specificities, and PPVs and NPVs were calculated.
The best fitting multivariate model to predict malaria in older children contained four 
clinical predictors: temperature >37.5°C, headache, vomiting and absence of chest pain. 
Older children possessing these symptoms were between 2.0 to 2.7 times more likely to 
have malaria. The final multivariate model in adults contained 6 clinical predictors with 
odds ratios more diverse than in older children. The predictors were: temperature >  
37.5°C (OR=3.77), fever duration of less than 7 days (OR=2.24), backache (OR=1.92), 
vomiting (OR=2.24), palpable spleen (OR=4.29) and absence of throat problem 
(OR=1.99). However, none of these independent symptoms and signs, neither in older 
children nor in adults, had sufficient sensitivity, specificity or predictive values to be 
useful as a diagnostic aid in a febrile patient. Table 5.13 presents the age-specific results 
of the multivariate analysis with attributed predictive values.
Table 5.13: Age-specific results of multivariate analysis with attributed predictive values
Older children (5 -1 4  years) OR p-value Sens (%) Spec (%) PPV (%) NPV (%)
Temperature >37.5°C 1.97 0 . 0 2 0 59.0 58.8 40.4 75.2
Headache 2.40 0.026 85.9 25.5 35.3 79.3
Vomiting 2.14 0.013 42.3 73.3 42.9 72.9
Absence of chest pain 2.74 0.029 91.0 18.8 34.6 81.6
Adults (>15 years) OR p-value Sens (%) Spec (%) PPV (%) NPV (%)
Fever less than 7 days 2.24 0.004 78.2 42.9 15.1 93.8
Backache 1.92 0.018 31.0 80.9 17.4 90.0
Vomiting 2.24 0.003 32.2 85.5 22.4 90.7
Absence of throat problem 1.99 0.007 66.7 54.9 16.1 92.7
Temperature >37.5°C 3.77 <0 . 0 0 1 44.8 83.4 26.0 92.1
Palpable spleen 4.29 0.004 10.3 98.2 42.9 89.4
OR = odds ratio; Sens = sensitivity; Spec = specificity; PPV = positive predictive value; NPV = negative
predictive value
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53.6.3  Clinical algorithms
A malaria score was calculated for each individual by a simple count of clinical 
predictors shown to be significantly associated with the measured outcome in the 
multivariate models. In older children the scores varied from 1 to 4 based on the 
following 4 signs and symptoms: temperature >37.5°C, headache, vomiting and absence 
of chest pain. In adults the scores varied from 1 to 6 based on the following 6 signs and 
symptoms: temperature >  37.5°C, fever in duration of less than 7 days, backache, 
vomiting, palpable spleen and absence of throat problem. Predictive values of various 
scores were also compared with study physician diagnosis of malaria and current practice 
malaria diagnosis made by observed health workers.
In both age groups, none of the scores had sufficient sensitivity, specificity or predictive 
values to present an acceptable diagnostic aid in a febrile patient. However, in older 
children, in comparison to the current malaria diagnostic practice and a study physician 
diagnosis where major deficiencies were reflected in low specificities of 12.4% and 
32.0% respectively, the score of 3 improved specificity to 61.2% but at the cost of poor 
sensitivity of 65.4%. Given the low prevalence of true malaria in the study sample size, 
even the most specific score of 4 could not increase positive predictive value more than 
77.3%. Negative predictive values were generally high for all score values and diagnostic 
practices (range: 72.4-100%).
In adults, a score of 2 showed a sensitivity and specificity of 87.4% and 41.9% 
respectively, while a score of 3 improved significantly specificity (84.0%), however at
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the cost of reduced sensitivity to 50.6%. The score of 3 showed improved specificity 
compared to the accuracy of physicians’ diagnosis (33.9%) and current practices (16.7%). 
Predictive values of different scores from age-specific algorithms, accuracy of 
physician’s and current practice malaria diagnosis are presented in Table 5.14.
Table 5.14: Predictive values of different age-specific scores and accuracy of physician’s 
and current practice malaria diagnosis_______________________________ _________
Older children (5 —14 years) Sens (%) Spec (%) PPV (%) NPV (%)
Malaria score
1 100 2.4 32.6 100
2 91.0 18.2 34.5 81.1
3 65.4 61.2 44.4 78.9
4 21.8 97.0 77.3 72.4
Physician’s diagnosis3 87.7 32.0 38.1 84.5
Current practice3 95.9 12.4 34.3 86.4
Adults (>15 years) Sens (%) Spec (%) PPV (%) NPV (%)
Malaria score
1 97.7 14.5 12.9 98.0
2 87.4 41.9 16.3 96.2
3 50.6 84.0 29.1 92.9
4 17.2 97.6 48.4 90.1
5 1.2 99.4 20.0 88.6
6 0 100 0 88.5
Physician’s diagnosis3 88.6 33.9 16.0 95.5
Current practice3 96.2 16.7 14.1 96.9
3 Results adjusted for the exclusion of negative blood slides reported through routine practice
Sens = sensitivity; Spec = specificity; PPV = positive predictive value; NPV = negative predictive value
In both age groups the scores based on the selected signs and symptoms poorly 
performed, as demonstrated by small areas under the Receiver Operating Characteristic 
(ROC) curves shown in Figure 5.4. The areas under the ROC curves of the examined 
scores were only 0.63 (95% Cl: 0.56-0.70) in older children and 0.73 (95% Cl: 0.68- 
0.79) in adults.
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Figure 5.4: Receiver operating characterteristic (ROC) curves for evaluated scores in older 
children and adults
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5.4 Discussion
Three major findings of this study were: 1) The accuracy of the routine clinical malaria 
diagnosis was low, particularly characterised by a massive overdiagnosis of malaria; 2) 
the quality of the health worker’s clinical assessment in considering alternative causes of 
fever was sub-optimal; and 3) the validity of the various clinical signs and symptoms to 
predict malaria was shown to be of very limited value as a diagnostic aid in febrile 
patients above 5 years of age.
5.4.1 Malaria prevalence and accuracy of the current clinical diagnosis of malaria 
The presence of fever was the most common clinical presentation (80.5%) in older 
children and adults presenting to the outpatient departments of health facilities in both 
study districts. The large majority of febrile older children and adults (88.2%) were 
routinely diagnosed for malaria in both study districts. It appears that in both age groups, 
health workers’, by presumptively diagnosing all fevers for malaria, use similar
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diagnostic reasoning as previously demonstrated in young children below 5 years of age 
(Section 3.3.4.2).
The practice of equating nearly all fevers as malaria resulted in a high diagnostic 
sensitivity (95.2%), but at the cost of poor specificity (13.4%) demonstrated in both study 
districts and across both age groups. Although the prevalence of malaria parasitaemia 
was generally higher in Kisii (23.7%) than in Kwale district (11.3%), and in older 
children (30.8%) compared to adults (11.4%), the positive predictive values (PPV) of 
current malaria diagnostic practices remained low in both areas of different malaria 
transmission and all age groups (range: 8.2-41.6%). An overall PPV of 20.3% suggests 
that only 1 out of 5 routinely made malaria diagnoses in febrile patients actually have 
evidence of malaria infection. These observations are consistent with the results of the 
studies published from various health facilities across Africa where between 24 and 48% 
of adults treated for malaria had a positive malaria slide (Mkawagile & Kihamia, 1986; 
Jonkman et al., 1995; Oster et al., 2000).
As previously described in the literature (Trape & Rogier, 1996; Snow & Marsh, 1998) 
and also indicated by malaria age-specific prevalence curves in this study (Figure 5.1), 
clinical immunity develops with the age, the incidence of malaria disease declines as 
children get older, and the incidence is generally low in adults regardless of the level of 
malaria transmission. In this study low prevalence of malaria among febrile adult patients 
has been demonstrated in both districts; therefore, a massive overdiagnosis of true 
malaria in adults above 14 years of age cannot be regarded as an appropriate practice and
216
more conservative malaria diagnostic approaches focusing an alternative causes of fever 
are urgently required.
The interpretation of the results are more complex in children 5-14 years of age, where 
the incidence of malaria disease is generally higher than in adults but effective immunity 
is still being developed with the speed dependant on the intensity of malaria transmission. 
This study demonstrated that in areas of high malaria transmission such as Kwale district 
the prevalence of malaria in older children was significantly higher than in adults (20 .0% 
vs 5.5%), however, it was low compared to 0-5 year old prevalence rates reported from 
the community surveys, and classifying the district as predominantly malaria hyper­
endemic area (Section 2.3.3.4). Therefore, it is reasonable to conclude that in Kwale 
district clinical immunity, reflected in declined incidence of malaria in older children, has 
largely been acquired by the age of five. These conclusions suggest that in older children, 
like in adults, a similar malaria diagnostic approach should be applied and the current 
practice of presumptive diagnosis of all fevers for malaria should not be considered 
appropriate.
Given the highly seasonal pattern of malaria transmission in Kisii district, the timing of 
the survey during the malaria season and a high prevalence of malaria in older children 
(39.2%), the interpretation of the health workers’ malaria diagnostic practices requires a 
more cautious approach among children aged 5-14 years. A higher prevalence of malaria 
disease in older children suggests a shift of the age-specific acquisition of functional 
immunity towards the older age groups above 5 years. However, it appears that even the
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low intensity of transmission in Kisii district is sufficient to create some functional 
immunity by the age of 15 years, as reflected in significantly lower prevalence of malaria 
in adults (17.6%) compared to older children. This pattern has also been shown under a 
low transmission intensity setting in South Africa (Kleinschmidt & Sharp, 2001) and 
models of acquired immunity suggest that only a few parasite exposures are required to 
develop an immune response to the clinical consequences of infection (Snow et al., 1994; 
Gupta et al., 1999). Therefore, from a malaria risk point of view, in older children, as 
opposed to adults, the health workers presumptive diagnosis of all fevers as malaria may 
be an appropriate practice during the malaria seasons. However, in Kisii district, malaria 
diagnostic practices and their interpretations may be different outside the malaria season.
In the absence of diagnostics, a massive overdiagnosis of malaria in older children and 
adults could be explained by sub-optimal quality of clinical assessment of febrile patients 
and insufficient efforts to identify clinical presentations suggestive of alternative causes 
of fever. The quality of current clinical assessment of febrile patients is discussed in the 
following section.
5.4.2 Quality of clinical assessment in febrile patients
The various national and international malaria case management guidelines suggest a 
search for alternative causes of fever before establishing a malaria diagnosis and 
prescribing antimalarial treatment in older children and adults (MoH, 1998; WHO, 
2000a). However, it has been suggested that the various predictors of alternative causes 
of fever will be dependent on their incidence, and acceptable criteria may differ between
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different epidemiological settings (WHO, 2003a). As such, there are currently no 
recommendations on which signs and symptoms present sufficient criteria to exclude 
malaria and detect alternative causes of fever.
The review of the clinical presentations in this study revealed that malaria related 
symptoms such as headache, chills and joint pain are still the commonest clinical 
presentations in febrile older children and adults (symptom range: 57.7-78.5%). Yet, 
signs and symptoms commonly related to respiratory illnesses such as presence of cough, 
chest pain, throat problem and running nose are also frequently present (symptom range: 
24.8-44.5%). Similarly, a substantial proportion of febrile patients presented with 
symptoms commonly related to gastrointestinal illnesses such as abdominal pain, 
vomiting and diarrhoea (symptom range: 9.0-43.2%). Common signs and symptoms of 
febrile patients with urinary problems, skin manifestations and other more obvious non­
malaria related illness were rarely present. Some of the observed district specific 
differences in the frequencies of signs and symptoms, especially those related to the 
respiratory illnesses, are likely to be due to the lower prevalence of malaria in Kwale 
district, however, misclassification due to the use of different physicians between districts 
and possible discordant assessments cannot be excluded. Nevertheless, the frequent 
presence of signs and symptoms commonly related to diseases other than malaria such as 
respiratory or gastrointestinal illnesses may present an opportunity for health workers to 
perform a differential diagnosis and potentially identify alternative causes of fever before 
establishing a diagnosis of malaria.
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However, the findings of our study revealed that none of the investigated signs and 
symptoms commonly related to the respiratory and gastrointestinal illnesses was 
considered in febrile patients in a proportion higher than 40%. Some of the respiratory 
symptoms such as cough, chest pain and running nose were more commonly assessed in 
Kwale than in Kisii district, however, these findings were more a reflection of a higher 
frequency of the respiratory symptoms in Kwale district and their spontaneous reporting 
by the patients than broader differential diagnosis performed by the health workers. 
Currently, it appears that the most of the health workers apply a vertical, presenting 
symptom based approach, with few exploratory assessment tasks being performed. As a 
result, a substantial proportion of the most common respiratory signs and symptoms 
(range: 36.1-89.0%), as well as gastrointestinal symptoms (range: 36.1-44.4%), remained 
unexplored and not considered when they were truly present. However, while such 
omissions in detecting various signs and symptoms may have an impact on under­
diagnosing of other febrile illnesses, the sub-optimal quality of clinical assessment is of 
importance for the reduction of the current malaria overdiagnosis only if clinical 
predictors, sufficiently accurate to predict malaria, truly exist. In the following section the 
validity of the various clinical signs and symptoms to predict malaria in older children 
and adults are discussed.
5.4.3 Validity of the clinical signs and symptoms to predict malaria 
This study detected 4 and 6 clinical predictors associated with malaria in older children 
and adults respectively. However, none of the investigated signs and symptoms had 
sufficient sensitivity and specificity to predict malaria in older children or in adults.
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Increased axillary temperature had the best validity in older children (sensitivity and 
specificity of 59%) and the absence of throat problem had the best predictive power in 
adults (sensitivity 66.7%, specificity 54.9%). In both age groups, positive predictive 
values were lower than 50% for all investigated predictors, indicating that malaria 
diagnosis based on the best fitting individual predictors would continue to result in 
significant overdiagnosis of true malaria cases.
These observations are consistent with the few studies published on clinical predictors in 
older children and adults in Africa. In Kilifi district in Kenya, Mwangi et al. (2005) 
reported 9 and 3 signs and symptoms significantly associated with malaria parasitaemia 
in older children and adults respectively. However, predictors with the best individual 
accuracy such as cough not heard (sensitivity 72.0%, specificity 43.0%) in older children, 
and joint pains (sensitivity 25.8%, specificity 84.0%) in adults, still had an unsatisfactory 
predictive power to present a valid diagnostic aid. Similarly in Tanzania, Oster et al. 
(2000) reported that difficulties in breathing, sore throat, chest pain and cough, abnormal 
chest sound and enlarged lymph nodes were associated with a diagnosis other than 
malaria, however, the sensitivities of predictors presented were generally unsatisfactory 
(range: 17-55%) to be used as a diagnostic guide.
In this study the validity of different clinical scores created from signs and symptoms 
associated with malaria parasitaemia in the febrile patient did not significantly improve 
the accuracy of the malaria diagnosis compared to the individual predictors. In the study 
undertaken among adults living in an area of low malaria transmission in India, the best
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performing score of 5 signs and symptoms had sensitivity of 54.6%, specificity of 57.5% 
and positive and negative predictive values of 14.7% and 90.5% respectively 
(Chandramohan et al., 2001). Out of 10 signs and symptoms suggested in India, only 3 
predictors (increased temperature, enlarged spleen and vomiting) remained part of the 
best fitting adult model in the population in the present study. Furthermore, in the study 
in Kilifi district in Kenya, 5 and 2 signs and symptoms were proposed as parts of the 
score models for older children and adults respectively (Mwangi et al., 2005). Of all 
predictors proposed by the Kilifi study, only temperature >37.5°C in older children 
remained part of the best fitting models in the present two-district study. However, such 
differences are not surprising and were described previously, for example, the absence of 
cough was the only symptom from the proposed 9 predictors score in The Gambia 
(Olaleye et al., 1998) that remained part of the model in the study in India 
(Chandramohan et al., 2001). These findings highlight the point that clinical malaria 
predictors may vary between various malaria settings. Unfortunately, due to the small 
sample size of true malaria cases in this study, the data from the two districts had to be 
combined and the district specific differences in malaria predictors could not be 
investigated.
Weighted scores based on the strength of the association between individual predictors 
and the presence of malaria has been shown to improve the accuracy of the clinical 
predictors in The Gambia (Olaleye et al., 1998; Bojang et al., 2000). However, the use of 
weighted scoring systems complicates clinical malaria case definitions and is likely to 
further compromise accuracy of clinical predictors when implemented by the health
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workers with limited training. This has also been suggested in The Gambia where further 
7% of misclassification was generated when weighted scores were applied by the field 
workers (Bojang et al., 2000).
5.4.4 Implications of study findings on national antimalarial drug policies 
In Kenya, Snow et al. (2004) estimated that annual number of routine malaria diagnoses 
made at government facilities is 7.35 million, of which 4.82 million (65.6%) are made in 
older children and adult patients. Under current SP treatment policy, older children and 
adults consume 337,903 USD or 85.9% of all age antimalarial drug costs countrywide. If 
we assume, as suggested by the results of this study, that only 20.3% of malaria 
diagnoses made in older children and adults are truly malaria, it can be estimated that the 
annual unnecessary cost of current practices under SP treatment is 269,309 USD among 
older children and adult patient groups. However, the amount of unnecessary cost would 
substantially increase if  the recently launched and more expensive artemether- 
lumefantrine (ART-LUM) treatment policy would be implemented under current 
diagnostic practices (MoH, 2004b); it can be estimated that only in older children and 
adults, the unnecessary cost for ART-LUM would increase to 8.6 million USD annually.
The results of this study suggest that significant improvements in malaria diagnostic 
accuracy cannot be achieved based on clinical signs and symptoms alone. For example, 
in comparison to the current practice, the best performing score of 2 would reduce the 
number of unnecessary malaria treatments in adults by only 2 .2% while at the same time 
reasonably high sensitivity of 87.4% is preserved. In older children, a decrease in the
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number of unnecessary treatments could not be achieved at all without increasing the 
rates of failure to treat up to unacceptable levels (37.4%). Therefore, the only potential 
cost-effective solution to improve malaria diagnostic accuracy under new and more 
expensive ART-LUM treatment policy is the use of malaria diagnostics. Traditionally, 
microscopy has been seen as a solution to this problem but it also has its limitations. The 
effects of microscopy on malaria case management in Kenya and the potential role of 
alternative malaria diagnostics are discussed in the following chapter.
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CHAPTER 6:
Effects of microscopy on malaria case management
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6.1 Introduction
6.1.1. Background
In most areas of sub-Saharan Africa the clinical diagnosis of malaria is often limited to a 
history of fever (Section 1.4.2). Since malaria is a disease that can rapidly progress to 
severe and potentially fatal complications if not treated early, low sensitivity of different 
clusters of signs and symptoms explored in the clinical predictors studies has been seen 
as a threat to the clinical management of the febrile child in malaria endemic areas 
(Marsh et al., 1996; Chandramohan et al., 2002). The conclusion of most studies was that 
parasitological confirmation is required to improve upon diagnostic accuracy.
While conventional first-line drugs, such as chloroquine and SP, are cheap and safe, 
significant over-treatment has to a certain degree been tolerated within international and 
national guidelines. However, with increased treatment failure rates to most of the first- 
line therapies in East Africa (EANMAT, 2003; Adjuik et al., 2002) and the introduction 
of new, more expensive and more complex to use drugs with uncertain safety-margins 
(WHO, 2001a), the adequate use of laboratory diagnosis of malaria becomes far more 
important. Laboratory diagnosis of malaria would be expected to reduce the number of 
treated individuals but, in high malaria endemic areas, does not necessarily overcome the 
problem of asymptomatic, coincidental malaria parasitaemia in someone unwell for 
another reason.
Recognising the limitations of presumptive malaria diagnosis several countries in sub- 
Saharan Africa, including Kenya, have, to some extent, decentralised malaria microscopy
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into peripheral health facilities. However, it remains unclear whether the provision of 
microscopy at the periphery of a health care system would have a sufficient impact on 
malaria case management and rational use of antimalarial drugs to justify the costs of 
establishing, maintaining and further expanding these services. The effectiveness of a 
strategy to provide microscopic malaria diagnosis is contingent on three factors: 1) the 
efficiency with which clinical staff use the service, 2) the accuracy of the blood smear 
examinations, and 3) the effect the results have on clinical management. If clinicians 
request malaria slides for incorrect indications, if  blood slide results are inaccurately read, 
or if clinicians choose to ignore the results when prescribing the treatment, the value of 
having this service is compromised.
6.1.2. Malaria microsconv in Kenyan context and national recommendations 
Since the early eighties, the Kenyan Ministry of Health has decentralised malaria 
microscopy to the level of all hospitals and most of the health centres. However, in 
practice a limited number of dispensaries and inter-level facilities such as sub-health 
centres may also have microscopes. Within the government health sector in Kenya, it has 
been estimated that approximately 50% of all outpatient malaria diagnoses are made at 
the level of health centres and hospitals (Snow et al., 2000). Health facility databases 
developed prior to the surveys (Section 2.4) have shown that in four study districts (Kisii, 
Kwale, Bondo and Makueni) 2.9 facilities with microscopy were available per 100,000 
people (district range: 2.1-3.2). A microscopic service was available in 42 (24.4%) of 172 
government facilities (district range: 18.4-32.6%), in 28 (44.4%) of 63 mission facilities
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(district range: 14.3-70.0%) and in 111 (38.0%) of 292 private facilities (district range: 
18.2-44.9%).
National Policy Guidelines fo r  Health Laboratory Services (MoH, 1995) specifies 
standards for laboratory structures and facilities, major equipment required, tests to be 
performed and laboratory staffing for each level of laboratory services. Within the district 
health system two levels of laboratory services are specified: peripheral, within health 
centres and dispensaries, and intermediate, within district hospitals. To some extent the 
guideline specifies standards related to malaria microscopy but only indicates that 
laboratories should have running tap water, power supply and binocular electric 
microscopes. The guideline further specifies that the staffing of laboratories at the 
peripheral level should include at least two laboratory technicians (trained for two years 
in basic laboratory disciplines) while the laboratories at the intermediate, district hospital 
level, should have twenty qualified laboratory workers of whom eight should be 
laboratory technologists (four years of laboratory training including a year of medical 
laboratory specialty). However, there are currently no officially recognised guidelines 
specifying standardised operating procedures for laboratory techniques, including 
microscopy.
The NMCP guideline promotes the use of microscopy wherever it is possible, however, it 
does not specify clinical indications for the use of microscopy and is ambiguous with 
regard to the interpretation of results. The guideline actually states: “In certain cases a 
slide may be negative even when the patient has malaria. Conversely, malaria
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parasitaemia may not be the cause o f the presenting illness” (MoH, 1998). The 
laboratory aspects of malaria case management are not addressed in the NMCP guideline. 
Kenyan country-specific IMCI guideline (MoH, 2000a), following recommendations 
from the international IMCI guideline (Gove, 1997), does not consider parasitological 
tests when diagnosing malaria in children <5 years and the guideline by definition does 
not address older children and adults.
This chapter presents observational data collected on current clinical and laboratory 
practices from the facilities with functional microscopy in four Kenyan districts. In this 
chapter the results of current effectiveness of malaria case management using microscopy 
are presented and the implications of the results on malaria diagnostic strategies in Kenya 
are discussed.
6.2 Methods
6.2.1 Study design and data collection
This survey was not primarily designed and statistically powered to measure the quality 
of routine microscopy and attributed case management practices across different age 
groups and levels of malaria endemicity; however, given the importance of the 
descriptive findings, the opportunistic data collected from health facilities with functional 
microscopy were considered valuable information to be presented in this chapter. 
Detailed presentation of the methods and materials used to conduct the health facility 
surveys is provided in Chapter 2.
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Briefly, a series of cross-sectional, age-specific, cluster sample health facility surveys 
were conducted in the four districts (Kisii, Kwale, Bondo and Makueni) between July 
2001 and April 2003. Surveys evaluating paediatric (< 5 years of age) outpatient malaria 
case management practices were conducted in each of the four districts, while surveys 
studying older children and adult (> 5 years of age) practices were undertaken in Kisii 
and Kwale districts.
Of relevance for this chapter, clinical practices in relation to microscopy (diagnostic 
procedures requested, results reported and medications prescribed) were recorded from 
patient-held records either during the exit caretaker interview during paediatric surveys or 
during the exit examination in surveys of older children and adults. A child < 5 years was 
considered to have fever if the caretaker told the interviewer that the child had fever as 
part of the presenting illness. A patient > 5 years was considered to have fever if this 
symptom was reported to have occurred over the last 48 hours or axillary temperature 
measured during the exit examination was > 37.5°C.
During the older children and adult survey, if  a blood slide was requested during the 
initial health worker consultation, the study finger prick sample was performed 
simultaneously with the same drop of blood in the clinical laboratory and thick and thin 
blood films were prepared and stained with 10% Giemsa by the laboratory technician. 
After the completion of the survey two expert microscopists read all slides independently 
and the third reading was performed for the discordant results. For each slide 100 high 
power magnification fields were examined before the slide was regarded as negative. The
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number of parasites per 200 white blood cells (WBC) was counted. Parasite density/pl of 
blood was calculated assuming an average leukocyte count of 8,000 WBC/pl of blood.
Characteristics of the surveyed laboratories were collected either during the health 
facility assessment through interviews with the laboratory in-charges or the data were 
obtained from the health facility database developed for the study districts prior to the 
surveys. The characteristics of the clinicians who managed the patients were collected 
during the health worker interview.
6.2.3 Statistical analysis
The data for each age-specific survey were aggregated and presented combined for all 
districts together. However, because of the structure of the different surveys and possible 
variations in the practices between age groups and areas of malaria endemicity, the 
analysis, where possible and appropriate, was carried out separately across four age 
groups (< 1 year, 1-4 years, 5-14 years and >15 years) and two areas of endemicity {high 
- Kwale and Bondo districts, and low -  Kisii and Makueni districts). The precision of 
proportions (95% confidence interval) was estimated accounting for the cluster sampling 
design.
To analyse the accuracy of the routine reading of malaria slides during older children and 
adult survey, the gold standard was defined as parasitaemia determined by two expert 
microscopists. The sensitivity, specificity, and positive and negative predictive values 
were calculated according to the following formula: Sensitivity = routine malaria slide
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reported as positive / positive slide reported by expert microscopists; Specificity = routine 
malaria slide reported as negative / negative slide reported by expert microscopists; 
Positive predictive value (PPV) = positive slide reported by expert microscopists / routine 
malaria slide reported as positive; Negative predictive value (NPV) = negative slide 
reported by expert microscopists / routine malaria slide reported as negative.
6.3 Results
6.3.1 Description of the survey samples
The paediatric survey was undertaken at the outpatient departments of 34 government 
health facilities with functional microscopy where 73 health workers were observed 
performing 1015 sick child consultations. Of 1015 consultations, the exit interview could 
not be performed with 129 (12.7%) caretakers and these children were excluded from the 
analysis. The older children and adult survey was undertaken at the outpatient 
departments of 17 government health facilities with functional microscopy where 31 
health workers were observed performing 456 consultations. Of 456 consultations, 26 
patients (5.7%) were excluded from the analysis because they did not have the exit 
examination performed. The distribution of the health facilities with functional 
microscopy, health workers and analysed health worker-patient consultations across four 
districts and two age-specific surveys are presented in Table 6.1.
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Table 6.1: Distribution of the health facilities with functional microscopy, health workers and 
analysed health worker-patient consultations across four districts: results from two age- 
specific surveys
District Kisii Kwale Bondo Makueni Total
Age-specific survey <5 >5 <5 >5 <5 >5 <5 >5 <5 >5
Health facilities 10 7 10 10 4 NA 10 NA 34 17
Health workers 21 14 22 17 10 NA 20 NA 73 31
Consultations 288 210 230 218 156 NA 212 NA 886 428
NA = not available since older children and adult survey was not performed in Bondo and Makueni districts
6.3.2 Characteristics of the laboratories with functional microscopy 
The assessment of 34 health facilities revealed that the majority of the surveyed 
laboratories were within health centres (55.9%), followed by hospitals (29.6%) and 
dispensaries (14.7%). Running water and electricity was available in 50.0% and 55.9% of 
laboratories, respectively. Most laboratories were equipped with only light microscopes 
(52.9%) while electric microscopes were available in 35.3% of facilities. Both types of 
microscopes were available only at the four district hospitals. At least one laboratory 
technologist was posted in 41.2% of the surveyed facilities, while 88.2% of laboratories 
were staffed with laboratory technicians. In-charges of laboratories reported that both 
thick and thin films were routinely performed in only 23.5% of facilities. In the majority 
of facilities (76.5%) only a thick film was used for the preparation of malaria slides. Field 
stain was most commonly used as the routine staining method for malaria microscopy 
(70.6%), while Giemsa staining was routinely done in 10 laboratories (29.4%). Routine 
performance of species differentiation was reported from approximately half of the 
laboratories (52.9%). However, this finding was not confirmed by reviewing the patients’ 
laboratory reports (Section 6.3.5). The majority of the laboratory in-charges (76.5%) 
reported that parasite densities were routinely counted for positive slides using semi- 
quantitative methods (plus or a descriptive scoring system). No laboratory sent malaria
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slides for quality control. Characteristics of the surveyed laboratories are presented in 
Table 6.2.
Table 6.2: Characteristics of the surveyed laboratories with functional microscopy
Laboratory characteristics N=34a (%>)
Laboratory within:
District Hospital 4(11.8)
Sub-district hospital 6(17.7)
Health centre 19 (55.9)
Dispensary 5 (14.7)
Electricity available 19(55.9)
Running water available 17(50.0)
Laboratory technologist available 14(41.2)
Laboratory technician available 30 (88.2)
Type of microscope available
Light 18 (52.9)
Electric 12 (35.3)
Light and electric 4(11.8)
Type of malaria films routinely prepared
Thick film only 26 (76.5)
Thick and thin film 8 (23.5)
Routine staining method performed
Field stain 24 (70.6)
Giemsa 10 (29.4)
Species differentiation routinely performed 18 (52.9)
Parasite densities routinely counted 26 (76.5)
Malaria slides sent for quality control 0
a Information collected only during the children survey from 34 health facilities including 15 out of 17 
facilities repeatedly surveyed during the older children and adult study
6.3.3 Characteristics of health workers who used microscopic services 
During the paediatric survey, none of the 73 health workers refused to participate in the 
study. However, of 73 health workers, 6 (8.2%), who performed a total of 56 
consultations, urgently left the health facility before an interview could be performed. 
During the older children and adult survey, the interview was completed with all of 31 
participating health workers. Clinical officers performed the majority of consultations 
(58.4% in the paediatric survey and 59.2% in the older children and adult survey). In both
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surveys, approximately half of the health workers received malaria in-service training and 
had the NMCP guideline. No health worker received IMCI training. The characteristics 
of health workers who used microscopic services are presented in Table 6.3.
Table 6.3: Characteristics of observed health workers who used microscopic services: 
results from two age-specific surveys_______________________________________
Health workers characteristics < 5 years > 5 years
N-67 (%) N=31 (%)
Male sex 37 (55.2) 19(61.3)
Pre-service training
Clinical officer 30 (44.8) 16(51.6)
Nurse 35 (52.2) 14 (45.2)
Nursing aide 2 (3.0) 1 (3.2)
HW received in-service malaria training 27 (40.3) 15 (48.4)
HW received IMCI training 0 0
HW possessed NMCP guideline 38 (56.7) 18(58.1)
HW = health worker
6.3.4 Utilisation of malaria blood slides
In both age groups, an equal proportion (80%) of patients presented with fever (95% 
CI<5: 77.1-84.0; 95% CI>5: 74.0-86.3). Of 886 children and 428 older children and adults 
included in this analysis, only 2.4% of children and 6.1% of patients > 5 years of age had 
a malaria slide requested but not subsequently performed. However, this figure may be 
underestimated since among all observed patients who were referred to laboratory 13.4% 
of children and 9.0% of older children and adults were lost to follow up since they did 
not have an exit interview or exit examination completed. These patients were excluded 
from the analysis and the reason for loss to follow up could not be established, however, 
it could be assumed that the majority of them had not returned to the consultation room 
and for the exit interview because the requested malaria slide may not have been
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performed. Therefore, the proportion of patients, adjusted for the loss in follow up, with a 
malaria slide requested but not performed, could have reached 15% in both age groups. 
Among all outpatients included in the analysis, a malaria blood slide was more frequently 
performed in older children and adults (74.3%, 95% Cl: 61.9-86.7) than in children < 5 
years of age (48.8%, 95% Cl: 39.0-58.5). A very similar pattern was revealed in patients 
with fever (Table 6.4). Furthermore, in both patient populations (all outpatients and 
febrile patients), a malaria slide was less frequently performed in infants in comparison to 
the other age groups; however, the difference was not statistically significant in 
comparison to the 1-4 year age group (see CIs in Table 6.4). Statistically significant 
differences were observed between the requests for a malaria slide for non-febrile 
patients and different age groups. Among 172 non-febrile patients <5 years of age, a 
malaria blood slide was performed for 20.9% (95% Cl: 13.8-28.9) children. In older 
children and adults, among 85 non-febrile patients a blood slide was performed for 52.9% 
(95% Cl: 29.2-76.7) patients. Table 6.4 presents presents the pattern of malaria blood 
slide utilisation across age groups and presence of fever.
Table 6.4: Utilisation of malaria blood slides across age groups and presence of fever
< 1 year 1-4 years 5-14 years ^ 15 years
No (%) 95% Cl No (%) 95% Cl No (%) 95% Cl No (%) 95% Cl
All
patients
N=333 
132(39.6) 28.2,51.1
N=553 
300 (54.3) 44.7, 63.8
N=92
73 (79.3) 67.0,91.7
N=336 
245 (72.9) 59.9, 85.9
Febrile
patients
N=257 
116(45.1) 32.9,57.4
N=457 
280(61.3) 51.2,71.4
N=78
66 (84.6) 75.0, 94.2
N=265 
207(78.1) 68.2,88.1
Cl = confidence interval
6.3.5 Laboratory reports of routine malaria microscopy
Among all patients who had a blood slide performed (432 children < 5 years and 318 
patients > 5 years), 59.5% (95% Cl: 50.6-68.4) children and 43.4% (95% Cl: 31.2-55.6)
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older children and adults had a positive blood slide reported through routine microscopic 
practices The routine reports of positive malaria slides demonstrate the usual malaria 
prevalence trends in relation to the age groups and different levels of endemicity, 
although none of the comparisons were statistically significant (Table 6.5). In high 
endemic areas, the trend suggests high levels of positivity in infants (59.7%) followed by 
a slight increase in children 1-4 years (62.8%) and subsequent decrease in older children 
(40.0%) and in particular in adults (21.6%). In low endemic areas, the infants had a lower 
proportion of positive slides reported (41.8%) compared to high endemic areas. 
Furthermore, the positivity rate in children 1-4 years of age was identical to the areas of 
high endemicity (62.6%) and remained rather stable in older age groups such children 5- 
14 years (64.6%) and adults (52.5%).
Table 6.5: Malaria blood slide positivity rates across age groups and the levels of malaria
endemicity: results of routine microscopic practices
Endemicity
< 1 year 1-4 years 5-14 years £ 15 years
No (%) 95% Cl No (%) 95% Cl No (%) 95% Cl No (%) 95% Cl
High3 46 (59.7) 47.3, 72.1 76 (62.8) 50.2, 75.4 10(40.0) 19.8,60.2 22 (21.6) 7.8, 35.4
Lowb 23 (41.8) 25.7, 57.8 112(62.6) 46.6,78.6 31 (64.6) 55.4, 73.8 75 (52.5) 32.8, 72.1
a Results from Kwale and Bondo districts in children < 5 years and Kwale district in patients > 5 years 
b Results from Kisii and Makueni districts in children < 5 years and Kisii district in patients > 5 years
The majority of patients (70.0% children and 60.1% older children and adults) with a 
routinely reported positive malaria slide had parasite densities quantified and reported 
either by using a plus scoring (one to four pluses) or descriptive (scanty, moderate, 
numerous and heavy) system. However, a significant proportion of patients had positive 
results reported without quantifying any parasite densities (30.0% and 39.9% in each age- 
specific survey). Among all positive malaria slides, the most common laboratory report
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included a one-plus score or scanty parasitaemia (46.7% in children < 5 years and 51.4% 
in patients > 5 years). Only 23.3% children <5 years of age and 8.7% older children and 
adults had any other parasite density reported than one plus or scanty. Of interest, among 
71 patients > 5 years of age with one plus or scanty parasitaemia routinely reported, only 
6 (8.5%) were confirmed as positive on expert microscopy. Furthermore, contrary to the 
information obtained from the interviews with laboratory in-charges (Section 6.3.2), none 
of the positive reports contained specification of Plasmodium species. Laboratory 
reporting of parasite densities for positive malaria slide results are presented in Table 6.6.
Table 6.6: Laboratory reports of parasite densities for positive malaria slide results: results 
of routine practices from two age-specific surveys__________________________________
Parasite densities reported < 5 years > 5 years
N=257 (%) 95% Cl N=138 (%) 95% Cl
+ /scanty 120 (46.7) 33.3, 60.1 71 (51.4) 26.3, 76.4
++/moderate 35 (13.6) 9.9,17.4 9 (6.5) 1.1,11.9
+++/numerous 4(1.6) 0,3.3 0 NA
++++/heavy 21 (8.1) 5.9, 11.1 3 (2.2) 0,5.0
Not quantified 77 (30.0) 21.5,38.8 55 (39.9) 13.2, 66.6
Cl = confidence interval; NA = not applicable
6.3.6 Interpretation of malaria blood slide results
Nearly all patients with reported positive malaria slide received antimalarial treatment 
(four age-group range: 95.1-98.9%). Similarly, health workers prescribed an antimalarial 
treatment for the majority of patients with a reported negative malaria slide: in children 
<5 years of age, 119 of 175 patients (68.0%, 95% Cl: 57.8-78.2) with a negative slide 
result were given an antimalarial; in older children and adults, 139 of 180 patients 
(77.2%, 95% Cl: 66.2-88.3) received antimalarial treatment when a malaria slide was 
reported negative. In the analysis across four age groups, the pattern and magnitude of
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this practice remained the same and no significant differences between the age groups 
were revealed. Approximately half of the patients with positive slide result received 
antibiotic treatment in children <5 years of age (130 of 257; 50.6%, 95% Cl: 40.7-60.5) 
as well as in older children and adults (69 of 138; 50.0%, 95% Cl: 40.4-59.6). The 
majority of patients with reported negative slide result had received antibiotic treatment 
(four age-group range: 56.1-81.0%). The antipyretic treatments were also prescribed for 
large majority of the patients regardless of the blood slide results (four age-group range: 
66.7-95.1%). The relationship between antimalarial, antibiotic and antipyretic 
prescriptions and blood slide results across age groups is presented in Table 6.7.
Table 6.7: Prescriptions of antimalarial, antibiotic and antipyretic drugs according to the
< 1 year 1-4 years 5-14 years £ 1 5 years
No % 95% Cl No % 95% Cl No % 95% Cl No % 95% Cl
Positive slide N==69 N=188 N=41 N==97
AM prescribed 67 97.1 92.8, 100 186 98.9 97.3, 100 39 95.1 87.6,100 93 95.9 92.4, 99.3
AB prescribed 36 52.2 35.6, 68.8 94 50.0 39.3, 60.7 27 65.9 47.3, 84.4 42 43.3 28.7, 57.9
AP prescribed 58 84.1 73.9, 94.2 160 85.1 78.9,91.4 39 95.1 87.6, 100 92 94.9 90.2, 99.5
Negative slide N==63 N=112 N==32 N=148
AM prescribed 42 66.6 54.4, 78.9 77 68.8 56.9, 80.6 24 75.0 57.6, 92.4 115 77.7 66.7, 88.7
AB prescribed 51 81.0 71.2, 90.7 77 68.8 59.6, 77.9 19 59.4 46.8, 72.0 83 56.1 45.0,67.1
AP prescribed 42 66.7 55.4, 78.0 80 71.4 61.3,81.6 27 84.4 67.6, 100 134 90.5 83.1,98.0
Cl = confidence interval; AM = antimalarial; AB = antibiotic; AP = antipyretic
The analysis of antimalarial, antibiotic and antipyretic prescriptions for a negative 
malaria slide across age groups did not reveal significant differences between areas of 
different malaria endemicity (Table 6.8). However, it was observed that infants received 
more commonly antibiotic treatment than patients > 1 5  years, the difference being 
statistically significant only in area of high endemicity. The relationship between
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negative blood slide result and antimalarial, antibiotic and antipyretic prescriptions across 
two levels of malaria endemicities and age groups is presented in Table 6.8.
Table 6.8: Prescriptions of antimalarial, antibiotic and antipyretic drugs for negative 
malaria slides across age groups and the levels of malaria endemicity ______________
< 1 year 1-4 years 5-14 years £  15 years
No % 95% Cl No % 95% Cl No % 95% Cl No % 95% Cl
High endemicity N==31 N =45 N==15 N==80
AM prescribed 20 64.5 44.9, 84.2 28 62.2 48.9, 75.5 13 86.7 53.3, 100 60 75.0 55.7, 94.2
AB prescribed 25 80.7 67.4, 93.9 27 60.0 43.9, 76.1 8 53.3 36.9, 69.7 40 50.0 33.0, 67.0
AP prescribed 24 77.4 64.7, 90.1 36 80.0 64.9, 95.1 12 80.0 44.8, 100 71 88.8 75.8, 100
Low endemicity N==32 N==67 N==17 N==68
AM prescribed 22 68.8 51.5, 86.0 49 73.1 55.2,91.1 11 64.7 43.3, 86.1 55 80.9 71.0, 90.8
AB prescribed 26 81.3 64.8, 97.7 50 74.6 64.4, 84.9 11 64.7 43.3,86.1 43 63.2 51.7,74.8
AP prescribed 18 56.3 36.8,75.7 44 65.7 53.6, 77.7 15 88.2 67.4, 100 63 92.7 85.8,99.5
Cl = confidence interval; AM = antimalarial; AB = antibiotic; AP = antipyretic
6.3.7 Accuracy of the routine malaria microscopy
During older children and adult survey malaria slide results reported by routine 
microscopic services were compared with the gold standard result, and sensitivity, 
specificity and positive and negative predictive values were calculated. A total of 318 
routine malaria slides were evaluated. The slide positivity rate of expert microscopy was 
14.5% (95% Cl: 9.1-19.8), without significant difference between the districts of high 
and low malaria transmission: 10.2% (95% Cl: 5.4-15.1) of blood slides in high endemic 
Kwale district and 17.3% (95% Cl: 8.9-25.7) in low endemic Kisii district were malaria 
positive on the expert microscopy. Using data pooled across both districts the sensitivity 
and the specificity of the routine microscopy were 67.4% and 60.7% respectively. The 
positive predictive value was very low (22.5%), while the negative predictive value was 
significantly higher (92.7%). The results on accuracy of routine blood slide microscopy 
are presented in Table 6.9.
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Table 6.9: Accuracy of the routine malaria microscopy
No/N % 95% Cl
Slide positivity rate (expert microscopy) 46/318 14.5 9.1, 19.8
Sensitivity 31/46 67.4 56.1,78.6
Specificity 165/272 60.7 47.1,74.3
Positive predictive value 31/138 22.5 12.6, 32.3
Negative predictive value 165/180 91.7 87.6, 95.7
Cl =confidence interval
Regardless of the levels of endemicity positive slides reported by routine practices were 
rarely confirmed as such by the expert microscopists (PPVhigh=21.9% and 
PPViow=22.6%). Conversely, in both areas of malaria endemicity routine slides reported 
as negative were in most cases truly confirmed as negative (NPVhigh=93.7% and 
NPViow=89.4%). Furthermore, the specificity in low endemic areas was significantly 
lower compared to high endemic areas (SPi0W=48.1% and SPhigh=78.1%). Conversely, 
sensitivity of routine microscopy was higher in areas of low endemicity (SEi0W=72.7% 
and SEhigh=53.9%), however the difference was not statistically significant. The results 
on the accuracy of blood slide microscopy in relation to the level of malaria endemicity 
are presented in Table 6.10.
Table 6.10: Accuracy of the routine malaria microscopy: results from two areas of malaria 
endemicity__________________________________________________________________
Low endemicity3 High endemicityb
No/N % 95% Cl No/N % 95% Cl
Slide positivity rate (expert microscopy) 33/191 17.3 8.9, 25.7 13/127 1 0 . 2 5.4, 15.1
Sensitivity 24/33 72.7 57.3, 88.2 7/13 53.9 24.3, 83.4
Specificity 76/158 48.1 29.0, 67.2 89/114 78.1 70.4, 85.7
Positive predictive value 24/106 2 2 . 6 7.6, 37.7 7/32 21.9 10.4, 33.4
Negative predictive value 76/85 89.4 81.0, 97.9 89/95 93.7 90.5, 96.5
3 Low endemic area - Kisii district
b High endemic area - Kwale district
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6.4 Discussion
It is expected that the introduction of microscopy into health facilities in Kenya would 
assist health workers to differentiate malaria from other fever-causing conditions and 
prompt diagnosis of other diseases, reduce unnecessary wastage of antimalarial drugs and 
potentially reduce the likelihood of emerging antimalarial drug resistance. It should be 
acknowledged that in the absence of any standard operating procedures for laboratories, 
recommendations on the clinical indications for the use of malaria microscopy and 
ambiguous instructions in the clinical guidelines on the interpretation of malaria slide 
results, a rigorous study of the quality of malaria case management at facilities with 
microscopy is difficult. However, the magnitude of the descriptive observations made in 
this study highlight a series of irrational practices which compromise effectiveness of 
malaria case management and indicates a need for careful review of malaria diagnostic 
strategies using microscopic services countrywide.
Three major findings in this study were: 1) malaria microscopy was a commonly 
requested and performed laboratory investigation, however, clinical indications for its use 
were frequently inappropriate; 2) clinical interpretation of malaria blood slide results was 
frequently irrational, in particular for the patients with a negative slide result; and 3) the 
quality of malaria microscopy and the accuracy of routine malaria slide readings was sub- 
optimal. The possible explanations for such findings across different patient populations 
are discussed in the following three sections while the implications of the findings on 
malaria diagnostic strategies in Kenya are discussed in the last section of the chapter.
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6.4.1 Clinical utilisation of microscopy
In all age groups, the importance of microscopic diagnosis is well recognised, a malaria 
slide was commonly requested, and for the large majority of laboratory requests an 
investigation was performed. Interestingly, older children and adults were more 
frequently referred for microscopy compared to children 1-4 years of age and infants 
(74.3% vs 54.3% vs 39.6 respectively). Utilisation of malaria blood slides in our survey 
was significantly higher than reported in Zambia, where 30% of children below 5 years 
of age and 25% of all outpatients were sent for microscopy (Barat et al., 1999). Several 
reasons may explain the higher use of microscopy in adults compared to children in the 
present study. First, health workers may still consider microscopy less important among 
febrile children since it interferes with the traditional concept of equating all fevers with 
malaria, therefore, they do not see the same justification for microscopy compared to 
adults where a diagnosis of exclusion has been traditionally promoted. In children this 
practice seems pragmatic and reflects IMCI recommendations, however, the value of 
requesting a slide at all may be questioned in this patient group. Second, since malaria 
microscopy frequently presents an additional cost, ranging from 10-50 KES (Tetteh & 
Mwangi, 2004) an economically more vulnerable group, such as mothers of children, 
may be less able to pay for this service compared to sick adults. Third, health workers 
may be more susceptible to articulated pressures by adult patients than mothers with sick 
children to perform a parasitological investigation, as this may be considered as an 
“expected” part of the consultation.
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An interesting finding of this study was that a substantial proportion of children (20.9%) 
without any signs or symptoms of fever were referred for microscopy. Moreover, in the 
older children and adult patient groups, more than half (52.9%) of non-febrile patients 
were referred for microscopy. These findings are in accordance with the results reported 
from Bungoma district in Kenya, where 40% of all non-febrile patients were referred for 
microscopy (Barat & Kramer, 1999), however, they are significantly higher than 9% 
reported in Zambia (Barat et al., 1999). Possible explanations for such irrational practices 
may include: 1) a deficiency in health workers knowledge on the role of fever in malaria;
2) lack of instructions in the national malaria guidelines on the clinical indications for the 
use of malaria microscopy; or 3) patients expectations for microscopy regardless of the 
clinical presentation.
6.4.2 Clinical interpretation of malaria slide results
The alarming finding in this study is that the majority of patients across all age groups 
with reported negative blood slide result subsequently received an antimalarial treatment 
(68.8% in children and 77.2% in older children and adults). Furthermore, such practice 
was equally present in low and high malaria endemic areas. The introduction of 
microscopes into a hospital in Malawi decreased significantly the number of unnecessary 
antimalarial prescriptions in adults and produced annual savings of 3% of annual drugs 
budget for the hospital (Jonkman et al., 1995). However, during the study in Malawi all 
clinicians strictly adhered to the recently introduced guidelines, prescribing antimalarial 
drugs only to parasitaemic patients.
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In the studies performed under routine practice conditions in Kenya, Zambia and Benin 
the experiences are different. In the present study, the magnitude of antimalarial 
treatment practice ignoring the negative malaria slide was similar (67.3%) to the practice 
in Benin (Holtz & Kachur, 2000), and greater compared to the 30% reported from 
Zambia (Barat et al., 1999) and 39% reported from Bungoma district in Kenya (Barat & 
Kramer, 1999). In a study targeting broader spectrum of conditions in six health centres 
across Kenya, the laboratory use changed clinician’s diagnosis in 45% of patients tested 
and only 21% of all outpatients with new condition (Carter & Lema, 1999). Findings 
from the inpatient setting in Tanzania revealed that only 13.3% of admitted patients with 
a clinical diagnosis of cerebral malaria had a positive blood slide (Makani et al., 2003). 
This practice, present at such a large scale, showed that probably the only major effect of 
the microscopic service is increasing cost to poor patients with little rational effect on use 
of antimalarial drugs.
For instance, in the four study districts, the average annual number of reported malaria 
diagnoses from 42 health facilities with microscopic services between 1996 and 2001 was 
232,294 (HMIS, 2001; Snow et al., 2004). Using the study age-specific data on the 
utilisation of microscopy, routine blood slide positivity, and the antimalarial prescription 
practices, the annual average costs of different treatment regimens were calculated and 
the differences in the treatment costs between the current practice and the practice 
adjusted to respect negative malaria slides were compared. In Table 6.11 the calculation 
process of the average four-district annual costs of SP and ART-LUM treatments 
according to different diagnostic practices and across age groups is presented.
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Assuming conservatively that all patients had received the cheapest antimalarial drug 
(SP) it was calculated that the incurred cost of SP treatment under the current diagnostic 
practice is 3,165 USD per average district on an average year. However, only a single 
change of practice at facilities with microscopic services, such as respect of negative 
parasitological results, would reduce cost of SP treatment by 41.3% and generate annual 
saving of 1,308 USD per average district on an average year. Of the 1,308 USD annual 
saving per district, 94.1% or 1,231 USD would be saved by respecting negative slides in 
older children and adult age groups (patients > 5 years of age).
With the change of treatment policy from SP to 30-fold more expensive ART-LUM (2.4 
USD adult treatment course), respect of negative parasitological results at facilities with 
microscopy would produce an average district annual saving of 43,475 USD on an 
average year, of which 90.0% or 39,123 USD per district would be created by changing 
the practice only in older children and adult age groups. These findings suggest that from 
the cost perspective microscopy in older children and adults has a large potential to 
reduce the number of unnecessary antimalarial treatments and create significant savings 
in antimalarial drug budgets. It might, however, be argued that the reduction in use of 
antimalarials would increase prescription of symptomatic and other antimicrobial 
treatments and compensate for the cost-savings on antimalarial drugs. Given that the 
majority of older children and adults with positive and negative slide results were 
currently prescribed inexpensive antipyretics (94% for positive and 89% for negative 
results) and antibiotics (50% for positive and 57% for negative results) anyway, it is not 
obvious that replacement costs would significantly undermine potential savings.
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Table 6.11: Average annual costs of SP and ART-LUM treatments according to different 
diagnostic practices and across age groups -  results from 42 facilities with microscopy in four 
study districts__________________________________________________________________
<1 year 1-4 yrs 5-14 yrs 1 15 yrs All ages
Morbidity
No of malaria diagnoses3 24,452 50,251 48,465 109,126 232,294
No of all outpatientsb 37,502 67,451 63,687 152,198 320,838
Utilisation of microscopy0
No of patients with performed BS 14,851 36,626 50,503 110,952 212,932
No of patients without BS performed 22,651 30,825 13,184 41,246 107,906
Positivity rated
No of patients with positive BS 7,767 22,965 28,382 43,937 103,051
No of patients with negative BS 7,084 13,662 22,121 67,015 109,882
Antimalarial (AM) prescription practices
a) No of AM treatments when BS positive6 7,542 22,712 26,991 42,135 99,380
b) No of AM treatments when BS negativef 4,718 9,399 16,591 52,071 82,779
c) No of AM treatments when BS not done8 12,164 18,156 4,852 14,972 50,144
Different diagnostic practices
No of AM treatments under current practice (a+b+c) 24,423 50,267 48,434 109,178 232,302
No of AM treatments respecting BS negative result (a+c) 19,706 40,868 31,843 57,107 149,524
Cost o f  different prac tices (USD)
a) Cost of SPh - current practice 318 1,307 2,519 8,516 12,660
b) Cost of SP - BS negative result respected 256 1,063 1,656 4,454 7,429
c) Cost of ART-LUM1 - current practice 21,981 70,374 92,025 262,027 446,407
d) Cost of ART-LUM - BS negative result respected 17,735 57,215 60,502 137,057 272,509
A verage annual savings
Savings on SP (USD) (a-b) 61 244 863 4,062 5,230
Age-specific percent of total saving on SP 1.2 4.7 16.5 77.7
Savings on ART-LUM (USD) (c-d) 4,246 13,159 31,523 124,970 173,898
Age-specific percent of total saving on ART-LUM 2.4 7.6 18.1 71.9
a Age-structured distribution of malaria diagnoses based on the age profile of malaria diagnoses presented in the Section 2.3 
b Average annual number of all outpatients was extrapolated from the age-specific percent of malaria diagnoses among all outpatients in 
this study: < 1 year- 65.2%; 1-4 yrs - 74.5%; 5-14 yrs - 76.1% and > 15 yrs -  71.7%
c Average annual number of performed blood slides was extrapolated from the age-specific percent of performed slides in this study: < 1 
year -  39.6%; 1-4 yrs - 54.3%; 5-14 yrs -  79.3% and > 15 yrs-72.9%  (Section 6.3.4.)
d Average annual number of positive and negative blood slides was extrapolated from the age-specific percent of routine microscopy 
reports in this study: < 1 year - 52.3%; 1-4 yrs - 62.7%; 5-14 yrs - 56.2% and ^ 15 yrs - 39.6% (Section 6.3.5.)
e Average annual number of patients with a positive blood slide receiving an antimalarial treatment was extrapolated from the age-specific 
percent of routinely reported positive slides having antimalarial treatment prescribed in this study:
< 1 year - 97.1%; 1-4 yrs - 98.9%; 5-14 yrs -95.1% and > 15 yrs -  95.9% (Section 6.3.6.)
f Average annual number of patients with a negative blood slide receiving an antimalarial treatment was extrapolated from the age-specific 
percent of routinely reported negative slides having antimalarial treatment prescribed in this study:
< 1 year - 66.6%; 1-4 yrs - 68.8%; 5-14 yrs -75.0% and > 15 yrs -  77.7% (Section 6.3.6.)
E Average annual number of patients having antimalarial treatments prescribed when a blood slide was not done was extrapolated from the 
age-specific percent of antimalarial prescriptions for patients not having blood slide done in this study: < 1 year - 53.7%; 1-4 yrs - 58.9%; 
5-14 yrs -36.8% and S 15 yrs - 36.3%
h Cost of SP treatment was calculated on the basis of the age-specific SP dosing schedule and attributed cost per tablet cited by the MSH 
International Drug Price Guide: < 1 year -  xh  tab (0.013 USD); 1-4 yrs -  1 tab (0.026 USD); 5 -14 yrs - 2 tabs (0.052 USD) and > 15 yrs -  
3 tabs (0.078 USD)
1 Cost of ART-LUM treatment was calculated on the basis of the age-specific ART-LUM dosing schedule and attributed cost per tablet 
based on WHO agreement with Novartis: < 1 year- 6 tab (0.9 USD); 1-4 yrs -  12 tab (1.4 USD); 5 -14 yrs -18 tabs (1.9 USD) and > 15 
yrs -  24 tabs (2.4 USD); SP = sulfadoxine-pyrimethamine; ART-LUM = artemether-lumefantrine; BS = blood slide; AM = antimalarial
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However, the change of any clinical practice is a challenging task and better 
understanding is needed of why these practices, such as non-respect of negative malaria 
slide results, occur. There could be several possible explanations. First, it may be that 
clinicians view blood slide diagnosis as a tool to confirm their clinical suspicion of 
malaria rather than to rule out malaria as a contributing cause of illness, particularly when 
the clinical examination does not reveal another obvious illness or is highly suggestive of 
malaria. If this hypothesis is true then the primary focus of intervention to improve upon 
current practices should be the clinicians’ knowledge on the role of microscopy in the 
management of malaria.
Second, the ambiguous text from the NMCP guideline stating that "in certain cases a 
slide may be negative even when the patient has malaria” (MoH, 1998), may have an 
additional effect in supporting the clinicians reasoning that malaria microscopy is only a 
tool to confirm their clinical suspicion but not to exclude malaria. Similar 
recommendations can be found in international guidelines (Section 1.5.2.2). Such 
recommendations convey ambiguous messages to clinicians and may undermine the real 
objective of introducing microscopy into peripheral facilities. A common explanation for 
such ambiguous recommendations is that parasites may be sequestered in the deep 
capillaries, and organisms may not be seen in circulating peripheral blood (Moody, 
2002). However, none of the referenced documents supported this statement by any data 
and an extensive search of the literature could not reveal any data supporting this 
hypothesis relevant to the management of uncomplicated malaria. Since the critical 
aspect of any guideline for the successful translation of the policy into the practice is to
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be explicit, the revision of the national NMCP guideline to an unambiguous statement is 
urgently required.
Third, clinicians may lack confidence when negative malaria slide results are reported 
through routine microscopy, and then doubt the quality of readings of a negative malaria 
slide. If a malaria slide result is truly unreliable, then clinicians’ deferring to presumptive 
treatment for negative results seems understandable, however, the results on the accuracy 
of malaria microscopy discussed in the following section only partly support this 
hypothesis. Nevertheless, even if  this hypothesis were true, it remains irrational that 
clinicians continue to request microscopy at all.
6.4.3 Quality of the routine malaria microscopy
Two major findings of the assessment of the quality of routine malaria microscopy were:
1) in older children and adults, clinicians should have some confidence that a blood slide 
reported routinely as negative is truly negative, however, they cannot be confident that 
laboratory reports of positive malaria slides are truly positive; and 2) the qualitative 
aspects of malaria microscopy such as staining of malaria smears, density quantification, 
species differentiation and quality control are mainly sub-optimal.
The finding that in older children and adults, the negative predictive value of routine 
microscopy was 91.7% overall, remaining high in low (89.4%) as well as in high (93.7%) 
malaria endemic areas should provide some confidence among clinicians that negative 
slides are truly negative. The results are in accordance with the studies performed in high
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endemic areas and across all age groups from Kenya (Barat & Kramer, 1999), Zambia 
(Barat et al., 1999) and Benin (Holtz & Kachur, 2000) where NPVs were consistently 
greater than 93%. However, the high NPV partly reflects the fact that in both high and 
low transmission settings in this study the prevalence of confirmed malaria was low in 
this age group. The low prevalence of ‘true malaria’ in both transmission settings in those 
aged 5 or more years (10% in the high transmission area and 17% in the low transmission 
area) also in part explains the low positive predictive value of routine microscopy for 
detecting true malaria in both settings. Thus approximately 4 of 5 routinely reported 
positive slides were in fact negative. These findings are similar, to those from a recent 
study in Tanzania where the positivity rate of research slides among patients above 5 
years of age admitted to hospital with severe malaria did not differ between lowland, high 
(19%) and highland, low (22%) malaria transmission settings (Reybum et al., 2004). 
However, while the low prevalence of true malaria in this age group helps explain the 
low positive predictive values there is clearly a major problem with the accuracy of 
routine microscopy. Even at a prevalence of true malaria of 10% the positive predictive 
value of routine microscopy could rise to 50% if routine microscopy was 90% sensitive 
and 90% specific compared with gold standard microscopy -  unfortunately accuracy 
targets well above those reported in this study.
This study suggested that a single change of diagnostic practice, respecting negative 
parasitological results, could produce significant savings in older children and adults 
under ART-LUM treatment policy in Kenya even if the accuracy of microscopy was not 
improved. However, this would be done at the cost of reducing sensitivity for identifying
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true cases by 33% and would result in 1 of 23 outpatients above 5 years of age being sent 
home without an antimalarial drug when they are in fact parasitaemic. The risks of such a 
trade-off are essentially unknown, however, they might be expected to be low in older 
children and adults with uncomplicated malaria who are considerably less vulnerable to 
developing severe, potentially fatal complications.
Finally, it should be acknowledged that the ideal solution, reducing the risk of failure to 
treat true cases and creating even more significant antimalarial drug cost savings, would 
be improvement in the accuracy of malaria microscopy accompanied by a change of 
diagnostic practice. An ideal 100% accuracy of malaria microscopy is probably an 
unrealistic target under field conditions. Sensitivities and specificities of above 90% are 
not unreasonable standards for a laboratory quality assurance scheme and likely to be 
acceptable targets to justify interventions focusing on a change of clinical diagnostic 
practice.
The condition of facilities accommodating the laboratories, with only 55.9% having 
electricity and 50.0% having running water, is significantly below the standards set up by 
the national laboratory policy guideline (MoH, 1995). Given the lack of electricity in 
more than half of the facilities, the presence of light microscopes in 52.9% facilities and 
not the electric ones recommended by the guideline, is a rational decision. In this aspect 
the standards set up in the policy guideline should incorporate and better reflect the 
scarce resources of the peripheral health facilities. More than two-thirds of laboratories 
use rapid Field’s method for routine staining of malaria smears rather than more complex
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to use Giemsa staining method. Although the species differentiation was reported to be 
routinely performed from more than half of the laboratories, none of the evaluated 
patients’ positive reports contained specification of Plasmodium species and only 23.5% 
of laboratories reported routinely performing malaria thin smears, an appropriate smear 
for species differentiation. Routine quantification of parasitaemia was reported from 
76.5% of laboratories and the result conforms to 30.0% of positive patients laboratory 
reports without parasite densities specified. However of all patients with reported positive 
results only 23.3% children and 8.7% patients above 5 years of age had a reported 
parasitaemia greater than one plus or scanty. Given the low rate of true positive results 
and complete absence of quality control it appears that reports of low parasitaemia may 
reflect a “practice of convenience” in busy and understaffed laboratories where a 
clinician might “expect” a positive result.
6.4.4 Implications of the study findings on malaria diagnostic strategies in Kenya 
The recent change of national antimalarial drug policy towards ART-LUM (MoH, 
2004b), with a 30-fold more expensive adult treatment course compared to SP, a more 
complex administration schedule and less certain safety profile (WHO, 2001a), suggests 
the need for adequate, laboratory supported, malaria diagnostic strategies to rationalise 
antimalarial drug use. However, it seems evident that the major impact of microscopy, as 
it is performed currently, is not reduction in the use of antimalarial drugs but more 
unnecessary additional cost and time wasted by patients at facilities with microscopy. 
Therefore, rather than expanding malaria microscopy into additional facilities in Kenya, 
emphasis should be placed on the improvement of the effectiveness of this service at
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facilities where it already exists and careful consideration of alternative malaria 
diagnostic strategies. In the light of the findings of this study, the following 
programmatic recommendations, on laboratory supported, malaria diagnostic strategy can 
be made:
1) Development of unambiguous clinical guidelines specifying how to use and interpret 
malaria slides in different age groups and areas of malaria endemicity.
2) Improvement of existing microscopic services by developing standard operating 
procedures, improving accuracy of malaria slide reading by further training of 
microscopists, and most importantly, introducing effective supervision and quality 
control.
3) An alternative malaria diagnostic strategy using rapid diagnostic tests should be 
considered and under prospective, rigorous trials its cost-effectiveness should be 
evaluated.
6.4.4.1 Development of clinical guidelines
Development of unambiguous clinical guidelines addressing the effective use of 
microscopy should take into consideration particular age groups, areas of endemicity or 
specific clinical situations where the major impact on the reduction of antimalarial drug 
use, or on patient care, can be expected. Furthermore, from a pragmatic point of view, the 
guidelines should also reflect the reality of health services in Kenya at different levels 
and their capacities to implement effectively such services.
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Bearing in mind the above concerns, only febrile patients, defined as those with increased 
temperature or history of fever during the present illness, should be considered for 
malaria microscopy. Due to the large number of patients attending these facilities, it 
would be impossible to examine blood slides on all patients presenting with fever. 
Therefore, the use of microscopy should be promoted in febrile older children and adult 
patients, a less vulnerable age group with lower risk of severe malaria compared to 
children. In this patient group the largest reduction of drug costs would be made (Table 
6 .11).
Children below 5 years in areas of high malaria endemicity are the age group with the 
highest risk of dying, carrying the largest malaria burden but consuming the lowest cost 
of antimalarial drugs; therefore, given the limited capacities of health services and the 
least impact on drug use and the cost, presumptive treatment of all fevers for malaria 
would be a reasonable approach in most malaria settings countrywide. Furthermore, such 
recommendations would be in accordance with already established and promoted IMCI 
guidelines.
In areas of low malaria endemicity, defined conservatively by IMCI as areas where less 
than 5% of childhood fevers are due to malaria, the role of microscopy might be 
promoted in febrile children, but with the probable exception of Nairobi and Central 
Province few such areas exist in Kenya. In such areas IMCI currently recommends that 
fever in the absence of measles, running nose or any other identifiable cause of fever 
presents a clinical indication to treat children for malaria. It might be expected that the
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use of laboratory diagnosis, may complement or replace clinical criteria to improve 
malaria diagnostic specificity, however, this remains to be evaluated.
Furthermore, children as well as adults, regardless of the malaria endemicity, should be 
evaluated for potential treatment failures and sent for microscopy if  fever persists in spite 
of antimalarial treatment. Herein, IMCI recommendations should be complemented to 
address use of microscopy for such specific clinical situations, where a significant impact 
on patient care can be expected. With regard to the interpretation of malaria slides, the 
guidelines should be explicit and discourage prescription of antimalarial drugs when 
parasites are not seen, and in particular for patients presenting with uncomplicated 
malaria.
6.4.4.2 Improvement of microscopic service
It has to be acknowledged that the quality of malaria microscopy depends absolutely on 
good techniques, availability of reagents and microscopes, and notably, well trained and 
supervised technicians. Furthermore, the quality control of malaria blood slides presents 
one of the key components assuring the accuracy of malaria microscopy. Unfortunately, 
at this point in time, quality control is virtually non-existent in Kenya. This four-district 
study, together with the study from Bungoma district (Barat & Kramer, 1999), revealed 
significant deficiencies in microscopic services in Kenya with high rates of inaccurate 
readings. It is important that further training is urgently provided to existing 
microscopists. However, if adequate quality of microscopy cannot be achieved, 
microscopic diagnosis is an unreliable tool that uses up scarce resources for doubtful
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benefits. Under such conditions, an improvement of clinical practices in accordance with 
guidelines would remain sub-optimal.
6.4A.3 Malaria rapid diagnostic test as an alternative diagnostic tool 
A potential solution to overcome the limitations of microscopy under field conditions is 
the introduction of RDTs, which are intended to allow simple and precise diagnosis of 
malaria in areas where standard laboratory diagnosis is not available or the quality cannot 
be maintained. Ideally, RDTs should offer high sensitivity, specificity, rapidity, ease of 
performance and interpretation, species differentiation, allow for quantitative analysis, 
ability to be stored under ambient conditions, and all at an affordable price. Currently, 
most of these performance characteristics are either achieved or in the process of 
refinement by the industry, yet the main obstacle for widespread use of RDTs, and in 
particular those detecting pLDH antigen which overcome the problem of persistent HRP- 
II antigaenemia, is their cost (WHO, 2000b). However, it could be expected that the 
increasing cost of first-line treatments will raise demand for RDTs that will force prices 
down and make this diagnostic tool more widely available.
Yet, the translation of any diagnostic tool into effective practice resulting in better case 
management still needs to be demonstrated. It is plausible that clinicians may “believe” 
rapid test results more than blood slides if the tests are highly sensitive, performed by 
themselves and introduced into the clinical practice as highly accurate tools. However, to 
prove these hypotheses, prospective, cost-effectiveness intervention trials under truly
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operational conditions across different areas of malaria endemicity are required to 
provide better evidence on the true influences of RDTs on health workers practices.
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CHAPTER 7:
Conclusions
7.1 Introduction
The three major areas of this thesis include: 1) evaluation of the quality of malaria case 
management in children (Chapter 3) and examination of factors influencing health 
workers treatment practices (Chapter 4); 2) description of the quality of routine clinical 
assessment, the accuracy of malaria diagnosis and exploration of the ability of clinical 
signs and symptoms to identify malaria in older children and adults (Chapter 5); and 3) 
description of the effects of routine microscopy on malaria case management (Chapter 6). 
In this Chapter the key findings presented and discussed in previous chapters are 
summarised, the implications of the findings for Kenyan and international contexts are 
highlighted, and some of the areas that demand further investigation are identified.
7.1.1 Quality of malaria case management in children
• The majority of fever episodes in sick children were detected by health workers 
and most fevers were diagnosed as malaria in line with national recommendations
• Performance of more complex clinical assessment tasks that are important for the 
detection of severe malaria and counselling of caratekers were sub-optimal
• Nearly all health facilities had SP in stock, however, only 45% of health workers 
had been trained on new protocols, 58% were in possession of guideline and only 
27% of facilities had malaria treatment wall charts
• Among children with uncomplicated malaria, only 55% had the recommended 
first-line treatment prescribed and 34% of children left a health facility either 
without any antimalarial treatment, or with a prescribed antimalarial drug that was 
either ineffective or given in a dose insufficient to cure malaria effectively
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The prompt detection and diagnosis of all fevers as malaria is an important step in 
ensuring access of febrile children to antimalarial treatment at health facilities in Kenya. 
Current practice is largely successful in achieving this. However, the sub-optimal 
performance of more complex assessment tasks indicates that current practices are likely 
to miss an important group of sick children with severe disease and poor prognosis. 
Perhaps, it was not surprising that the counseling component was the weakest part of the 
clinical process in the study. In the past, counseling standards have frequently been 
neglected in various malaria specific guidelines and only recently, with the introduction 
of IMCI guidelines, has its importance been emphasised. In Kenya, the adequate 
performance of counselling is gaining increasing significance with the change of policy 
towards ART-LUM treatment, a drug with more complex pharmacokinetic properties 
than SP and requiring a more complicated dosing schedule. Thus, patients’ adherence and 
appropriate drug administration at home will be critical to achieving the full clinical and 
public health utility of ART-LUM. The quality of health workers counseling may be a 
major determinant of this process.
Although malaria is commonly diagnosed, sub-optimal treatment practices mean that 
children are not guaranteed access to effective antimalarial treatment at government 
health facilities in Kenya. A number of useful lessons should be considered for the future 
implementation of new antimalarial drug policies. Three years after the policy changed 
from chloroquine to SP in Kenya bottlenecks in the provision of in-service training and 
job aides are still common and changing clinical practice remains a significant challenge 
even when inexpensive and simple to administer drugs such as SP are recommended.
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Deciding on a new drug policy is arguably the easier part of a complex process that 
should result in effective delivery of antimalarial treatment. With the announcement of a 
new ART-LUM treatment policy in Kenya and limited health workers’ experience with 
this drug that is more complex to use, it is clear that considerable attention to the process 
of implementation will be necessary to achieve effective treatment.
7.1.2 Predictors of the quality of health worker treatment practices
• Associations between several programmatic interventions (such as in-service 
malaria training, distribution of guidelines and wall charts, and more frequent 
supervision), and the quality of health worker treatment practice for 
uncomplicated malaria have been demonstrated
It was encouraging to observe that the MoH’s limited efforts at implementing the malaria 
treatment policy seemed to influence health workers’ treatment performance. However, 
generalising these findings beyond Kenyan borders should be undertaken cautiously. 
Previous studies with a similar design have suggested that some of the programmatic 
interventions identified as improving performance in this study are only sometimes 
associated with improved treatment practice, and on occasions even associated with more 
errors. Given the discordant results between various studies, and the fact that in-service 
training and provision of job aids are major programmatic activities of many malaria 
control programmes, it is clear that an appropriate question requiring further investigation 
is what are the common characteristics of “successful” interventions and what are their 
most cost-effective combinations?
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Analyses of the predictors of health worker performance using data from cross-sectional 
surveys are useful, yet unsatisfying. They are helpful for generating hypotheses, but the 
strength of the evidence is generally insufficient to support a convincing conclusion of 
causality. What is urgently needed are prospective, cost-effectiveness intervention trials 
that serve the dual purpose of providing programmatic guidance on how to strengthen 
and maintain health worker practices while providing better evidence on the factors that 
most powerfully influence health worker performance.
7.1.3 Quality of clinical assessment, accuracy of current malaria diagnosis and ability of 
clinical signs and symptoms to predict malaria in older children and adults
• Health workers’ performance of clinical assessment tasks aimed at determination 
of alternative causes of fever was commonly poor
• Current diagnostic practice equates nearly all fevers with malaria and results in a 
massive overdiagnosis of malaria in older children and in adults, in areas of 
different malaria endemicity
• However, algorithms based on clinical signs and symptoms show little promise of 
being able to improve our ability to predict malaria in febrile older children and 
adults
In older children and adults, the sub-optimal performance of clinical assessment and 
massive overdiagnosis of malaria leads to wastage of antimalarial drugs, increased 
exposure to adverse drug effects, potential failure to diagnose other fever-causing 
conditions and a greater likelihood of emerging antimalarial drug resistance. In fact in
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Kenya, the majority of malaria diagnoses are made in older children and adults, resulting 
in a disproportionate consumption of antimalarial drugs in a population at lower risk of 
morbidity and mortality. From the cost perspective, the problem of the overdiagnosis of 
clinical malaria will become even more important with deployment of ART-LUM that is 
30-fold more expensive for a treatment course in adults than SP.
While health workers clearly overdiagnose malaria what is the possibility of using a 
clinical approach to improve their diagnostic accuracy? These data suggest that it is 
unlikely that the accuracy of malaria diagnosis can be improved based on clinical criteria 
alone. The findings of this study on clinical predictors of malaria thus support previous 
studies with similar conclusions. The use of parasite-based diagnosis is the only potential 
solution to improve malaria diagnostic accuracy and reduce the number of unnecessary 
treatments and costs. At the same time the clinical consultation and examination needs to 
be substantially improved to ensure adequate diagnosis of non-malaria conditions.
7.1.4 Effects of microscopy on malaria case management
• The clinicians interpretation of malaria smear results was characterised by an 
overwhelming tendency to ignore negative malaria smear results and continue to 
prescribe antimalarial drugs
• The quality of routine malaria slide reporting was poor with considerable 
overreporting of positive slides, however, most of the results routinely reported as 
negative were truly negative
263
In concluding that parasite-based diagnosis is a key requirement of improving the 
targeting of malaria treatment this clearly demands an accurate diagnostic service. The 
data on malaria microscopy in this study highlight major deficiencies in clinical and 
laboratory practices that need to be addressed if the problem of malaria overdiagnosis is 
to be overcome by promoting any parasite-based diagnostic strategy for widespread use 
in peripheral facilities in Kenya. Sub-optimal accuracy of blood slide readings in this 
study may be explained by the absence of any standard operating procedures, lack of 
quality control in operating laboratories and insufficient in-service training of 
microscopists. All of these programmatic activities are urgently required. At present it 
seems quite evident that the current, major impact of microscopy, rather than a reduction 
in the use of antimalarial drugs, is unnecessary additional cost and time wasted by 
patients at facilities where this service is available.
A potential solution to overcome the complex technical aspects of microscopy is the 
introduction of rapid diagnostic tests, which are simple and quick to perform, easy to 
interpret, can be stored under ambient conditions, and therefore have a potential to be 
deployed into rural health facilities where laboratories and qualified staff are not 
available. Yet, the ability to translate such a diagnostic tool into effective practice 
resulting in better case management still needs to be demonstrated. It is plausible 
however that clinicians may “believe” rapid test results more than blood slides if the tests 
are highly sensitive, performed by themselves and introduced into clinical practice as 
highly accurate tools. However, to prove these hypotheses, prospective, cost- 
effectiveness intervention trials under truly operational conditions in different areas of
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malaria endemicity are required to provide better evidence on the true influence of RDTs 
on health workers’ practices.
This study has demonstrated that a careful review of malaria diagnostic strategies is 
required countrywide. Regardless of the choice of the malaria diagnostic tool, of 
paramount importance is that policy makers ensure that the introduction of diagnostics is 
accompanied with clear instructions on their use and interpretation. At present Kenyan 
and international guidelines continue to promote the concept that a negative malaria test 
does not exclude malaria. The permitted option to ignore a negative test seems to 
undermine all other improvement approaches. As such, the development of guidelines 
presents only the first step in the implementation of diagnostic strategies. The provision 
of effective in-service training, dissemination of guidelines, translation of guidelines into 
simple job aids such as malaria diagnostic and treatment wall charts, and more frequent 
supervision of both clinical and laboratory health workers are minimal requirements 
necessary to ensure that a malaria diagnostic strategy is going to be successfully 
implemented. Although changing clinical practice remains a challenge, several 
retrospective and prospective studies including this one, support the view that these 
programmatic interventions may be successful and improve health workers clinical 
management in accordance with standards.
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Appendices
Appendix I
Division of Malaria Control, Ministry of Health 
Malaria Case Management -  Quality of Care Survey 
Direct observation study
(Form DOMC/HF1)
ID Number...........................................   1___1 -1_I I_1 -1 1 -1 I I 1
Date..................................................   [ _ |_ ]  [ _ |_ ] [ _ |_ ]
Name of District.................................................[___________________________________]
Name of HF___________________________ [_____________________  ]
Interviewer initials_________________________________________________ [_______ ]
Name of Health Worker.................................... [__________________________________ ]
Child’s name____________________________  [_______________________ ]
Consultation starting time________________________________ [__|_] hours [_|_]min
Consultation interrupted at (in case)__________________________[__| ]hours [_|_]min
Consultation continued at (in case)___________________________[__| ]hours [_|_]min
1. General questions
a. Did the HW greet mother?(Y/N)........................................................................... ........ [_ ]
b. Did the HW ask if this is the first visit for this illness to this facility? (Y/N)...... .......LJ
c. Does HW determine child’s age? (Y/N)................................................................ ........ [_ ]
If yes, is it done by:
Asking caretaker.............................................. ....................................................L_J
Examining child’s health card..............................................................................[_J
Other (specify)........................................ \ ][ ]
d. Does HW determine child’s weight? (Y/N)........................................................... .........[_]
If yes, is it done in a way that:
HW weighs the child that day.........................................................................[_J
Other OPD staff weighs the child that day............................................... ....
HW reviews previous child’s records..............................................................[_J
Other (specify)................................... 1 ir ]
e. Does HW determine weight for age in child’s health card? (Y/N).................................[ ]
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f. Why did mother bring the child? {mark only Yfor complaints mentioned without 
prompting)
fever......................................................................... .................................................[__ ]
cough........................................................................................................................ [_ ]
difficult breathing..................................................................................................... [__ ]
not eating well.......................................................................................................... [__ ]
vomiting....................................................................................................................[__ ]
diarrhoea...................................................................................................................[__ ]
malaria...................................................................................................................... [__ ]
ear problem...............................................................................................................[__ ]
convulsions...............................................................................................................[__ ]
stomach ache.............................................................................................................[__ ]
skin problem.............................................................................................................[__ ]
headache................................................................................................................... [__ ]
other (specify)............................................................ [__][______________________]
other (specify)_____________________________ [__ ][__________ ]
2. Fever/temperature assessment
Did the Health worker do the following:
a. Ask if the child has fever? (Y/N)...................................................................................... [_]
b. Ask for how long? (Y/N).................................................................................................. [_]
c. Measure the temperature with thermometer? (Y/N)........................................................ [_]
d. Feel the child to see if the child is hot? (Y/N)...................................................................[_]
3. General danger signs
a. Is the child awake and alert? (Y/N).................................................................................. [_]
If no, did the HW try to wake the child? (Y/N)________________________________ [_]
b. Does health worker ask:
If the child is able to drink or breastfeed? (Y/N).............................................................. [_]
If the child vomits everything? (Y/N)_______________________________________ [__]
If the child has had convulsions? (Y/N)______________________________________[__]
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4. Clinical history
Does Health worker ask:
a. If the child has cough or difficult breathing? (Y/N)......................................................[__ ]
b. If the child has diarrhoea? (Y/N)................................................................................... [__ ]
c. If the child has an ear problem? (Y/N)........................................................................... [__]
5. Malaria assessment
a. HW looks for conjunctival pallor? (Y/N).................................... ................................. [__ ]
b. HW looks for palmar pallor? (Y/N)...............................................................................[__]
c. HW checks for splenomegaly? (Y/N)............................................................................. [__]
d. HW checks for skin pinch? (Y/N)...................................................................................[__]
e. HW counts breaths? (Y/N).............................................................................................[__]
IfYes,
How long? <30sec □  30-59sec □  60sec and more □
f. Was the patient positioned to view signs of chest indrawing or deep breathing?
(Y/N).................................................................................................................................... [_ ]
g. Did the HW have the child undressed for examination? (Y/N).......................................[__ ]
h. Did HW use stethoscope? (Y/N).....................................................................................[__ ]
i. Did HW ask about previous skin reactions when taking SP? (Y/N)............................... [__]
j. Did the HW ask about previous use of drugs during the present illness? (Y/N).............[__]
IfYes, which drugs caretaker reported?
6. Laboratory requests
a. BS requested (Y/N)........................................................................................................... [__]
b. HB requested (Y/N).......................................................................................................... [__]
c. Blood sugar requested (Y/N)............................................................................................. [__]
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7. Diagnosis and treatment
a. Did the HW tell the caretaker child’s diagnosis? (Y/N) ________________________[__]
b. Write out exactly what diagnosis the HW told the caretaker:
c. Did the HW tell the mother what treatments to give to the child? (Y/N)__________  [__]
d. Did the HW explain how to give the medication? (Y/N)_______________________ [__]
e. Write out exactly what was explained to the caretaker:
f. Did the HW explain about tepid sponging? (Y/N)............................................................[_]
g. Did the HW advise the caretaker to give extra fluid? (Y/N)............................................ [_]
8. Caretaker counseling
a. Has a course of antimalarials been prescribed by the HW? (Y/N)...................................[_]
IfYes, does the HW
observe the child taking STAT dose? (Y/N)................................................................[_]
advises caretaker what to do in case of vomiting?(Y/N).............................................. [_]
b. Did the HW tell the mother to continue feeding or breastfeeding? (Y/N).......................[_]
c. Did the HW ask the mother to return immediately if the child is unable to drink or 
breastfeed? (Y/N)_______________________________________________________ [__]
d. Did the HW ask the mother to return immediately if the child becomes sicker? (Y/N).. [__]
e. Did the HW ask the mother to return for follow up for this illness? (Y/N)...................... [_]
IfYes, in how many days?__________________________________________[__|_]
f. Were you asked to come back if fever persists?(Y/N)..................................................... [_]
IfYes, in how many days?......................................................................................[__|_]
g. Did the HW ask the mother if she has any questions? (Y/N)........................................... [_]
h. Was the patient referred? (Y/N)....................................................................................... [_]
IfYes, where to ................................ [_________________________________________ ]
Consultation ending time[ |__] hours [__|__]min
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Appendix II
Division of Malaria Control, Ministry of Health 
Malaria Case Management -  Quality of Care Survey
Exit interview
(Form DOMC/HF2)
ID Number   [ _ J - [ _ U _ J  L J - L _ U _ J
D ate.....................................................   [ _ |_ ]  [ _ U  [ _ U
Name of District  ______________________ [_____________________________________ ]
Name of HF_____________  [_____________________________________ ]
Interviewer initials_____________________________________________________[________ ]
Name of Health W orker....................................... [___________ ]
Child’s name.................................................................................. [_________________________]
Arrival time to the health facility.............................................................[_|__ ]hours [_|_]mins
Departure time from the health facility...................................................[_|__ ]hours [_|_]mins
1. General questions:
a. Did the HW refer your child to another facility (hospital)? (Y/N)___________________ [_]
b. Did the HW admit your child to this facility?(Y/N)..............................................................[_]
If yes to either a. or b. finish questionnaire with question 13 only
c. Were you greeted by HW? (Y/N).......................................................................................... [_]
d. Was the child weighed? (Y/N)____________________________________   [__]
e. Did you have the child’s health card with you? (Y/N)....................................................... [_]
f. Were you asked for child’s age? (Y/N)...................................................................................[_]
g. Did HW ask you if this is your first visit to HF for this illness? (Y/N)............................ [_]
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8) Which complaints did you report when HW asked you? {Mark only Y 
fo r complaints mentioned without prompting)
fever_________________________________________________________________ [__]
cough________________________________________________________________ [__]
difficult breathing______________________________________________________ [__]
not eating well_________________________________________________________ [__]
vomiting______________________________________________________________[__]
diarrhoea_____________________________________________________________ [__]
malaria_______________________________________________________________ [__]
ear problem___________________________________________________________ [__]
convulsions___________________________________________________________ [__]
stomach ache________________________________   [__]
skin problem__________________________________________________________ [__]
headache_____________________________________________________________ [__]
other (specify)................................................................[__ ][_______________________ ]
other (specify)................................................................[__ ][_______________________ ]
9. Fever/temperature assessment
a. Did HW ask you if your child has fever? (Y/N)....................................................................[_]
b. Was fever measured by thermometer? (Y/N)(show thermometer).................................... [_]
c. Were you asked for how long child has fever? (Y/N)........................................................... [_]
10. General danger signs
a. Were you asked if child can drink or breastfeed? (Y/N)................................................... [_]
b. Were you asked if child had convulsions? (Y/N)..................................................................[_]
c. Were you asked if  child vomits everything? (Y/N)...............................................................[_]
11. Clinical history
a. Were you asked if child has diarrhoea? (Y/N)..................................................................... [_]
b. Were you asked if child has cough or difficult breathing? (Y/N)..................................... [_]
c. Were you asked if  child has an ear problem? (Y/N).............................................................[_]
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12. Malaria assessment
a. Did the HW check child’s eyes? (Y/N)................................................................................[__ ]
IfYes, Confirmed by caretaker’s demonstration? (Y/N)................................................. [__ ]
b. Did the HW look child’s palms? (Y/N)...............................................................................[_ J
IfYes, Confirmed by caretaker’s demonstration? (Y/N)................................................. [__ ]
c. Did the HW pinch the child’s skiri? (demonstrate) (Y/N).................................................. [__ ]
d. Did HW ask you about previous skin reactions when taking SP? (Y/N)......................... [__ ]
e. Were you asked on previous use of drugs for this illness? (Y/N)..................................... [__ ]
IfYes, which drug did you report?..................................................................................... [__ ]
f. Did you undress the child? (Y/N).......................................................................................... [_]
g. Did the HW use stethoscope to examine the child? (Y/N)(s/zow stethoscope)....................[_]
h. Was the child sent to the laboratory? (Y/N)......................................................................... [_]
IfYes, read from the card and tick all laboratory results reported:
B S + v e  | j (scantyj j + j j ++ | j +++ j | + + + + 1 j other__________________ ) BS-ve | |
Hb done | [result Blood sugar done I (result other tests________ result_____________
13. Diagnosis & Treatment
a. Did the HW tell you what is wrong with your child? (Y/N)................................................ [_]
IfYes, W hat did the health worker say was wrong with your child?
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b. Which diagnosis were written on the card?
c. Treatment prescribed (including name of drug, dose and route of administration)
14. Caretaker counseling
a. Were you told to continue feeding or breastfeeding?(Y/N)_____________________ [__]
b. Were you told to give extra fluids? (Y/N)____________________________________ [__]
c. Were you explained about tepid sponging? (Y/N)______________________________[__]
d. Were you asked to return immediately if the child becomes unable to
drink or breastfeed? (Y/N)..................................................................................................[_]
e. Were you asked to return immediately if the child becomes sicker? (Y/N)_________ [__]
f. Were you asked to return for follow up for this illness? (Y/N)___________________ [__]
IfYes, in how many days? ______________________________________________ [__|_]
g. Were you asked to come back if fever persists? (Y/N)...................................................... [_]
IfYes, in how many days? ............................................................................................ [__|_]
h. Were you asked if you have any questions? (Y/N)____________________________ [__]
i. Were you given any drugs to give the child at home? (Y/N)_____________________ [__]
If yes, were you explained how to give the drugs at home by any of HWs? (Y/N).. [__]
If yes, who explained it? (Mark Y where mother specifies)
1. Clinician who saw the child........................................................................................ [_]
2. Pharmacist____________________  [__]
3. Others (specify).....................................................[__][__________________ ]
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h. Were you told to buy medication outside the health facility? (Y/N).................................[__]
i. If HW explained how to give medications at home, ask caretaker to 
explain how she is going to give them (for dispensed and prescribed to buy 
drugs)
Nam e o f m edicine D How much each time H ow m any tim es/day Days
j. Was the child given the first dose of drug at the clinic? (Y/N)..........................................[__]
IfYes, did any HW observe the child swallowing the drug(Y/N).................................... [__]
IfYes, who observed?
1. HW who saw the child (Y/N)...................................................................... [_]
2. Pharmacist(Y/N)............................................................................................ [_]
3. Other HW(specify) (Y/N)...............................[ ] [_ J
k. If the child was given the first dose of drug, which drug was given?
(write the name(s)) [_______________________________________________ ][__|__|__]
g. Did any of HWs tell you what to do if child vomits medicines? (Y/N)............................[__]
IfYes, what were you told?
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Appendix III
Division of Malaria Control, Ministry of Health 
Malaria Case-Management -  Quality of Care Survey 
Mother/caretaker interview
(Form DOMC/HF3)
L J - L U _ J - L J - [ _ U _ ]
1. Child’s Residence:
District................................................................. [______________________________________]
Location_______________________________ [__________________________________  1
Sub-location____________________________ [______________________________________]
Enumeration Area/Village..................................[______________________________________]
Household heads name....................................... [______________________________________]
Clan elder’s/ Village Head’s name__________ [______________________________________]
Nearest school..................................................... [______________________________________]
Nearest bus stage................................................. [______________________________________]
Nearest shop nam e..............................................[______________________________________]
Nearest HF name................................................. [___________________________________ 1
To be completed later:
Confirmed EA.......................... [______________________________________ ]_- _[__|__|__|__]
2. Is the first attendance at this facility for this illness episode(Y/N)_________________ [__]
3. How much money did mother pay for:
Laboratory examinations (KES)........................................................................[ I I |_]
Drugs (KES)....................................................................................................... [__ I__I__I_]
Consultation (KES)............................................................................................ [__ |__|__|_]
Transport (one way fare) (KES).........................................................................[__ j__j__j_]
Total Cost (KES).................................................................................................[__ |__|__|_]
4. Does your child’s present illness involve a fever? (Y/N)___________   [__]
If No, end interview IfYes, Continue
5. For how many days has the child had a fever (Today = 1 ) _____________________ [__|__]
297
LJ-[ I I ]-[ l-[ I I 1
6 . Before the child was brought to this HF did s/he receive any other treatment (Y/N)... [__]
If yes,
7. What was the first treatment (s) given to the child and its cost — unprompted (see drug
chart)
[_______________________ ] .......................................... r i if i i i
[_______________________ ] .......................................... r i if i m
[_ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ ] ... . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . r I IF 1 I 1
[_______________________ i .......................................... r Mr i i i
8 . What was the total cost of treatment, tests and consultation the mother
had to pay at this point of intervention (KES)________________________________ [__|__|__]
9. Where were these drugs obtained from
1.drugs kept at home; 2. shop; 3. private pharmacist; 4. private doctor; 5. 
community pharmacist (e.g. BI); 6 . government dispensary, health centre or 
hospital; 7. mission dispensary, health centre or hospital; 8 . other
(specify___________________ )................................................................................................ [_ J
10. Provide name of shop or facilityf___________ ] ______[__]-[__|__|__|__]
11. How many anti-malarial tablets/drops or spoons given to the child in to tal..................[_|_ ]
12. How many days ago was this treatment given (today = 01 ).......................................... [_| ]
13. Were any other treatments given after this treatment (Y/N).........................................[__ ]
If yes, complete additional sheet
298
Caretaker - supplementary sheet
1. Is this the 1. Second; 2. Third; 3. Fourth or 4. Fifth treatment since the
illness began before attending the present facility______________________________ [__]
2. What were the treatment (s) given to the child and its cost -  unprompted (see drug 
chart)
[________________________] ......................................... r i ir  i i l
[_______________________ ] .......................................... L U L L U
[_______________________ ] .......................................... L U L L U
[_______________________ ] .......................................... L U L L U
3. What was the total cost of treatment, tests and consultation the mother
had to pay at this point of intervention (KES).................................................................[__|__|__]
4. Where were these drugs obtained from
1.drugs kept at home; 2. shop; 3. private pharmacist; 4. private doctor; 5. 
community pharmacist (e.g. BI); 6 . government dispensary, health centre or 
hospital; 7. mission dispensary, health centre or hospital; 8 . other
(specify___________________ ).................................................................................................[ _ ]
5. Provide name of shop or facility[__________________________].............. [__]-[__|__| | ]
6 . How many anti-malarial tablets/drops or spoons given to the child in to tal.................. [__|_]
7. How many days ago was this treatment given (today = 01).............................................[__|_]
8 . Were any other treatments given after this treatment (Y/N)________________________[__]
If yes, complete additional sheet
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Appendix IV
Division of Malaria Control, Ministry of Health 
Malaria Case Management -  Quality of Care Survey 
Service Provider Interview
(Form DOMC/HF4)
ID Number........................................................................................ [_]-[_|__|_]-[_]
D ate............................................................................................................... L U L U L U
Name of District.................................................. [_____________________________________ J
Name of HF.......................................................... [_______  _]
Interviewer initials_____________________________________________________[________ ]
Name of Health W orker ..................................[__________________________________  1
1. Background
a. What is the health worker’s cadre?
Doctor...................................................................................................................... .___ [__]
Clinical officer................................................................................................................. [_]
Registered nurse___________________________________ [__]
Registered community nurse.......................................................................................... [_]
Enrolled nurse.................................................................................................................. [_]
Enrolled community nurse..............................................................................................[_]
c h w .................................................................................................................................r 1
Others (specify)..................................... ......... [__ ][___________________________ 1
b. Age (years).......................................................................................................................... [__|__]
c. Sex (M/F)................................................................................................................................. [ _ ]
d. Place of birth (District)...........................................................................[_________________ ]
e. How long have you worked at this facility? (years-months)______________ [__|__]-[__|__]
f. Are you the facility in-charge?(Y/N).......................  [__]
2. Training
a. What year did you graduate from clinical medicine or nursing or medical
school?................................................................................................................... [__|__|__|__]
b. Have you ever attended an in-service training on malaria case management?(Y/N).......[__]
If No, go to question 3 IfYes, continue
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c. Please tell us who was giving the course (organisation), the year you 
attended the course, the duration of the course, the number of 
participants, and whether the course included supervised clinical practice:
Who gave the course Year Duration (days) No. participants Clinical practice(Y/N)
1.         '
2 .         __________________
3.
d. Was the course based on the new malaria guidelines for health workers
[Show example]? (Y/N)____________________________________________________[__]
e. Which in-service trainings did you attend in the last ten years?
3. Guidelines
a. Do you have the new malaria guidelines for health workers [Show example]? (Y/N).... [ ]
b. Did you read the new malaria guidelines for health workers?(Y/N)_________________[__]
c. Which other guidelines do you have? [List below]
4. Supervision
a. Do you have supervision on your job performance? (Y/N)..................................................[_]
If no, go to question 5 If Yes, Continue
b. Is the supervision done by someone resident (R) or someone outside (O) the
facility? (R/O)........................................................................................................................... [_]
c. How many times during the last 6 months have you met with a
supervisor about your performance? (times)............................................................... [__|__]
d. For how many of those did he or she observe you take care of sick children?(times) [__]
e. Did you receive any feedback from the last supervisory session? (Y/N)________   [__]
If yes in which form? (Describe)............................................ [_________________________ ]
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Appendix V
Division of Malaria Control, Ministry of Health 
Malaria Case-Management -  Quality of Care Survey 
Health facility assessment
(Form DOMC/HF5)
ID Number............................................................................................... [_]-[_|__|__]
D ate.....................   L U U J L U
Name of District.................................................... [_____________________________________]
Name of HF............................................................[_____________________________________]
Interviewer initials...........................................................................................................[________ ]
1. Observation
a. Is there a functioning weighing scale? (Y/N)____________________________________[_]
b. Are all sick children weighed?(Y/N)....................................................................................[_]
Those that are weighed,
Where are they weighed? (Y/N)
1. At a separate weighing station before examined........................................................... [_]
2. In the consultation room ................................................................................................. [_]
3. Other (specify).................................................................... [ ] [____________________ ]
c. Is there a functioning thermometer? (Y/N)____________________________________[__]
If Yes, how many?(number)........................................................................................... [__|__]
d. Do all sick children have measured temperature?(Y/N)................................................ [_]
Those that have measured temperature,
Where is the temperature measured? (Y/N)
a. At a separate station before examination.................................................................. [_]
b. In the consultation room............................................................................................ [_]
c. Other (specify) ______________________________ [__] [____________________ ]
e. Is there an ORT corner where mothers can give oral hydration to their children? (Y/N)[__]
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f. Are there exposed wall charts?(Y/N)________________________________________ [__]
If Yes, which charts? (write the names of all charts)
g. Are records kept of sick child visits?(Y/N)___________________________________ [__]
If Yes, where are they kept? (Check all that apply)
On a card given to the mother.........................................................................................[_]
In a register_____________________________________________  [__]
In a file kept at the clinic..................................................................................................[_]
Other (specify)...................................................................[ ] [____________________ ]
2. Laboratory
a. Is there a microscope? (Y/N).................................................................................................[_]
If Yes,
Is the microscope used currently?(Y/N).............................................................................. [_]
If No,
Why it is not used?
b. Objective power of microscope............................................................................ X[________ ]
c. How are blood films for malaria parasitology routinely prepared (Y/N):
Thick film____________________________________________________________[__]
Thin film_____________________________________________________________[__]
Describe staining methods routinely used______________[______________________]
d. Is parasite species identification done?(Y/N)__________________________________[__]
e. Are parasite densities done for positive cases?(Y/N)____________________________ [__]
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f. Are sub-samples of the malaria slides sent for quality control? (Y/N)_____________ [_]
If Yes,
How many positive slides were sent in last one year?(number).............................. [__|__|_]
How many negative slides were sent in last one year?(number)............................ [__|__|_]
g. Did you receive results of the quality control? (Y/N).........................................................[_]
h. Is there a Haemoglobinometer? (Y/N).................................................................................[_]
If Yes,
Is the haemoglobinometer in use currently? (Y/N)______________________________ [_]
If No, why it is not used?
i. Are there any other possibilities to determine Hb at the facility? (Y/N)_____________ [__]
If Yes, describe........................................................................ [___________ ]
j. Is there a Glucometer?(Y/N).................................................................................................. [_]
If Yes,
Is the Glucometer in use currently?(Y/N)............................................................................. [_]
If Not, why is not used?
k. Are there any other possibilities to determine blood sugar?(Y/N)__________________[__]
If Yes, describe........................................................................ [__________________________]
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3. Pharmacy checklist
[ ]-[ i i ]
For each of the following items check quantity in stock and for how long 
lasted stock outs in the last 6 months:
DRUGS PREPARATION QUANTITY IN STOCK NOW STOCK OUT TIME
PERIOD
Chloroquine syrup ____________  ____________  _________
Chloroquine tabs ____________  ____________  _________
Chloroquine inj. ____________  ____________  _________
SP tablets ____________  ____________  _________
SP syrup ____________  ____________  _________
Amodiaquine tab ____________  ____________  _________
Amodiaquine syrup ____________  ____________  _________
Quinine tabs ____________  ____________  _________
Quinine inj ____________  ____________  _________
Other antimalarials:
Paracetamol tabs 
Paracetamol syrup 
Other antipyretics:
Benzyl penicilline vials 
Chloramphenicol vials 
Other injectable AB:
Dextrose 50% vial 
Dextrose 25% vial 
Dextrose 5% bottle 
Diazepam inj 
Paraldehyde inj 
Phenobarbitone inj 
ORS sachets 
Water for inj.
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ITEM QUANTITY IN STOCK NOW STOCK OUT TIME PERIOD
Needles 21 G
Needles 23 G
Other needles
Syringe 2 ml
Syringe 5 ml
Syringe 10 ml
Spinal needles
NG tubes
IV giving set
Blood bags
Blood giving sets
Stethoscope
Otoscope
BP machine
Tongue depressor
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Appendix VI
Division of Malaria Control, Ministry of Health 
Malaria Case Management -  Quality of Care Survey 
Direct observation study
ID Number.................................................................................... [ | ]-[ | | ]
Date.................   L J J L U L U
Name of HF........................................................ [__________________________________ ]
Name of Health Worker__________   [___________________________________ ]
Patient’s name...........................................................................[_______________________ ]
Consultation starting time_________________________________[__|_] hours_[__ |_]min
Consultation interrupted at (in case).....................................................[__|_]hours_[__ |_]min
Consultation continued at (in case).......................................................[__|_]hours_[__|_]min
1. General questions
a. Did the HW greet patient?(Y/N).......................................................................................[_]
b. Did the HW ask if this is the first visit for this illness to this facility? (Y/N).................[_]
c. Does HW determine patient’s age? (Y/N)........................................................................ [__]
d. Does HW determine patient’s weight? (Y/N).................................................................. [__]
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e. What are the patient’s main complaint(s)? {mark only Yfor complaints mentioned 
without prompting)
fever........................................... ...............................................................................[__ ]
chills......................................................................................................................... [__ ]
shivering................................................................................................................... [__ ]
headache................................................................................................................... [__ ]
joint pain................................................................................................................... [__ ]
general body weakness............................................................................................. [__ ]
neck pain................................................................................................................... [__ ]
nausea....................................................................................................................... [__ ]
cough..............................   [_ ]
difficult breathing......................................................................................................[__ ]
chest pain.................................................................................................................. [__ ]
running nose..............................................................................................................[__ ]
throat problem...........................................................................................................[__ ]
lack of appetite..........................................................................................................[__ ]
vomiting.................................................................................................................... [__ ]
diarrhoea................................................................................................................... [__ ]
constipation ....................................................................................................[__ ]
malaria...................................................................................................................... [__ ]
ear problem...............................................................................................................[__ ]
stomach ache.............................................................................................................[__ ]
skin problem.............................................................................................................[__ ]
other (specify)............................................................ [_______________ ______ ][ ]
other (specify)............................................................ [______________________][ ]
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2. Fever/temperature assessment
Did the Health worker do the following:
a. Ask if the patient has fever? (Y/N) f 1
b. Ask for how long? (Y/N)...................................:______________________________ [__]
c. Ask if fever is present every day? (Y/N)..........................................................................[_]
d. Measure the temperature with thermometer? (Y/N)....................................................... [_]
e. Feel the patient to see if the patient is hot? (Y/N)______________________________ [_]
3. Clinical history
Does Health worker ask:
a. If the patient has throat problem? (Y/N).........................................................................[_]
b. If the patient has running nose? (Y/N).............................................................................[_]
c. If the patient has cough?................................................................................................... [_]
If Yes, does HW ask for duration of cough? (Y/N)................................................... [_]
e. If the patient has difficulties in breathing? (Y/N)........................................................... [_]
f. If the patient has chest pain? (Y/N).................................................................................. [_]
g. If the patient has diarrhoea? (Y/N).................................................................................. [_]
If Yes, does he ask for duration of diarrhoea? (Y/N)_______________________ [_]
i. Ask if patient is vomiting? (Y/N)______________________________________   [__]
j. Ask if patient has an ear problem? (Y/N).........................................................................[_]
k. Ask if patient has chills? (Y/N)......................................................................................... [_]
k. Ask if patient has shivering? (Y/N).................................................................................. [_]
1. Ask if patient has headache? (Y/N)_________________  [__]
m. Ask if patient has joint pains? (Y/N)............................................................................... [_]
n. Record any other question asked by HW
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4. Clinical examination
Did the Health worker do the following:
a. HW checks patient’s throat? (Y/N)________________________________________ [_]
b. HW checks patient’s ear? (Y/N)___________________________________________[_]
c. HW looks for conjunctival pallor? (Y/N)___________________________________ [_]
d. HW looks for palmar pallor? (Y/N)_______________________________________ [_]
e. HW checks pulse rate? (Y/N)____________________________________________ [_]
f. HW checks lymph nodes? (Y/N)__________________________________________ [_]
If Yes, which nodes?
g. HW checks for splenomegaly? (Y/N)............................................................................... [_]
h. HW counts breaths? (Y/N)...............................................................................................[_]
i. Did HW auscultate chest? (Y/N)_____________________________________  [__]
j. Did HW ask about previous skin reactions when taking SP? (Y/N).................................[_]
k; Did the HW ask about previous use of drugs during the present illness? (Y/N).............[_]
If Yes, which drugs patient reported?
1. Record any other clinical examination done by HW
m. Was patient sent to laboratory (Y/N)______________________________________ [__]
Consultation ending time[ |__] hours [__|__]min
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Appendix VII
Temporary Patients Card
ID Number........................................................... L U -
Appendix VIII
Division of Malaria Control, Ministry of Health 
Malaria Case Management -  Quality of Care Survey 
Exit Examination Form
ID Number..................................................
D ate........................................................................
Name of H F ..........................................................[
1. General questions
a. Patient’s nam e........................................................................... [_________________________]
b. Patient’s age (years).............................................. ................. [ u
c. Initial or Follow up visit for the same illness to this facility (I/F)................ . . . . . . . . . . . . . . . L J
d. What are the patient’s main complaint(s)? (mark only Yfor 
complaints mentioned without prompting)
fever..................................................................... . . . . . . . . . . . . . . . L J
chills........................................................... .. . . . . . . . . . . . . . L J
shivering............................................................ .. . . . . . . . . . . . . . L J
headache............................................................ .. . . . . . . . . . . . . . L J
joint pain ............................................................ .. . . . . . . . . . . . . . L J
general body weakness.................................. .. . . . . . . . . . . . . . L J
neck pain............................................................ .. . . . . . . . . . . . . . L J
nausea................................................................. .. . . . . . . . . . . . . . L J
cough.................................................................. .. . . . . . . . . . . . . . L J
difficult breathing........................................... . .. .. .. .. .. .. .. L J
chest pain ........................................................... . .. .. .. .. .. .. .. L J
running nose...................................................... .. . . . . . . . . . . . . . L J
throat problem .................................................. . .. .. .. .. .. .. .. L J
lack of appetite................................................. . .. .. .. .. .. .. .. L J
vomiting............................................................. .. . . . . . . . . . . . . . L J
diarrhoea............................................................ .. . . . . . . . . . . . . . L J
constipation....................................................... . .. .. .. .. .. .. .. L J
malaria................................................................ .. . . . . . . . . . . . . . L J
ear problem................................................ .. .. .. .. .. .. .. . L J
stomach ache.............................................. . .. .. .. .. .. .. .. L J
skin problem .................................................... .. .. .. .. .. .. .. . L J
other (specify).................................................. ....................r ir 1
other (specify).................................................. ....................r ][ J
 U _J-LU _1
r i i t _ u  l_u
_____________________i
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2. History and Symptoms
a. Fever in last 48 hrs (Y /N ).... [ 1 If Yes, how many days J
b. Gen body weakness (Y/N) ... [ 1 If Yes, how many days.[
c. Lack of appetite (Y/N)..........[ 1 If Yes, how many days J
d. Headache (Y/N).....................[ 1 If Yes, how many days J
e. Joint pains (Y/N)....................[ 1 If Yes, how many days J
f. Vomiting (Y/N) .....................[ 1 If Yes, how many days .\
g. Diarrhoea (Y /N )...................[ 1 If Yes, how many days.[
h. Constipation (Y /N ).............. [ 1 If Yes, how many days J
i. Chills (Y/N) ........................... [ 1 If Yes, how many days .\
j. Shivering (Y /N ).....................[ 1 If Yes, how many days .\
k. Abdominal ache(Y/N) .........[ 1 If Yes, how many days J
1. Nausea(Y/N).......................... [ 1 If Yes, how many days J
m. Cough (Y /N )........................ [ 1 If Yes, how many days .\
n. Difficult breathing (Y/N) .... [ 1 If Yes, how many days.[
o. Chest pain (Y/N) ..................[ 1 If Yes, how many days. \
p. Throat pain (Y/N) ............... [ 1 If Yes, how many daysJ
q. Running nose (Y/N) ............ [ 1 If Yes, how many days J
r. Other symptoms (specify):
1 I H I 1 1
times/day. [____]
type_______
s. Has patient ever had skin reaction on previous use of SP?(Y/N )....................................... [_]
t. Previous use of drugs for the same illness? (Y/N)............................................................... [_]
If Yes, which drugs (specify):
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3. Clinical Signs [ _ I _ H _ I _ I _ ]
a. Temp (°C)........ [_____ ] b.Weight (kg)... [_____] c. Anaemia(Y/N) [_____]
d.Throat e._Ear_____________________________
f. R R ................... [ ] g. Pulse..............[____ ] h.Chest Indrawing(Y/N)[____ ]
i. Lungs_________________________________________________________________
j. Spleen (cm) .....[______] k. Liver (cm ).........[____ ]
1. Lymph nodes enlarged(Y/N) [___] If Yes, which[____________________________]
m. Other signs on physical examination (specify):
4. Laboratory Results:
5. Diagnosi(e)s
a. If diagnosis is malaria, is it
treatment failure(Y/N)........................................................................................... [_]
simple (Y/N).............................................................................................................. [_]
severe (Y/N)_____   [__]
if severe specify why___________________________________________
а. Malaria diagnosis according to guidelines (fever in the absence of other
cause of fever)? (Y/N )________________________________________________________[__]
б.Treatment
a. Is patient referred?(Y/N)___________________________________________________ [__]
b. Is patient admitted? (Y/N)..................................................................................................... [__]
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Appendix IX
Division of Malaria Control, Ministry of Health 
Malaria Case Management -  Quality of Care Survey 
Service Provider Interview
ID Number_________________     [_|__ ]
Date..:   L U  L U  L U
Name of HF..........................................................[______________________________________]
1. Background
a. What is the health worker’s cadre?
Doctor.............................................................................................................................. [__ ]
Clinical officer................................................................................................................[__ ]
Registered nurse............................................................................................................ [__ ]
Registered community nurse.........................................................................................[__ ]
Enrolled nurse.................................................................................................................[__ ]
Enrolled community nurse............................................................................................ [__ ]
c h w ............................................ .................................................................................. r 1
Others (specify)  .............. ;........................ [______________________________ ][__]
b. Age (years)........................................................................................................................... [_I__ ]
c. Sex (M/F)..... ......... ................................................................................................................ [__]
d. How long have you worked at this facility? (years-months).............................[__|__]-[__|__]
e. Are you the facility in-charge? (Y/N)................................................................................... [__ ]
2. Training
a. What year did you graduate from clinical medicine or nursing or medical
school?................................................................................................................... [ _ I _ I _ I _ J
b. Have you ever attended an in-service training on malaria case management?(Y/N)..... [__ ]
If No, go to question 3 If  Yes, continue
c. Which year did you attend the in-service training on malaria case mangement?[ |__|__|__]
d. Has the course/training included supervised clinical practice?(Y/N)..............................[__ ]
e. How many days did the course last?.................................................................................[_|__ ]
d. Was the course based on the malaria guidelines for health workers
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[Show example]? (Y/N)..............................................................  [__]
3. Guidelines
a. Do you have the new malaria guidelines for health workers [Show example]? (Y/N).... [ ]
b. Which other guidelines do you have? [List below]
c. Which in-service trainings did you attend in the last ten years?
4. Supervision
a. Do you have supervision on your job performance? (Y/N)................................................ [__]
If Yes, how many times you had supervision in the last 6 months? (Y/N)...............[__|__]
5. Barriers
a. What are the most difficult problems that you face in performing out­
patient malaria case management?
b. According to your clinical experience, which drugs satisfactorily treat
malaria? {mark Y for all mentioned without prompting and then offer 
not mentioned reasons)
1. Chloroquine (Y/N).................................................................................................................. [__ ]
2. SP (Y/N)................................................................................................................................. [_ J
3. Amodiaquine (Y/N)................................................................................................................[__ ]
4. Quinine (Y/N).........................................................................................................................[__ ]
5. Other (specify) (Y/N)______________________ [______________ ] [__]
6 . Other (specify) (Y/N)..............................................[ ] [__]
7. Other (specify) (Y/N)..............................................[ ] [__]
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Appendix X
Consent Information Sheet
M alaria outpatient case managem ent in government health facilities in Kenya: An
evaluation o f  current practices
• It is important that MoH provides good quality of care to patients with malaria and 
assessing how patients are treated in different areas helps this process.
• We are doing the study to monitor treatment of patients who may have malaria in 
this District
• During the study we observe how health workers treat patients and we also re­
examine them to see if there are better ways to assess patients
• If you agree/ you allow your child to take part in this study an observer will be 
present when you are seen by a health worker and you/your child will be re­
examined carefully by a study doctor, who will alter treatment if  necessary, and a 
finger prick blood film will be prepared for microscopy if  malaria is suspected . 
This will be done at the same time as any blood test ordered by the health worker.
• The results of malaria slides will not be available today so you/your child will not 
individually benefit from this test but the hope is that these results will help to 
improve the quality of malaria related care in the District and Kenya in the future
We now want to ask you if you would like / you will allow your child to be involved in 
this study
Remember:
• If you are not happy to participate in the study you/your child will still get looked after 
in the same way as every patient here.
• If you agree to start but then change your mind you/your child can withdraw from the 
study at any time and you/your child will still get looked after in the same way as 
every patient here.
Do you want to ask any questions?
The organizations involved in the study include:
DOMC, MoH, KEMRI, WELLCOME TRUST RESEARCH LABORATORIES
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Appendix XI
Consent Agreement Sheet
I , ____
named
 (parent / guardian of child
)  have been informed about the study entitled:
Malaria outpatient case management in government health facilities in Kenya:
An evaluation of current practices
The nature, implications, duration, purpose, voluntary nature and inconveniences that may 
reasonably be expected have been explained to me by:
____________________________________________ (name of person taking consent).
I have been given the opportunity to ask questions concerning the study and these have 
been answered to my satisfaction.
I understand that I may at any time during the study revoke my consent without any loss or 
penalty
NDIO I am happy to join I for my child to join this study.
Patients/Parents signature______________________________Date_________
Patients/Parents name______________________________________________
Village address ______________________________________________
Identity card no _________________
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